<https://okn.wobd.org/grant/1P01AI118688-01A1> <http://schema.org/name> "Disruption of T cell tolerance in type 1 diabetes" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_135> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/NCIT_C16880> .
<http://purl.obolibrary.org/obo/MONDO_0100163> <http://schema.org/name> "COVID-19–associated multisystem inflammatory syndrome in children" .
<https://okn.wobd.org/grant/1UL1TR002373-01> <http://schema.org/identifier> "1UL1TR002373-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_180> <http://schema.org/datePublished> "2023-08-29"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/author> <https://okn.wobd.org/person/university_of_utah_health_care> .
<https://okn.wobd.org/person/north_miami_beach_high_school> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_160> <http://schema.org/name> "Reducing Ethical and Social Prejudicial Effects of COVID-19 Testing in Underserved Populations (RESPECT-UP)" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_145> <http://schema.org/name> "COVID-19 Testing in Underserved and Vulnerable Populations Receiving Care in San Diego Community Health Centers" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_73> <http://schema.org/sameAs> "10.60773/wx0n-5518" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_61> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_150> <http://schema.org/name> "Communities Fighting COVID!: Returning Our Kids Back to School Safely" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_196> <http://schema.org/identifier> "phs003238" .
<https://okn.wobd.org/grant/1P30DK045735-01> <http://schema.org/endDate> "1997-12-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1K12HD047349-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_77> <http://schema.org/name> "Creating a Sustainable Infrastructure for SARS-CoV-2 Testing at Syringe Exchange Programs" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_31> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_58> <http://schema.org/name> "A Handheld Microchip for GC Analysis of Breath to Screen for COVID-19" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_200> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_119> <http://schema.org/author> <https://okn.wobd.org/person/umass_chan_medical_school> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_221> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_119> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://ror.org/00fj8a872> <http://schema.org/alternateName> "Office of the Director" .
<https://okn.wobd.org/grant/1R01GM089784-01A1> <http://schema.org/funder> <https://ror.org/04q48ey07> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_80> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_133> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/n1eh-8t78> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_41> <http://schema.org/url> "https://radxdatahub.nih.gov/study/41" .
<https://okn.wobd.org/grant/1R01DA037628-01A1> <http://schema.org/funder> <https://ror.org/00fq5cm18> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_138> <http://schema.org/identifier> "phs002782" .
<https://okn.wobd.org/grant/8G12MD007595-04> <http://schema.org/startDate> "2009-09-24"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_57> <http://schema.org/description> "A rapid, sensitive, low-cost diagnostic device for early detection of novel Coronavirus Disease (COVID-19) can significantly change the paradigm in real-time and efficient management of patients and available healthcare resources specifically during this time of increased demand for hospital services. The quantitative real-time polymerase chain reaction (qPCR) represents the most important method for the diagnosis of COVID-19 at its early stage of infection and before the appearance of clinical symptoms. However, qPCR-based molecular diagnostics are bulky, expensive, or lab-based, or require trained personnel for system operation. The majority of the FDA EUA-approved COVID diagnostics are PCR-based which require nucleic acid extraction and amplification and thermal cycling. Such systems also require relatively expensive/bulky equipment for sample processing. Recent studies have shown large variations up to 10,000 fold variations in limit of detection (LoD) of some of the nucleic acid-based and antigen-based COVID-19 diagnostics currently approved under emergency use authorization (EUA). Therefore, there is still a need in developing POC diagnostics and particularly antigen-based SARS-CoV-2 detection devices with LoD comparable to PCR-based assays. The main goal of this interdisciplinary project was to develop a portable diagnostic system for rapid and sensitive detection of intact SARS-CoV-2 in small volume of COVID-19 patient samples such as anterior/nasopharyngeal/oropharyngeal swab samples using an inexpensive, disposable, and mass-producible microfluidic cartridge." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_119> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_51> <http://schema.org/sameAs> <https://doi.org/10.60773/6e21-bq61> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_183> <http://schema.org/author> <https://okn.wobd.org/person/university_of_southern_maine> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_90> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_166> <http://schema.org/author> <https://okn.wobd.org/person/university_of_missouri_kansas_city> .
<https://okn.wobd.org/person/health_promed_san_juan> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://ror.org/03q21mh05> <http://schema.org/name> "National Cancer Institute, Cairo University" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_130> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://ror.org/04byxyr05> <http://schema.org/alternateName> "Instituto Nacional de Salud Infantil y Desarrollo Humano Eunice Kennedy Shriver" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_172> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2901879> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_93> <http://schema.org/dateModified> "2024-04-10"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_149> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR002538-01> .
<https://ror.org/01s5ya894> <http://schema.org/name> "National Institute of Neurological Disorders and Stroke" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_84> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_65> <http://schema.org/datePublished> "2022-07-21"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1TL1TR001871-01> <http://schema.org/funder> <https://ror.org/04pw6fb54> .
<https://okn.wobd.org/grant/1U54CA132379-01A1> <http://schema.org/startDate> "2008-09-26"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_204> <http://schema.org/description> "This Phase III project built on the successes of the Phase I and Phase II projects but used a novel approach to adapt to the changing pandemic context; facilitation of rapid testing by people who inject drugs (PWID) via a supported employment program that trains PWID as peer health workers (PHW). PWID are vulnerable to contracting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and to the effects of the disease caused by SARS-CoV-2, coronavirus disease 2019 (COVID-19) due to structural disadvantage, health vulnerabilities, and stigmatization that prevents adequate access to medical care. While the project has previously processed more than 6,000 self-collected polymerase chain reaction (PCR) tests for PWID across the state of Oregon, the ever-changing nature of the pandemic, including new variants and the availability of SARS-CoV-2 vaccines, called for additional strategies that can increase access to and uptake of testing among PWID. Rapid tests may offer an advantage over PCR tests for PWID experiencing structural vulnerabilities such as houselessness and lack of access to technology so that they can receive results in real-time and be quickly connected to needed resources. Accessibility of rapid testing for PWID has been previously limited by workforce shortages and the inability to reach PWID who need testing. This study proposed a novel community-engaged strategy to improve the accessibility of rapid tests through a supported employment program for PWID, Peer Connect2Test (PeerC2T), to become PHW to distribute SARS-CoV-2 rapid test kits to other PWID. It was expected that PeerC2T would improve knowledge, self-efficacy, and health behaviors among PHW (Aim 1). The RE-AIM framework was used in Aims 2 and 3 to evaluate whether PeerC2T improves SARS-CoV-2 testing uptake among other PWID (RE; Aim 2) and identify intervention considerations (AIM; Aim 3). The overall goal of this project was to build on the partnership with HIVA to develop a transformative community-driven intervention to promote widespread access to rapid testing among PWID. Collaboration will continue with the RADx-UP Coordination and Data Collection Center. Findings will clarify the implications of supported employment programs for PWID for SARS-CoV-2 testing uptake among PWID and other public health efforts to improve health outcomes among PWID. Thus, findings from this study may have broad public health implications for leveraging supported employment programs for PWID to prevent the transmission of other infectious diseases." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_90> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/pz40-d968> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_60> <http://schema.org/sameAs> <https://doi.org/10.60773/5ahc-nx20> .
<https://okn.wobd.org/grant/1U01HG010961-01> <http://schema.org/endDate> "2023-02-28"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_177> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://ror.org/012pb6c26> <http://schema.org/parentOrganization> "National Institutes of Health" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_79> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_63> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/e8nb-ns15> .
<https://okn.wobd.org/person/university_of_iowa> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_122> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R25EB020393-01A1> <http://schema.org/name> "Community Research Education and Engagement for Data Science (CREEDS)" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/better_community_development> <http://schema.org/name> "Better Community Development" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_38> <http://schema.org/date> "2024-01-03"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_136> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2901879> .
<https://okn.wobd.org/grant/1R01AI121250-01A1> <http://schema.org/endDate> "2021-05-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R21AI133331-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9375180" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_29> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_218> <http://schema.org/datePublished> "2024-03-04"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_137> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01EB025022-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_129> <http://schema.org/datePublished> "2023-08-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_74> <http://schema.org/datePublished> "2022-11-07"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_145> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1U54HL108460-01> <http://schema.org/startDate> "2010-09-20"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/75N93021C00016-0-9999-4> <http://schema.org/endDate> "2022-03-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_124> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_124> <http://schema.org/dateCreated> "2022-01-06"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1P30MH062246-01> <http://schema.org/name> "CENTER FOR AIDS PREVENTION STUDIES" .
<https://okn.wobd.org/grant/1UM1AI106716-01> <http://schema.org/funder> <https://ror.org/043z4tv69> .
<https://okn.wobd.org/grant/2U54MD007601-31> <http://schema.org/url> "https://reporter.nih.gov/project-details/9450427" .
<http://purl.obolibrary.org/obo/NCIT_C94552> <http://schema.org/name> "Breath" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_88> <http://schema.org/url> "https://radxdatahub.nih.gov/study/88" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_72> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_184> <http://schema.org/datePublished> "2023-08-29"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1U19NS112953-01> <http://schema.org/endDate> "2024-05-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_211> <http://schema.org/sameAs> <https://doi.org/10.60773/wydm-qa91> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_134> <http://schema.org/description> "Getting Asian Americans INFORMED to Facilitate COVID-19 Testing and Vaccinations, was a timely project to identify and address sociocultural, ethical and behavioral barriers related to COVID-19 testing and vaccination to enable Asian Americans to make well-informed decisions about getting tested for COVID-19. Asian Americans have experienced among the highest COVID-19 mortality rates when measured in case fatality and proportionate mortality due to COVID-19. Excess COVID-19 related deaths observed in Asian Americans are in part due to under-testing. Asian Americans may face multiple challenges, including sociocultural (limited English proficiency, lack of trust, excess fears and social stigma related COVID-19), ethical (lack of proven benefits of various guidelines, unequal access to testing resources), and behavioral (tobacco and e-cigarette use, other competitive behaviors) factors. The pandemic was rapidly evolving and presented urgent needs to develop highly efficient channels to communicate accurate, easily comprehensive, cultural appropriate and practical information. This application was a supplement to a parent R01 \"A Family-Focused Intervention for Asian American Male Smokers\", as known to the public as a community-based intervention research program \"Healthy Family Project\". The Healthy Family Project has provided more than 1,200 smokers and families a family-oriented intervention delivered by lay health workers (LHW) showing efficacies in reducing tobacco use and promoting healthy nutrition and physical activity among Chinese, Korean and Vietnamese Americans. Leveraging the community partnerships and the individual / family-based LHW intervention approaches that were developed, this project achieved three aims: (1) Develop and evaluate \"INdividual and Family-Oriented Responsive Messaging EDucation\" (INFORMED) intervention in increasing knowledge about COVID-19 testing and decreasing decisional conflicts of getting tested for COVID-19. The INFORMED intervention consisted of two components: a 12-week automated SMS text messaging intervention that delivered 12 weekly messages plus as needed additional messages responsive to updated testing and vaccination guidelines, lay health workers' direct educational outreach via video conferencing to participants. A 2-arm randomized controlled trial that compared INFORMED delivered by LHW educational outreach plus automated text messaging to a text message only condition with 240 Chinese, Hmong and Vietnamese Americans. (2) Conduct in-depth prospective investigation of sociocultural, ethical and behavioral factors related to COVID-19 testing uptake in Chinese, Hmong and Vietnamese American over-time. (3) Explore acceptance of COVID-19 vaccination in these groups to understand the associated sociocultural, ethical and behavioral factors and whether vaccination acceptance is associated with COVID-19 testing behaviors. This study used multiple approaches to understand and address relevant sociocultural, ethical and behavioral factors for COVID-19 testing and vaccination. An important objective of this project was to equip Chinese, Hmong and Vietnamese American communities to be informed of the evolving landscape of the pandemics so as to make well-informed decisions on COVID-19 testing and vaccination." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_182> <http://schema.org/sameAs> <https://doi.org/10.60773/8bdv-2c25> .
<https://ror.org/00adh9b73> <http://schema.org/parentOrganization> "National Institutes of Health" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_216> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/grant/2P2CHD050924-11> <http://schema.org/funder> <https://ror.org/04byxyr05> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_93> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/85ty-n986> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_100> <http://schema.org/dateCreated> "2021-11-16"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR001863-01> .
<https://okn.wobd.org/person/fred_hutchinson_cancer_research_center> <http://schema.org/name> "Fred Hutchinson Cancer Research Center" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_52> <http://schema.org/sameAs> <https://doi.org/10.60773/6y92-jm05> .
<https://okn.wobd.org/grant/1U01HG010971-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/person/nationwide_children_s_hospital> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_210> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0010691> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_32> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_216> <http://schema.org/datePublished> "2024-03-04"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_158> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_179> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_139> <http://schema.org/dateCreated> "2022-01-29"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_70> <http://schema.org/identifier> "phs002604" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/vaeg-ht26> .
<https://okn.wobd.org/grant/1K12HD000850-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_136> <http://schema.org/date> "2023-05-16"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_96> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005109> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_121> <http://schema.org/name> "COVID-19 Test At Home Feasibility Sub-Study" .
<https://okn.wobd.org/grant/1UL1TR000460-01A1> <http://schema.org/identifier> "1UL1TR000460-01A1" .
<https://okn.wobd.org/person/los_angeles_county_department_of_health_services> <http://schema.org/name> "Los Angeles County Department of Health Services" .
<https://okn.wobd.org/grant/8P51OD011132-52> <http://schema.org/endDate> "2016-04-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1UL1TR002378-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_82> <http://schema.org/datePublished> "2023-08-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_138> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2901879> .
<https://okn.wobd.org/grant/1U01CA260539-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/10222232" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_153> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_109> <http://schema.org/dateCreated> "2022-01-06"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_179> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_209> <http://schema.org/datePublished> "2023-12-06"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_87> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_126> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/150" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_112> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1UL1TR002736-01> <http://schema.org/funder> <https://ror.org/04pw6fb54> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_143> <http://schema.org/identifier> "phs002800" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_31> <http://schema.org/description> "Clear2Go was a solution/app that provided digital, non-refutable cryptographic proof of testing or vaccination that was used to evaluate risk of allowing individuals to return to normal work, travel, and public life activities. It was a mobile service that mapped a person's vetted identity and biometrics to the phone and then cryptographically binded it with their COVID-19 test and vaccination records. The person then proved their status by utilizing the credentials with a QR code or NFC tap." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_54> <http://schema.org/datePublished> "2022-06-06"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/thai_cdc> <http://schema.org/name> "Thai CDC" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_118> <http://schema.org/sameAs> <https://doi.org/10.60773/wqc5-e480> .
<https://okn.wobd.org/grant/1P30AI060354-01> <http://schema.org/identifier> "1P30AI060354-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_27> <http://schema.org/date> "2023-10-23"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_213> <http://schema.org/name> "Community Collaboration to Combat Coronavirus (C-FORWARD)" .
<https://okn.wobd.org/grant/1R01GM138385-01A1> <http://schema.org/url> "https://reporter.nih.gov/project-details/9974241" .
<https://okn.wobd.org/person/froedtert_medical_college_of_wisconsin_clinics_15> <http://schema.org/name> "Froedtert & Medical College of Wisconsin clinics (15)" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_68> <http://schema.org/funding> <https://okn.wobd.org/grant/8UL1TR000002-07> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/137" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_141> <http://schema.org/sameAs> "10.60773/86zb-bq66" .
<https://okn.wobd.org/grant/1U01DA053941-01> <http://schema.org/identifier> "1U01DA053941-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_212> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_209> <http://schema.org/description> "Latinos have disproportionately suffered from COVID-19. In California, Latinos make up 39% of the population but 46% of deaths and more than half of all cases. Agricultural employees are essential workers and the risk of SARS-CoV-2 transmission is high because social distancing and masking are difficult especially in very hot weather. In addition, the risk of SARS-CoV-2 transmission within households is high as one-third of agricultural employees live in crowded and multi-family housing (>1 persons/room). In these households, self-isolation or quarantine is simply not feasible when a family member has been exposed. Non-pharmaceutical interventions such as testing, social distancing, quarantine, and isolation have played a critical role in mitigating the impact of COVID-19. However, despite being at increased risk of infection, testing rates among Latinos is lower compared to Whites and Latinos are more likely to be positive when tested and to require higher level of care at the time of positive test. In the US, nearly 13% of Hispanic or Latino have received at least one dose, and 10% have been fully vaccinated, despite eligibility open to all on April 19th, 2021. There is a major gap in COVID-19 vaccination among underserved and/or vulnerable Latino population. This study proposed a three-tiered approach to address barriers to COVID-19 vaccination in predominantly Latino counties in California, Yolo, Fresno, Madera, and Stanislaus. ÓRALE COVID-19! was proposed to overcome motivational and logistic barriers to testing by decreasing the time from symptoms, to seeking testing, to securing testing, to receiving test results, to consult about self-isolation, quarantine, and increase the proportion who successfully self-isolated and quarantine. The aims of this study were: (1) reduce vaccine hesitancy, improve vaccine update while continuing to promote testing with culturally and linguistically appropriate targeted communication and incentives guided by trusted community partners, (2) Develop a literacy-supported decision making process to reduce vaccine hesitancy, improve vaccine update while continuing to promote testing, and (3) evaluate the impact of interventions on vaccine hesitancy, uptake of vaccine and testing through robust statistical and mathematical models that provide a flexible framework to evaluate different scenarios of vaccine rollout. The study leveraged strong community partnerships, expertise of collaborators with local CEAL member to incorporate CEAL-developed resources that strengthened the implementation of the interventions, strong team organization, survey development expertise, translation of materials that were critical for communication and dissemination, robust data capturing, harmonization, statistical, and modeling support, evaluation unit, and testing data that was integrated to vaccination efforts to allow for a comprehensive characterization and evaluation of interventions on vaccine hesitancy and uptake. Vaccine prioritization and access to regular testing to Latino farmer worker communities that experience structural barriers such as overcrowded housing and have strong cultural values on support of large extended facilities is critical to reduce the burden associated with COVID-19." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_215> <http://schema.org/name> "The Puerto Rico Community Action Research and Engagement (PR-CARE) to Eliminate Disparities of COVID-19 Among Rural Underserved and Vulnerable Populations" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_197> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_169> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_152> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_160> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/funding> <https://okn.wobd.org/grant/2R37AI051652-06> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_146> <http://schema.org/funding> <https://okn.wobd.org/grant/8UL1TR000042-07> .
<https://okn.wobd.org/grant/1U24TR001608-01> <http://schema.org/name> "Center for Innovative TRIals in ChilDrEN and AdulTs (TRIDENT)" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_127> <http://schema.org/dateCreated> "2022-01-12"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1P30ES023513-01A1> <http://schema.org/name> "UC Davis Environmental Health Sciences Core Center" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_70> <http://schema.org/funding> <https://okn.wobd.org/grant/1P30AI045008-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_82> <http://schema.org/name> "Scaling Up SARS-CoV-2 Testing to Serve Latinx Communities" .
<https://okn.wobd.org/grant/4R33HD105590-03> <http://schema.org/endDate> "2024-11-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_73> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR001863-01> .
<https://okn.wobd.org/person/university_of_massachusetts_chan_medical_school> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_184> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/grant/1UL1TR003142-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9903514" .
<https://okn.wobd.org/grant/8UL1TR000042-07> <http://schema.org/startDate> "2006-09-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://schema.org/startDate> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/funding> <https://okn.wobd.org/grant/1S10OD026929-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_48> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_155> <http://schema.org/identifier> "phs002875" .
<https://okn.wobd.org/grant/1UL1TR002541-01> <http://schema.org/identifier> "1UL1TR002541-01" .
<http://purl.obolibrary.org/obo/MONDO_0011122> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://www.uniprot.org/taxonomy/694009> <http://schema.org/name> "Severe acute respiratory syndrome coronavirus" .
<https://okn.wobd.org/grant/1T32EB009380-01> <http://schema.org/identifier> "1T32EB009380-01" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/148" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_187> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/grant/9P30AI050410-04> <http://schema.org/funder> <https://ror.org/04xeg9z08> .
<https://okn.wobd.org/grant/1U54GM115516-01A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/person/howard_university> <http://schema.org/name> "Howard University" .
<https://okn.wobd.org/grant/1R35GM119850-01> <http://schema.org/endDate> "2021-06-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_60> <http://schema.org/sameAs> "10.60773/5ahc-nx20" .
<https://okn.wobd.org/grant/1S10OD023527-01> <http://schema.org/name> "JEOL JEM-1400Plus Transmission Electron Microscope" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_51> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/99" .
<https://okn.wobd.org/grant/1S10OD023527-01> <http://schema.org/funder> <https://ror.org/00fj8a872> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_123> <http://schema.org/description> "The purpose of this project was to study how perceived legitimacy of important institutions and mistrust in sources of COVID-19 information affect compliance with public health guidance designed to mitigate the impact of COVID-19, including maintaining physical distancing, mask-wearing, testing, and vaccination. Creating capacity to interact with study participants and Community Advisory Board members virtually was a necessary first step. This study recruited 240 low-income housing residents who formed a core sample for multiple waves of research activities. The core participant group were equipped with tablets with HD webcams, internet connectivity for the duration of the study, and basic digital literacy instruction and technical support. Participants were asked to complete online assessments and participate in focus groups throughout the two-year study period. The overarching goal was to increase the effectiveness of COVID-19 outreach and guidance in low-income housing communities. The study did this over the following aims: 1) Investigate why low-income housing residents report high levels of COVID-19 vaccine hesitancy and poor compliance with public health guidance; 2) Assess telehealth as a potential tool for addressing low-income housing resident mistrust in COVID-19 guidance; and 3) Develop community-informed strategies to address resident concerns about COVID-19 testing and to make testing more relevant to their needs." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_127> <http://schema.org/sameAs> "10.60773/y7xk-ma85" .
<https://okn.wobd.org/grant/1R01NS076465-01> <http://schema.org/startDate> "2011-09-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/2UL1TR000427-06> <http://schema.org/identifier> "2UL1TR000427-06" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_168> <http://schema.org/identifier> "phs002964" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_170> <http://schema.org/sameAs> <https://doi.org/10.60773/cwrf-q204> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_44> <http://schema.org/sameAs> <https://doi.org/10.60773/eya4-rh89> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_53> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/prf9-6708> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_157> <http://schema.org/datePublished> "2023-08-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1DP1AI158186-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/10008571" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_141> <http://schema.org/dateCreated> "2022-02-02"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_42> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_191> <http://schema.org/url> "https://radxdatahub.nih.gov/study/191" .
<http://schema.org/sameAs> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2000/01/rdf-schema#Literal> .
<https://okn.wobd.org/grant/1R01MH117406-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/person/uc_davis_children_s_hospital> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_49> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/694009> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_31> <http://schema.org/datePublished> "2024-04-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_84> <http://schema.org/sameAs> "10.60773/sh92-7q42" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_150> <http://schema.org/dateCreated> "2022-04-18"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_174> <http://schema.org/identifier> "phs003031" .
<https://okn.wobd.org/person/hugo_w_moser_research_institute_at_kennedy_krieger> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<http://schema.org/datePublished> <http://www.w3.org/2000/01/rdf-schema#domain> <http://schema.org/Thing> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_61> <http://schema.org/dateModified> "2022-12-09"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/5R01DK035385-02> <http://schema.org/name> "NEUROHUMORAL CONTROL OF INTERNAL ANAL SPHINCTER" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_218> <http://schema.org/sameAs> <https://doi.org/10.60773/xf2h-5k20> .
<https://okn.wobd.org/grant/8UL1TR000042-07> <http://schema.org/funder> <https://ror.org/04pw6fb54> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/101" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_116> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_58> <http://schema.org/funding> <https://okn.wobd.org/grant/5R01DK035385-02> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_72> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/grant/1UL1TR001085-01> <http://schema.org/name> "Spectrum Stanford Center for clinical and Translational Research and Education" .
<http://purl.obolibrary.org/obo/MONDO_0005711> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_125> <http://schema.org/sameAs> <https://doi.org/10.60773/an3v-wq86> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_159> <http://schema.org/sameAs> <https://doi.org/10.60773/ksgc-r355> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_88> <http://schema.org/sameAs> "10.60773/7x5v-ym43" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_54> <http://schema.org/date> "2023-04-28"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_97> <http://schema.org/datePublished> "2023-08-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_52> <http://schema.org/date> "2023-10-23"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_108> <http://schema.org/author> <https://okn.wobd.org/person/temple_university> .
<https://okn.wobd.org/grant/1UL1TR001442-01> <http://schema.org/funder> <https://ror.org/04pw6fb54> .
<http://schema.org/endDate> <http://www.w3.org/2000/01/rdf-schema#domain> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/1R01MH113094-01> <http://schema.org/startDate> "2016-09-19"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005550> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_159> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_74> <http://schema.org/sameAs> "10.60773/073r-9g87" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_44> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/eya4-rh89> .
<https://okn.wobd.org/grant/2P2CHD050924-11> <http://schema.org/name> "Carolina Population Center" .
<https://okn.wobd.org/grant/1UL1TR001863-01> <http://schema.org/name> "Yale Clinical and Translational Science Award" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_70> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_200> <http://schema.org/datePublished> "2023-12-07"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_149> <http://schema.org/url> "https://radxdatahub.nih.gov/study/149" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_176> <http://schema.org/funding> <https://okn.wobd.org/grant/8UL1TR000042-07> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_136> <http://schema.org/description> "Robust, efficient and reliable testing for SARS-CoV-2 is extraordinarily challenging due to lack of ultra- sensitive assays and ever evolving knowledge of the virus. Standard PCR based assays still result in very high false negative rates in the earliest days of infection. Microfluidic processing of clinical samples is low cost and shows great promise for translating most liquid biopsy assay to the clinic. This laboratory was one of the first to apply microfluidic technologies for the isolation of both circulating tumor cells and exosomes in the blood of patients with cancer. For SARS-CoV-2 patients, saliva, stool, and plasma are all thought to be potential resources for both virus detection as well as other clinical biomarkers that might inform us of infection. Thus, for this U18, the study optimized exosome capture technology, the EVHB-Chip, for the isolation of intact SARS-CoV-2 virus, testing its utility for each of these biofluids. To complete this work, this study completed a full clinical validation and benchmarking of the assay. Once fully optimized, the detection assay was compared against existing EUA SARS-CoV-2 detection assay to determine detection sensitivity and specificity. Further, the study planned to demonstrate that the increased sensitivity and specificity enabled by the microfluidic device would result in earlier detection of SARS-CoV-2, reducing false negatives in this testing window. At the completion of this work, the study collected the data training sets and submitted a full EUA plan that would enable the FDA's authorization of the test to be used in the clinic." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_166> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005287> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/funding> <https://okn.wobd.org/grant/1P30AI036214-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_54> <http://schema.org/description> "The devastation caused by emerging pathogens with fast transmission capacity, such as SARS-CoV-2, has demonstrated the importance of preparedness for future viral outbreaks; this includes the ability for fast deployment of in-situ testing tools and epidemiological surveillance with high temporal and spatial resolution; particularly in places that are most vulnerable to becoming reservoirs of infectious agents. This study involved the development of a versatile multiplexing detection platform for SARS-CoV-2 in saliva. The system integrated signals from different biorecognition elements. Aptamer, antibody, and ACE2 were immobilized onto laser inscribed graphene electrodes, and detection mechanisms targeting SARS-CoV-2 spike protein were studied under varying testing conditions (pH, temperature, ionic strength). After determining the operating conditions for enhanced performance of each biosensor, a self-referencing approach was used between complementary recognition elements (i.e., possible combinations of aptamers, antibodies, and ACE2 enzyme biosensors) to evaluate the effects on accuracy of test results (i.e., risk of false-positive and false-negative results). A saliva pre-treatment protocol was developed to facilitate SARS-CoV-2 testing in human saliva using the multiplex biosensor platform. An open channel microfluidics system was designed to automatically split and channel a single saliva sample into multiple streams to the biosensors without saturation, biofouling, and pump requirement. The development of a functional and reliable multiplex biosensor system is useful for addressing longstanding needs in public health as the respiratory Coronavirus family continues its seasonal visits, which may repeat over several decades, much like the occasional visits from the influenza virus, with varying degrees of virulence." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_219> <http://schema.org/date> "2024-03-04"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1ZIANR000035-01> <http://schema.org/funder> <https://ror.org/01y3zfr79> .
<https://okn.wobd.org/grant/1K23AI121485-01A1> <http://schema.org/startDate> "2016-06-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_159> <http://schema.org/name> "A Community Health Worker Intervention to Identify and Decrease Barriers to Pre-Procedural COVID-19 Testing Among Los Angeles County Department of Health Safety-Net Patients" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/119" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_163> <http://schema.org/date> "2024-04-10"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_130> <http://schema.org/url> "https://radxdatahub.nih.gov/study/130" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_70> <http://schema.org/funding> <https://okn.wobd.org/grant/1R35GM119774-01> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/128" .
<https://okn.wobd.org/grant/1R35GM138152-01> <http://schema.org/endDate> "2025-06-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01DK107585-01A1> <http://schema.org/url> "https://reporter.nih.gov/project-details/9175916" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_70> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_71> <http://schema.org/author> <https://okn.wobd.org/person/health_research> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_209> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_148> <http://schema.org/identifier> "phs002874" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_79> <http://schema.org/sameAs> <https://doi.org/10.60773/3gd9-km98> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_51> <http://schema.org/datePublished> "2022-11-07"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_205> <http://schema.org/dateCreated> "2023-07-27"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_200> <http://schema.org/dateCreated> "2023-07-13"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_129> <http://schema.org/url> "https://radxdatahub.nih.gov/study/129" .
<https://okn.wobd.org/grant/1T32AI007291-01A1> <http://schema.org/name> "RESEARCH IN MICROBIAL DISEASE" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_36> <http://schema.org/identifier> "phs002535" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_212> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_55> <http://schema.org/author> <https://okn.wobd.org/person/wayne_state_university> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_150> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/qyrm-p781> .
<https://okn.wobd.org/grant/1S10OD025082-01> <http://schema.org/funder> <https://ror.org/00fj8a872> .
<http://schema.org/DefinedTerm> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2000/01/rdf-schema#Class> .
<http://purl.obolibrary.org/obo/MONDO_0100130> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_81> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/organization/national_center_for_chronic_disease_prev_and_health_promo> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Organization> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_49> <http://schema.org/date> "2023-10-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_73> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R35GM119850-01> <http://schema.org/identifier> "1R35GM119850-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_139> <http://schema.org/description> "People living with an autoimmune disease, including those with systemic lupus erythematosus (SLE), have been especially impacted by the COVID-19 pandemic. The purpose of this research project was to identify barriers and facilitators to COVID-19 testing and vaccination among people living with SLE using both qualitative and quantitative methods. This study also evaluated the efficacy of a novel peer-led intervention to enhancing these behaviors among people living with SLE and others in their household/social network using a randomized controlled trial design. The aims of this project were achieved by leveraging an existing patient roster of over 2500 people living with SLE in Birmingham, Alabama. This study also recruited people living with SLE in New Orleans, Louisiana. This research has broader implications for testing/vaccination in clinical populations." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_57> <http://schema.org/sameAs> <https://doi.org/10.60773/8jx9-5s54> .
<https://okn.wobd.org/grant/1UL1TR002014-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9322051" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_87> <http://schema.org/identifier> "phs002619" .
<https://okn.wobd.org/grant/1P30MH058107-01> <http://schema.org/name> "EARLY DETECTION, PREVENTION, AND TREATMENT OF HIV" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_96> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_157> <http://schema.org/name> "Safety, Testing/Transmission, and Outcomes in Pregnancies with COVID-19 (STOP COVID-19)" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_212> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/grant/1R01DE026471-01A1> <http://schema.org/funder> <https://ror.org/004a2wv92> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_178> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/5061-0a66> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_207> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_130> <http://schema.org/dateCreated> "2022-01-12"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_34> <http://schema.org/identifier> "phs002533" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_27> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<http://purl.obolibrary.org/obo/MONDO_0004995> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_116> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005044> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_180> <http://schema.org/url> "https://radxdatahub.nih.gov/study/180" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_214> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<http://purl.obolibrary.org/obo/MONDO_0006663> <http://schema.org/name> "perinatal asphyxia" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_130> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005550> .
<https://okn.wobd.org/person/florida_international_university> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_85> <http://schema.org/sameAs> <https://doi.org/10.60773/c7y1-s751> .
<https://okn.wobd.org/person/university_of_maryland> <http://schema.org/name> "University of Maryland" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_172> <http://schema.org/url> "https://radxdatahub.nih.gov/study/172" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_111> <http://schema.org/name> "Use of Behavioral Economics in Repeat SARS-CoV-2 Antibody Testing in Disadvantaged Communities" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_207> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/NCIT_C189188> .
<https://okn.wobd.org/grant/1UL1TR002378-01> <http://schema.org/funder> <https://ror.org/04pw6fb54> .
<https://okn.wobd.org/grant/1K12NS098482-01> <http://schema.org/funder> <https://ror.org/01s5ya894> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_151> <http://schema.org/identifier> "phs002871" .
<https://okn.wobd.org/grant/1U01CA260539-01> <http://schema.org/funder> <https://ror.org/040gcmg81> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_130> <http://schema.org/identifier> "phs002763" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_221> <http://schema.org/date> "2024-09-13"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_37> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/grant/1UL1TR002345-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9474890" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_32> <http://schema.org/dateModified> "2024-04-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_174> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_30> <http://schema.org/description> "The pandemic caused by COVID-19 has been associated with a very high disease burden as well as high global financial costs. With this pandemic came massive shut downs of both private and public businesses including schools, retail stores, and restaurants. In order to be able to safely open these places of business and have millions of workers return to work and children return to school safely, there is a dire need for a rapid, simple, and inexpensive test which can be administered in non-clinical settings including businesses, schools, and even at home. There are over 600 tests currently being developed, including potentially promising tests using saliva samples and nasopharyngeal swabs. However, these tests have several disadvantages including requirement of instruments, discomfort with nasopharyngeal swabs, and/or long processing times. A simple, low-cost, rapid saliva-based test was developed using test strips that incorporate novel high affinity SARS-CoV-2 binder nanodiscs. The aims of this study were focused on producing and optimizing the test strip components and performing a feasibility study on archived patient samples. By completing these goals, test strips that have the capability of use in office settings, schools, sports events, and potentially at home were produced. To achieve these goals, a partnership was established between bioActive Labs LLC, led by Dr. Jeff Hall who has more than 25 years of experience in design and development of medical diagnostics, and this study's lab, which has engineered the new binder proteins and developed the SARS-CoV-2 assays." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_85> <http://schema.org/name> "Bridging the Evidence-to-Practice Gap: Evaluating Practice Facilitation as a Strategy to Accelerate Translation of a Systems-Level Adherence Intervention into Safety Net Practices/Project Evidence" .
<https://okn.wobd.org/grant/1UL1TR001860-01> <http://schema.org/endDate> "2021-05-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_158> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/enx6-h124> .
<http://purl.obolibrary.org/obo/MONDO_0012727> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/funding> <https://okn.wobd.org/grant/1P01AI118688-01A1> .
<https://okn.wobd.org/grant/1R01HL124209-01A1> <http://schema.org/endDate> "2019-11-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.obolibrary.org/obo/MONDO_0005550> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_138> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/1986198> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_123> <http://schema.org/sameAs> "10.60773/m294-pw55" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_120> <http://schema.org/author> <https://okn.wobd.org/person/emory_university> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_194> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/grant/1T32GM128596-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9570007" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_29> <http://schema.org/date> "2024-08-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_48> <http://schema.org/datePublished> "2022-11-07"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.obolibrary.org/obo/NCIT_C35016> <http://schema.org/name> "Shock" .
<https://okn.wobd.org/grant/1UL1TR001878-01> <http://schema.org/name> "Institutional Clinical and Translational Science Award" .
<https://okn.wobd.org/grant/1R01MH117406-01> <http://schema.org/identifier> "1R01MH117406-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_83> <http://schema.org/author> <https://okn.wobd.org/person/university_of_texas_southwestern> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_115> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_58> <http://schema.org/identifier> "phs002563" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_74> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR001878-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_83> <http://schema.org/identifier> "phs002601" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_274> <http://schema.org/url> "https://radxdatahub.nih.gov/study/274" .
<https://okn.wobd.org/grant/6U48DP006395-01M001> <http://schema.org/name> "Prevention Research Center in St. Louis" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_58> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_182> <http://schema.org/author> <https://okn.wobd.org/person/johns_hopkins_school_of_medicine> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_54> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/694009> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_168> <http://schema.org/name> "Longitudinal at Home Smell Testing to Detect Infection by SARS-CoV-2" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_80> <http://schema.org/url> "https://radxdatahub.nih.gov/study/80" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_30> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_155> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_90> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/grant/1P30ES005022-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/3102363" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_181> <http://schema.org/datePublished> "2023-12-07"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/215" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_110> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2901879> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/115" .
<https://okn.wobd.org/grant/2U54MD007601-31> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_115> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/grant/1R01CA234614-01A1> <http://schema.org/name> "Modeling Hepatoblastoma using pluripotent stem cell derived hepatocyte-like cells" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_123> <http://schema.org/sameAs> <https://doi.org/10.60773/m294-pw55> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_137> <http://schema.org/author> <https://okn.wobd.org/person/cornell_university> .
<https://ror.org/049v75w11> <http://schema.org/alternateName> "U.S. National Institute on Aging" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/185" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_216> <http://schema.org/date> "2024-03-04"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://ror.org/04byxyr05> <http://schema.org/alternateName> "NIH/Eunice Kennedy Shriver National Institute of Child Health and Human Development" .
<https://okn.wobd.org/person/arizona_state_university> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_182> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_51> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/6e21-bq61> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/52" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_109> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005550> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_90> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_180> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/grant/1R35GM119774-01> <http://schema.org/endDate> "2021-05-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/author> <https://okn.wobd.org/person/university_of_california_san_diego> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_211> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_92> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_201> <http://schema.org/description> "This project evaluated a systematic and scalable community-engaged test and treat protocol that provided rapid access to COVID-19 at-home tests for self-administration, next steps/guidance and education, and information on local resources to facilitate treatment in underserved populations. The protocol was designed and implemented in two communities, Pitt County, NC, and Merced County, CA, in collaboration with key community partners over a 15-month period. As part of this test and treat protocol, a community engagement toolkit as a resource was evaluated to implement community-based test distribution and test and treat responses in underserved populations. The central hypothesis was that the toolkit will enable rapid design and implementation of a community driven, scientifically robust, and impactful COVID-19 test and public health intervention." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_160> <http://schema.org/description> "The community-engaged project, Reducing Ethical and Social Prejudicial Effects of COVID-19 Testing in Underserved Populations (RESPECT-UP), aimed to understand the social, ethical, and behavioral factors surrounding COVID-19 testing in vulnerable urban and rural African American Communities in Alabama (top 20% of the Social Vulnerability Index - SVI). This project also aimed to develop, in the form of RESPECT-UP Toolkits, multilevel strategies to reduce COVID-19 disparities, which include inequities in testing, while considering vaccine availability." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_218> <http://schema.org/url> "https://radxdatahub.nih.gov/study/218" .
<https://okn.wobd.org/grant/8P20GM103395-12> <http://schema.org/name> "Alaska INBRE-2: Environmental Agents and Disease" .
<https://ror.org/04byxyr05> <http://schema.org/alternateName> "NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_182> <http://schema.org/url> "https://radxdatahub.nih.gov/study/182" .
<https://okn.wobd.org/grant/1U54CA132379-01A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/1P30AI045008-01> <http://schema.org/funder> <https://ror.org/043z4tv69> .
<https://okn.wobd.org/grant/1K12HD047349-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/6811967" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_60> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/5ahc-nx20> .
<https://okn.wobd.org/grant/1R01DA013806-01> <http://schema.org/name> "HIV HCV COINFECTION--ANTIVIRAL THERAPY AND FIBROSIS" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_75> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005044> .
<http://purl.obolibrary.org/obo/MONDO_0005046> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/grant/1R01AI123538-01A1> <http://schema.org/identifier> "1R01AI123538-01A1" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_75> <http://schema.org/datePublished> "2023-08-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_174> <http://schema.org/dateCreated> "2022-08-19"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_195> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_45> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/129" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_111> <http://schema.org/sameAs> "10.60773/mq9p-yx64" .
<https://okn.wobd.org/person/fox_subacute_care> <http://schema.org/name> "Fox Subacute Care" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_126> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_71> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0012727> .
<https://okn.wobd.org/grant/1R01HL124209-01A1> <http://schema.org/funder> <https://okn.wobd.org/organization/national_heart_lung_and_blood_institute> .
<https://okn.wobd.org/grant/1UL1TR002366-01> <http://schema.org/name> "Frontiers: University of Kansas Clinical and Translational Science Institute " .
<https://okn.wobd.org/dataset/radx_data_hub/radx_167> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/david_geffen_school_of_medicine_at_ucla> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_207> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_181> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_85> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.obolibrary.org/obo/MONDO_0008383> <http://schema.org/name> "rheumatoid arthritis" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_197> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_46> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_212> <http://schema.org/identifier> "phs003377" .
<https://okn.wobd.org/grant/1R01AI151059-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_48> <http://schema.org/url> "https://radxdatahub.nih.gov/study/48" .
<https://okn.wobd.org/grant/1R01AI163029-01> <http://schema.org/funder> <https://ror.org/043z4tv69> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/188" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_34> <http://schema.org/description> "Vibrent Health has expanded the Vibrent Digital Health Solutions Platform (DHSP) implementation to additional populations among diverse user groups for additional validation of the technology's performance, usability, and reliability in refinement of analytics generating predictive algorithms for infection and that support individual, organizational, community and societal-level decision-making in the COVID-19 pandemic response. This included aims to innovate a technology that can differentiate between COVID-19 and flu (or other respiratory illness); development and testing of a novel WIFI-based contact tracing tool using a University's enterprise WIFI system and software release of augmented contact tracing capabilities in Vibrent's DHSP; and development of a full technical integration approach and strategy to support data exchange between this solution and the NCI data hub." .
<https://okn.wobd.org/grant/1R01AI141630-01A1> <http://schema.org/identifier> "1R01AI141630-01A1" .
<https://okn.wobd.org/grant/1U19NS112953-01> <http://schema.org/name> "Cracking the Olfactory Code" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_134> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_52> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/6y92-jm05> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_190> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR002538-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_141> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R56HL149881-01A1> <http://schema.org/funder> <https://okn.wobd.org/organization/national_heart_lung_and_blood_institute> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/funding> <https://okn.wobd.org/grant/1P30CA240139-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_135> <http://schema.org/sameAs> <https://doi.org/10.60773/2ndc-4822> .
<https://okn.wobd.org/grant/1R01AI146165-01A1> <http://schema.org/identifier> "1R01AI146165-01A1" .
<https://okn.wobd.org/grant/2UL1TR000457-06> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_39> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01HG011274-01> .
<https://okn.wobd.org/grant/1R01HL105704-01> <http://schema.org/startDate> "2011-04-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_62> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_159> <http://schema.org/author> <https://okn.wobd.org/person/los_angeles_county_department_of_health_services> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_44> <http://schema.org/funding> <https://okn.wobd.org/grant/1P30GM131944-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_38> <http://schema.org/url> "https://radxdatahub.nih.gov/study/38" .
<https://okn.wobd.org/grant/4UH3OD023365-03> <http://schema.org/funder> <https://ror.org/00fj8a872> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_133> <http://schema.org/datePublished> "2022-06-07"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_49> <http://schema.org/sameAs> "10.60773/7gn8-9w03" .
<https://okn.wobd.org/grant/1R01AG066749-01> <http://schema.org/identifier> "1R01AG066749-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_127> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR002319-01> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/58" .
<https://okn.wobd.org/person/health_research> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_183> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/38sx-dw45> .
<https://okn.wobd.org/grant/1P30AI060354-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/6764539" .
<https://okn.wobd.org/person/african_women_s_cancer_awareness_association_awcaa> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/person/better_community_development> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/person/brigham_womens_hospital> <http://schema.org/name> "Brigham Womens Hospital" .
<https://okn.wobd.org/grant/1UL1TR002319-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/1P30AI027767-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/3101088" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_118> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_118> <http://schema.org/dateCreated> "2022-01-06"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_203> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_122> <http://schema.org/identifier> "phs002742" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/61" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_38> <http://schema.org/dateModified> "2024-01-03"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_220> <http://schema.org/url> "https://radxdatahub.nih.gov/study/220" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_194> <http://schema.org/identifier> "phs003234" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_155> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/gkzn-9x83> .
<https://okn.wobd.org/grant/1R01AI155696-01> <http://schema.org/funder> <https://ror.org/043z4tv69> .
<https://okn.wobd.org/person/be_health_empowered_bhe_group> <http://schema.org/name> "Be Health Empowered (BHE) Group" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_43> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/NCIT_C154635> .
<https://okn.wobd.org/person/upenn> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/grant/1KL2TR003108-01> <http://schema.org/funder> <https://ror.org/04pw6fb54> .
<https://okn.wobd.org/person/seattle_children_s> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<http://purl.obolibrary.org/obo/MONDO_0011918> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_186> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_55> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005550> .
<https://okn.wobd.org/grant/1R01MH115676-01A1> <http://schema.org/funder> <https://ror.org/04xeg9z08> .
<http://schema.org/description> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2000/01/rdf-schema#Literal> .
<https://ror.org/00fj8a872> <http://schema.org/name> "NIH Office of the Director" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_212> <http://schema.org/sameAs> <https://doi.org/10.60773/554r-hn06> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_129> <http://schema.org/description> "The novel coronavirus that causes COVID-19 has negatively impacted global health status and economies worldwide. In the U.S., vulnerable populations experience significant disparities in terms of both infection and mortality rates, especially in the State of Texas, where Hispanic, African American, and other groups have experienced substantial disparities in both incidence and mortality. For example, Hispanics comprise 29.4% of the state's population, but 40.1% of COVID-19 cases and 47.9% of confirmed fatalities. The communities prioritized in this study include populations with medical comorbidities and those experiencing homelessness, and underserved Hispanics and African Americans in three racially diverse regions: South Texas, Houston/Harris County, and Northeast Texas. All of these regions are experiencing crisis-level surges in COVID-19 cases and fatalities. Testing disparities in Texas are evident, but understudied, and rapid deployment and evaluation of prevention, diagnostic, and mitigation strategies is imperative. Building on the partnerships and resources of the UTHealth Center for Clinical and Translational Science (CCTS), the goal of this study was to partner with community and stakeholder colleagues to identify dynamic disease hotspots and testing deserts in racially diverse neighborhoods of the target regions and to use that information to inform the rapid adaptation and deployment of multilevel level just-in-time adaptive intervention strategies to reach vulnerable populations. This study accomplished the following aims: 1) Identify disparities and dynamics of SARS-CoV-2 testing and infections in three Texas regions by (i) estimating real-time testing availability and uptake patterns utilizing data from regional health departments and hospital records; (ii) estimating real-time disparities in incidence rate and positive test rate of SARS-CoV-2 infections and COVID-19, and (iii) identifying, characterizing and predicting dynamic disease hotspots and testing deserts in vulnerable communities utilizing spatial-temporal modeling approaches. 2) Use multilevel network modeling methods to examine the structural properties of interorganizational networks; and apply network optimization methods to identify influential organizations that can maximize system-level organizational performance to better coordinate local testing and service delivery needs. 3) Engage CCTS community networks to develop, implement and evaluate a targeted, adaptive multilevel intervention to increase reach, uptake, implementation, and sustainment of SARS-CoV-2 diagnostics among priority vulnerable populations. This study evaluated the reach, effectiveness and implementation of the Community level Just-In-Time Adaptive Interventions (Community JITAIs) to increase SARs-CoV-2 testing and reduce infections in identified high risk priority neighborhoods, and conducted an embedded study to evaluate the use of community health worker-delivered SARS-CoV-2 diagnostics. This work was continued in Phase II of the funding by examining the aims in light of the COVID-19 vaccine being available to the populations of interest." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_123> <http://schema.org/name> "Addressing Low-Income Housing Resident Mistrust in COVID-19 Guidance" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_31> <http://schema.org/date> "2024-04-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_93> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_33> <http://schema.org/identifier> "phs002519" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_30> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_209> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2901879> .
<https://okn.wobd.org/grant/1R01ES021006-01A1> <http://schema.org/funder> <https://ror.org/00j4k1h63> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_124> <http://schema.org/identifier> "phs002744" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_173> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_53> <http://schema.org/date> "2022-12-09"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_157> <http://schema.org/sameAs> <https://doi.org/10.60773/geyp-w645> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_182> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_75> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_186> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/grant/1P20GM121342-01A1> <http://schema.org/identifier> "1P20GM121342-01A1" .
<https://okn.wobd.org/grant/1U54GM104940-01> <http://schema.org/identifier> "1U54GM104940-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_166> <http://schema.org/sameAs> <https://doi.org/10.60773/td0b-xf65> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_190> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_185> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_146> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR002538-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_27> <http://schema.org/url> "https://radxdatahub.nih.gov/study/27" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_205> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR002538-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_61> <http://schema.org/datePublished> "2022-11-07"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_200> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/b47b-ek03> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_99> <http://schema.org/author> <https://okn.wobd.org/person/northwestern_university> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_148> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1P30AI060354-01> <http://schema.org/endDate> "2009-06-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1U54CA132384-01A1> <http://schema.org/funder> <https://ror.org/040gcmg81> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_143> <http://schema.org/funding> <https://okn.wobd.org/grant/1U24TR001608-01> .
<https://okn.wobd.org/grant/1P30CA042014-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/3101801" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_194> <http://schema.org/url> "https://radxdatahub.nih.gov/study/194" .
<https://okn.wobd.org/grant/1R01AI153044-01A1> <http://schema.org/identifier> "1R01AI153044-01A1" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_159> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_113> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR001442-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_190> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<http://schema.org/funding> <http://www.w3.org/2000/01/rdf-schema#domain> <http://schema.org/Thing> .
<https://okn.wobd.org/grant/1R01HD106120-01> <http://schema.org/endDate> "2026-05-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_93> <http://schema.org/datePublished> "2023-08-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1P01CA214274-01A1> <http://schema.org/endDate> "2023-08-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/7R01HG010040-02> <http://schema.org/identifier> "7R01HG010040-02" .
<https://okn.wobd.org/grant/1U54CA132384-01A1> <http://schema.org/endDate> "2013-08-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_100> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_67> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_76> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_166> <http://schema.org/identifier> "phs002947" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_36> <http://schema.org/name> "Personalized Analytics and Wearable Biosensor Platform for Early Detection of COVID-19 Decompensation (DECODE)" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_57> <http://schema.org/sameAs> "10.60773/8jx9-5s54" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_140> <http://schema.org/identifier> "phs002775" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_126> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/grant/1R01AI135992-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_44> <http://schema.org/datePublished> "2023-08-29"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_157> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01DK113642-01A1> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_86> <http://schema.org/description> "The Rapid Acceleration of Diagnostics for Underserved Populations (RADx-UP) initiative supports supplements to individual NIH awards to increase COVID-19 testing among underserved populations. Leveraging the infrastructure of another project in NYC (National Cancer Institute, R01CA220591, Evaluation of Smoke-Free Housing Policy Impacts on Tobacco Smoke Exposure) and a longstanding set of partnerships among the NYC Housing Authority (NYCHA) and their resident boards, the NYC Health Department, NYC's municipal hospital system, NYU Grossman School of Medicine, and community partnerships, this study executed community-engaged investigations to improve COVID-19 testing for NYCHA residents. NYCHA is the largest public housing authority in North America, with 400,000 official residents living in 15% of the nation's public housing units. NYCHA provides a home to nearly 5% of NYC residents. Developments are spread throughout the city but concentrate in lower-income neighborhoods. Median family income is $20,000, and approximately 90% of NYCHA residents are Black or Hispanic. Apartment turnover is low due to subsidized rental assistance, and developments have organized resident associations, which facilitate capacity for sustained engagement and opportunities for community activation. Aim 1: Develop Sustainable Community Engagement Structures to Guide Current and Future Deployment of Evidence-Based COVID-19 Testing and Vaccination Options for NYC Public Housing Residents. In partnership with a network of community-based organizations (CBOs), NYCHA Resident Associations, and several municipal agencies, a platform for NYCHA-facing initiatives to reduce disparities in COVID-19 morbidity and mortality was established. The platform spanned distinct NYC neighborhoods to give NYCHA residents a voice in shaping COVID-19 testing initiatives. Aim 2: Quantify Inequities in COVID-19 Testing and SARS CoV-2 infection among Public Housing Residents. Triangulation occurred across granular and timely data sources to determine baseline testing and COVID-positivity rates among NYC's public housing resident population, with an emphasis on subgroups with (a) limited access to testing sites, (b) adequate access to testing sites but low testing rates, and (c) high positive test rates. Development-specific maps of testing sites were promulgated and prospective surveillance of testing using routine public health data was established. Aim 3: Discover Facilitators and Barriers to Testing, Isolation, and Follow-Up Care. To guide improvements to COVID-19 testing services, a mixed methods approach was applied to identify barriers to testing, implications and financial burden associated with a positive test result, feasibility of self-isolation for positive results, acceptability of tracing contacts, and privacy concerns. NYCHA residents and CBO partners were engaged in primary data collection and analysis in order to foster a shared understanding of prevention, testing, and management of COVID-19 among public housing residents. Aim 4. Test Community-Informed Strategies to Increase Testing Uptake. Leveraging an array of recently-launched testing initiatives across NYC, including on-site testing clinics, mobile vans, and door-to-door testing, a comparative effectiveness study was conducted to test the impact of a community health worker (CHW) model delivering a menu of community-informed testing options with and without navigation support, including home-testing strategies, on acceptance and uptake of COVID-19 screening tests." .
<https://okn.wobd.org/grant/1UL1TR002366-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9514338" .
<https://okn.wobd.org/grant/1P30MH058107-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_152> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/NCIT_C50873> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_37> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_63> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/48" .
<https://okn.wobd.org/grant/1K12HD047349-01> <http://schema.org/startDate> "2004-08-23"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_78> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_166> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_168> <http://schema.org/dateCreated> "2022-06-24"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.obolibrary.org/obo/MONDO_0005249> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_204> <http://schema.org/sameAs> "10.60773/66qd-hj95" .
<https://okn.wobd.org/grant/1R01CA249054-01> <http://schema.org/funder> <https://ror.org/040gcmg81> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_189> <http://schema.org/datePublished> "2023-02-21"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_137> <http://schema.org/author> <https://okn.wobd.org/person/children_s_national_research_institute> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_99> <http://schema.org/sameAs> "10.60773/nxck-yd76" .
<https://okn.wobd.org/grant/1TL1TR001871-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/1P30GM131944-01> <http://schema.org/endDate> "2024-05-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_82> <http://schema.org/sameAs> "10.60773/wbd9-yd79" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_187> <http://schema.org/dateCreated> "2022-11-28"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/university_of_southern_maine> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_147> <http://schema.org/funding> <https://okn.wobd.org/grant/1U24TR001608-01> .
<https://okn.wobd.org/person/hugo_w_moser_research_institute_at_kennedy_krieger> <http://schema.org/name> "Hugo W Moser Research Institute at Kennedy Krieger" .
<https://okn.wobd.org/grant/1K12HD000850-01> <http://schema.org/startDate> "1986-12-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_216> <http://schema.org/description> "This project employed a data-informed approach for implementing preventive interventions designed to advance health equity and ameliorate health disparities among vulnerable populations. Building on the successful Phase I and II projects, this project further tailored the Promotores de Salud COVID-19 evidence-based health promotion intervention to experimentally evaluate a brief behavioral self-affirming implementation intention (SAII) intervention; an approach that is evidence-based for increasing acceptance of health messaging, increasing intentions to change, increasing health promoting behaviors, and decreasing psychological distress. The study hypothesized (a) the SAII would increase SARS-CoV-2 rapid testing, testing and vaccine acceptance, and health outcomes through enhancing health promotion messaging, reducing stigma, and affirming self-perceptions; and (b) the SAII would serve as a buffer that moderates (lowers) negative effects of COVID-19-related stressors and discrimination on testing and health outcomes. The key targets of the intervention were structural social determinants of health (i.e., discrimination and mistrust) as barriers to testing acceptance. Project aims were: (1) To pilot test rapid SARS-CoV-2 test distribution and an English and Spanish version of the SAII intervention. The culturally tailored SAII intervention were offered in Spanish and English and can be administered orally and did not require English language proficiency or literacy; and (2) Conduct a clustered randomized trial (CRT) testing a health equity effectiveness hypothesis. The project used a 2-group × 2-time (pre-post) design to randomly assign 400 participants sampled from Mexican Consulate event attendees to either an SAII + Promotores de Salud condition or to a control condition (the Promotores de Salud intervention only) and test (a) hypothesized main effects of the intervention on testing and vaccine acceptance and health outcomes, and (b) hypothesized buffering effects of COVID-19 stressors and discrimination on testing and health outcomes. Linear and generalizable multilevel structural equation modeling were specified for evaluation. The study design was powered to detect moderate main effects (ES = .30) and moderating effects of the SAII intervention." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_182> <http://schema.org/identifier> "phs003056" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_138> <http://schema.org/url> "https://radxdatahub.nih.gov/study/138" .
<https://okn.wobd.org/grant/1U01HG010971-01> <http://schema.org/identifier> "1U01HG010971-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_128> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005109> .
<https://okn.wobd.org/grant/7R01HG010040-02> <http://schema.org/endDate> "2022-02-28"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_146> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_175> <http://schema.org/url> "https://radxdatahub.nih.gov/study/175" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_190> <http://schema.org/identifier> "phs003127" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_174> <http://schema.org/datePublished> "2023-08-29"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/2U54MD007595-11> <http://schema.org/identifier> "2U54MD007595-11" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_99> <http://schema.org/author> <https://okn.wobd.org/person/and_william_and_mary_college> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/189" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_30> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2901879> .
<https://okn.wobd.org/grant/1R01DK113642-01A1> <http://schema.org/endDate> "2022-03-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://ror.org/04q48ey07> <http://schema.org/alternateName> "NIGMS" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_149> <http://schema.org/dateCreated> "2022-04-18"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/pediatric_rheumatology_covid_consortium_prcc_hackensack_meridian> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/person/children_s_hospital_colorado> <http://schema.org/name> "Children's Hospital Colorado" .
<https://okn.wobd.org/grant/1UL1TR003017-01> <http://schema.org/startDate> "2019-03-11"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_137> <http://schema.org/sameAs> "10.60773/8yrw-qt94" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_190> <http://schema.org/dateCreated> "2022-11-28"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_126> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/wp37-4648> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_109> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/12814> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_70> <http://schema.org/sameAs> <https://doi.org/10.60773/tpfh-0630> .
<https://okn.wobd.org/grant/1P30DK045735-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/3102185" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_152> <http://schema.org/funding> <https://okn.wobd.org/grant/1P30AI042853-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_60> <http://schema.org/name> "COVID-19 Network of Networks Expanding Clinical and Translational Approaches to Predict Severe Illness in Children (CONNECT to Predict SIck Children)" .
<https://okn.wobd.org/grant/1R01HL105704-01> <http://schema.org/endDate> "2016-03-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_162> <http://schema.org/author> <https://okn.wobd.org/person/see_attached_list> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_44> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005550> .
<https://okn.wobd.org/grant/1R35GM119774-01> <http://schema.org/funder> <https://ror.org/04q48ey07> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01AI125416-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_176> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR002538-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_196> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_170> <http://schema.org/dateCreated> "2022-07-22"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_74> <http://schema.org/author> <https://okn.wobd.org/person/fresenius_medical_care_north_america> .
<http://schema.org/ScholarlyArticle> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2000/01/rdf-schema#Class> .
<http://purl.obolibrary.org/obo/NCIT_C3137> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_142> <http://schema.org/identifier> "phs002799" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_109> <http://schema.org/url> "https://radxdatahub.nih.gov/study/109" .
<https://okn.wobd.org/grant/1R01AI163029-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/1P30ES030283-01A1> <http://schema.org/startDate> "2020-07-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_41> <http://schema.org/sameAs> "10.60773/w5vb-c640" .
<https://okn.wobd.org/grant/1R01DE026471-01A1> <http://schema.org/url> "https://reporter.nih.gov/project-details/9381186" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_140> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/person/frederiksted_health_care_st_croix> <http://schema.org/name> "Frederiksted Health Care (St. Croix" .
<https://okn.wobd.org/grant/1KL2TR003108-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9893089" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_100> <http://schema.org/identifier> "phs002645" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/181" .
<https://okn.wobd.org/grant/1UL1TR002001-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_147> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_42> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/grant/1KL2TR003108-01> <http://schema.org/startDate> "2019-07-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_212> <http://schema.org/sameAs> "10.60773/554r-hn06" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_194> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_73> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://ror.org/043z4tv69> <http://schema.org/identifier> "https://ror.org/043z4tv69" .
<https://okn.wobd.org/grant/1UM1HG008898-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_85> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/grant/1R01HG009518-01A1> <http://schema.org/endDate> "2022-05-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_41> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_200> <http://schema.org/sameAs> "10.60773/b47b-ek03" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_214> <http://schema.org/identifier> "phs003376" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/funding> <https://okn.wobd.org/grant/1P30CA045508-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_83> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_202> <http://schema.org/author> <https://okn.wobd.org/person/howard_university> .
<https://okn.wobd.org/grant/1R01MD016593-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_127> <http://schema.org/funding> <https://okn.wobd.org/grant/8UL1TR000042-07> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_151> <http://schema.org/description> "This study sought to understand the factors associated with COVID-19 morbidity and mortality disparities and to lay the foundation to reduce disparities for those underserved and vulnerable populations that are disproportionately affected by, have the highest infection rates of, and/or are most at risk for adverse outcomes from the COVID-19 pandemic. This implementation study assessed the modality and venue preferences for COVID 19 testing in rural, incarcerated, and other underserved populations in the state of Alabama. The objective of the study was to evaluate the implementation of a rapid scale-up SARS CoV-2 testing strategy. The original goal of the study was to conduct 30,000 tests in rural counties statewide. In Aim 1, the study defined higher case burden as counties with more than 25 daily cases of COVID-19 per 100,000 total population and lower case burden as less than 10 daily cases per 100,000, both using a 7-day average. In order to identify communities particularly vulnerable to morbidity and disease spread, age, race, income and education were mapped based on census data; and the COVID vulnerability index which included social determinants of health as well as data regarding healthcare access, and COVID-19 disease risk factors. The study also mapped areas where mitigation efforts are particularly poor via cell phone movement and a surrogate measure of belief in COVID-19 science and public policy recommendations. These data were used to work with community partners to prioritize rural counties for testing delivery. All analyses used publicly available aggregate data and did not enroll individuals. As such, these Aim 1 data were not transmitted to the CDCC. For Aim 2, the study partnered with a third-party survey vendor to collect the full battery of Tier 1 Common Data Elements (CDEs) required for the project. The survey sample (n~300) was a representative sample of the rural populations from various counties in which the tests were administered. This data was uploaded to the CDCC including all required CDEs. For Aim 3, in collaboration with community partners, specifically the Alabama Area Health Education Centers (AHEC), the study administered COVID-19 tests within underserved rural populations statewide. All told from 10/01/20 until 02/28/22, the study administered over 23,000 PCR tests, which resulted in a 12% positivity rate. This included testing with the Visby point-of-care PCR test developed via RADx-TECH, which had particular uptake in rural jails across Alabama. In accordance with DHHS reporting requirements, this study collected basic demographic data from all those who were tested, including race, gender, and age. As approved by NIH, this limited dataset was provided for all persons tested via this project, but not all CDEs, as testing was done as standard of care and not for research purposes. Aim 4 of the study evaluated the effectiveness of the testing initiative’s implementation strategy, which was completed by June 2022. This study wanted to know how appropriate and feasible the testing initiative has been for those involved. The target population for this aim of the study were researchers, administrators, and testing staff who have been involved in the project, and did not include the general population and communities offered testing services. As such, there was no individual-level data capture aligned with the CDCC CDE model. This study collected over 100 surveys and conducted 50 in-depth interviews for this aim." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_183> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_33> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_176> <http://schema.org/author> <https://okn.wobd.org/person/greynolds_park_elementary> .
<https://okn.wobd.org/person/north_jersey_community_research_initiative> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/grant/1U54CA260492-01> <http://schema.org/endDate> "2022-08-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_192> <http://schema.org/url> "https://radxdatahub.nih.gov/study/192" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_55> <http://schema.org/author> <https://okn.wobd.org/person/central_michigan_university> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_128> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_73> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_138> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/e4v6-7k61> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_97> <http://schema.org/funding> <https://okn.wobd.org/grant/3P50HD103525-01S1> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_48> <http://schema.org/funding> <https://okn.wobd.org/grant/1S10OD025082-01> .
<https://okn.wobd.org/grant/1UL1TR002378-01> <http://schema.org/startDate> "2017-09-22"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1P30ES023513-01A1> <http://schema.org/endDate> "2020-03-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_69> <http://schema.org/sameAs> <https://doi.org/10.60773/dnv2-mx89> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_109> <http://schema.org/dateModified> "2023-05-16"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://ror.org/04byxyr05> <http://schema.org/name> "Eunice Kennedy Shriver National Institute of Child Health and Human Development" .
<https://okn.wobd.org/grant/1P30MH062246-01> <http://schema.org/startDate> "2001-09-24"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_63> <http://schema.org/name> "Detection and Automatic Privacy-Protected Contact Tracing System Designed for COVID-19" .
<https://okn.wobd.org/grant/1DP1AI158186-01> <http://schema.org/endDate> "2025-07-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_29> <http://schema.org/url> "https://radxdatahub.nih.gov/study/29" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_170> <http://schema.org/funding> <https://okn.wobd.org/grant/1ZIANR000035-01> .
<https://okn.wobd.org/grant/1R01AI155696-01> <http://schema.org/startDate> "2020-09-22"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_62> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/grant/1R01AI151059-01> <http://schema.org/startDate> "2020-03-10"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/2UL1TR000457-06> <http://schema.org/funder> <https://ror.org/04pw6fb54> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_168> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2901879> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_179> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1P01AI118688-01A1> <http://schema.org/endDate> "2021-05-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_57> <http://schema.org/dateModified> "2023-10-18"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_176> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/grant/1T32DA007292-01A1> <http://schema.org/name> "NIDA EPIDEMIOLOGY TRAINING PROGRAM--JOHNS HOPKINS UNIV" .
<https://okn.wobd.org/person/children_s_hospital_boston> <http://schema.org/name> "Children's Hospital Boston" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_145> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/swwm-cp96> .
<https://okn.wobd.org/grant/1S10OD025082-01> <http://schema.org/name> "Object Storage for Secure Data Sharing" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_191> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_45> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_81> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/grant/1P30AI027763-01> <http://schema.org/startDate> "1988-09-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_139> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/author> <https://okn.wobd.org/person/uc_davis_children_s_hospital> .
<https://www.uniprot.org/taxonomy/1986198> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/person/university_of_kansas_medical_center> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_219> <http://schema.org/dateModified> "2024-03-04"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_113> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_176> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_142> <http://schema.org/name> "Leveraging Social Networks to Increase COVID-19 Testing Uptake: A Comparison of Credible Messenger and Chain Referral Recruitment Approaches" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_211> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_118> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2901879> .
<https://okn.wobd.org/grant/1UL1TR003142-01> <http://schema.org/name> "Stanford Center for Clinical & Translational Education and Research (Spectrum)" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_62> <http://schema.org/dateModified> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_137> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01HG009120-01A1> .
<https://okn.wobd.org/grant/1R01MH113094-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_200> <http://schema.org/description> "The focus of this project was to triangulate data from semi-structured surveys, serology testing and census tract-linked public health and economic data to better understand social and behavioral factors related to COVID-19 testing and vaccine uptake in minority communities, and to develop communication strategies to increase acceptance of testing and vaccination. Social and behavioral factors were identified through a semi-structured survey, based on the Johns Hopkins University COVID-19 Community Response Survey available from the NIH Public Health Emergency and Disaster Research Response (DR2) platform, and incorporating the common data elements from the RADx CDCC. The survey collected detailed information on participants' medical history and current health, family structure and living\nconditions, employment and socioeconomic status, social distancing knowledge and practices, access to health care, presence of symptoms related to COVID-19 in themselves and among their contacts, their history of virus testing and attitudes toward testing, their vaccination history, and their interest in receiving a vaccine. This study was working with community partners to recruit participants from communities which score poorly on Delaware's community health index." .
<https://okn.wobd.org/grant/1P30AI036214-01> <http://schema.org/identifier> "1P30AI036214-01" .
<https://ror.org/006zn3t30> <http://schema.org/alternateName> "Instituto Nacional de Artritis y Enfermedades Musculoesqueléticas y de la Piel" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_189> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_71> <http://schema.org/author> <https://okn.wobd.org/person/the_jackson_laboratory> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_217> <http://schema.org/datePublished> "2024-03-04"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01MD016593-01> <http://schema.org/startDate> "2021-07-28"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/8P20GM103429-11> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/sameAs> <https://doi.org/10.60773/tca1-nb16> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_46> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/person/ocapica> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_58> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_163> <http://schema.org/url> "https://radxdatahub.nih.gov/study/163" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_162> <http://schema.org/dateModified> "2022-12-09"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/6U48DP006395-01M001> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/1R01HL149450-01A1> <http://schema.org/funder> <https://okn.wobd.org/organization/national_heart_lung_and_blood_institute> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_141> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://ror.org/01y3zfr79> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Organization> .
<https://okn.wobd.org/grant/1R35GM138152-01> <http://schema.org/identifier> "1R35GM138152-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_219> <http://schema.org/sameAs> "10.60773/w561-ag09" .
<https://okn.wobd.org/grant/1UG3OD023365-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_163> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/v1h1-pp81> .
<https://okn.wobd.org/grant/1UL1TR002378-01> <http://schema.org/endDate> "2022-06-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1P30AI045008-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_83> <http://schema.org/author> <https://okn.wobd.org/person/project_vida> .
<https://www.uniprot.org/taxonomy/347537> <http://schema.org/name> "Bat SARS CoV Rf1/2004" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_116> <http://schema.org/name> "Exploring Barriers and Facilitators to Women Who Use Drugs (WWUD) Awareness, Acceptance and Uptake of COVID-19 Testing (The CARE Study)" .
<https://okn.wobd.org/grant/1R35GM138152-01> <http://schema.org/funder> <https://ror.org/04q48ey07> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_54> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://ror.org/00372qc85> <http://schema.org/alternateName> "Instituto Nacional de Imágenes Biomédicas y Bioingeniería" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_57> <http://schema.org/identifier> "phs002561" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_166> <http://schema.org/dateCreated> "2022-06-13"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_110> <http://schema.org/datePublished> "2024-08-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1UL1TR001863-01> <http://schema.org/startDate> "2016-07-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_100> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2901879> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_49> <http://schema.org/funding> <https://okn.wobd.org/grant/1K08AI130381-01A1> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_63> <http://schema.org/date> "2023-05-26"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/7P30DK034987-01A1> <http://schema.org/identifier> "7P30DK034987-01A1" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_79> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/347537> .
<https://okn.wobd.org/grant/1K12HD000850-01> <http://schema.org/name> "PEDIATRIC PHYSICIAN SCIENTIST PROGRAM AWARD" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_86> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_127> <http://schema.org/url> "https://radxdatahub.nih.gov/study/127" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_117> <http://schema.org/url> "https://radxdatahub.nih.gov/study/117" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_46> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/1qmd-nt62> .
<https://okn.wobd.org/grant/1R01HG011274-01> <http://schema.org/endDate> "2025-06-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1UL1TR002373-01> <http://schema.org/funder> <https://ror.org/04pw6fb54> .
<https://okn.wobd.org/person/johns_hopkins_school_of_medicine> <http://schema.org/name> "Johns Hopkins School of Medicine" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_133> <http://schema.org/date> "2023-06-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_128> <http://schema.org/name> "COVID Self-Testing Through Rapid Network Distribution (C-STRAND)" .
<https://okn.wobd.org/grant/1R01GM122080-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9247297" .
<https://okn.wobd.org/person/african_women_s_cancer_awareness_association_awcaa> <http://schema.org/name> "African Women's Cancer Awareness Association (AWCAA)" .
<https://okn.wobd.org/grant/1R01AI141630-01A1> <http://schema.org/url> "https://reporter.nih.gov/project-details/9818434" .
<https://okn.wobd.org/grant/1P30DK063720-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/6584737" .
<https://okn.wobd.org/grant/1T32AI007384-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_96> <http://schema.org/funding> <https://okn.wobd.org/grant/1P30AI060354-01> .
<https://okn.wobd.org/grant/1DP1AI158186-01> <http://schema.org/identifier> "1DP1AI158186-01" .
<https://www.uniprot.org/taxonomy/2697049> <http://schema.org/name> "Severe acute respiratory syndrome coronavirus 2" .
<https://okn.wobd.org/grant/2U54MD007595-11> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/person/miller_children_s_hospital> <http://schema.org/name> "Miller Children's Hospital" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_211> <http://schema.org/url> "https://radxdatahub.nih.gov/study/211" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_83> <http://schema.org/url> "https://radxdatahub.nih.gov/study/83" .
<https://okn.wobd.org/grant/1P30DK092950-01> <http://schema.org/funder> <https://ror.org/00adh9b73> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_220> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_121> <http://schema.org/datePublished> "2022-09-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/4UH3AI122309-03> <http://schema.org/url> "https://reporter.nih.gov/project-details/9522566" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_151> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_188> <http://schema.org/author> <https://okn.wobd.org/person/sognef_inc> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/55" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR002736-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_175> <http://schema.org/author> <https://okn.wobd.org/person/emory_university> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_62> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/person/nyu> <http://schema.org/name> "NYU" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_38> <http://schema.org/name> "ILI Labels and Longitudinal Novel Engagement with Symptom Surveillance (ILLNESS) Study" .
<https://okn.wobd.org/grant/1P01AI118688-01A1> <http://schema.org/funder> <https://ror.org/043z4tv69> .
<https://okn.wobd.org/grant/1R03DK117252-01> <http://schema.org/name> "Identification of Hepatitis B Virus permissiveness factors" .
<https://okn.wobd.org/grant/1UL1TR002319-01> <http://schema.org/startDate> "2017-06-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01AI121250-01A1> <http://schema.org/name> "IL-33 Blockade as a Novel Therapeutic for T-cell Mediated Hypercytokinemia Syndromes" .
<https://okn.wobd.org/grant/8UL1TR000042-07> <http://schema.org/url> "https://reporter.nih.gov/project-details/8265602" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_128> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_191> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://ror.org/01s5ya894> <http://schema.org/alternateName> "Instituto Nacional de Trastornos Neurológicos y Accidentes Cerebrovasculares" .
<https://okn.wobd.org/person/university_of_illinois_urbana_champaign> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_144> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/grant/1R01AI153044-01A1> <http://schema.org/url> "https://reporter.nih.gov/project-details/10177121" .
<https://okn.wobd.org/grant/1U24TR001608-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9144584" .
<https://okn.wobd.org/person/the_university_of_texas_health_science_center_at_tyler> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/person/froedtert_medical_college_of_wisconsin_clinics_15> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/grant/1R01MH117406-01> <http://schema.org/endDate> "2023-03-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/7P30DK034987-01A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/1UL1TR002541-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9623983" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_87> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/grant/1R01AI155696-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/1U54GM115516-01A1> <http://schema.org/endDate> "2022-06-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/the_jackson_laboratory> <http://schema.org/name> "The Jackson Laboratory" .
<https://okn.wobd.org/grant/1R01GM122080-01> <http://schema.org/identifier> "1R01GM122080-01" .
<https://okn.wobd.org/grant/1U54GM138062-01A1> <http://schema.org/name> "Center for Pacific Innovations, Knowledge, and Opportunities (PIKO)" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_213> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_67> <http://schema.org/sameAs> <https://doi.org/10.60773/cfem-qh07> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_132> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/grant/2UL1TR000427-06> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/1P30AI027763-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/3101081" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_190> <http://schema.org/description> "While public health measures with school closure helped mitigate the spread of COVID-19, Latino children from rural agricultural communities are experiencing learning gaps due to disproportionate access to resources. Analyzing data collected from SARS-CoV-2 test results of students returning to in-person learning in the Yakima School District, combined with risk communication, may provide a mechanism to identify outbreaks early and stop transmission, as well as provide reassurance to families and to staff about the safety of on-site instruction. Risk communication was used as a tool to educate the community on the benefits of the testing program, while addressing social, behavioral, and ethical concerns for testing and vaccine hesitancy to prepare them for vaccine readiness. The study had three aims and involved a clustered randomized controlled trial (RCT) where K-5 elementary schools were the unit of randomization. The study collaborated with Yakima School District in the Yakima area and planned to enroll at least 900 participants. Aim 1. Identify the rural Latino community's social, ethical, behavioral needs and resources for students to return to school and maintain onsite learning using qualitative assessments with school stakeholders, parents, and students. Aim 2. Evaluate the effectiveness of risk communication on student attendance using a cluster randomized controlled trial (RCT) with two intervention arms: current learning model (comparison) and risk communication). Prior to launching Aim 2, a pilot study was conducted in April-June 2021 with one school to understand the implementation steps and workflow. The larger RCT trial was implemented in 14 elementary schools in Fall 2021-Spring 2022 school year. Schools were randomized to receive the intervention (risk communication) or serve as a comparison or control group (continue the current practice). Participants in the intervention group received comic books once every three months. Participants randomly selected into the control group were given comic books at the end of the study. Parents of participants randomized to the Intervention group were given two health educational videos focused on COVID-19 throughout the school year. Caregivers of participants randomized to the control group received the two videos at the end of the study period. Primary outcomes for children were absenteeism (hours per week missing onsite learning). Secondary outcomes were assessed via surveys with 300 parents, with 150 parents of children from the control and 150 parents of children from the intervention group. Parents were asked about their children's physical activity and emotional regulation; parents were assessed for their perceived stress, COVID-related stress, and depressive symptomatology. Secondary outcome survey assessments were optional and offered to participants to be completed at time of enrollment, halfway through the study, and towards the end of the school year. Parents were provided the option to have their children enrolled in the Yakima School District's weekly SARS-CoV-2 testing program, separate from the study. There wase a Data Use Agreement (DTUA) with the Yakima School District's approval to access the SARS-CoV-2 test results of students enrolled in the research study. Access to student test information and results allowed the team to observe the effect that participation in weekly COVID-19 testing had on the primary and secondary outcomes that were assessed in this study. Aim 3. Assess implementation outcomes of the program with school stakeholders, parents, and children guided by the RE-AIM (Reach, Effectiveness, Adoption, Implementation, and Maintenance) framework. Aim 3 occurred after Aim 1 and 2 were completed." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_37> <http://schema.org/name> "COVID-19 Experience Study (C19EX) Survey" .
<https://okn.wobd.org/grant/1P30NS047101-01> <http://schema.org/startDate> "2003-09-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_51> <http://schema.org/dateModified> "2023-06-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/university_of_dayton> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_115> <http://schema.org/datePublished> "2023-08-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_162> <http://schema.org/description> "The primary objective of this study was to design and validate a predictive decision support system for the identification, treatment and management of SARS-CoV-2 associated with multisystem inflammatory syndrome in children (MIS-C). To develop this system, the study adapted and retrained machine learning algorithms which have previously trained in patients with Kawasaki Disease, a pediatric inflammatory vasculopathy with clinical overlap with MIS-C but different etiology. This study, performed in collaboration with the International Kawasaki Disease Registry (IKDR) consortium. This dataset contains the development and international validation data for all algorithms developed as part of this study." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_128> <http://schema.org/sameAs> "10.60773/c9fp-qk33" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_189> <http://schema.org/date> "2023-02-21"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_93> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/grant/1P30ES005022-01> <http://schema.org/startDate> "1988-09-28"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://schema.org/url> <http://www.w3.org/2000/01/rdf-schema#domain> <http://schema.org/Thing> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/funding> <https://okn.wobd.org/grant/1U01HG010961-01> .
<https://okn.wobd.org/grant/1UL1TR002001-01> <http://schema.org/funder> <https://ror.org/04pw6fb54> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_134> <http://schema.org/name> "Getting Asian Americans INFORMED To Facilitate COVID-19 Testing and Vaccination" .
<https://ror.org/012pb6c26> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Organization> .
<https://okn.wobd.org/grant/1U19AI135995-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9455502" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_208> <http://schema.org/sameAs> <https://doi.org/10.60773/86j7-he45> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_213> <http://schema.org/dateCreated> "2023-08-03"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_197> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_162> <http://schema.org/dateCreated> "2022-06-10"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_210> <http://schema.org/datePublished> "2023-12-06"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_143> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR002319-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_108> <http://schema.org/author> <https://okn.wobd.org/person/springside_chestnut_hill_academy> .
<https://okn.wobd.org/grant/1P30AI045008-01> <http://schema.org/endDate> "2004-06-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1P30CA045508-01> <http://schema.org/startDate> "1987-08-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1UL1TR001860-01> <http://schema.org/identifier> "1UL1TR001860-01" .
<https://okn.wobd.org/grant/1R01HG009120-01A1> <http://schema.org/name> "Integrative approaches for mapping the genetic risk of complex traits" .
<https://okn.wobd.org/grant/1U54CA260492-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/1S10OD025082-01> <http://schema.org/startDate> "2018-04-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01HL140898-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/1UL1TR001442-01> <http://schema.org/startDate> "2015-08-13"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_143> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_217> <http://schema.org/url> "https://radxdatahub.nih.gov/study/217" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_111> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/mq9p-yx64> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/54" .
<https://okn.wobd.org/grant/1R01NS076465-01> <http://schema.org/funder> <https://ror.org/00fj8a872> .
<https://ror.org/00adh9b73> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Organization> .
<https://okn.wobd.org/person/pediatric_research_in_inpatient_settings_pris_network> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/person/university_of_hawaii> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/grant/1UL1TR003167-01> <http://schema.org/name> "Center for Clinical and Translational Sciences (CCTS)" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_182> <http://schema.org/author> <https://okn.wobd.org/person/university_of_maryland_school_of_medicine> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_110> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<http://schema.org/identifier> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2000/01/rdf-schema#Literal> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_110> <http://schema.org/dateCreated> "2022-01-06"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/8P51OD011132-52> <http://schema.org/funder> <https://ror.org/00fj8a872> .
<https://okn.wobd.org/grant/1R01HG009518-01A1> <http://schema.org/url> "https://reporter.nih.gov/project-details/9602317" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_38> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_57> <http://schema.org/name> "A Rapid, Sensitive, Point-of-Care, Antigen-Based Diagnostics for SARS-CoV-2" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_143> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_200> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_62> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2901879> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_30> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_76> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/grant/4UH3AI122309-03> <http://schema.org/identifier> "4UH3AI122309-03" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_172> <http://schema.org/author> <https://okn.wobd.org/person/john_hopkins_university> .
<https://okn.wobd.org/person/dartnet> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_176> <http://schema.org/author> <https://okn.wobd.org/person/booker_t_washington_high_school> .
<https://okn.wobd.org/grant/1R01CA234614-01A1> <http://schema.org/url> "https://reporter.nih.gov/project-details/9818992" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_65> <http://schema.org/description> "A novel testing platform that detects SARS-CoV-2 virions in a patient's breath was developed. When a person exhales into the COVID breathalyzer, droplets and other emitted particles are captured by a liquid impactor inside the collection unit. Subsequently, the captured particles were deposited onto a microfluidic chip that contains the nanowell sensors (patent pending) capable of detecting the presence of SARS-CoV-2 virus. The device provided results within a time frame of 20 minutes using an impedance measurement approach. Importantly, the novel platform technology in development could be easily adapted to future needs and challenges, not only as the virus causing COVID-19 evolves in future years, but also to provide multiplexing capabilities to detect multiple viruses in tandem. The target product profile (TPP) of this solution stood out against the current and future standard of care in viral antigen screening tests as a new disposable breathalyzer that is not invasive compared to traditional sampling techniques, is easy to use with rapid point of care results, and has accurate reporting with high sensitivity and specificity." .
<https://okn.wobd.org/grant/1R01AI155696-01> <http://schema.org/endDate> "2025-08-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/216" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_38> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/grant/1R01HL105704-01> <http://schema.org/funder> <https://okn.wobd.org/organization/national_heart_lung_and_blood_institute> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_176> <http://schema.org/author> <https://okn.wobd.org/person/north_miami_high_school> .
<http://schema.org/author> <http://www.w3.org/2000/01/rdf-schema#domain> <http://schema.org/CreativeWork> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_79> <http://schema.org/date> "2024-04-10"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_144> <http://schema.org/funding> <https://okn.wobd.org/grant/7P30DK034987-01A1> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_49> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/NCIT_C189188> .
<https://okn.wobd.org/person/booker_t_washington_high_school> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/grant/75N93021C00016-0-9999-4> <http://schema.org/url> "https://reporter.nih.gov/project-details/10495340" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_130> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/77xd-fh20> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_68> <http://schema.org/sameAs> <https://doi.org/10.60773/67qn-0273> .
<https://okn.wobd.org/person/nationwide_children_s_hospital> <http://schema.org/name> " Nationwide Children's Hospital" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_185> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_177> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_44> <http://schema.org/funding> <https://okn.wobd.org/grant/1U54GM138062-01A1> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_176> <http://schema.org/identifier> "phs003037" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_148> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_66> <http://schema.org/name> "AICORE-kids: Artificial Intelligence COVID-19 Risk AssEssment for kids" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_179> <http://schema.org/funding> <https://okn.wobd.org/grant/1U54GM104942-01> .
<https://okn.wobd.org/grant/1R03DK117252-01> <http://schema.org/startDate> "2018-04-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_123> <http://schema.org/dateModified> "2022-12-02"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1K12NS098482-01> <http://schema.org/name> "Child Neurologist Career Development Program (CNCDP)" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_197> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/k8wj-0k62> .
<https://okn.wobd.org/grant/1U24TR001608-01> <http://schema.org/startDate> "2016-07-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_149> <http://schema.org/sameAs> "10.60773/v97k-6w36" .
<https://okn.wobd.org/person/and_johns_hopkins_university_school_of_medicine_washington_university> <http://schema.org/name> "and Johns Hopkins University School of Medicine: Washington University" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/author> <https://okn.wobd.org/person/valley_childrens_healthcare> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_112> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/jv00-r132> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_177> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_76> <http://schema.org/name> "Community-Based COVID-19 Testing Evaluation" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_115> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01AI135992-01> <http://schema.org/funder> <https://ror.org/043z4tv69> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_217> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://www.uniprot.org/taxonomy/12637> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_43> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/NCIT_C3137> .
<https://ror.org/004a2wv92> <http://schema.org/parentOrganization> "National Institutes of Health" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_220> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/grant/9P30AI050410-04> <http://schema.org/url> "https://reporter.nih.gov/project-details/6321754" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_136> <http://schema.org/sameAs> <https://doi.org/10.60773/1e6t-6b11> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_43> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_99> <http://schema.org/author> <https://okn.wobd.org/person/outreach_community_health_ctr> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_155> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_187> <http://schema.org/sameAs> <https://doi.org/10.60773/eg9v-8e46> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_77> <http://schema.org/url> "https://radxdatahub.nih.gov/study/77" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_159> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/person/university_of_washington> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_197> <http://schema.org/description> "Symptomatic or close-contact participants were enrolled and asked to perform daily tests for 10 days. Each participant performed a rapid antigen test (Quidel or Abbott) followed by home-based sample collection and subsequent highly sensitive RT-qPCR assay (Roche, LOD = 1,800 NDU/mL) performed in a CLIA-certified lab." .
<https://okn.wobd.org/grant/5T32HL007227-10> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://ror.org/0493hgw16> <http://schema.org/alternateName> "NCMHD" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/183" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_146> <http://schema.org/identifier> "phs002870" .
<https://okn.wobd.org/person/university_of_kansas_medical_center> <http://schema.org/name> "University of Kansas Medical Center" .
<https://okn.wobd.org/grant/1P30DK098722-01A1> <http://schema.org/url> "https://reporter.nih.gov/project-details/8975559" .
<https://okn.wobd.org/grant/1UL1TR001860-01> <http://schema.org/name> "UC Davis Clinical and Translational Science Center" .
<https://okn.wobd.org/grant/1R01NS076465-01> <http://schema.org/endDate> "2016-05-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/4UH3OD023365-03> <http://schema.org/url> "https://reporter.nih.gov/project-details/9726635" .
<https://okn.wobd.org/grant/1U54CA132384-01A1> <http://schema.org/name> "Comprehensive SDSU/UCSD Cancer Center Partnership 1 of 2" .
<https://okn.wobd.org/grant/1R01HL149450-01A1> <http://schema.org/identifier> "1R01HL149450-01A1" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_74> <http://schema.org/author> <https://okn.wobd.org/person/university_of_pennsylvania> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_200> <http://schema.org/identifier> "phs003033" .
<https://okn.wobd.org/grant/1UL1TR002736-01> <http://schema.org/endDate> "2023-05-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_208> <http://schema.org/name> "SCALE UP Utah II: Community-Academic Partnership to Address COVID-19 Testing and Vaccination Among Utah Community Health Centers" .
<https://okn.wobd.org/grant/1P30DK063720-01> <http://schema.org/identifier> "1P30DK063720-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_195> <http://schema.org/datePublished> "2023-04-13"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/university_of_california_santa_barbara> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/grant/1R01CA249054-01> <http://schema.org/name> "Clinical and Molecular Heterogeneity in the Myelodysplastic Syndromes" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_113> <http://schema.org/description> "UC San Diego's Superfund Research Center (SRC), supported by the NIEHS Superfund Research Program since 2000, was engaged in research and Public Health initiatives that examined the cumulative impacts of poor nutrition and other health disparities on the etiology of a variety of diseases. The ethnically diverse low-income communities in San Diego SRC engages are predominantly populated by people of color where poverty, pollution, inadequate infrastructure, and structural racism create unhealthy living conditions. These same communities are being ravaged by COVID-19, which is caused by infection by the SARS-CoV-2 virus. With California becoming one of the global pandemic epicenters in the US, coupled with the growing need for rapid COVID-19 testing, SRC partnered with expertise at UC San Diego to develop simple, rapid and inexpensive FDA-authorized COVID-19 testing that were offered using community-driven, contextually relevant strategies to accelerate broad testing uptake among underserved communities in San Diego. While all areas of San Diego County are seeing rising cases of COVID-19 infections, southern San Diego communities along the US-Mexico border, including Chula Vista, Otay Mesa and San Ysidro, are experiencing disproportionate increases in infections. Among these communities, San Ysidro stands out for several reasons. First, it represents one of the poorest communities in San Diego, a condition that drives health disparities. Second, San Ysidro has the highest incidence of COVID-19 cases in San Diego County, even with current (inadequate) levels of testing. Third, San Ysidro is located a significant distance from the major health centers in San Diego, such as UC San Diego Health, and access to adequate testing is problematic. Fourth, San Ysidro is home to San Ysidro Health (SYH), a federally qualified health center that is the largest healthcare delivery system serving San Ysidro residents, and which has a long-standing relationship with UC San Diego. This local health facility has struggled to access COVID-19 testing. Taken together, these factors make San Ysidro a good place to create a prototype two-year community-engaged testing research project. Further, regular prenatal and pediatric care visits were still being conducted to sustain their known positive impacts on pregnancy and child health outcomes; this creates an excellent opportunity to engage families in COVID-19 testing in an otherwise hard-to-reach population. The SYH Maternal and Child Health Center (MCHC) was a busy prenatal and pediatric care site located less than 2 miles from the US-Mexico border, and was the focus of this project. Through a multi-level community-engaged approach and in partnership with a diverse Community and Scientific Advisory Board (CSAB), a set of contextually relevant strategies were developed, implemented, and evaluated. These strategies accelerated the broad delivery and uptake of COVID-19 testing among pregnant women and children and support scaling across the entire San Ysidro community of 27,000 residents. It was hypothesized that the implementation of an extensive and rapid COVID-19 testing program would markedly decrease the disparities experienced by underserved communities in testing access and ultimately in morbidity and mortality from COVID-19." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_180> <http://schema.org/sameAs> "10.60773/ans9-t377" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/funding> <https://okn.wobd.org/grant/1T32CA203702-01A1> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_142> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_174> <http://schema.org/sameAs> "10.60773/kha0-tt06" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_63> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005550> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/74" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_48> <http://schema.org/date> "2024-01-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_71> <http://schema.org/datePublished> "2022-11-07"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_206> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/grant/8P51OD011132-52> <http://schema.org/name> "Support of Yerkes National Primate Research Center" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_162> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100163> .
<https://okn.wobd.org/grant/1R03DK117252-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9510187" .
<https://okn.wobd.org/grant/1P30AI027767-01> <http://schema.org/name> "BIRMINGHAM CENTER FOR AIDS RESEARCH" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_96> <http://schema.org/funding> <https://okn.wobd.org/grant/2P2CHD050924-11> .
<https://okn.wobd.org/grant/1P30ES005022-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/1R35GM138152-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_67> <http://schema.org/datePublished> "2022-11-11"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1DP2DA040254-01> <http://schema.org/name> "Engineering Humoral Immunity to Functionally Cure HIV Infection" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_156> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_60> <http://schema.org/author> <https://okn.wobd.org/person/bristol_myers_squibb_children_s_hospital_robert_wood_johnson_university_hospital> .
<https://okn.wobd.org/grant/75N93021C00016-0-9999-4> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_83> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_108> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/3v5j-f685> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_122> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/694009> .
<https://okn.wobd.org/grant/1U01AI122285-01> <http://schema.org/name> "Microbial, immune, metabolic perturbations by antibiotics (MIME study)" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_184> <http://schema.org/description> "In the United States, underserved and socially vulnerable populations have endured higher rates and disparities of COVID-19 infection, morbidity, and mortality. This disproportionate burden has shown the light on the root causes of COVID-19 disparities such as longstanding systemic racial bias in health care delivery, discrimination, and poor social determinants of health that lead to health disparities for medical conditions such as asthma, diabetes, hypertension, and obesity, all of which increase risk and susceptibility to COVID-19 and its sequalae. To address these root causes, academic and other research institutions and health care systems must shift their lens from one that focuses solely on changing behaviors among underserved and vulnerable populations. Behaviors among health care and research institutions must change to breakdown the structural barriers to trust, testing, treatment, and prevention of COVID-19. Prior to asking patients and community members to trust in research and researchers, the focus should be on radical institutional transformation to advance trustworthiness. Trying to address social, ethical, and behavioral issues (SEBI) influencing access acceptability and uptake of COVID-19 testing during a pandemic is extremely challenging, yet achievable when there are existing community-academic partnerships. The distinction between trust and trustworthiness suggests that trustworthiness is an antecedent to trust. This study employed a continuous engagement approach to advance institutional trustworthiness and improve the strength of an existing community-engaged research (CEnR) partnership. In collaboration with community and community-based pharmacy partners, the purpose was to codesign a sustainable model for trustworthy CEnR partnerships to address SEBI of COVID-19 testing." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_71> <http://schema.org/name> "Identifying Biomarker Signatures of Prognostic Value for Multisystem Inflammatory Syndrome in Children (MIS-C)" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/datePublished> "2022-01-26"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_100> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/1986198> .
<https://okn.wobd.org/grant/1R35GM119774-01> <http://schema.org/name> "Real-time tracking of virus evolution for vaccine strain selection and epidemiological investigation" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_28> <http://schema.org/dateModified> "2024-04-09"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_30> <http://schema.org/date> "2022-12-09"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/morgan_state_university> <http://schema.org/name> "Morgan State University" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_72> <http://schema.org/sameAs> <https://doi.org/10.60773/sqkn-3a50> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_127> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR002538-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_120> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01DA037628-01A1> <http://schema.org/name> "Prevention of Substance Use in At-risk Students: A Family-centered Web Program" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_203> <http://schema.org/name> "Sin Duda: A Community-Driven Approach to Expand Reach, Access and Uptake of COVID-19 Home-Based Tests for At-Risk Latinos" .
<https://okn.wobd.org/grant/1UL1TR001873-01> <http://schema.org/name> "Clinical and Translational Science Award" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_33> <http://schema.org/date> "2024-01-04"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1UL1TR001442-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9085716" .
<https://okn.wobd.org/grant/1R56HL149881-01A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/2U54MD007601-31> <http://schema.org/endDate> "2022-06-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_201> <http://schema.org/identifier> "phs003366" .
<https://okn.wobd.org/person/university_of_dayton> <http://schema.org/name> "University of Dayton" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_162> <http://schema.org/datePublished> "2022-11-07"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://www.uniprot.org/taxonomy/147711> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/grant/1P30MH062246-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/6210396" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_274> <http://schema.org/description> "Vulnerable populations including those with medical comorbidities, people living in rural settings and minorities experience significant COVID-19 disparities. Additionally, Hispanics and Blacks are significantly more likely to be infected and hospitalized when compared to White, Non-Hispanics. This study built on RADx-UP Phases I & Phase II work reaching these populations in three racially diverse regions: Houston/Harris County, South Texas, and Northeast Texas to increase SARS-CoV-2 testing, vaccination, and risk mitigation behaviors to reduce COVID-19 morbidity, mortality, and inequities among underserved populations in Texas. The study leveraged the partnerships and resources of the Center for Clinical and Translational Science (CCTS) including long-standing community partnerships. Phase III included mixed methods and community-engaged approaches to inform adaptation of existing (and the development of new) multilevel intervention messages, materials and strategies with a focus on increasing rapid SARS-CoV-2 testing. It also included a broader focus on addressing the social determinants of health (SDOH) and an emphasis on combating misinformation. Innovative elements of the study included testing a novel approach to optimize community engagement that uses real-time data to inform intervention adaptation and implementation, using advances in social computing and machine learning to better understand patterns of misinformation in social media, and using multilevel social network analysis techniques to increase intervention agility, intensity, and reach. This project had three aims: Aim 1: Expand existing sources of population-based COVID-19 surveillance data to quantify infection, testing and vaccination trends in three Texas regions, and use innovative methods to inform and evaluate the proposed interventions. Aim 2: Adapt and implement the adapted multilevel community just-in-time adaptive intervention (MC-JITAI) to increase SARS-CoV-2 testing, mitigation behaviors, and COVID-19 vaccination, among underserved and vulnerable populations in three regions of Texas and conduct; informed by 1) previously collected data (from Phase II), 2) misinformation monitoring studies, and 3) social network information to improve SARS-CoV-2 testing. Aim 3: Evaluate the adapted (in Aim 2) multilevel community intervention (MC-JITAI) and determine how enhancements based on social networks improves SARS-CoV-2 testing and COVID-19 vaccination, in three regions of Texas. Data shared came from Aim 3 where the intervention was evaluated and were baseline measures of the intervention arm." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_160> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_136> <http://schema.org/identifier> "phs002778" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_130> <http://schema.org/name> "Investigating the Effectiveness of COVID-19 Testing Choices, Community Engagement, and Culturally-Embedded mHealth Literacy Delivery in a Medically-Underserved, Community-Based Sample" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_210> <http://schema.org/url> "https://radxdatahub.nih.gov/study/210" .
<https://okn.wobd.org/grant/1P30DK063720-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/1P30NS047101-01> <http://schema.org/funder> <https://ror.org/01s5ya894> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_115> <http://schema.org/url> "https://radxdatahub.nih.gov/study/115" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_54> <http://schema.org/author> <https://okn.wobd.org/person/iowa_state_university> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_152> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01DA055491-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_166> <http://schema.org/url> "https://radxdatahub.nih.gov/study/166" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_143> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0003265> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_189> <http://schema.org/description> "In the US, COVID-19 unveiled a disproportionate health burden in low income and underserved segments of society. In Louisiana, some of the greatest health and economic consequences are evident in Black communities. Furthermore, despite the widespread availability of SARS-CoV-2 vaccines, approximately 30% of the US population reports that they will not get vaccinated, and Black citizens and those with lower socio-economic status are more likely to have vaccine hesitancy. Thus, there is an urgent need to address vaccine hesitancy within the context of the COVID-19 pandemic and the current testing environment. The Louisiana Clinical and Translational Science (LA CaTS) Center provides the essential infrastructure and key foundational support for biomedical research in the region and is uniquely positioned to lead a community-engaged research project to determine solutions to decrease vaccine hesitancy and improve testing rates in the most underserved populations. Faith-based organizations (churches, mosques, temples, etc.) are trusted sources of information, especially among Black communities, and may represent an opportunity to convey accurate, unbiased health information regarding COVID-19 vaccinations and testing to the community. Many Black churches have well-developed health ministries that integrate faith and health for their members and the communities they serve. This study used a mixed-methods study design to determine the effectiveness of training church health ministers to educate their congregations about the safety and efficacy of COVID-19 vaccines for decreasing vaccine hesitancy and improving testing knowledge in underserved Black communities. The study randomized 98 participants from five churches to an intervention group that received counseling from their health ministers on the benefits of getting vaccinated and tested, or to a delayed intervention control group. The effects of the intervention on the primary outcome, vaccine hesitancy measured by a questionnaire, were administered to both groups after three weeks. Following the three-week control period, the delayed intervention control group also received the intervention and again administered the questionnaire. The study then conducted focus groups among a sub-sample of participants to obtain more granular information on sources of vaccine hesitancy and for their vaccine-related decisions. The achievement of the study's goals significantly increased the understanding of vaccine hesitancy within Black urban communities in Louisiana. The results informed the development of targeted interventions to increase vaccine coverage in the large, underserved populations across the American South." .
<https://okn.wobd.org/grant/1R01CA193776-01> <http://schema.org/identifier> "1R01CA193776-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_110> <http://schema.org/date> "2024-08-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_96> <http://schema.org/sameAs> "10.60773/yrkh-gy81" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_143> <http://schema.org/funding> <https://okn.wobd.org/grant/8UL1TR000042-07> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_67> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/grant/1R01CA193776-01> <http://schema.org/endDate> "2020-04-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_35> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_152> <http://schema.org/url> "https://radxdatahub.nih.gov/study/152" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_210> <http://schema.org/name> "Rapid Optimization of COVID-19 Testing for People Affected by Diabetes" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_53> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_101> <http://schema.org/funding> <https://okn.wobd.org/grant/1UM1AI106716-01> .
<https://okn.wobd.org/grant/1U54CA260492-01> <http://schema.org/startDate> "2020-09-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/79" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_274> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_138> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/person/csula> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_199> <http://schema.org/datePublished> "2023-08-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/169" .
<https://okn.wobd.org/grant/2P2CHD050924-11> <http://schema.org/endDate> "2020-08-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_146> <http://schema.org/datePublished> "2023-08-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_194> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005550> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_187> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_191> <http://schema.org/datePublished> "2023-08-29"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/kids_frankford_friends> <http://schema.org/name> "Kids (Frankford Friends" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_113> <http://schema.org/dateModified> "2024-04-10"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_127> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://ror.org/012pb6c26> <http://schema.org/identifier> "https://ror.org/012pb6c26" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_163> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_53> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/person/university_of_connecticut> <http://schema.org/name> "University of Connecticut" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_48> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/dwzp-am60> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_83> <http://schema.org/name> "Community Network-Driven COVID-19 Testing of Vulnerable Populations in the Central US (C3)" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_145> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_33> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/person/greynolds_park_elementary> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_79> <http://schema.org/sameAs> "10.60773/3gd9-km98" .
<https://okn.wobd.org/grant/1R01AI146165-01A1> <http://schema.org/name> "Epigenetic Profiling of circulating cell-free DNA for the Monitoring of Graft-Versus-Host Disease after Hematopoietic Cell Transplantation" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_88> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/7x5v-ym43> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_188> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_221> <http://schema.org/datePublished> "2024-09-13"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/fulford_elementary> <http://schema.org/name> "Fulford Elementary" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_127> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/170" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/112" .
<https://okn.wobd.org/grant/1DP2DA040254-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/8968056" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_186> <http://schema.org/sameAs> <https://doi.org/10.60773/0h5r-v081> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_44> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01MD016593-01> .
<https://okn.wobd.org/grant/1UL1TR002014-01> <http://schema.org/identifier> "1UL1TR002014-01" .
<https://ror.org/0493hgw16> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Organization> .
<https://ror.org/006zn3t30> <http://schema.org/alternateName> "NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases" .
<https://ror.org/00fj8a872> <http://schema.org/alternateName> "OD" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_75> <http://schema.org/sameAs> "10.60773/v9jf-fj56" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_90> <http://schema.org/datePublished> "2023-08-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1U19AI135995-01> <http://schema.org/identifier> "1U19AI135995-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_159> <http://schema.org/identifier> "phs002920" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_52> <http://schema.org/description> "Developing next generation technology to simplify wastewater RNA extraction and quantification makes wastewater surveillance feasible and scalable in facilities and rural communities. Wastewater testing for SARS-CoV-2 in rural communities using field-friendly technology provides important information to local authorities and citizens about the spread and trend of SARS-CoV-2 infection in their communities. This project accomplished two aims: 1) Develop next generation wastewater assessment technology, and 2) Implement and evaluate the next generation wastewater assay. Aim 1 adapted technology termed exclusion-based sample preparation (ESP) to simplify and improve RNA extraction from wastewater. ESP was paired with loop-mediated isothermal amplification (LAMP) technology for RNA detection to create a sensitive, robust, and field-friendly platform for testing wastewater for SARS-CoV-2 RNA. The next generation assay was compared with established techniques on metrics of sensitivity, specificity, and usability (e.g., assay time, number of assay steps). Aim 2 first validated the next generation assay in the field at congregate living facilities in a side-by-side comparison with conventional wastewater surveillance. Next, building on existing relationships in Eastern Kentucky, a purposive group of wastewater treatment plant operators, watershed watch citizen scientists, and school science teachers were recruited and trained to test wastewater in their communities and schools using the field-friendly next generation wastewater assay. Field results were validated in the lab. A robust mixed methods evaluation using the RE-AIM framework assessed community perceptions of feasibility, acceptability, and utility of wastewater surveillance for SARS-CoV-2 and identified community measures taken in response to test results." .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/218" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_130> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01DE026471-01A1> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_156> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR002373-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_125> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01MH117406-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_29> <http://schema.org/datePublished> "2024-08-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_180> <http://schema.org/sameAs> <https://doi.org/10.60773/ans9-t377> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_156> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_114> <http://schema.org/funding> <https://okn.wobd.org/grant/1K12NS098482-01> .
<https://okn.wobd.org/person/clemson_university> <http://schema.org/name> "Clemson University" .
<https://okn.wobd.org/grant/1R01DK113642-01A1> <http://schema.org/url> "https://reporter.nih.gov/project-details/9317645" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_140> <http://schema.org/datePublished> "2023-08-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_136> <http://schema.org/dateModified> "2023-05-16"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://www.uniprot.org/taxonomy/114727> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_87> <http://schema.org/url> "https://radxdatahub.nih.gov/study/87" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/author> <https://okn.wobd.org/person/long_beach> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_86> <http://schema.org/url> "https://radxdatahub.nih.gov/study/86" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_114> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_81> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/person/uab_children_s_of_alabama> <http://schema.org/name> "UAB Children's of Alabama" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_195> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_215> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005550> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_68> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/NCIT_C94552> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/214" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_118> <http://schema.org/sameAs> "10.60773/wqc5-e480" .
<https://okn.wobd.org/person/oregon_health_science_university> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://ror.org/04xeg9z08> <http://schema.org/alternateName> "NIMH" .
<http://purl.obolibrary.org/obo/MONDO_0100163> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/grant/1P30DK098722-01A1> <http://schema.org/funder> <https://ror.org/00adh9b73> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_97> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_127> <http://schema.org/sameAs> <https://doi.org/10.60773/y7xk-ma85> .
<https://okn.wobd.org/person/sable_palm_elementary> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/grant/8UL1TR000002-07> <http://schema.org/funder> <https://ror.org/04pw6fb54> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/83" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_137> <http://schema.org/description> "SARS-CoV-2 infection exhibits a wide range of clinical outcomes in both children and adults, from asymptomatic and mild disease to severe viral pneumonia, ARDS, acute kidney injury, thrombotic disorders, and serious cardiac, cerebrovascular and vascular complications. It is now known that severe infection can occur both in young children and young adults (<21) and that nearly 40% of those who are admitted Covid-19 require ICU support, including mechanical ventilation. One of the most severe manifestations of SARS-CoV-2 infection is the multisystem inflammatory syndrome in children (MIS-C), a serious condition associated with severe inflammation with multi-organ involvement that can result in a variety of clinical presentations including pneumonia, sepsis, coagulation abnormalities, and renal/kidney failure. Thus, novel approaches for early and accurate diagnosis of COVID-19 associated syndromes and evaluation of clinical severity and outcomes of COVID-19 disease in children were urgently needed. This study identified RNA transcriptomic and cell-free DNA omics biomarkers that were used to develop and validate host-based assays from nasal swab and blood samples, with the goal of regulatory submission for FDA Emergency Use Authorization (EUA)." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_150> <http://schema.org/date> "2024-04-10"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_135> <http://schema.org/sameAs> "10.60773/2ndc-4822" .
<https://okn.wobd.org/grant/1R01CA193776-01> <http://schema.org/funder> <https://ror.org/040gcmg81> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/name> "RADx Data Hub" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_189> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_67> <http://schema.org/sameAs> "10.60773/cfem-qh07" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_199> <http://schema.org/description> "This study tested an adaptation of the HIV Continuum of Prevention, Care, and Treatment Framework (CoPCT) for use in tracking COVID-19 testing and follow-up in a medically and socially vulnerable population. Utilizing the integrated research collaborative framework that facilitates dialogue among researchers, community members, and service providers as a tool for optimizing the adaptive intervention, this study took place at the North Jersey Community Research Initiative (NJCRI). The Multiphase Optimization Strategy (MOST) was used to optimize an adaptive intervention that successfully navigates COVID-19 medically or socially vulnerable people through a continuum of prevention, care and treatment (CoPCT) modeled on the HIV CoPCT. The COVID-19 CoPCT starts with testing and continues with successful adherence to prevention or treatment guidelines to help prevent and/or treat COVID-19. The study assessed the effectiveness of Navigation Services compared to referrals in increasing COVID-19 testing and Brief Counseling in increasing adherence to the State of NJ recommendations for COVID-19 prevention and treatment. The effect of Critical Dialogue on testing behavior among people who decline to be tested for COVID-19 was also examined. The investigators developed decision rules about what evidence-based-interventions work best for what types of people (e.g., those who test right away, versus decliners) and in what period of the COVID-19 continuum. This study shed light on factors associated with testing and adherence to NJ recommendations. Investigators followed Community Based Participatory Research principles in implementing a sequential, multiple assignment randomized trial (SMART) design." .
<https://okn.wobd.org/grant/1U54GM104940-01> <http://schema.org/endDate> "2017-06-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://www.uniprot.org/taxonomy/2839062> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/grant/8G12MD007595-04> <http://schema.org/identifier> "8G12MD007595-04" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_121> <http://schema.org/dateModified> "2024-04-09"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/see_attached_list> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_196> <http://schema.org/sameAs> "10.60773/6hh3-jr12" .
<https://okn.wobd.org/grant/1ZIAAI001175-01> <http://schema.org/identifier> "1ZIAAI001175-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_28> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_206> <http://schema.org/name> "RADx Tech COVID-19 Viral Dynamics/COVID Detect" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_47> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/vbbc-kt11> .
<https://okn.wobd.org/grant/1T32EB009380-01> <http://schema.org/startDate> "2009-07-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_146> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_43> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_99> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1P30CA042014-01> <http://schema.org/funder> <https://ror.org/040gcmg81> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_180> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/ans9-t377> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/funding> <https://okn.wobd.org/grant/1TL1TR001871-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_44> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/usvi> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_74> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/grant/1UL1TR000460-01A1> <http://schema.org/endDate> "2017-05-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_162> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/694009> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_148> <http://schema.org/dateCreated> "2022-04-18"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/56" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_54> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_182> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/8bdv-2c25> .
<https://okn.wobd.org/person/montefiore> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_134> <http://schema.org/dateCreated> "2022-01-29"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_59> <http://schema.org/date> "2022-12-09"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_271> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_118> <http://schema.org/description> "The purpose of this study was to test the performance of the Saliva Test device in detecting SARS-CoV-2 in symptomatic people for Emergency Use Authorization (EUA) as a point-of-care (POC) test. The 2322 Saliva Test was a rapid real-time RT-PCR test intended for the qualitative detection of RNA from the SARS-CoV-2 virus in saliva specimens from individuals suspected of SARS-CoV-2 infection by a healthcare professional. There were three studies under the banner of 2322 (2322a, 2322b1, and 2322b2). The test device underwent algorithmic changes after 2322a and thus was renamed 2322b. After partial enrollment eligibility criteria widened and the 2322b study adopted a 1 or 2 to designate the change in eligibility. Note: no device performance data were included in the dataset." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_125> <http://schema.org/url> "https://radxdatahub.nih.gov/study/125" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_125> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/an3v-wq86> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_59> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0019526> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_59> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01GM120553-01> .
<https://okn.wobd.org/person/maria_fareri_children_s_hospital_at_westchester_medical_center> <http://schema.org/name> "  Maria Fareri Children's Hospital at Westchester Medical Center" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_129> <http://schema.org/identifier> "phs002761" .
<https://okn.wobd.org/grant/1P42ES010337-01> <http://schema.org/identifier> "1P42ES010337-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_108> <http://schema.org/datePublished> "2022-11-07"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1UM1HG008898-01> <http://schema.org/funder> <https://ror.org/00baak391> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_203> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_159> <http://schema.org/sameAs> "10.60773/ksgc-r355" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_168> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/grant/5P30CA008748-20> <http://schema.org/url> "https://reporter.nih.gov/project-details/3101248" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_70> <http://schema.org/description> "Wastewater based testing (WBT) holds great promise for cost-effective population surveillance and transmission tracking of SARS-CoV-2 but optimal sampling modalities and protocols are unknown. Taking advantage of a diverse inner city urban campus encompassing undergraduate, postgraduate dorms, research buildings and medical facilities, this project included optimization of WBT surveillance strategies for waste streams at the building level, surrounding sewersheds, and wastewater treatment plants, as well as modeling of case counts using normalized WBT data. Metatranscriptomics approaches were applied to track circulating and emerging SARS-CoV-2 variants and to develop point-of-use microfluidics systems for timely WBT." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_271> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/grant/1UL1TR001873-01> <http://schema.org/startDate> "2016-07-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_67> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/cfem-qh07> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_118> <http://schema.org/author> <https://okn.wobd.org/person/university_of_iowa> .
<https://ror.org/00372qc85> <http://schema.org/alternateName> "NIH National Institute of Biomedical Imaging & Bioengineering" .
<https://okn.wobd.org/grant/1U01HG010971-01> <http://schema.org/startDate> "2019-09-18"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_101> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<http://purl.obolibrary.org/obo/MONDO_0019526> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_129> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_127> <http://schema.org/description> "This proposal tested the hypothesis that frequent screening testing would provide additional benefit, beyond current school-based mitigation strategies, to prevent SARS-CoV-2 transmission. This study completed a cluster randomized trial to compare the incidence of school-based SARS-CoV-2 transmission between weekly surveillance testing of students and school staff versus testing only symptomatic students and staff. In this proposal, 12 middle and high schools from five predominantly African-American school districts in the St. Louis metropolitan area were cluster randomized to screening testing plus symptomatic testing versus symptomatic testing alone. This study performed qualitative listening sessions and interviews with members of the school community including parents, teachers, administrators, and students to understand the facilitators and barriers to testing, the concerns regarding in-person school, and potential issues involving vaccine hesitancy evident in all populations and groups. This study provided critically needed, rigorous data to inform the utility of screening testing in schools and if it is important in aiding schools in the African-American community to return to in-person instruction. Additionally, the measurements of school-based transmission rates helped participating schools in the African-American community assess the impact of their mitigation strategies, demonstrated potential risk points for transmission that can be targeted for further intervention, and reassured the community on the safety of their schools. Finally, the study results aided participating researchers, school districts and communities in understanding how to mitigate concerns about in-person schooling and the reliability of the mitigation strategies (with or without screening testing) in preventing COVID-19 transmission." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_206> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2901879> .
<https://ror.org/043z4tv69> <http://schema.org/parentOrganization> "National Institutes of Health" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_40> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_130> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_161> <http://schema.org/dateCreated> "2022-05-19"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_204> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2901879> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_173> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/grant/5T32GM007618-08> <http://schema.org/endDate> "1988-06-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01AI163029-01> <http://schema.org/endDate> "2026-06-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://www.uniprot.org/taxonomy/9606> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_75> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_100> <http://schema.org/url> "https://radxdatahub.nih.gov/study/100" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_199> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1K08AR073339-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9504877" .
<https://okn.wobd.org/grant/9P30AI050410-04> <http://schema.org/funder> <https://ror.org/04byxyr05> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_163> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_208> <http://schema.org/identifier> "phs003368" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_68> <http://schema.org/dateModified> "2024-01-18"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_130> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/grant/1R35GM119850-01> <http://schema.org/startDate> "2016-07-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_125> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_179> <http://schema.org/sameAs> "10.60773/8s4e-d179" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/134" .
<https://okn.wobd.org/grant/1P30DK045735-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_83> <http://schema.org/sameAs> "10.60773/mx0a-y046" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_147> <http://schema.org/sameAs> "10.60773/02m0-qe56" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_213> <http://schema.org/url> "https://radxdatahub.nih.gov/study/213" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_74> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01GM122080-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_45> <http://schema.org/identifier> "phs002581" .
<https://okn.wobd.org/person/university_of_nebraska_medical_center> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_199> <http://schema.org/dateCreated> "2023-05-16"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_83> <http://schema.org/description> "Community network-driven COVID-19 testing of vulnerable populations in the Central US (C3) implemented and evaluated a COVID-19 testing approach that combines an evidence-based Social Network Testing Strategy (SNS) with community developed COVID-19 public health messages (SNS+). C3 engaged two disenfranchised populations across rural and urban sites in states across the Central US (TX, LA, AR, IN, IL). C3 leveraged NIDA's Justice Community Opioid Innovation Network (JCOIN), the PIs' extensive community located COVID-19 testing programs, and a network of established community partnerships. The collaborative community-academic partnerships, research and engagement infrastructure, and team's leadership across JCOIN ensured that C3 could rapidly recruit, enroll and test most disenfranchised community members, (n=2400) and through this process, accelerate any forthcoming COVID-19 public health prevention interventions. C3 focused on two communities most impacted by COVID-19: 1) Criminal justice involved (CJI)-non-incarcerated people with previous history of arrest/jail/prison, probation/parole and drug-court attendance; and 2) Low-income Latinx community members at 250% or below Federal Poverty Level. Both of these diverse populations, and the overlap between them, have some of the highest rates of COVID-19 infection and death in the United States. Messaging that affirms individual agency and corrects misinformation, combined with accessible and acceptable testing, was required to accelerate COVID-19 prevention for these populations. Contextually adapted and theory-driven messages – misinformation correction and self-affirmation – were used to increase awareness, self-efficacy and community engagement in the adapted testing strategy, the Social Network testing Strategy (SNS). SNS is an evidence-based testing intervention that has been widely used in multiple settings with marginalized individuals (i.e. substance-users) who facilitate the recruitment of their social contacts into testing services. SNS combined with theory-driven, contextually appropriate COVID-19 messaging (SNS+) address challenges to current COVID-19 testing strategies which are limited by misinformation, stigma, distrust, and limited affirmation of ability to prevent COVID-19. C3 in partnership with community: Developed COVID-19 messages that emphasize self-affirmation and misinformation correction for implementation in SNS; Tested the efficacy (number of network members COVID-19 tested) of a combined SNS-messaging (SNS+) intervention versus standard SNS using adaptive randomization; and Evaluated C3 implementation strategies and key implementation outcomes (i.e. cost) using the RE-AIM framework. The disenfranchised populations to be engaged in C3 reflected those most impacted by COVID-19 and least able to adopt COVID-19 prevention practices. C3 was shovel-ready for implementation in the short time frame of the RADx-UP mechanism, with significant institutional commitments and community support, to ensure the procedures and interventions were tailored, feasible, acceptable and effective for at-risk communities." .
<https://okn.wobd.org/grant/1U01DA053941-01> <http://schema.org/funder> <https://ror.org/00fj8a872> .
<https://okn.wobd.org/person/north_miami_middle_school> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_108> <http://schema.org/name> "SCENTinel: A Rapid Smell Test for COVID-19 Surveillance" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_149> <http://schema.org/funding> <https://okn.wobd.org/grant/3P50HD103525-01S1> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_78> <http://schema.org/identifier> "phs002567" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_54> <http://schema.org/dateModified> "2023-04-28"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_52> <http://schema.org/dateModified> "2023-10-23"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_71> <http://schema.org/identifier> "phs002609" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_150> <http://schema.org/sameAs> "10.60773/qyrm-p781" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_30> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_219> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_274> <http://schema.org/dateCreated> "2024-06-28"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1U01AI122285-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9037283" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_124> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_117> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_117> <http://schema.org/dateCreated> "2022-01-06"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01DA013806-01> <http://schema.org/identifier> "1R01DA013806-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_78> <http://schema.org/sameAs> <https://doi.org/10.60773/ddc6-ar41> .
<https://okn.wobd.org/person/university_of_arkansas_for_medical_sciences> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/grant/1UL1TR002538-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9623976" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_184> <http://schema.org/name> "Community Mistrust and Measures of Institutional Trustworthiness (COMMIT)" .
<https://okn.wobd.org/grant/1UL1TR003107-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9893085" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/39" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_125> <http://schema.org/name> "Epidemiologic Intelligence Network (EpI-Net) to Promote COVID-19 Testing and Prevention Practices Among Socially Vulnerable Communities in Puerto Rico" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_156> <http://schema.org/url> "https://radxdatahub.nih.gov/study/156" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_136> <http://schema.org/datePublished> "2022-07-20"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_35> <http://schema.org/date> "2024-01-03"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_219> <http://schema.org/sameAs> <https://doi.org/10.60773/w561-ag09> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_139> <http://schema.org/identifier> "phs002786" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_108> <http://schema.org/author> <https://okn.wobd.org/person/fox_subacute_care> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_86> <http://schema.org/sameAs> <https://doi.org/10.60773/s0km-xf55> .
<https://okn.wobd.org/grant/1P30MH062246-01> <http://schema.org/identifier> "1P30MH062246-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_67> <http://schema.org/url> "https://radxdatahub.nih.gov/study/67" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_52> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_162> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0016168> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_31> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_274> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2901879> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_69> <http://schema.org/name> "Virus Counter: Rapid and Sensitive Diagnostics Based on Digital Detection of Individual Pathogens" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/description> "The University of Miami (UM), with three primary campuses in Miami, Florida, was geographically spread within one of the worst COVID-19 hotbeds at the time of study. UM deployed an elaborate human surveillance testing, tracking, and tracing (3T) system to monitor the student body, faculty, and staff. The 3T system included a major hospital that is part of UM and that treats COVID-19 patients. To augment the COVID-19 monitoring system, UM deployed a pilot wastewater surveillance program for detecting SARS-CoV-2 from clusters of buildings on campus. Weill Cornell Medicine (WCM) is located in New York City, NY, an area that (at the time of study) had one of the worst outbreaks of COVID-19. WCM established an international consortium for SARS-CoV-2 environmental surveillance, including in NYC and globally with the MetaSUB Consortium, which created metagenomic and metatranscriptomic maps of the world's sewage. Based on this work at both UM and WCM, the aim of the project was to develop, implement, and demonstrate effective and predictive wastewater surveillance by optimizing sampling, concentration, and detection strategies. Working closely with the RADx-rad Data Coordination Center (DCC), work under application SF-RAD included the development and implementation of data standards and informatics infrastructure and performing integrative analyses that made all data, results, and models available to the community, thus providing a critical contribution to the national SARS-COV-2 RADx-rad Wastewater Detection Consortium. The objectives were addressed through three aims. Aim 1: Data Standardization, focused on developing and implementing data standards and quality metrics, and establishing the operational infrastructure to manage SARS-CoV-2 wastewater-based surveillance datasets and metadata. Aim 2: Wastewater Characterization, focused on optimizing wastewater surveillance protocols and parameters for wastewater sampling, sample concentration, and viral detection technologies. Aim 3: Integration with Human Health Surveillance, focused on metatranscriptomic analyses and on the integration of wastewater quantification data with community and hospital COVID-19 prevalence, to develop predictive models to detect local and community level spread of COVID-19. The results from this project developed and deployed experimental and informatics infrastructure and operations as part of the national RADx-rad SARS-CoV-2 wastewater surveillance network and provided a proof-of-concept implementation to use wastewater for infectious disease surveillance for early detection of localized COVID-19 outbreaks." .
<https://okn.wobd.org/grant/1UL1TR002736-01> <http://schema.org/name> "Miami Clinical and Translational Science Institute" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_190> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/NCIT_C35041> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_109> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_183> <http://schema.org/sameAs> "10.60773/38sx-dw45" .
<https://okn.wobd.org/grant/1P30AI073961-01> <http://schema.org/endDate> "2012-05-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_170> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/cwrf-q204> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_181> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_54> <http://schema.org/author> <https://okn.wobd.org/person/university_of_florida> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_121> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/grant/1UL1TR001878-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9261656" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_41> <http://schema.org/sameAs> <https://doi.org/10.60773/w5vb-c640> .
<https://okn.wobd.org/person/seattle_children_s> <http://schema.org/name> "Seattle Children's" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_115> <http://schema.org/sameAs> "10.60773/1scn-wv48" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_46> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_27> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/hz9w-yy91> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_65> <http://schema.org/sameAs> <https://doi.org/10.60773/vprs-gc97> .
<https://okn.wobd.org/grant/1P30ES030285-01> <http://schema.org/identifier> "1P30ES030285-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_109> <http://schema.org/datePublished> "2022-07-27"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_132> <http://schema.org/datePublished> "2023-08-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_181> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_101> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/n328-4344> .
<https://okn.wobd.org/grant/1KL2TR003108-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_65> <http://schema.org/identifier> "phs002583" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_78> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/ddc6-ar41> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_43> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01AI123538-01A1> .
<https://okn.wobd.org/grant/1KL2TR003108-01> <http://schema.org/endDate> "2024-06-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_196> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/NCIT_C3038> .
<https://okn.wobd.org/grant/1S10OD018499-01> <http://schema.org/funder> <https://ror.org/00fj8a872> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_84> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/grant/1UL1TR002366-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/1R01AI129709-01A1> <http://schema.org/url> "https://reporter.nih.gov/project-details/9412645" .
<https://okn.wobd.org/grant/1UL1TR003142-01> <http://schema.org/startDate> "2019-07-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/50" .
<https://okn.wobd.org/grant/1T32CA203702-01A1> <http://schema.org/funder> <https://ror.org/040gcmg81> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_134> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_201> <http://schema.org/url> "https://radxdatahub.nih.gov/study/201" .
<https://okn.wobd.org/grant/3OT2HL156812-01S2> <http://schema.org/funder> <https://okn.wobd.org/organization/national_heart_lung_and_blood_institute> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_212> <http://schema.org/datePublished> "2024-07-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01AI088364-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/7866123" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_168> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_69> <http://schema.org/url> "https://radxdatahub.nih.gov/study/69" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_114> <http://schema.org/dateModified> "2022-12-09"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.obolibrary.org/obo/MONDO_0005240> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/grant/1R01AI121250-01A1> <http://schema.org/identifier> "1R01AI121250-01A1" .
<https://okn.wobd.org/person/arch_creek_elementary> <http://schema.org/name> "Arch Creek Elementary" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_77> <http://schema.org/sameAs> "10.60773/amzc-p035" .
<https://okn.wobd.org/grant/1R01GM120553-01> <http://schema.org/endDate> "2021-07-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/st_thomas_east_end_medical_center_st_thomas> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_211> <http://schema.org/name> "Collaborative Community Networks to Optimize Implementation of Low Barrier COVID-19 Testing Efforts Among Diverse Latinx Populations in Northern California" .
<https://okn.wobd.org/grant/1R01AI123105-01A1> <http://schema.org/url> "https://reporter.nih.gov/project-details/9154447" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_157> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_137> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005550> .
<https://okn.wobd.org/grant/1P30ES023513-01A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_145> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_78> <http://schema.org/datePublished> "2023-08-29"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_178> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/grant/1R01CA249054-01> <http://schema.org/startDate> "2020-04-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_218> <http://schema.org/dateModified> "2024-03-04"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_192> <http://schema.org/author> <https://okn.wobd.org/person/albert_einstein_college_of_medicine> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_143> <http://schema.org/datePublished> "2023-08-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_114> <http://schema.org/description> "COVID-19, a global pandemic due to its rapid progression, is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). There are different assays for COVID-19 testing, including nucleic acid, serological, antigen, and ancillary tests used in hospitals. In this study, a biochip assay that can simultaneously detect SARS-CoV-2 protein and RNA from biofluids by using surface markers, and simultaneously detect/quantify target proteins and RNA at single virus resolution was developed. Amplification of the signals were achieved by targeting different regions of the viral RNA (e.g., viral nucleocapsid N1, N2), and a tyramide signal amplification (TSA) assay for viral surface proteins. To demonstrate the clinical utility of the technology, it was deployed and tested using different biofluids, including NPS, and saliva from COVID-19 patients." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_109> <http://schema.org/sameAs> "10.60773/kt6c-e369" .
<https://okn.wobd.org/grant/1R01AI125416-01> <http://schema.org/startDate> "2016-06-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/funding> <https://okn.wobd.org/grant/7R01HG010040-02> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_73> <http://schema.org/datePublished> "2023-08-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_135> <http://schema.org/description> "Latinos in Florida account for over 30% of all COVID-19 cases and hospitalizations. Most Latinos live in rural areas, work as migrant farmworkers and have higher rates of underlying medical conditions, limited access to health care, and live in circumstances that interfere with implementation of community mitigation measures, all potentially leading to increased risk of COVID-19 exposure, morbidity and mortality. The community partner, the Hispanic Services Council (HSC) trained local promotoras de salud (community health workers), and in the past two years has reached 5,900 underserved Latino immigrant families in SW Florida. Recently, HSC promotoras reached over 300 Latino families to ask about the impact of COVID-19 on their health and well-being. The study built on ongoing partnership (R34At010661-01) with HSC and the promotoras to collect data using mixed methods to assess healthcare, social, economic, and contextual factors that influence the ability and willingness to get tested for COVID-19 and/or vaccinated. The findings guided products, including community education and population-specific marketing strategies, to improve testing and vaccination uptake. In partnering with and sharing information with other NOSI recipients the study hoped to increase testing for COVID-19 across diverse communities in the USA and to inform targeted implementation of COVID-19 vaccines. AIM 1: To work with the community partner, HSC and promotoras to examine in southwest Florida rural Latino migrant and immigrant communities, the multilevel barriers that affect COVID-19 testing and vaccine uptake at individual, interpersonal, institutional (e.g., health care system) and community levels. Aim 1a. Qualitative focus groups (in 4 rural cities) will be facilitated by promotora partners using interview guides informed by an NIMHD framework and existing COVID-19 relevant measures. Aim 1b. Facilitators and barriers identified in Aim 1a and responses to questions that are adapted from existing questionnaires will be used to predict willingness for COVID-19 testing and vaccination (in n = 500 rural Latinos), as well as actual testing behavior. Exploratory moderators will be investigated. AIM 2: Determine strategies to address social determinants of health (SDOH) that present barriers to participation in testing, testing follow-up and vaccine uptake to inform development of intervention strategies to increase access to and acceptability of testing and vaccine behavior in rural Latino groups. Aim 2a. Based on Aim 1, community engagement strategies will be formulated to inform culturally sensitive implementation of testing and vaccines for Florida's rural Latino population. Products including education materials for improved COVID-19 health literacy and social marketing strategies will be developed. Aim 2b. Charlas (informal group conversations, n = 50) facilitated by promotoras will provide feedback on potential products. Findings will lead to further product refinement, which can then be implemented by HSC in the Latino communities they serve, while being evaluated for effectiveness by the research group." .
<https://okn.wobd.org/person/16th_street_community_health_ctr> <http://schema.org/name> "16th Street Community Health Ctr" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_199> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_68> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_44> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_59> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_96> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_82> <http://schema.org/identifier> "phs002584" .
<https://okn.wobd.org/grant/1P30AI036214-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/2072354" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_186> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1DP1AI158186-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_27> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_170> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005550> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_179> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_197> <http://schema.org/dateCreated> "2023-03-24"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_199> <http://schema.org/url> "https://radxdatahub.nih.gov/study/199" .
<https://okn.wobd.org/grant/1R21AI129851-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_199> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_214> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_149> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_36> <http://schema.org/url> "https://radxdatahub.nih.gov/study/36" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_68> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://ror.org/04pw6fb54> <http://schema.org/identifier> "https://ror.org/04pw6fb54" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_55> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/person/fred_hutchinson_cancer_research_center> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/211" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_57> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/8jx9-5s54> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_58> <http://schema.org/funding> <https://okn.wobd.org/grant/1P01HL114471-01A1> .
<https://okn.wobd.org/grant/1UL1TR002538-01> <http://schema.org/endDate> "2023-02-28"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_45> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/11709> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_83> <http://schema.org/author> <https://okn.wobd.org/person/howard_brown_health_center> .
<https://okn.wobd.org/grant/1R01CA234614-01A1> <http://schema.org/startDate> "2019-08-19"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R35GM138152-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/10029180" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_207> <http://schema.org/author> <https://okn.wobd.org/person/inc> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_150> <http://schema.org/funding> <https://okn.wobd.org/grant/1U24TR001608-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_48> <http://schema.org/dateModified> "2024-01-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01AI121250-01A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/65" .
<http://purl.obolibrary.org/obo/MONDO_0005377> <http://schema.org/name> "nephrotic syndrome" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_85> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/c7y1-s751> .
<https://okn.wobd.org/grant/1UL1TR003167-01> <http://schema.org/startDate> "2019-07-24"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_62> <http://schema.org/url> "https://radxdatahub.nih.gov/study/62" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_132> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_174> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_142> <http://schema.org/description> "Until the advent of treatment or a vaccine, the ability to contain COVID-19 relied on widespread identification of (asymptomatic) positive cases, their subsequent quarantine, and contact tracing of those potentially exposed. Therefore testing efforts must be targeted to those highly vulnerable yet unserved populations, including individuals who use opioids and other substances. These individuals may have had poor respiratory or pulmonary health due to substance use (e.g. opioids, methamphetamine), which may have made them more susceptible to the virus. Also, these individuals were also more likely to have been incarcerated, or reside on the street, in shelters or in crowded accommodation, further placing them at risk for transmission. This study proposed research to establish efficacy and sustainability of a community-social network outreach model that partnered infectious disease health providers with community based organizations to successfully implement (reach, uptake, delivery and sustainment) COVID-19 point of service, rapid-testing among a highly vulnerable and often underserved population, those who use opioids and other substances. Two distinct social network recruitment strategies with demonstrated efficacy identifying hidden populations and increasing uptake of HIV testing will be adapted and compared. Guided by the EPIS framework, social cognitive theory, and Andersen's model, this study comprised three phases. Phase 1: Adaptation of outreach recruitment strategies, worked with the project community advisory board (CAB) to adapt chain-referral and credible messenger strategies for uptake of COVID-19 testing, to finalize recruitment and on-site testing protocols, and to train the CAB in the new protocols and in continuous quality improvement strategies (Aim 1). Phase 2: Strategy Efficacy Trial and Implementation Evaluation, compared the two strategies in a cross-over design at two community based organizations (CBOs) with longstanding history of serving hard-to-reach populations in their communities. The comparison of strategies was not to identify the statistical superiority of one sampling strategy in providing population estimates over the other, but instead to identify the ability of each recruitment strategy to reach the target population and increase uptake of COVID-19 tests. This study examined the impact of each strategy on (i) reach (recruitment of target population), (ii) COVID-19 testing/repeat testing, and (iii) service delivery (i.e. quarantine, medical care and contact tracing) among those who test positive for COVID-19 (exploratory) (Aim 2). Phase 3: Sustainment, CBOs implemented the strategy proven efficacious based on outcomes, and this study examined their sustainment of the program (Aim 3). Implementation evaluation identified participant-, staff-, and organizational-level factors that influence the feasibility, acceptability, and sustainability of each strategy in these CBOs. (Aim 4). This investigation provided much needed information to improve health outcomes and to identify effective system-level responses to prevent or arrest the spread of COVID-19 among the social networks of those who use opioids and other substances, a highly vulnerable and often overlooked population." .
<https://okn.wobd.org/person/indiana_university_of_school_of_medicine> <http://schema.org/name> "Indiana University of School of Medicine" .
<http://schema.org/name> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2000/01/rdf-schema#Literal> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_135> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://ror.org/03q21mh05> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Organization> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_195> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_201> <http://schema.org/sameAs> <https://doi.org/10.60773/18dv-6j23> .
<https://okn.wobd.org/grant/1T32AI007291-01A1> <http://schema.org/startDate> "1986-09-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_160> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_179> <http://schema.org/dateCreated> "2022-09-06"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_113> <http://schema.org/dateCreated> "2022-01-06"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/69" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_111> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_40> <http://schema.org/datePublished> "2024-04-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_137> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01AI153044-01A1> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_33> <http://schema.org/url> "https://radxdatahub.nih.gov/study/33" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_167> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_112> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_135> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_213> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_158> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_200> <http://schema.org/url> "https://radxdatahub.nih.gov/study/200" .
<https://okn.wobd.org/grant/1DP2AI138242-01> <http://schema.org/name> "Precision monitoring of kidney transplants via single-cell and single-molecule sequencing" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_186> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/0h5r-v081> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_220> <http://schema.org/name> "Increasing COVID-19 Vaccine Uptake Through a Patient Navigation Intervention Among Underserved Populations" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_177> <http://schema.org/name> "Southeast Asians in the US: Health Equity and Research to Understand COVID-19 Stories (SEA US, HEAR US)" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_167> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/83zk-vv89> .
<https://okn.wobd.org/grant/1R01EB025022-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_120> <http://schema.org/name> "Ultra-Sensitive Immunoassay Test for Quantitation of SARS-CoV-2 Antigen" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_201> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/funding> <https://okn.wobd.org/grant/5T32GM007618-08> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_204> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/1986198> .
<https://ror.org/01y3zfr79> <http://schema.org/alternateName> "NINR" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_117> <http://schema.org/description> "Presently, the application of molecular technology such as RT-qPCR and digital PCR (dPCR) to quantify SARS-CoV-2 and related targets in wastewater is cumbersome, time-consuming, and costly. While progress has been made on the development of methods and the interpretation of data, much remains to be improved for the technology to be used as a public health management tool. A major drawback in the current approaches are: 1) the lack of streamlined and consistent pre-analytical processing steps, 2) coverage across the relevant targets requires a high number of reactions (>20) from any single sample to provide quantitative information, and 3) a lack of vision of the development of a pathogen/marker panel, much like those used in clinical arenas, for interpretation of the data across different states, regions and nations. The goal of this project was to successfully navigate these three limitations toward development of an advanced digital array PCR system as part of the development of public health warning system that is not dependent on clinical testing and has the ability to rapidly address novel pathogen thrust in the future." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_140> <http://schema.org/funding> <https://okn.wobd.org/grant/1U54GM104942-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_79> <http://schema.org/datePublished> "2023-08-29"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_132> <http://schema.org/author> <https://okn.wobd.org/person/usvi> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_48> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_86> <http://schema.org/name> "Rapid Acceleration of Acceptable COVID Testing and Care Options for NYC Public Housing Residents (RADx NYCHA)" .
<https://okn.wobd.org/grant/1P20GM121342-01A1> <http://schema.org/startDate> "2018-09-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_191> <http://schema.org/name> "Mobile Health-Targeted SARS-CoV-2 Testing and Community Interventions to Maximize Migrant Children's School Attendance During the COVID-19 Pandemic" .
<https://okn.wobd.org/grant/1U54CA132384-01A1> <http://schema.org/url> "https://reporter.nih.gov/project-details/7591872" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_61> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/grant/1R21AI133331-01> <http://schema.org/name> "Host-Pathogen Interactions From Measurements of Urinary Cell Free DNA in Kidney Transplantation" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_83> <http://schema.org/datePublished> "2023-08-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.obolibrary.org/obo/MONDO_0005015> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_35> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/grant/1R01GM089784-01A1> <http://schema.org/endDate> "2015-03-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_123> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/m294-pw55> .
<https://okn.wobd.org/person/university_of_illinois_urbana_champaign_and_northwestern_university> <http://schema.org/name> "University of Illinois Urbana-Champaign and Northwestern University" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_221> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/grant/1R01MH113094-01> <http://schema.org/name> "In situ transcriptome imaging in single cells" .
<https://okn.wobd.org/person/howard_brown_health_center> <http://schema.org/name> "Howard Brown Health Center" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_172> <http://schema.org/sameAs> <https://doi.org/10.60773/cghr-4117> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_169> <http://schema.org/date> "2024-01-18"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01HG011274-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_52> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<http://purl.obolibrary.org/obo/MONDO_0016168> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/grant/1UM1AI106716-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/8555005" .
<https://okn.wobd.org/grant/1U54GM104942-01> <http://schema.org/startDate> "2012-08-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/175" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_81> <http://schema.org/description> "This 2-arm clustered, randomized community trial tested a multilevel, COVID-19 testing and linkage to care (e.g., health insurance, medical appointments, community resources, contact tracing) intervention against a nontailored, attention-control condition on uptake of COVID-19 testing with adult African American church-affiliated members at 6 months. Contact tracing approval (beliefs and participation contact tracing) and COVID-19 prevention behaviors were also examined. Findings from this study could provide a theory-based, multilevel model for delivering scalable, wide-reaching COVID-19 testing and linkage to care services, including contact tracing, by supporting African American faith leaders with culturally-appropriate, easy-to-use tools and health agency partnerships." .
<https://okn.wobd.org/grant/1R01AI129709-01A1> <http://schema.org/identifier> "1R01AI129709-01A1" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_214> <http://schema.org/name> "Empowering Schools as Community Assets to Mitigate the Adverse Impacts of COVID-19" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_75> <http://schema.org/funding> <https://okn.wobd.org/grant/1U54GM104942-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_60> <http://schema.org/identifier> "phs002569" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_135> <http://schema.org/name> "Social, Ethical, and Behavioral Implications Research on COVID-19: Testing and Vaccine Uptake Among Rural Latino Migrants in Southwest Florida" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/149" .
<https://okn.wobd.org/grant/75N93021C00015-0-9999-2> <http://schema.org/url> "https://reporter.nih.gov/project-details/10397343" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_182> <http://schema.org/sameAs> "10.60773/8bdv-2c25" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_79> <http://schema.org/identifier> "phs002568" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_77> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/grant/1R01AI135992-01> <http://schema.org/identifier> "1R01AI135992-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_210> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/NCIT_C16880> .
<https://okn.wobd.org/grant/1UL1TR002373-01> <http://schema.org/endDate> "2022-06-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_207> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_126> <http://schema.org/url> "https://radxdatahub.nih.gov/study/126" .
<https://okn.wobd.org/grant/1R01ES028615-01> <http://schema.org/name> "Gene X Environment Interactions in the Pathogenesis of Uterine Fibroids" .
<https://okn.wobd.org/grant/1K08AR073339-01> <http://schema.org/endDate> "2023-03-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/3P50HD103525-01S1> <http://schema.org/startDate> "2020-07-28"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_188> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_34> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_44> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/grant/1P30NS047101-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/6702967" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_41> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://schema.org/includedInDataCatalog> <http://www.w3.org/2000/01/rdf-schema#range> <http://schema.org/DataCatalog> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_137> <http://schema.org/dateModified> "2024-01-18"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_31> <http://schema.org/dateModified> "2024-04-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_79> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_183> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_140> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_210> <http://schema.org/identifier> "phs003373" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_53> <http://schema.org/dateModified> "2022-12-09"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01DK113642-01A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_145> <http://schema.org/sameAs> "10.60773/swwm-cp96" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_139> <http://schema.org/sameAs> "10.60773/wtx3-4882" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_44> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://ror.org/01s5ya894> <http://schema.org/alternateName> "The National Institute of Neurological Disorders and Stroke" .
<https://okn.wobd.org/grant/1U01DA053941-01> <http://schema.org/name> "Development and Proof-of-Concept Implementation of the South Florida Miami RADx-rad SARS-CoV-2 Wastewater-Based Surveillance Infrastructure" .
<https://okn.wobd.org/grant/1U54GM138062-01A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://ror.org/04xeg9z08> <http://schema.org/alternateName> "Instituto Nacional de la Salud Mental" .
<https://okn.wobd.org/grant/1R01DK107585-01A1> <http://schema.org/funder> <https://ror.org/00adh9b73> .
<https://okn.wobd.org/grant/1UL1TR002736-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_73> <http://schema.org/name> "Keeping Rural Minority 'Essential' Workplaces Open Safely During the COVID-19 Pandemic: The Role of Frequent Point-of-Care Molecular Workplace Surveillance for Miners (The Miners' Pandemic Project)" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_183> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_166> <http://schema.org/author> <https://okn.wobd.org/person/inc> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_43> <http://schema.org/funding> <https://okn.wobd.org/grant/2T32CA009140-11> .
<https://okn.wobd.org/grant/1P30MH062246-01> <http://schema.org/funder> <https://ror.org/04xeg9z08> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_101> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01DA013806-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_166> <http://schema.org/datePublished> "2023-08-29"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_28> <http://schema.org/url> "https://radxdatahub.nih.gov/study/28" .
<https://okn.wobd.org/grant/1R01HL124209-01A1> <http://schema.org/identifier> "1R01HL124209-01A1" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100130> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/207" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_162> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_181> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/prjv-tg60> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_127> <http://schema.org/datePublished> "2023-08-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_195> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/76" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_121> <http://schema.org/sameAs> "10.60773/v1k1-md20" .
<https://ror.org/00j4k1h63> <http://schema.org/alternateName> "NIEHS" .
<https://okn.wobd.org/person/uab_children_s_of_alabama> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://www.uniprot.org/taxonomy/12637> <http://schema.org/name> "Dengue virus" .
<https://okn.wobd.org/grant/1UM1HG008898-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9049025" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_192> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_62> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/grant/1R01HL149450-01A1> <http://schema.org/endDate> "2023-06-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_111> <http://schema.org/date> "2024-04-10"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/author> <https://okn.wobd.org/person/university_of_hawaii> .
<https://okn.wobd.org/grant/1DP1AI158186-01> <http://schema.org/startDate> "2020-09-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_153> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_76> <http://schema.org/funding> <https://okn.wobd.org/grant/1KL2TR003108-01> .
<http://purl.obolibrary.org/obo/MONDO_0100096> <http://schema.org/name> "COVID-19" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_176> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_116> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/7P30DK034987-01A1> <http://schema.org/endDate> "1989-11-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://ror.org/0493hgw16> <http://schema.org/name> "National Institute on Minority Health and Health Disparities" .
<https://okn.wobd.org/grant/1R01AI088364-01> <http://schema.org/identifier> "1R01AI088364-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_28> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_97> <http://schema.org/sameAs> <https://doi.org/10.60773/6kbx-7v76> .
<https://okn.wobd.org/grant/1U54GM138062-01A1> <http://schema.org/identifier> "1U54GM138062-01A1" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/156" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_113> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/grant/3T32GM083937-01A1S1> <http://schema.org/url> "https://reporter.nih.gov/project-details/7883874" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_182> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_205> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_170> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/NCIT_C3038> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_53> <http://schema.org/datePublished> "2022-08-05"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_93> <http://schema.org/sameAs> "10.60773/85ty-n986" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/funding> <https://okn.wobd.org/grant/1R35GM119850-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_93> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_58> <http://schema.org/dateModified> "2024-01-18"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1UL1TR001860-01> <http://schema.org/funder> <https://ror.org/04pw6fb54> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_145> <http://schema.org/dateCreated> "2022-04-18"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_86> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_81> <http://schema.org/url> "https://radxdatahub.nih.gov/study/81" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_201> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/grant/1T32EB028092-01A1> <http://schema.org/identifier> "1T32EB028092-01A1" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_202> <http://schema.org/name> "Social, Behavioral, and Ethical Implications of COVID-19" .
<https://okn.wobd.org/grant/1R01AI135992-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9455427" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_119> <http://schema.org/url> "https://radxdatahub.nih.gov/study/119" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_202> <http://schema.org/identifier> "phs003365" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_47> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2971083> .
<https://ror.org/01s5ya894> <http://schema.org/alternateName> "National Institute of Neurological Disorders & Stroke" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_65> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/person/nyu_grossman_school_of_medicine> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_52> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_132> <http://schema.org/author> <https://okn.wobd.org/person/puerto_rico> .
<https://ror.org/04q48ey07> <http://schema.org/identifier> "https://ror.org/04q48ey07" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_28> <http://schema.org/sameAs> "10.60773/54ae-xy13" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_176> <http://schema.org/author> <https://okn.wobd.org/person/j_f_k_middle_school> .
<https://okn.wobd.org/grant/1UL1TR002366-01> <http://schema.org/startDate> "2017-09-07"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_119> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1K08AR073339-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_86> <http://schema.org/datePublished> "2023-08-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://www.uniprot.org/taxonomy/147711> <http://schema.org/name> "Rhinovirus A" .
<https://ror.org/00fj8a872> <http://schema.org/parentOrganization> "National Institutes of Health" .
<https://okn.wobd.org/grant/1S10OD023527-01> <http://schema.org/startDate> "2017-05-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_80> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_86> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/s0km-xf55> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_213> <http://schema.org/sameAs> "10.60773/pp0p-gj15" .
<http://schema.org/distribution> <http://www.w3.org/2000/01/rdf-schema#range> <http://schema.org/DataDownload> .
<https://ror.org/006zn3t30> <http://schema.org/identifier> "https://ror.org/006zn3t30" .
<https://okn.wobd.org/grant/1T32AI007384-01> <http://schema.org/startDate> "1990-08-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0012727> .
<https://okn.wobd.org/grant/9P30AI050410-04> <http://schema.org/funder> <https://okn.wobd.org/organization/national_heart_lung_and_blood_institute> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_39> <http://schema.org/description> "The purpose of this study was to better understand behavioral and physiological functioning in relation to recent self-reported influenza and influenza-like-illness (ILI), including coronavirus disease (COVID-19). Over 65,000 Achievement members responded to a weekly one-click survey asking if they had experienced ILI within the previous 7-day period. If they responded no, they were given the option to complete a survey about their risk factors and behavior. If they responded yes, they were given the option to complete a survey asking about the specifics of the incident. Participants were also asked to sync their wearable activity trackers and health apps in order for researchers to better understand changes in behavioral and physiological outcomes related to self-reported ILI experiences." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/funding> <https://okn.wobd.org/grant/1P01CA214274-01A1> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_152> <http://schema.org/dateCreated> "2022-04-20"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1U54GM115677-01> <http://schema.org/identifier> "1U54GM115677-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_118> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/grant/1P30AI060354-01> <http://schema.org/funder> <https://ror.org/043z4tv69> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_88> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/grant/1R01NS076465-01> <http://schema.org/name> "Epigenome Interactions in Complex Neurogenetic Disorders" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_190> <http://schema.org/funding> <https://okn.wobd.org/grant/3P50HD103525-01S1> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_119> <http://schema.org/sameAs> "10.60773/2seb-yr47" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_155> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/grant/8UL1TR000002-07> <http://schema.org/startDate> "2006-09-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1U54GM104942-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/8339639" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_137> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_37> <http://schema.org/description> "This study was conducted virtually through the Achievement studies platform during the current COVID-19 pandemic. Participants were asked to complete a survey every day to capture information about whether they had experienced symptoms corresponding to respiratory, influenza-like-illness (ILI), and COVID-19 infections within the previous 24-hour period, their experiences with the healthcare system, treatments, diagnostic testing, and their behaviors and potential risk factors. Participants were also asked to share their wearable activity tracker data. The purpose of this study was to better understand the geographic spread of diseases, impacts on daily life, and behavioral and physiological functioning in relation to recent self-reported respiratory disease, ILI, and coronavirus disease (COVID-19) events." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_210> <http://schema.org/author> <https://okn.wobd.org/person/georgia_institute_of_technology> .
<https://okn.wobd.org/person/yale_pediatric_genomics_discovery_program> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_65> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/vprs-gc97> .
<https://okn.wobd.org/grant/1U01HG010971-01> <http://schema.org/funder> <https://ror.org/00baak391> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_80> <http://schema.org/sameAs> "10.60773/dp9b-t353" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_60> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/7R01HG010040-02> <http://schema.org/startDate> "2018-11-16"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1U19NS112953-01> <http://schema.org/identifier> "1U19NS112953-01" .
<http://purl.obolibrary.org/obo/NCIT_C143827> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_28> <http://schema.org/datePublished> "2022-08-12"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_141> <http://schema.org/url> "https://radxdatahub.nih.gov/study/141" .
<https://okn.wobd.org/grant/1U01HG010961-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9904877" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_144> <http://schema.org/datePublished> "2023-08-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_137> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_84> <http://schema.org/url> "https://radxdatahub.nih.gov/study/84" .
<https://www.uniprot.org/taxonomy/1986198> <http://schema.org/name> "Coronaviridae sp." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_219> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/funding> <https://okn.wobd.org/grant/1R21AI133331-01> .
<https://okn.wobd.org/grant/1S10OD018499-01> <http://schema.org/startDate> "2014-08-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_130> <http://schema.org/datePublished> "2023-08-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R21AI129851-01> <http://schema.org/startDate> "2017-09-04"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_57> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_202> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_149> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_48> <http://schema.org/identifier> "phs002523" .
<https://okn.wobd.org/grant/1R21AI129851-01> <http://schema.org/identifier> "1R21AI129851-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_161> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<http://schema.org/author> <http://www.w3.org/2000/01/rdf-schema#range> <http://schema.org/Person> .
<https://okn.wobd.org/grant/1R25EB020393-01A1> <http://schema.org/identifier> "1R25EB020393-01A1" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_181> <http://schema.org/description> "Among those at highest risk for exposure to COVID-19 is the large population of frontline essential workers (FEW) in lower status occupations (e.g., retail, in-home health care), among whom Black and Latino/Hispanic (BLH) persons are over-represented. For those not vaccinated for COVID, regular COVID-19 screening testing is recommended even when asymptomatic for those with frequent close contact with others in indoor settings such as FEW. However, BLH-FEW experience serious impediments to COVID-19 testing and testing\nrates are lower among BLH than White populations. This community-engaged study was led by a collaborative team at New York University and the Northern Manhattan Improvement Corporation (NMIC). Its main goal was to optimize a behavioral intervention to boost COVID-19 testing rates for BLH-FEW. Consistent with RFA-OD-21-008, the study used the multiphase optimization strategy (MOST) framework to test four candidate intervention components grounded in past research. Participants will be N=448 BLH-FEW who have not been tested for COVID-19 in the past six months and who are not vaccinated for COVID-19, randomly assigned to an intervention condition, and assessed at 6- and 12-weeks post-baseline." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_30> <http://schema.org/name> "A Rapid Saliva Antigen Test for SARs-CoV-2 Detection" .
<https://okn.wobd.org/grant/1R01HD106120-01> <http://schema.org/funder> <https://ror.org/04byxyr05> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/53" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/213" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_202> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/person/louisiana_state_university_of_health_sciences_center> <http://schema.org/name> "Louisiana State University of Health Sciences Center" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_37> <http://schema.org/date> "2024-04-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_52> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2901879> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_184> <http://schema.org/sameAs> <https://doi.org/10.60773/5b7f-0206> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_120> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/grant/1R01HL124209-01A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_34> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_153> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_59> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_41> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_172> <http://schema.org/author> <https://okn.wobd.org/person/umass_chan_medical_school> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_40> <http://schema.org/date> "2024-04-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1S10OD023527-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<http://purl.obolibrary.org/obo/MONDO_0800175> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_172> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://www.uniprot.org/taxonomy/114727> <http://schema.org/name> "H1N1 subtype" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_151> <http://schema.org/sameAs> "10.60773/1tqv-dv25" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_204> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_100> <http://schema.org/sameAs> <https://doi.org/10.60773/sx9p-ww84> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_39> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_209> <http://schema.org/identifier> "phs003371" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_146> <http://schema.org/funding> <https://okn.wobd.org/grant/3P50HD103525-01S1> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_121> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_205> <http://schema.org/funding> <https://okn.wobd.org/grant/3P50HD103525-01S1> .
<https://okn.wobd.org/grant/1R01AI123538-01A1> <http://schema.org/startDate> "2017-01-25"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01AI135992-01> <http://schema.org/endDate> "2022-12-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.obolibrary.org/obo/NCIT_C101788> <http://schema.org/name> "Lipopolysaccharide" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_59> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/grant/1UL1TR003167-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_172> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/grant/1R01AI088364-01> <http://schema.org/startDate> "2010-04-06"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01DK107585-01A1> <http://schema.org/endDate> "2021-08-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_136> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_92> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01AI129709-01A1> <http://schema.org/startDate> "2017-12-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/children_s_hospital_los_angeles> <http://schema.org/name> "Children's Hospital Los Angeles" .
<https://okn.wobd.org/grant/1R35GM119774-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_51> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/NCIT_C16880> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_167> <http://schema.org/identifier> "phs002948" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_78> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_58> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/grant/75N93021C00016-0-9999-4> <http://schema.org/identifier> "75N93021C00016-0-9999-4" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_216> <http://schema.org/sameAs> "10.60773/hwkn-r448" .
<https://ror.org/004a2wv92> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Organization> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_55> <http://schema.org/author> <https://okn.wobd.org/person/penn_state_university> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01AI088364-01> .
<https://okn.wobd.org/grant/1U54GM104940-01> <http://schema.org/funder> <https://ror.org/04q48ey07> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_211> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/wydm-qa91> .
<https://okn.wobd.org/grant/1R01ES021006-01A1> <http://schema.org/identifier> "1R01ES021006-01A1" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_136> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/grant/2R37AI051652-06> <http://schema.org/funder> <https://ror.org/043z4tv69> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_90> <http://schema.org/name> "COVID-19 Large Network Center" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_133> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_84> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_210> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<http://purl.obolibrary.org/obo/MONDO_0044339> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/person/inc_and_university_of_illinois_hospital_and_health_system> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/grant/1UL1TR002014-01> <http://schema.org/funder> <https://ror.org/04pw6fb54> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_76> <http://schema.org/sameAs> <https://doi.org/10.60773/1835-3770> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_110> <http://schema.org/sameAs> "10.60773/rqhz-1a60" .
<https://okn.wobd.org/grant/1DP2AI138242-01> <http://schema.org/endDate> "2022-03-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_219> <http://schema.org/url> "https://radxdatahub.nih.gov/study/219" .
<https://ror.org/040gcmg81> <http://schema.org/identifier> "https://ror.org/040gcmg81" .
<https://okn.wobd.org/person/university_of_maryland_school_of_medicine> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_147> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR002541-01> .
<https://okn.wobd.org/grant/8P20GM103395-12> <http://schema.org/identifier> "8P20GM103395-12" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_70> <http://schema.org/dateModified> "2022-12-09"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/90" .
<https://okn.wobd.org/grant/1UL1TR001878-01> <http://schema.org/identifier> "1UL1TR001878-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_63> <http://schema.org/dateModified> "2023-05-26"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01MH117406-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9579504" .
<https://okn.wobd.org/grant/1DP2GM137418-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9782565" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_145> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_192> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2901879> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_137> <http://schema.org/funding> <https://okn.wobd.org/grant/1U01DA053941-01> .
<https://okn.wobd.org/grant/1U01AI069918-01> <http://schema.org/endDate> "2011-06-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1UL1TR001866-01> <http://schema.org/name> "Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_86> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005550> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_179> <http://schema.org/description> "As of June 30, 2021, 23% of West Virginia's (WV) 55 counties were ranked within the top 20% of most vulnerable counties to COVID-19 in the United States. Central to the state's extreme vulnerability is higher prevalence of medical comorbidities, lower access to care among rural populations, and decreased vaccine uptake compared to urban counterparts. Of considerable concern, testing has decreased statewide to allow for active dispersal of the vaccines. Unfortunately, low testing compounds vulnerability to COVID-19 in medically underserved populations where vaccine uptake is low, as they are extremely susceptible to persistent localized outbreaks of the virus and subsequently higher morbidity and mortality. The RADx-UP Phase Two proposal built upon previously funded RADx-UP Phase One by identifying and targeting vaccine desert communities then tailoring testing event services to the needs of individual communities building upon their perceptions of what is important. Providing a dynamic solution for continued testing is critical. This study defined vaccine deserts using overall vaccination rate and the change in vaccine uptake over a two-week period. Machine learning with time series modeling was used to characterize county level transmissibility, incorporating here for the first-time vaccination rates. Risk estimates at the county level were overlaid with zip codes where vaccine deserts have been identified using bottom decile for overall vaccination rate and change in vaccination over a 14-day period. Once a community was identified, study liaisons connected study staff to advocates to conduct semi-structured interviews to identify partner sites to host testing events and collect data to tailor promotions, food, and media messaging to the specific needs of each community targeted. Testing events involved sample and survey data collection, with promotions and chance giveaways to incentivize communities to participate. The study built upon RADx-UP one activity by focusing heavily on first responders in each community to aid in hosting testing events, and faith based and on profits where applicable. The study involved co-investigators with strong connections to southern WV, an area with limited resources for RADx-UP Phase One. Additionally, this study conducted a pilot study to examine the performance of the ABBOTT ID Now isothermal PCR system in 600 participants. Effect of the intervention was evaluated through monitoring of pre and post testing rate for the county using spatial regression analyses. A unique attribute of the statistical framework that proposed to evaluate the testing strategy was an ability to describe the impact on nearby counties in addition to the targeted community. This project leveraged existing and developed its own unique partnerships with local and state agencies for implementation of a community engaged testing delivery model within vaccine deserts. A critical and novel aspect of this approach is establishment of a grass roots first responders research network which can be leveraged to implement screening programs in isolated medically underserved communities or study first responder health outcomes." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_129> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/33" .
<https://okn.wobd.org/grant/8UL1TR000042-07> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/1R21AI129851-01> <http://schema.org/funder> <https://ror.org/043z4tv69> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_43> <http://schema.org/date> "2022-12-09"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_147> <http://schema.org/name> "Implementation Science Center in Cancer Control Equity: A Competitive Revision to Accelerate COVID Testing in Vulnerable Communities - Project 08" .
<https://ror.org/04q48ey07> <http://schema.org/parentOrganization> "National Institutes of Health" .
<https://okn.wobd.org/person/mit> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_69> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_148> <http://schema.org/sameAs> <https://doi.org/10.60773/r2zx-gw24> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_122> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/grant/3OT2HL156812-01S2> <http://schema.org/identifier> "3OT2HL156812-01S2" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_211> <http://schema.org/description> "This project evaluated community-engaged approaches to improving access and uptake of COVID-19 testing among majority Latinx communities in Northern California, and to understanding local epidemiology and factors driving the stark ethnic disparities observed in COVID-19 case rates. In Aim 1, the project evaluated implementation of a Latino Task Force (LTF) collaborative network across 3 counties in California (Marin, Merced and San Francisco), adapted from San Francisco's LTF model to promote locally-adapted COVID-19 test and respond initiatives in two majority-Latinx communities: one suburban (Marin) and one rural (Merced). In Aim 2, the project determined the population-level prevalence of active (PCR+) SARS-CoV-2 infection, most at-risk subgroups, and attitudes and preferences of community members regarding COVID-19 testing services during baseline mass testing campaigns at the Marin and Merced sites. The campaigns offered testing to all community residents regardless of symptoms at easily accessible venues, implemented in partnership with each site's LTF. In Aim 3 (pending NIH approval for change in scope), the study evaluated implementation of community-responsive COVID-19 testing strategies, delivered by local community health workers (promotoras) and tailored to the needs of the two study communities post-COVID-19 vaccine scale-up in Northern California." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_158> <http://schema.org/url> "https://radxdatahub.nih.gov/study/158" .
<https://okn.wobd.org/grant/1P30ES030285-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/1R01AI121250-01A1> <http://schema.org/funder> <https://ror.org/043z4tv69> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_138> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_206> <http://schema.org/description> "The COVID Detect/COVID-19 viral dynamics study was planned and performed to assess SARS-CoV-2 viral dynamics in early infection, accuracy/persistence of SARS-CoV-2 antigen/PCR testing, clinical aspects of mild COVID-19, and potential SARS-CoV-2 transmission dynamics or risk factors. This study included a cohort of adult students and employees of University of Illinois Urbana-Champaign (UIUC) and Northwestern University who tested positive for SARS-CoV-2 as part of campus surveillance programs (isolation participants) or close contacts (particularly roommates) of individuals testing positive for SARS-CoV-2 (quarantine participants). Isolation participants were enrolled within 24 hours of positive testing and quarantine participants were enrolled within 5 days of last known exposure. All participants were required to have negative campus surveillance testing within 7 days of enrollment. Isolation participants completed daily surveys and collected observed nasal swabs and saliva (UIUC only) for 14 days. Quarantine participants completed daily surveys and collected samples for 7 days if SARS-CoV-2 RT-PCR remained negative; if converted positive by SARS-CoV-2 PCR, they collected daily samples for full 14 days. Each day of sample collection were analyzed as follows: nasal swab for SARS-CoV-2 POC Quidel antigen, nasal swab into VTM for SARS-CoV-2 Roche RT-PCR, saliva for SARS-CoV-2 PCR (UIUC only), and nasal swab into VTM for storage and subsequent whole genome virus sequencing and viral culture assay." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_147> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/grant/8UL1TR000002-07> <http://schema.org/name> "UC Davis Clinical and Translational Science Center" .
<https://okn.wobd.org/grant/1U01AI069918-01> <http://schema.org/identifier> "1U01AI069918-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_132> <http://schema.org/identifier> "phs002741" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_149> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/tca1-nb16> .
<https://okn.wobd.org/person/the_ann_robert_h_lurie_children_s_hospital_of_chicago> <http://schema.org/name> "The  Ann & Robert H. Lurie Children's Hospital of Chicago" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_176> <http://schema.org/funding> <https://okn.wobd.org/grant/3P50HD103525-01S1> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_85> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_72> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<http://schema.org/affiliation> <http://www.w3.org/2000/01/rdf-schema#range> <http://schema.org/Organization> .
<https://okn.wobd.org/grant/1K01MH112436-01> <http://schema.org/name> "Social-structural and spatial determinants of HIV testing and linkage to care among high risk women in Tanzania" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_197> <http://schema.org/url> "https://radxdatahub.nih.gov/study/197" .
<https://okn.wobd.org/grant/1T32HD044355-01> <http://schema.org/endDate> "2008-04-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_137> <http://schema.org/funding> <https://okn.wobd.org/grant/8P20GM103395-12> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_209> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/96jm-wg84> .
<https://okn.wobd.org/person/central_michigan_university> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_65> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2901879> .
<https://okn.wobd.org/grant/1R01CA249054-01> <http://schema.org/identifier> "1R01CA249054-01" .
<https://okn.wobd.org/grant/1R01DA037628-01A1> <http://schema.org/endDate> "2020-01-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/grant/1S10OD023527-01> <http://schema.org/identifier> "1S10OD023527-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_202> <http://schema.org/url> "https://radxdatahub.nih.gov/study/202" .
<https://okn.wobd.org/grant/1P30AI045008-01> <http://schema.org/startDate> "1999-07-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_220> <http://schema.org/sameAs> "10.60773/cpws-7m93" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_206> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/grant/1P30DK098722-01A1> <http://schema.org/identifier> "1P30DK098722-01A1" .
<https://okn.wobd.org/grant/5T32GM007618-08> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_45> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_196> <http://schema.org/dateCreated> "2023-03-24"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_170> <http://schema.org/funding> <https://okn.wobd.org/grant/1U19NS112953-01> .
<https://okn.wobd.org/grant/1U01HG010961-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_117> <http://schema.org/date> "2024-01-18"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/url> "https://radxdatahub.nih.gov/study/56" .
<https://okn.wobd.org/grant/1K23AI121485-01A1> <http://schema.org/endDate> "2021-05-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.obolibrary.org/obo/NCIT_C3038> <http://schema.org/name> "Fever" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_189> <http://schema.org/dateModified> "2023-02-21"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_111> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/person/springside_chestnut_hill_academy> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_206> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_146> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/grant/1R01HL140898-01> <http://schema.org/endDate> "2022-11-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_99> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_112> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/person/j_f_k_middle_school> <http://schema.org/name> "J.F.K. Middle School" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/dateModified> "2024-01-18"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_34> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_210> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0011122> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_205> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_46> <http://schema.org/name> "Understanding the COVID-19, Racism, and Violence Syndemic and Its Effects on COVID-19 Testing Disparities" .
<https://okn.wobd.org/grant/1U54GM115677-01> <http://schema.org/funder> <https://ror.org/04q48ey07> .
<https://okn.wobd.org/grant/1R35GM141535-01> <http://schema.org/endDate> "2026-05-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/2U54MD007595-11> <http://schema.org/endDate> "2023-12-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01GM089784-01A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_212> <http://schema.org/name> "Community Activation to TrAnsform Local sYSTems (CATALYST)" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_60> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_63> <http://schema.org/description> "The goal of the project was to develop a pipeline for automatic detection and tracing of active SARS-CoV-2 infection in a cost-effective, highly accurate, real-time, portable, and super-encrypted manner. This integrated approach first captured viral particles from patient samples to activate fluorescence reporters, followed by signal detection using a smartphone fluorimeter, along with blockchain-based data processing and tracing. Designer DNA net nanostructures were deployed that match the spatial pattern of trimeric spike glycoprotein clusters on the viral outer surface for specific and rapid SARS-CoV-2 virion detection, smartphone-based point-of-care device for portable signal reading, and blockchain encryption for privacy protection during result recording and track tracing, therefore, this detection and tracing model allowed a direct, automatic, and cost-effective detection, a highly flexible result acquisition process and a super-encrypted data transition and tracing system." .
<https://okn.wobd.org/grant/4R33HD105590-03> <http://schema.org/startDate> "2021-01-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_27> <http://schema.org/dateModified> "2023-10-23"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_201> <http://schema.org/date> "2024-07-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_159> <http://schema.org/dateCreated> "2022-05-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_139> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_47> <http://schema.org/description> "This project involved the design, fabrication, and proof-of-concept testing of a novel MOF-SCENT system (Metal-Organic Frameworks for Screening COVID-19 by Electronic-Nose Technology) that features the following advantages: (1) Highly selective and sensitive detection of a variety of VOCs; (2) fast response and recovery time; (3) portable, low-cost, robust, easy-to-use, and deployable in any clinical, community, and everyday setting. The accurate, sensitive, low-cost, robust, and portable MOF-SCENT system provides a realistic approach to dramatically increase testing capacity for COVID-19 because it can be rapidly integrated into and adopted by the public and healthcare systems by deploying a large number of such systems at central facilities (e.g., airports, shopping malls), point-of-care sites (e.g., hospitals, pharmacies, urgent care centers), and workplaces and even homes. The manufacturing of the MOF-SCENT system can be easily scaled to >50,000 units because the simple design can be fabricated out of stainless steel in common machine shops and the MOF material is commercially available or can be synthesized in organic synthesis laboratories. The detector of the MOF-SCENT system could be manufactured based on existing portable vector network analyzer (VNA) interrogators (new VNA technology called MN7021A RF Sensor, Keysight Technologies, Santa Rosa, CA). Commercially-available VNAs would be stripped down to increase production output and reduce costs (Keysight Technologies can head up the effort to mass-produce the interrogators). Capital costs for the production ramp-up of large numbers of MOF-SCENT systems are minimal because existing machine shops and Keysight Technologies' electronic assembly infrastructure would be used. Installation of the MOF-SCENT system at homes, grocery stores, pharmacies, and medical clinics can significantly increase daily accessibility to on-demand accurate testing and thereby mitigate the second wave of infections of SARS-CoV-2. Keysight Technologies is the world's largest test and measurement manufacturer, with a well-established supply chain, superior logistics and technical support infrastructure, and a commitment to quality control." .
<https://ror.org/01y3zfr79> <http://schema.org/identifier> "https://ror.org/01y3zfr79" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_48> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_30> <http://schema.org/sameAs> <https://doi.org/10.60773/bsnf-k280> .
<https://okn.wobd.org/person/university_of_california_san_diego> <http://schema.org/name> "University of California San Diego" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_191> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_141> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_60> <http://schema.org/date> "2024-01-18"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_85> <http://schema.org/description> "The COVID-19 pandemic is a major public health crisis, revealing deep and persistent racial/ethnic disparities in health. In New York City (NYC), one of the most affected cities in the U.S., Black and Latinx communities suffered the highest rates of hospitalizations and mortality from COVID-19. Age-adjusted death rates for Blacks are more than twice those for Whites across the U.S. Data suggest that this may even represent a gross underestimate of the magnitude of the mortality from COVID-19 because Blacks and Latinx are less likely than their White counterparts to be tested for COVID-19. Delayed testing and lack of testing among high-risk individuals significantly increases the spread of the virus, and is associated with reduced ability to access life-saving treatment. Without an understanding of the complex and interrelated factors that occur at multiple levels of influence, existing testing strategies may fail to serve populations most vulnerable to COVID-19 morbidity, particularly poor and minority populations. As such, partnerships with Federally Qualified Health Centers (FQHCs), where most Blacks and Latinx people receive care, are urgently needed. The FHCs at NYULH, which is the nation's second largest network of FQHCs, is a unique platform to address this problem. This three-phase study employed a multipronged, sequential mixed methods design (i.e., one methodology builds on the findings of the other) to gain a comprehensive understanding of the multilevel factors that drive uptake of testing (and vaccination) for COVID-19 in Black and Latinx patients (primary outcome), and participation in follow-up care offered by safety-net health systems. Phase 1 leveraged the FHC electronic health record (EHR) database to quantitatively examine individual-level sociodemographic, clinical, and healthcare utilization factors associated with receiving a PCR test for COVID-19 among 400 Black and Latinx patients who receive care at the FHCs. This phase also captured the community- and structural-level determinants of testing using validated self-report measures (RADX-UP Common Data Elements, NIH PhenX Toolkit) among the same patients (Aim 1). In Phase 2, the data sources from Phase 1 were coupled with qualitative data (e.g., focus groups, ethnographic observation, and document analysis) to capture organizational and ethical issues to shed light on important social, cultural, and contextual factors associated with uptake of COVID-19 testing and potential vaccine (Aim 2). In partnership with the Community Oversight Task Force (COTF), in Phase 3, data obtained from Phases 1 and 2 were integrated and used to refine, test, and disseminate data governance guidelines, and tailored toolkits about COVID-19 testing and vaccines (Aim 3). This study contributed to the scientific knowledge about the testing attitudes and behaviors of vulnerable communities to lay the foundation for implementing outreach strategies to increase the delivery of timely testing and follow-up among minority communities in the short-term and generate important data for large-scale COVID-19 testing and vaccination initiatives in the long-term." .
<https://okn.wobd.org/grant/1DP2AI138242-01> <http://schema.org/funder> <https://ror.org/00fj8a872> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_87> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<http://purl.obolibrary.org/obo/MONDO_0011918> <http://schema.org/name> "anxiety" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_55> <http://schema.org/url> "https://radxdatahub.nih.gov/study/55" .
<https://okn.wobd.org/grant/1K12NS098482-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_214> <http://schema.org/funding> <https://okn.wobd.org/grant/1U24TR001608-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_74> <http://schema.org/author> <https://okn.wobd.org/person/renal_research_institute> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_96> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_135> <http://schema.org/datePublished> "2023-08-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/university_of_illinois_at_urbana_champaign_and_louisiana_state_university> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_123> <http://schema.org/url> "https://radxdatahub.nih.gov/study/123" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_212> <http://schema.org/dateCreated> "2023-08-03"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/81" .
<http://purl.obolibrary.org/obo/MONDO_0005354> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_27> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_159> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/ksgc-r355> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_110> <http://schema.org/identifier> "phs002702" .
<https://okn.wobd.org/person/northwestern_university> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_76> <http://schema.org/funding> <https://okn.wobd.org/grant/1U54GM138062-01A1> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_218> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_62> <http://schema.org/identifier> "phs002572" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_149> <http://schema.org/name> "SCALE UP COUNTS: A Health Information Technology Approach to Increasing COVID-19 Testing in Elementary and Middle Schools and Serving Disadvantaged Communities" .
<https://okn.wobd.org/grant/2UL1TR000427-06> <http://schema.org/url> "https://reporter.nih.gov/project-details/8467414" .
<https://okn.wobd.org/grant/1P30ES030285-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9687966" .
<https://ror.org/0493hgw16> <http://schema.org/parentOrganization> "National Institutes of Health" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_137> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01AI151059-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_67> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_140> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<http://purl.obolibrary.org/obo/NCIT_C143827> <http://schema.org/name> "Sepsis, CTCAE" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/118" .
<http://purl.obolibrary.org/obo/NCIT_C94552> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/grant/2R37AI051652-06> <http://schema.org/startDate> "2002-02-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_207> <http://schema.org/datePublished> "2023-12-06"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_92> <http://schema.org/url> "https://radxdatahub.nih.gov/study/92" .
<https://okn.wobd.org/grant/1R01CA234614-01A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_144> <http://schema.org/url> "https://radxdatahub.nih.gov/study/144" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_157> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1UL1TR000460-01A1> <http://schema.org/funder> <https://ror.org/04pw6fb54> .
<https://okn.wobd.org/person/oregon_rural_practice_based_research_network> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_40> <http://schema.org/identifier> "phs002540" .
<http://schema.org/ResearchProject> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2000/01/rdf-schema#Class> .
<https://okn.wobd.org/grant/1R01HG009120-01A1> <http://schema.org/startDate> "2017-03-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/university_of_maryland> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_37> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/grant/1R01DK113642-01A1> <http://schema.org/name> "GENITALIA OUTGROWTH AND HYPOSPADIAS" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_197> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/person/georgia_institute_of_technology> <http://schema.org/name> "Georgia Institute of Technology" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_153> <http://schema.org/identifier> "phs002868" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_152> <http://schema.org/funding> <https://okn.wobd.org/grant/1P30AI036214-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_46> <http://schema.org/datePublished> "2023-08-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1K08AI130381-01A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://ror.org/01s5ya894> <http://schema.org/alternateName> "NINDS" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_159> <http://schema.org/datePublished> "2023-08-29"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_151> <http://schema.org/sameAs> <https://doi.org/10.60773/1tqv-dv25> .
<https://okn.wobd.org/grant/1R01HG011274-01> <http://schema.org/startDate> "2020-09-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/the_university_of_texas_health_science_center_houston> <http://schema.org/name> "The University of Texas Health Science Center Houston" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_41> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2901879> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_86> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_86> <http://schema.org/identifier> "phs002618" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_133> <http://schema.org/name> "COVID-19 Detection through Scent Analysis with a Compact Gas Chromatography Device" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_126> <http://schema.org/name> "Support for Safe Return to In-Person School: COVID-19 Testing, Learning, and Consultation" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_66> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/grant/1K12NS098482-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9185059" .
<https://okn.wobd.org/grant/1K12HD047349-01> <http://schema.org/funder> <https://ror.org/04byxyr05> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_208> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/86j7-he45> .
<https://okn.wobd.org/grant/1UL1TR003167-01> <http://schema.org/funder> <https://ror.org/04pw6fb54> .
<https://okn.wobd.org/grant/7R01HG010040-02> <http://schema.org/funder> <https://ror.org/00baak391> .
<http://schema.org/date> <http://www.w3.org/2000/01/rdf-schema#domain> <http://schema.org/Thing> .
<https://okn.wobd.org/grant/5P30CA008748-20> <http://schema.org/funder> <https://ror.org/040gcmg81> .
<https://okn.wobd.org/grant/1UL1TR002736-01> <http://schema.org/startDate> "2018-06-28"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_137> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01AI146165-01A1> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/funding> <https://okn.wobd.org/grant/2UL1TR000457-06> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_119> <http://schema.org/identifier> "phs002736" .
<https://okn.wobd.org/person/brigham_womens_hospital> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/grant/1P30MH058107-01> <http://schema.org/identifier> "1P30MH058107-01" .
<https://okn.wobd.org/grant/1P30DK063720-01> <http://schema.org/startDate> "2003-05-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1UL1TR002366-01> <http://schema.org/endDate> "2022-06-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01AI125416-01> <http://schema.org/name> "Defining the role of the RNA modification N6-methyladenosine in the hepatitis C virus lifecycle" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_176> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/person/university_of_california_santa_barbara> <http://schema.org/name> "University of California-Santa Barbara" .
<https://okn.wobd.org/grant/1U54GM115677-01> <http://schema.org/name> "RI-Center for Clinical and Translational Science" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_78> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_29> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/347537> .
<http://purl.obolibrary.org/obo/NCIT_C154635> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_162> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/grant/1K23AI121485-01A1> <http://schema.org/url> "https://reporter.nih.gov/project-details/9180192" .
<https://okn.wobd.org/person/renal_research_institute> <http://schema.org/name> "Renal Research Institute" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_215> <http://schema.org/dateCreated> "2024-01-04"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_66> <http://schema.org/sameAs> "10.60773/q345-4e35" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_138> <http://schema.org/description> "Infectious disease outbreaks like Coronavirus Disease 2019 (COVID-19) can overwhelm healthcare systems when screening tools are lacking or scarce. In the face of an ongoing COVID-19 pandemic and with single-plex qPCR fluorometry inadequate for high throughput clinical diagnostics, the demand for testing exceeds the capacity, leading to limited availability, long queue times, backlogs in COVID-19 diagnoses, and delayed access to specialized treatment for COVID-19 patients. The goal of this RADx funded project was to develop an easily scalable and massively paralleled multiplexed screening method by next generation sequencing (NGS) with sample-specific barcoded indexes to allow pooling of up to 9200 samples. The approach enabled detection of SARS-COV-2 viral gRNA content (load) and expression profiles; detection of host's transcriptional response to infection simultaneously (expression profile). Transcriptional profiles were analyzed in the context of clinical data (electronic medical records of symptoms, treatments and outcomes) in order to identify and select features (biomarkers) that were predictive of clinical outcome using machine learning methods. These selected biomarkers were then validated in an independent clinical sample. Comparative testing of alternative sample collection (NP swab, saliva, oral swab) and handling protocols is ongoing with the goal of matching new protocols with existing SOPs for PCR-based testing in CLIA-certified facilities. In addition to increasing testing throughput, this precision medicine approach may have provided a very early look at who may be asymptomatic but infectious, or who is about to get very sick. Methods developed during this project may be adaptable to viruses or other pathogens in future pandemics. The initial aim of this project was to demonstrate proof of principle that the methodology can capture both virus and host RNA sequence using commercially available anonymous NP, OP and saliva samples." .
<http://schema.org/funding> <http://www.w3.org/2000/01/rdf-schema#range> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_220> <http://schema.org/datePublished> "2024-07-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01CA234614-01A1> <http://schema.org/identifier> "1R01CA234614-01A1" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_142> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/8P20GM103395-12> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/person/puerto_rico_science> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_215> <http://schema.org/sameAs> "10.60773/5aar-0w08" .
<https://okn.wobd.org/grant/1P30AI060354-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_144> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/person/university_of_hawaii_at_manoa_and_university_of_guam> <http://schema.org/name> "University of Hawaii at Manoa and University of Guam" .
<https://okn.wobd.org/person/inc_nys_department_of_health> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/grant/1U54GM104940-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/1F30DK123915-01> <http://schema.org/funder> <https://ror.org/00adh9b73> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_180> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_125> <http://schema.org/dateCreated> "2022-01-06"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_217> <http://schema.org/identifier> "phs003484" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_207> <http://schema.org/author> <https://okn.wobd.org/person/hugo_w_moser_research_institute_at_kennedy_krieger> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_135> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_96> <http://schema.org/funding> <https://okn.wobd.org/grant/1P30AI094189-01A1> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_142> <http://schema.org/sameAs> <https://doi.org/10.60773/ywfr-4e53> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_101> <http://schema.org/sameAs> "10.60773/n328-4344" .
<https://okn.wobd.org/grant/1P30AI064518-01> <http://schema.org/endDate> "2010-06-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/technology_and_research_trust_san_juan> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/grant/1P42ES010337-01> <http://schema.org/name> "MOLECULAR MECHANISMS AND MODELS FOR EXPOSURE" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_68> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/67qn-0273> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_217> <http://schema.org/dateModified> "2024-03-04"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://ror.org/043z4tv69> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Organization> .
<https://okn.wobd.org/grant/1R01AI155696-01> <http://schema.org/identifier> "1R01AI155696-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_216> <http://schema.org/url> "https://radxdatahub.nih.gov/study/216" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_110> <http://schema.org/name> "A Scalable Aptamer-Based Electrochemical Biosensor for Rapid Detection of SARS-CoV-2 from Saliva" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_72> <http://schema.org/datePublished> "2022-11-07"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_183> <http://schema.org/identifier> "phs003057" .
<https://okn.wobd.org/grant/4UH3AI122309-03> <http://schema.org/funder> <https://ror.org/043z4tv69> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_216> <http://schema.org/identifier> "phs003514" .
<https://ror.org/01s5ya894> <http://schema.org/identifier> "https://ror.org/01s5ya894" .
<https://okn.wobd.org/person/central_michigan_university> <http://schema.org/name> "Central Michigan University" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_192> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/1986198> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_120> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1U54GM138062-01A1> <http://schema.org/funder> <https://ror.org/04q48ey07> .
<https://okn.wobd.org/grant/1R01HL149450-01A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_122> <http://schema.org/url> "https://radxdatahub.nih.gov/study/122" .
<https://okn.wobd.org/grant/1P01CA214274-01A1> <http://schema.org/funder> <https://ror.org/040gcmg81> .
<https://okn.wobd.org/grant/1P30AI045008-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/2833977" .
<https://okn.wobd.org/grant/8P51OD011132-52> <http://schema.org/identifier> "8P51OD011132-52" .
<https://okn.wobd.org/grant/1U01DA053941-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://www.uniprot.org/taxonomy/347537> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/29" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_188> <http://schema.org/description> "The urgent need to curb the spread of SARS-CoV-2 demands availability of diagnostics that are more rapid, accurate, sensitive and affordable than qPCR and antibody tests. Current qPCR tests are specific and sensitive, but lengthy turnaround times limit interventions against disease spread. Antibody testing is faster, but false- positive/negative rates are high. Here, this study proposed to repurpose extracellular vesicle (EV) separation and characterization technologies into a fully automated SARS-CoV-2 testing platform that is low-cost, accurate, sensitive, rapid (within 3 h), and practical. The device was optimized to analyze blood, saliva, and nasopharyngeal (NP) swabs collected at home, without risking transmission to healthcare workers. The sample is processed with an automated device developed with Sognef, and data are transferred to the Sognef servers for analysis through an app that can be downloaded to any smart device. This technology is similar to Abbott's recently launched BinaxNOW COVID-19 Ag Card, but has the advantage of multiparametric detection of viral RNA (vRNA), including Spike (S) and Nucleocapsid (N) protein-coding regions, plus a panel of host EV microRNAs (exomiRs) that reveals infection even when viral loads are below detectable limits. This approach decreased false-positives/negatives, the major limitation of antigen/antibody tests. Examine relationships of miRNA panels with characteristics such as: symptomatic vs asymptomatic, qPCR-determined viral load, biological sex, age (including pediatric populations), and comorbidities. The study optimized a COVID-19 device that uses simple bind-elute microfluidics for sample separation followed by electrical, probe-based detection of i) all validated exomiRs from Aim 1 and ii) three conserved vRNAs. It is envisioned that the device will be used first for either finger-pricked blood or saliva, followed, if positive, by an optional confirmatory second test of NP swab viral transport medium (VTM) that could be done with the same device. The device was tested in multiple centers worldwide in two phases: Phase 1 – every center will perform a double-blinded validation using their biorepository specimen, and Phase 2 – in a β-testing phase, the study provided a large number of devices to healthcare providers for regular testing of workers." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_60> <http://schema.org/url> "https://radxdatahub.nih.gov/study/60" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_81> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_49> <http://schema.org/dateModified> "2023-10-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_87> <http://schema.org/description> "Local health departments are employing widely varying approaches to address the dramatic health inequities associated with the COVID-19 pandemic. Learning collaboratives have been effective in other settings for bringing entities together to support joint problem solving and reduce variance in approach. These collaboratives built upon shared experiences to help their members understand not only what to do but how to do it, providing knowledge and skills that were critical to successful implementation of interventions. This study aimed to examine the effectiveness of a diverse, regional learning collaborative of health departments that rapidly adapt, test, and implement community-driven solutions for COVID testing disparities using a pragmatic, hybrid type II trial design. Based on preliminary data from a community-led approach developed in a severely affected Kansas county (Wyandotte), the project built Local Heath Equity Action Teams in 10 counties (4 urban and 6 rural) disproportionately affected by COVID and provided them with the training and resources needed to achieve COVID testing equity. These Local Health Equity Action Teams came together into a multi-jurisdictional learning collaborative or Community Partner Program (Aim 1) that can share best practices and collaborate on developing, testing and evaluating multi-component intervention packages for addressing COVID. Initial supported interventions included: community-sponsored pop-up testing events; home-based and worksite testing; community-informed communication strategies; and support packages for at-risk individuals and families receiving testing. Additional interventions developed or proposed by local community partners or identified through national RADx-UP efforts were continuously considered by the collaborative. Working with the local Action teams, a series of semi-structured interviews and surveys were conducted within each local community (Aim 2) to better understand common and subgroup (racial, ethnic, geographic, etc.) barriers to and facilitators of testing. Existing epidemiologic surveillance tools were leveraged to develop and track a series of county-level metrics of COVID testing inequities. Guided by the RE-AIM framework and the Consolidated Framework for Intervention Research, the effectiveness (Aim 3) of the collaborative in improving uptake of COVID testing in vulnerable communities was examined, as will the reach, adoption, implementation and maintenance of intervention components within each local community. This study not only advanced understanding of how to achieve COVID testing equity but also provided a framework for supporting underserved communities as they respond to future public health emergencies and COVID vaccination challenges." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_42> <http://schema.org/sameAs> <https://doi.org/10.60773/0pp8-qx15> .
<https://okn.wobd.org/grant/1P20GM121342-01A1> <http://schema.org/url> "https://reporter.nih.gov/project-details/9416671" .
<https://okn.wobd.org/grant/1K01MH112436-01> <http://schema.org/funder> <https://ror.org/04xeg9z08> .
<https://ror.org/04pw6fb54> <http://schema.org/alternateName> "NIH NCATS" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_113> <http://schema.org/url> "https://radxdatahub.nih.gov/study/113" .
<https://okn.wobd.org/person/usvi> <http://schema.org/name> "USVI)" .
<https://ror.org/04xeg9z08> <http://schema.org/identifier> "https://ror.org/04xeg9z08" .
<https://okn.wobd.org/person/howard_brown_health_center> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_129> <http://schema.org/author> <https://okn.wobd.org/person/the_university_of_texas_health_science_center_houston> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_136> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/1e6t-6b11> .
<https://okn.wobd.org/grant/1UL1TR002345-01> <http://schema.org/funder> <https://ror.org/04pw6fb54> .
<https://ror.org/04q48ey07> <http://schema.org/name> "National Institute of General Medical Sciences" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_42> <http://schema.org/datePublished> "2022-07-25"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1UL1TR001085-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/8720997" .
<https://www.uniprot.org/taxonomy/10239> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_129> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/869q-b786> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_101> <http://schema.org/date> "2024-04-10"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01ES028615-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/1P30AI073961-01> <http://schema.org/funder> <https://ror.org/043z4tv69> .
<https://okn.wobd.org/grant/1P30MH058107-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/2550656" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_47> <http://schema.org/sameAs> "10.60773/vbbc-kt11" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_110> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_174> <http://schema.org/funding> <https://okn.wobd.org/grant/1T32AI007384-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_152> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_70> <http://schema.org/datePublished> "2022-11-07"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_39> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/grant/1S10OD025082-01> <http://schema.org/identifier> "1S10OD025082-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_51> <http://schema.org/url> "https://radxdatahub.nih.gov/study/51" .
<https://okn.wobd.org/grant/1T32CA203702-01A1> <http://schema.org/name> "Molecular and Translational Oncology Research" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_184> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/5b7f-0206> .
<https://okn.wobd.org/grant/1R01AI129709-01A1> <http://schema.org/endDate> "2020-11-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_182> <http://schema.org/datePublished> "2023-08-29"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_184> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_156> <http://schema.org/sameAs> "10.60773/61bs-2j03" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_110> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_53> <http://schema.org/description> "Reliable real-time detection of SARS-CoV-2 virus represents a considerable challenge, with available tools requiring extensive sample preparation and/or expensive lab-based equipment to obtain accurate results. The objective of this study was to build a touch-screen sensor array to directly capture, detect, and identify model SARS-CoV-2 virus particles with minimal false alarms. This ambitious goal was achieved by the interdisciplinary team of General Electric (GE) Research scientists and engineers, and was a synergistic combination of the proposed innovations and the prior scientific and engineering accomplishments of the team." .
<https://okn.wobd.org/grant/1R01AI146165-01A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_169> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_152> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/grant/1R01AI125416-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9157887" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/208" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_71> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_155> <http://schema.org/url> "https://radxdatahub.nih.gov/study/155" .
<https://okn.wobd.org/grant/1R01EB025022-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9393052" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_213> <http://schema.org/identifier> "phs003374" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_155> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_108> <http://schema.org/author> <https://okn.wobd.org/person/university_of_pennsylvania> .
<https://okn.wobd.org/grant/1R01AI153044-01A1> <http://schema.org/name> "Statistical innovation to integrate sequences and phenotypes for scalable phylodynamic inference" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_61> <http://schema.org/identifier> "phs002570" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_70> <http://schema.org/funding> <https://okn.wobd.org/grant/5P30CA008748-20> .
<https://okn.wobd.org/grant/2R37AI051652-06> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_184> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/description> "In the wake of COVID-19 pandemic, Multisystem Inflammatory Syndrome in Children (MIS-C) has evolved as a new threat to children exposed to SARS-CoV-2. The emergence of MIS-C is so new and so rapidly evolving that there are currently no diagnostic tests to identify these patients nor are there tools to predict disease progression. Through established, funded, multi-center consortia in the U.S. (CHARMS: Characterization of MIS-C and its Relationship to Kawasaki Disease funded by PCORI) and the UK (DIAMONDS), clinical data and samples were collected to support the proposed studies. First, transcript, protein and antibody datasets from children with COVID-19, MIS-C, and with other febrile illnesses were generated. These data were used to devise tests to distinguish children at risk of progression to severe COVID-19 or MIS-C and diagnostic tests to distinguish these conditions from other causes of fever in children. Continuing the established collaboration with Columbia University, the antibody repertoire against all known human coronaviruses was defined and how pre-existing antibody to other coronaviruses may shape the immune response in acute SARS-CoV-2 infection and MIS-C was determined. The first two years (R61) built on the expertise of the assembled teams to discover unique proteomic and transcriptomic patterns in MIS-C and SARS-CoV-2-infected patients and relate clinical parameters to the antibody response to coronaviral antigens profiled on peptide arrays. This work leveraged already banked plasma, serum, and RNA samples from children with COVID-19, MIS-C, Kawasaki disease and other inflammatory conditions. Rigorous Go/No-Go criteria were established and used to determine progression to the R33 phase. The final two years (R33) focused on platform development and multicenter and bi-national test validation to diagnose and predict severity in children with SARS-CoV-2 infection or MIS-C based on aptamer technology, lateral-flow protein detection, point-of-service RNA or antibody profiling with commercial partners. De-identified clinical and molecular data were deposited in the RADx-rad hub to facilitate data sharing. Many potential hurdles in this type of research have already been overcome: a) IRB-approved patient recruitment for data and samples is on-going, b) clinical samples have been banked, c) strong preliminary data has been generated on RNAseq, aptamer proteomics, and coronaviral antibody responses, and d) the teams have a strong track record of previous collaboration and productivity. The synergistic expertise of these investigative teams in this multi-center proposal provided a unique opportunity to create diagnostic and prognostic tools for children suffering from the spectrum of SARS- CoV-2 illnesses. Public Health Relevance: As the COVID-19 pandemic evolved in early 2020, case reports appeared describing children with unusual febrile illnesses with elevated inflammatory markers and multi-system involvement that is now termed Multisystem Inflammatory Syndrome in Children (MIS-C). The illness occurs weeks following exposure to SARS-CoV-2 and these children have a wide spectrum of disease severity ranging from cardiogenic shock to milder illness that can be self-limited. To address an urgent, unmet clinical need, investigative teams across three countries joined forces to discover and validate a diagnostic test to identify children with MIS-C and predict progression of disease." .
<https://okn.wobd.org/grant/1R01AG066749-01> <http://schema.org/name> "Finding combinatorial drug repositioning therapy for Alzheimer's disease and related dementias" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_177> <http://schema.org/identifier> "phs003029" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_49> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_203> <http://schema.org/datePublished> "2023-12-06"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_137> <http://schema.org/url> "https://radxdatahub.nih.gov/study/137" .
<https://ror.org/04q48ey07> <http://schema.org/alternateName> "U.S. National Institute of General Medical Sciences" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_182> <http://schema.org/funding> <https://okn.wobd.org/grant/1U24TR001608-01> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/96" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_216> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/grant/1U54CA260492-01> <http://schema.org/funder> <https://ror.org/040gcmg81> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_116> <http://schema.org/funding> <https://okn.wobd.org/grant/1T32DA007292-01A1> .
<https://okn.wobd.org/grant/1R01AG066749-01> <http://schema.org/funder> <https://ror.org/049v75w11> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_200> <http://schema.org/name> "Social and Behavioral Implications for COVID-19 Testing in Delaware's Underserved Communities" .
<https://ror.org/049v75w11> <http://schema.org/alternateName> "The National Institute on Aging" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/168" .
<https://okn.wobd.org/grant/1UL1TR002538-01> <http://schema.org/name> "Utah Center for Clinical and Translational Science" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_72> <http://schema.org/identifier> "phs002642" .
<https://okn.wobd.org/grant/1R01GM120553-01> <http://schema.org/name> "Structural Studies of Coronavirus Fusion Proteins" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_36> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/grant/1S10OD025082-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_118> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/wqc5-e480> .
<https://okn.wobd.org/grant/1P01HL114471-01A1> <http://schema.org/funder> <https://okn.wobd.org/organization/national_heart_lung_and_blood_institute> .
<https://okn.wobd.org/grant/1K12HD047349-01> <http://schema.org/identifier> "1K12HD047349-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_178> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/grant/1R01AI129709-01A1> <http://schema.org/funder> <https://ror.org/043z4tv69> .
<https://okn.wobd.org/grant/1R01MH113094-01> <http://schema.org/endDate> "2021-06-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/temple_university> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_161> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_216> <http://schema.org/dateModified> "2024-03-04"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/139" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_116> <http://schema.org/identifier> "phs002720" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_100> <http://schema.org/datePublished> "2023-08-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_76> <http://schema.org/funding> <https://okn.wobd.org/grant/8P20GM103429-11> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_166> <http://schema.org/author> <https://okn.wobd.org/person/hugo_w_moser_research_institute_at_kennedy_krieger> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0800175> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_135> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/2ndc-4822> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_214> <http://schema.org/funding> <https://okn.wobd.org/grant/2U54MD007601-31> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_208> <http://schema.org/description> "SCALE-UP II was a state-wide, pragmatic study conducted among 11 Community Health Center (CHC) systems and 38 clinics across Utah. These CHCs serve low socioeconomic status, racially/ethnically diverse, and rural/frontier populations. The long-term objective of SCALE-UP II was to increase the reach, uptake, and sustainability of COVID-19 testing among underserved populations. Through RADx-UP Phase I funding (SCALE-UP Utah), the team had established population health management (PHM) interventions that have been used since Jan 2021 to increase the uptake of COVID-19 testing and vaccination among CHC patients. Interventions were based on a PHM approach that uses widely available technology (i.e. cell phones and text messaging). SCALE-UP II built on SCALE-UP Utah PHM interventions and investigated novel interventions (i.e., Conversational Agents; Reactive Patient Navigation) that are tailored to address individuals' hesitancy factors and the interplay between vaccination and testing." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_63> <http://schema.org/sameAs> "10.60773/e8nb-ns15" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_97> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01DK113642-01A1> <http://schema.org/startDate> "2017-04-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/sable_palm_elementary> <http://schema.org/name> "Sable Palm Elementary" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_65> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_117> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_170> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_177> <http://schema.org/sameAs> <https://doi.org/10.60773/50dx-sm74> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_32> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_166> <http://schema.org/funding> <https://okn.wobd.org/grant/1U24TR001608-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/funding> <https://okn.wobd.org/grant/1DP2AI138242-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_213> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_158> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_127> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0019526> .
<https://okn.wobd.org/grant/1R01DK121072-01A1> <http://schema.org/endDate> "2025-01-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1T32CA203702-01A1> <http://schema.org/identifier> "1T32CA203702-01A1" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_101> <http://schema.org/funding> <https://okn.wobd.org/grant/1T32HD044355-01> .
<https://okn.wobd.org/grant/1KL2TR003108-01> <http://schema.org/name> "Institutional Career Development" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_169> <http://schema.org/datePublished> "2022-11-08"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://ror.org/00baak391> <http://schema.org/name> "National Human Genome Research Institute" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_37> <http://schema.org/datePublished> "2024-04-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01AI140442-01> <http://schema.org/name> "MERS coronavirus: antagonism of double-stranded RNA induced host response by accessory proteins" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_66> <http://schema.org/sameAs> <https://doi.org/10.60773/q345-4e35> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_174> <http://schema.org/url> "https://radxdatahub.nih.gov/study/174" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_124> <http://schema.org/date> "2023-08-24"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01MD016593-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/10299837" .
<https://okn.wobd.org/grant/1K23AI121485-01A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<http://schema.org/datePublished> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_146> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_54> <http://schema.org/identifier> "phs002546" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/author> <https://okn.wobd.org/person/children_s_hospital_los_angeles> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_212> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/554r-hn06> .
<https://okn.wobd.org/grant/1DP2GM137418-01> <http://schema.org/identifier> "1DP2GM137418-01" .
<https://okn.wobd.org/person/penn_state_university> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/grant/1P30ES030285-01> <http://schema.org/name> "Gulf Coast Center for Precision Environmental Health" .
<https://okn.wobd.org/grant/1R01MD016593-01> <http://schema.org/endDate> "2026-04-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_133> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/url> "https://radxdatahub.nih.gov/study/50" .
<https://okn.wobd.org/grant/1UL1TR002014-01> <http://schema.org/name> "Penn State Clinical and Translational Science Institute" .
<https://okn.wobd.org/grant/1UL1TR002373-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_157> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/geyp-w645> .
<https://okn.wobd.org/person/and_johns_hopkins_university_school_of_medicine> <http://schema.org/name> "and Johns Hopkins University School of Medicine" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_43> <http://schema.org/url> "https://radxdatahub.nih.gov/study/43" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_205> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR002345-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_42> <http://schema.org/identifier> "phs002550" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_166> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/td0b-xf65> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_166> <http://schema.org/description> "Underserved populations are at dramatically higher risk of becoming infected with Severe Acute Respiratory Syndrome, Coronavirus-2 (SARS-CoV-2) and death from COVID-19. Children with IDD are vulnerable to the negative impact of school closure. School districts provide critical services beyond the education, including nutritional, social, therapy (physical, occupational, and speech-language) and healthcare services. Risks are heightened for children with IDD, as they are often unable to wear masks, practice social distancing and/or implement effective hand hygiene. Access to rapid and reliable SARS-CoV-2 testing is essential for children with IDD and school staff in order to safely return to school. Members of the research team developed an innovative, scalable, low-cost method for SARS-CoV-2 testing using saliva samples. Investigators at the Washington University Intellectual and Developmental Disabilities Research Center (IDDRC@WUSTL), in collaboration with the University of Missouri-Kansas City Institute of Human Development and the Kennedy Krieger Institute in Maryland (which includes an IDDRC, the Maryland Center for Developmental Disabilities, and the Kennedy Krieger School Programs), were ideally positioned to determine the best implementation strategies to maximize use of a saliva-based SARS-CoV-2 diagnostic test for vulnerable children and school staff in a school setting. The IDDRC@WUSTL has a long-standing relationship with the Special School District (SSD) of St. Louis County, whose mission is to serve children with IDD, and the national network of the Association of University Centers on Disabilities (AUCD). First, the study determined the most effective messaging and implementation strategies to maximize weekly SARS-CoV-2 testing in a school setting. In this adaptive clinical trial, 52,000 diagnostic tests were administered to students and school staff at SSD, whose student population is 48% Black. Second, the study measured national attitudes among parents/guardians of children with IDD and school staff regarding the impact of COVID-19 and the importance of SARS-CoV-2 testing. At the successful completion of this project, this study improved the acceptance, adoption, and process for SARS-CoV-2 diagnostic testing in a school-based setting to enable delivery of critical educational activities for children with IDD in an underserved community. By identifying the most effective methods for SARS-CoV-2 testing in a vulnerable population of children with IDD, the study established a blueprint for wider adoption of COVID-19 mitigation efforts, such as vaccination." .
<https://okn.wobd.org/grant/1P30MH058107-01> <http://schema.org/funder> <https://ror.org/04xeg9z08> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_55> <http://schema.org/date> "2024-01-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1T32HD044355-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_112> <http://schema.org/identifier> "phs002707" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_63> <http://schema.org/url> "https://radxdatahub.nih.gov/study/63" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_215> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_153> <http://schema.org/datePublished> "2023-08-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01GM122080-01> <http://schema.org/startDate> "2016-08-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_216> <http://schema.org/sameAs> <https://doi.org/10.60773/hwkn-r448> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_157> <http://schema.org/sameAs> "10.60773/geyp-w645" .
<https://okn.wobd.org/grant/2UL1TR000457-06> <http://schema.org/name> "Clinical and Translational Science Center" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_47> <http://schema.org/name> "MOF-SCENT: Metal-Organic Frameworks for Screening COVID-19 by Electronic-Nose Technology to Improve Selectivity and Time Response" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_35> <http://schema.org/description> "The purpose of the study was to investigate the feasibility of digital health solutions to provide SARS-CoV-2, the causative agent for COVID-19, related de-identified data to the NIH-sponsored data hub through the hub and spoke model. Once in operation, the data distribution model consisted of a centralized architecture in which selected digital health solutions - the spokes - can transmit participant de-identified data to be used by the scientific community for COVID-19 research. The completed study included 300 participants, 100% medically underserved, with at least 51% from the AI/AN community. A combination of hard and soft data were collected, consisting of vital data, medical history and questionnaire data, and participant COVID-19 viral and antibody testing results collected during the study." .
<https://okn.wobd.org/grant/9P30AI050410-04> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01AI163029-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_209> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_212> <http://schema.org/date> "2024-07-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/8P20GM103429-11> <http://schema.org/identifier> "8P20GM103429-11" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_218> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/xf2h-5k20> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_129> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1T32EB009380-01> <http://schema.org/name> "Training in Multi-Scale Analysis of Biological Structure and Function" .
<https://okn.wobd.org/grant/3P50HD103525-01S1> <http://schema.org/funder> <https://ror.org/00fj8a872> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_121> <http://schema.org/url> "https://radxdatahub.nih.gov/study/121" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_189> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/person/upmc_children_s_hospital_of_pittsburgh_university_of_pittsburgh> <http://schema.org/name> "UPMC Children's hospital of Pittsburgh/University of Pittsburgh" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_30> <http://schema.org/identifier> "phs002689" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_209> <http://schema.org/url> "https://radxdatahub.nih.gov/study/209" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_115> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/1scn-wv48> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_43> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/NCIT_C3038> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/177" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_274> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/grant/1R01HL105704-01> <http://schema.org/identifier> "1R01HL105704-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_49> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_147> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005550> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_88> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_128> <http://schema.org/sameAs> <https://doi.org/10.60773/c9fp-qk33> .
<https://okn.wobd.org/grant/1P30AI064518-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/6911215" .
<https://okn.wobd.org/grant/1P30CA042014-01> <http://schema.org/startDate> "1986-07-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_142> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/11709> .
<https://okn.wobd.org/person/progressive_community_health_ctr> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/grant/1R01HL140898-01> <http://schema.org/identifier> "1R01HL140898-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_100> <http://schema.org/name> "Alive Church Network: Increasing COVID-19 Testing in Chicago's African American Testing Deserts" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_145> <http://schema.org/description> "Pronounced inequities and disparities in coronavirus disease (COVID-19) morbidity and mortality have been reported, largely due to comorbid conditions and social determinants of health. Approximately 95% of COVID-19 related deaths occur among individuals with underlying medical conditions. Of all racial/ethnic groups, Hispanic/Latino communities in San Diego County have experienced the greatest burden of COVID-19 disease and deaths. Furthermore, testing challenges to date are evident, including long turnaround of test results and longer waiting times for African American and Hispanics compared to whites. The goal of this community-engaged proposal was to develop, test, and evaluate a rapid, scalable capacity building project to enhance COVID-19 testing in three regional community health centers (CHCs) in San Diego County. In collaboration with CHC partners, their consortium organization (Health Quality Partners), and community stakeholders, the following Specific Aims were proposed: 1) Compare the effectiveness of automated calls and text messaging for uptake of COVID-19 testing among asymptomatic adult patients with select medical conditions and those 65 years of age and older receiving care at participating CHCs. Secondarily, all study participants were invited to receive flu vaccination and feasibility and acceptability of study participants to refer adult family household members who are essential workers for COVID-19 testing were assessed. 2) Gather patient, provider, CHC leadership, and community stakeholder insights to establish best practices for future scale-up of COVID-19 testing sustainability and vaccination. This community-engaged project included underserved (socioeconomically disadvantaged and large proportion of Hispanic/Latinos) as well as COVID-19 vulnerable individuals (patients with medical comorbidities and 65 years of age and older). The approach considered regional COVID-19 morbidity and mortality disparities to identify strategies to address disproportionate infection rates and follow-up. By working in partnership with health care providers, health care system leaders, and community stakeholders, this team had the potential to build evidence-based approaches and identify sustainable solutions to understand and address the current and future pandemics in these underserved and vulnerable populations." .
<https://okn.wobd.org/grant/1R01DK121072-01A1> <http://schema.org/name> "Optimization of the engineered 3D hepatic microenvironment enhances pluripotent stem cell derived hepatocyte" .
<https://ror.org/040gcmg81> <http://schema.org/alternateName> "NCI" .
<https://okn.wobd.org/grant/1P30AI042853-01> <http://schema.org/name> "CENTER FOR AIDS RESEARCH" .
<https://okn.wobd.org/grant/1P30AI094189-01A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://ror.org/043z4tv69> <http://schema.org/alternateName> "Instituto Nacional de Alergias y Enfermedades Infecciosas" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_96> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_54> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/grant/1UL1TR002366-01> <http://schema.org/identifier> "1UL1TR002366-01" .
<https://ror.org/00baak391> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Organization> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_101> <http://schema.org/dateCreated> "2021-11-16"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_65> <http://schema.org/date> "2022-12-09"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_178> <http://schema.org/dateCreated> "2022-08-22"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_173> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_68> <http://schema.org/funding> <https://okn.wobd.org/grant/4UH3OD023365-03> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_157> <http://schema.org/identifier> "phs002905" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_178> <http://schema.org/name> "COVID-19 Test At Home Efficacy Sub-Study" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_157> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/694009> .
<https://okn.wobd.org/grant/7R01HG010040-02> <http://schema.org/url> "https://reporter.nih.gov/project-details/9824311" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_110> <http://schema.org/url> "https://radxdatahub.nih.gov/study/110" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_214> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_73> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_161> <http://schema.org/sameAs> "10.60773/w35s-2a90" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_185> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_203> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/grant/1R01MH117406-01> <http://schema.org/name> "The Spatiotemporal Landscape of the Human Brain Epitranscriptome" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_96> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_29> <http://schema.org/identifier> "phs002685" .
<https://okn.wobd.org/person/umass_chan_medical_school> <http://schema.org/name> "UMass Chan Medical School" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_148> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_117> <http://schema.org/sameAs> <https://doi.org/10.60773/md02-q556> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_142> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_137> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01AI135992-01> .
<https://okn.wobd.org/grant/1UL1TR002736-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9716795" .
<https://okn.wobd.org/grant/1P42ES010337-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_205> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR002001-01> .
<https://okn.wobd.org/grant/1R56HL149881-01A1> <http://schema.org/name> "Regulation of blood coagulation by the ZPI/PZ anticoagulant system" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_202> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_70> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR001873-01> .
<https://ror.org/04pw6fb54> <http://schema.org/alternateName> "NCATS NIH" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_176> <http://schema.org/name> "Maximizing Child Health and Learning Potential: Promoting A School Culture of Safety in the Era of COVID-19: Feasibility of Strategic COVID-19 Testing Protocols in At-Risk Urban Schools" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_214> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/grant/1R01HG009518-01A1> <http://schema.org/name> "Big Data Methods for Decoding Gene Regulation" .
<https://okn.wobd.org/grant/1P30NS047101-01> <http://schema.org/identifier> "1P30NS047101-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_83> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_116> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/person/los_angeles_county_department_of_health_services> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_175> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005148> .
<https://okn.wobd.org/grant/1UL1TR002014-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_42> <http://schema.org/sameAs> "10.60773/0pp8-qx15" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_170> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_109> <http://schema.org/sameAs> <https://doi.org/10.60773/kt6c-e369> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_49> <http://schema.org/description> "Vulnerable populations do not just need testing; they need surveillance. The ideal surveillance tool would operate in the background with minimal involvement of the population to be tested; it would be simple, affordable, reliable, and accurate. Unfortunately, no such assay existed. This project examined a smart mask that changes colors when the wearer has been exposed to biomarkers (proteases) of COVID-19 -- a novel approach to surveillance because most people are already wearing masks, especially in high-risk settings. The first goal was to optimize the reagents that will test the proteases. The peptide sequences were customized such that the reagents change color only when two key SARS proteases were present. After characterizing the colorimetric reagents, Aim 2 integrated these reagents into an adhesive test strip that can be affixed to any existing cloth or surgical mask. Aim 3 involved validation with human subjects. First, biobanked saliva samples that were confirmed to be either COVID-19-positive or COVID-19-negative were used. Next, how long people infected with SARS-CoV-2 must breathe through the smart mask before it changed color was evaluated. Finally, the smart mask was used for surveillance of a population that was concurrently being tested regularly via PCR. The sensitivity and specificity of the smart masks were calculated through comparison to PCR. True positives, true negatives, false positives, and false negatives were measured and 800 subjects were recruited at the University of California, San Diego." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_79> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_108> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_147> <http://schema.org/datePublished> "2023-08-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_146> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<http://schema.org/endDate> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_172> <http://schema.org/author> <https://okn.wobd.org/person/morehouse_school_of_medicine> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_120> <http://schema.org/sameAs> "10.60773/5ff3-nc70" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/funding> <https://okn.wobd.org/grant/1ZIAAI001222-01> .
<http://purl.obolibrary.org/obo/NCIT_C37935> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_205> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_208> <http://schema.org/dateCreated> "2023-07-28"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_174> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_170> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/grant/1UL1TR002001-01> <http://schema.org/identifier> "1UL1TR002001-01" .
<https://okn.wobd.org/grant/2P2CHD050924-11> <http://schema.org/identifier> "2P2CHD050924-11" .
<https://okn.wobd.org/grant/1P30NS047101-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/author> <https://okn.wobd.org/person/miller_children_s_hospital> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_137> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01AI125416-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_155> <http://schema.org/description> "The investigators at Xavier University of Louisiana utilized a multicenter approach including clinic, health care institution, and community survey-based research project to assess the beliefs and behavior regarding willingness to be vaccinated with a prospective COVID-19 vaccine among African Americans in the Southeastern Louisiana region. The COVID-19 pandemic disproportionately impacted the African American across the United States. Louisiana ranked 1st in the nation in per capita incidence of COVID-19. African Americans make up over 50% of the deaths of all known COVID-19 patients in the state, while only representing about 32% of the population. With the development of the COVID-19 vaccine, an urgent assessment of the African American community's readiness for vaccine uptake was needed to inform a pharmacist-led intervention model that would increase vaccine uptake. The Specific Aims of this proposal were: Specific Aim #1: To identify factors of vaccine hesitancy and the potential acceptance of a COVID-19 vaccine among the adult African-American community in Southeastern Louisiana. Specific Aim #2: To assess the personal and financial impact of COVID-19, knowledge of COVID-19, as well as experience with the healthcare system with regards to COVID-19. Specific Aim #3: To use the results of Aim #1 and #2 to inform a community pharmacist certification course and a pharmacist led intervention model among pharmacist vaccinators. Method: Specific Aim #1 and #2 were assessed by a survey at the start of study with an abbreviated follow-up survey 9 months later from clinic, community member and community pharmacy patient respondents. Changes in vaccine hesitancy and the impact on vaccine uptake were determined. Aim #3 was assessed by a pharmacist led education intervention model with vaccine uptake surveillance in community pharmacies across Louisiana to assess COVID-19 and other ACIP eligible vaccines. Impact: The implications of this project were to understand health related beliefs and behaviors related to COVID-19 and vaccination and their impact on the likely uptake of a COVID-19 vaccine among African Americans. It also provided data to facilitate the development of strategies to improve COVID-19 vaccination in a vulnerable community with community pharmacists as vaccinators and with a pre-and post analysis plan to assess the intervention’s success. This grant also facilitated training early stage investigators and diversified the health research workforce as the majority of researchers are among underrepresented minorities and/or women." .
<https://okn.wobd.org/grant/1UL1TR001442-01> <http://schema.org/endDate> "2020-03-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1T32AI007384-01> <http://schema.org/identifier> "1T32AI007384-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_125> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<http://purl.obolibrary.org/obo/MONDO_0004992> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_213> <http://schema.org/description> "The novel Severe Acute Respiratory Syndrome (SARS) Coronavirus 2019 (SARS-CoV-2 or COVID-19) emerged as a new viral infection in December 2019. Now a global pandemic, COVID-19 has presently sickened more than one million Americans in just three months with more than 50,000 deaths as of April 27, 2020. COVID-19 presents as a mild dry cough with or without fever and sore throat in the majority of people, yet progression to acute respiratory distress syndrome is possible but the symptom profile appears to be evolving. Initially, data emerging from China suggested the virus had the greatest morbidity and mortality in populations over the age of 70, however, recent data suggest that over 40% of individuals ill enough to require hospitalization are under the age of 50. As with prior coronavirus episodes, wide clinical variation from asymptomatic carriage to acute respiratory distress is unfolding. As with any rapidly changing viral outbreak, data is emerging daily, and little is known about duration of transmissibility, risk of transmission from asymptomatic carriers, environmental contamination and the dynamics of transmission within the home, shelter, or other residential community setting. Further, the long-term sequela of COVID-19 survivors, including their long-term immunity, lung function and other clinical sequela as well as the potential for re-infection is unknown. Effective control requires changes in human behavior including reducing mobility, adoption of non-pharmaceutical interventions including masking and social distancing and testing and isolation of those infected or suspected to be infected. However, there are multilevel barriers to optimal testing in the population; these barriers are complex, dynamic and recursive (Figure 1). The framework portrays these multilevel determinants including the environment, population characteristics, and health behaviors that impact testing utilization and ultimately, health outcomes, including feedback loops indicating that downstream factors may negatively or positively reinforce upstream factors. The framework posits that there are environmental/health care system factors (e.g., testing supplies) and population predisposing, enabling, and need factors, all of which influence testing utilization and subsequent health outcomes. Predisposing factors include sociodemographic and other behavioral characteristics (employment and income). Enabling resources (or lack of) may include factors such as transportation access (e.g., public, personal), concentrated areas of poverty, and testing access (i.e., testing deserts). Need factors include general concerns about the pandemic and personal risk for infection. Health and healthcare inequities will exacerbate poor testing access. Latinx and Blacks are almost three and two times, respectively, more likely to be uninsured compared to non-Latinx whites. Blacks of all ages are also more likely to report not being able to see a doctor in the past year because of cost, which has direct implications for testing. In addition, longstanding issues of institutional (i.e., medical, research, public health) racism, mistrust and distrust, language barriers, and the cost of missing work all decrease the likelihood of testing among these subgroups. Blacks also experience higher rates of chronic conditions at earlier ages and at higher death rates, placing them at increased risk for COVID-19 illness severity and mortality and limiting their ability to seek testing. Racism, stigma, and systemic inequities at multiple levels, including healthcare systems, undermine prevention efforts, increase levels of chronic and toxic stress, and ultimately, sustain these inequities. Community-based studies will be critical for understanding disparities that underpin testing access and uptake. This study was able to define the optimal testing modality in order to maximize testing acceptance, uptake and timeliness of results. In Baltimore City currently, few sites offer testing to patients without symptoms and most still require both a state-level identification and a medical order prior to testing. Efforts to penetrate testing deserts often translate into weekly or monthly pop-up testing sites that are highly unpredictable for community members. Clinics dedicated to low-income residents have signs declaring limited capacity with testing offered while supplies last. This intervention sought to overcome these multi-faceted barriers. Beyond increasing understanding of testing, this study helped to characterize the total spectrum of SARS-CoV-2 infection. COVID-19 is associated with a wide range of symptoms as well as spectrum of clinical illness. Little is known among patients who, ultimately, develop evidence of antibody demonstrating history of infection, yet who do not progress to hospitalization or Acute Respiratory Distress Syndrome (ARDS). For patients who do develop symptoms severe enough to warrant hospitalization, clinical evaluation includes multiple measures of inflammation IL-6, LDH, ESR, CRP, CBC with differential. Additionally, clinical evaluation includes liver function testing and coagulopathy with D-Dimer. This study sought to explore the extent of dysregulation among these parameters in individuals whose symptom spectrum is either prior to or does not lead to acute hospitalization. Moreover, this study provided critical information on community and specifically household transmission of SARS-CoV-2. Household transmission of both viral and bacterial pathogens is common and well established. In the outbreaks of SARS, the Middle Eastern Respiratory Syndrome (MERS) and Avian Influenza (H1N1), household transmission ranged between 5% in MERS, 6.2% in SARS, and 81% in H1N1. The transmissibility of COVID-19 is estimated to be higher than both MERS and SARS, yet lower than H1N1. Sub-clinical transmission within households has also been identified between MERS index cases and household contacts. With most of the household/residential studies, it is unclear whether direct contact with the index case or contact with a fomite within the residence is the source of transmission. Thus, this study helped define the optimal SARS-CoV-2 testing modality for maximizing testing uptake through a randomized comparative effectiveness trial. The three testing modalities were: (1) standard-of-care (SOC) or fixed site testing, (2) community-based, mobile van testing, and (3) self-collected, home-based testing. Population-based sample of households within Baltimore city with randomization to SARS-CoV-2 testing modality and follow-up for up to 12 months. The overall study is divided into two Phases: Phase I and Phase II. Phase I involved informed consent and a baseline survey only. Phase II involved randomization and SARS-CoV-2 testing. At consent into Phase II, participants were randomized as a part of the comparative effectiveness trial and thus, only those who consent to Phase II of the study were included in primary and secondary analyses." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_51> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_170> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0010528> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_43> <http://schema.org/name> "Diagnosis of MIS-C in Febrile Children" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_214> <http://schema.org/datePublished> "2024-04-11"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_211> <http://schema.org/datePublished> "2023-12-06"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_48> <http://schema.org/description> "The data collection system was extended and improved in using wearables for the early detection of COVID-19 infection. With over 5,000 patients recruited in the original Phase 1 IRB-approved study, the existing algorithms were further optimized, especially on its application in individuals with diverse ethnic backgrounds (Aim 1). This study further integrated and optimized the Personal Health Dashboard (MyPHD) to enable real-time online detection of COVID-19 (Aim 2). MyPHD was deployed on the different concentrated populations including pediatric kidney transplant patients, Pac-12 student athletes, and senior living residents (Aim 3)." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_48> <http://schema.org/sameAs> "10.60773/dwzp-am60" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/59" .
<https://okn.wobd.org/grant/1R25EB020393-01A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/person/children_s_hospital_of_orange_county> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_163> <http://schema.org/dateModified> "2024-04-10"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01AI141630-01A1> <http://schema.org/endDate> "2024-04-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1UG3OD023365-01> <http://schema.org/identifier> "1UG3OD023365-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_72> <http://schema.org/date> "2022-12-09"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_43> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/grant/1K08AI130381-01A1> <http://schema.org/funder> <https://ror.org/043z4tv69> .
<https://okn.wobd.org/grant/1DP2AI138242-01> <http://schema.org/startDate> "2017-09-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1P30DK092950-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_77> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005109> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_80> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_218> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/31" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_35> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1P30AI042853-01> <http://schema.org/identifier> "1P30AI042853-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_140> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_188> <http://schema.org/sameAs> <https://doi.org/10.60773/yn52-cp83> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_28> <http://schema.org/sameAs> <https://doi.org/10.60773/54ae-xy13> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_76> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://schema.org/alternateName> <http://www.w3.org/2000/01/rdf-schema#domain> <http://schema.org/Thing> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_43> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/person/florida_international_university> <http://schema.org/name> "Florida International University" .
<https://okn.wobd.org/grant/4UH3AI122309-03> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/1R01DK121072-01A1> <http://schema.org/startDate> "2020-02-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01AG066749-01> <http://schema.org/endDate> "2025-03-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_126> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_157> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_143> <http://schema.org/sameAs> <https://doi.org/10.60773/q8pd-9n90> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_101> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/182" .
<https://okn.wobd.org/grant/1UL1TR001878-01> <http://schema.org/endDate> "2021-05-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1P30AI094189-01A1> <http://schema.org/identifier> "1P30AI094189-01A1" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_96> <http://schema.org/name> "LITE CONNECT: Addressing Testing Gaps and Epidemiologic Disparities of COVID-19 Among Transgender People in the United States" .
<https://okn.wobd.org/grant/75N93021C00015-0-9999-2> <http://schema.org/name> "NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE: UNIVERSAL INFLUENZA RESEARCH ACTIVITIES" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_166> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/grant/1P30DK098722-01A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/1U54CA132379-01A1> <http://schema.org/funder> <https://ror.org/040gcmg81> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/author> <https://okn.wobd.org/person/seattle_children_s> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_52> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/grant/1U54GM115677-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/8948608" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_66> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_41> <http://schema.org/description> "This project was in response to the NIH's RADx-rad Emergency Responses to the COVID-pandemic for new or non-traditional technologies developed for single extracellular vesicle, exosome and extracellular RNA (exRNA) isolation and analysis and reposition them for detection of SARS-CoV-2. The project's group was a grantee in the NIH Common Fund Extracellular RNA Communication (ERC) Program advancing a new and emerging technology of Acoustofluidic Separation (AFS) for label-free, high yield and purity exosomes from biofluids which is coupled to extracellular RNA characterization using Surface Enhanced Raman Spectroscopy (SERS) for single EV identification. This project was to reposition the AFS EV technology and SERS for the non-invasive earliest detection of SARS-CoV-2 in saliva of infected patients. Host immunity to SARS-CoV-2 was also assessed in the saliva samples, permitting the earliest detection of SARS-CoV-2 infection and host immunity non-invasively in a saliva sample." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_173> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/grant/1T32AI007384-01> <http://schema.org/name> "AIDS TRAINING GRANT" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_75> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/grant/1T32AI007384-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/3531363" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_185> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<http://schema.org/infectiousAgent> <http://www.w3.org/2000/01/rdf-schema#range> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/126" .
<https://okn.wobd.org/grant/1UL1TR003142-01> <http://schema.org/funder> <https://ror.org/04pw6fb54> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_118> <http://schema.org/author> <https://okn.wobd.org/person/umass_chan_medical_school> .
<https://okn.wobd.org/grant/1UL1TR003107-01> <http://schema.org/identifier> "1UL1TR003107-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_117> <http://schema.org/sameAs> "10.60773/md02-q556" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/151" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_137> <http://schema.org/name> "Discovery and Clinical Validation of Host Biomarkers of Disease Severity and Multi-system Inflammatory Syndrome in Children (MIS-C) and COVID-19" .
<https://ror.org/006zn3t30> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Organization> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/84" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_148> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_207> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_147> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://ror.org/00adh9b73> <http://schema.org/alternateName> "NIDDK" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/63" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_176> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/person/bristol_myers_squibb_children_s_hospital_robert_wood_johnson_university_hospital> <http://schema.org/name> "Bristol Myers Squibb Children’s Hospital @ Robert Wood Johnson University Hospital" .
<https://www.uniprot.org/taxonomy/12814> <http://schema.org/name> "Respiratory syncytial virus" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_27> <http://schema.org/name> "Wastewater Detection of COVID-19" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_125> <http://schema.org/description> "In Puerto Rico (PR), the first COVID-19 case was confirmed early March 2020. To date, cases have exponentially increased partly due to the lifting of locked-down restriction by the PR government, limited COVID-19 testing, and contact tracing. Puerto Ricans living on the island are particularly vulnerable to the current overlapping of the COVID-19 pandemic and natural disasters (earthquake, hurricanes/storms). Limited access to molecular COVID-19 testing throughout PR has been a significant challenge. Without adequate testing, estimates for SARS-CoV-2 (COVID-19) infection rates are limited and targeted prevention efforts (focused testing) may hinder. A group of epidemiologists led by Dr. Marzán (MPI) developed a web-based COVID-19 Epidemiologic Surveillance System (ESSS) in collaboration with the Puerto Rico Public Health Trust (PRPHT, community partner for this grant) with more than 46,000 surveys completed. The ESSS tool was an online geocoded survey that identified real-time data of COVID-19 signs and symptoms during the last 24 hours; and thus, prioritized communities for COVID-19 testing. Leveraging the current PHSU-PRI COVID-19 prevention efforts and the ESSS infrastructure, the research team tested the preliminary impact of an epidemic intelligence (EpI-Net) community-based intervention aimed at increasing COVID-19 testing uptake and prevention practices among socially vulnerable communities in PR. The working hypothesis was that the integration of lay community leaders, trained in the use of COVID-19 prevention technology tools (EpI-Net), resulted in increased COVID-19 testing uptake and prevention practices among the targeted socially and epidemiologically vulnerable communities in Puerto Rico. This highly innovative and impactful study shifted current COVID-19 prevention strategies by 1) establishing an epidemic intelligence infrastructure using a technology-based COVID-19 syndromic surveillance (ESSS) platform to identify in real time potential COVID-19 outbreaks and, thus, conduct targeted COVID-19 testing, 2) by implementing a population-based COVID-19 prevention intervention (EpI-Net) co-led by epidemiologists and lay community leaders trained as health promotors." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_118> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_191> <http://schema.org/funding> <https://okn.wobd.org/grant/1U24TR001608-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/author> <https://okn.wobd.org/person/nationwide_children_s_hospital> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_148> <http://schema.org/sameAs> "10.60773/r2zx-gw24" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_108> <http://schema.org/author> <https://okn.wobd.org/person/northwestern_university> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_151> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/funding> <https://okn.wobd.org/grant/1R03DK117252-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_162> <http://schema.org/name> "A Data Science Approach to Identify and Manage Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 Infection and Kawasaki Disease in Pediatric Patients" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_186> <http://schema.org/sameAs> "10.60773/0h5r-v081" .
<https://okn.wobd.org/grant/1R01MD016593-01> <http://schema.org/name> "Socioecological Determinants of Immunoepigenetic Signatures of Diabetes Risk in Indigenous Communities" .
<https://okn.wobd.org/grant/1R01EB025022-01> <http://schema.org/identifier> "1R01EB025022-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_221> <http://schema.org/identifier> "phs003595" .
<https://okn.wobd.org/grant/1UL1TR003107-01> <http://schema.org/startDate> "2019-07-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1DP2DA040254-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_97> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_87> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1UL1TR001860-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/1R01AI151059-01> <http://schema.org/endDate> "2025-02-28"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1T32HD044355-01> <http://schema.org/identifier> "1T32HD044355-01" .
<https://okn.wobd.org/grant/1K23AI121485-01A1> <http://schema.org/name> "Longitudinal analysis of respiratory tract microbiome change and sequence-based infection diagnosis during mechanical ventilation" .
<https://okn.wobd.org/person/health_promed_san_juan> <http://schema.org/name> "Health ProMed (San Juan" .
<https://ror.org/00fj8a872> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Organization> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_143> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR002538-01> .
<https://ror.org/00372qc85> <http://schema.org/alternateName> "NIH National Institute of Biomedical Imaging and Bioengineering" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_90> <http://schema.org/url> "https://radxdatahub.nih.gov/study/90" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/184" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_100> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/34" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_211> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_42> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/grant/1P30DK098722-01A1> <http://schema.org/startDate> "2015-08-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_92> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/grant/3OT2HL156812-01S2> <http://schema.org/url> "https://reporter.nih.gov/project-details/10217326" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/author> <https://okn.wobd.org/person/children_s_national_health_system> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_92> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/a7c6-ff66> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_100> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_190> <http://schema.org/name> "ReOpening Schools Safely and Educating Youth (ROSSEY)" .
<https://okn.wobd.org/grant/1R01AI129709-01A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_210> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR001863-01> .
<https://okn.wobd.org/grant/9P30AI050410-04> <http://schema.org/name> "UNC Center for Aids Research" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_138> <http://schema.org/dateModified> "2022-01-28"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/cook_county_hhs> <http://schema.org/name> "Cook County HHS" .
<https://okn.wobd.org/grant/1R01ES028615-01> <http://schema.org/startDate> "2017-09-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_66> <http://schema.org/description> "This work was directed at characterizing pediatric COVID-19 and stratifying incoming patients by projected (future) disease severity. Such stratification has several implications: immediately improving treatment planning, and as disease mechanistic pathways are uncovered, directing treatment. Predicting future severity informed the risks of outpatient treatment; to the patients themselves, their family, other caregivers/cohabitants, and to schools and employers. As varying levels of reopening are adopted across the country (and the world), such prognostication informed policy on the handling of pediatric carriers in the community. Based on preliminary analysis, it is asserted that a combination of novel assays including quantitative serology inflammatory markers (cytokine/chemokine profiles, immune profiles), transcriptomics, epigenomics, longitudinal physiological monitoring, time series analysis, imaging, radiomics and clinical observation including social determinants of health, contains adequate information even at early stages of infection to stratify the disease and predict disease severity. An artificial intelligence/machine learning approach was utilized to integrate this rich and heterogeneous dataset, characterize the spectrum of disease and identify biosignatures that predict severity in progressive disease. To facilitate translation of the approaches developed in this work to a wide user community, a Translational Development function was incorporated to oversee the design-control process and ensure readiness of the methods for regulatory review. Incorporated into the timelines are appropriate regulatory milestones intended to conform with the Emergency Use Authorization (EUA) programs in effect for SARS-CoV-2 diagnostics." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_190> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/a4fj-3408> .
<https://okn.wobd.org/grant/1R01HG009120-01A1> <http://schema.org/identifier> "1R01HG009120-01A1" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_182> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/grant/1U19AI135995-01> <http://schema.org/funder> <https://ror.org/043z4tv69> .
<https://okn.wobd.org/grant/1P30ES005022-01> <http://schema.org/identifier> "1P30ES005022-01" .
<https://okn.wobd.org/grant/8G12MD007595-04> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_212> <http://schema.org/dateModified> "2024-01-09"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_175> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_132> <http://schema.org/description> "SARS-CoV-2, the virus that causes COVID-19, has ravaged underserved and vulnerable populations in the United States (US), including in the US territories of Puerto Rico (PR) and the US Virgin Islands (USVI). Pre-pandemic data from the Eastern Caribbean Health Outcomes Research Network (ECHORN) Cohort Study (ECS) (NIH/NIMHD U24MD006938; Pl: Nunez-Smith) indicate nearly 61% of the population-based representative sample (n=3000) has at least one chronic condition making them high risk for severe complications from COVID-19. Nearly 30% of ECS participants report food insecurity. These ECS data were recently requested by the Congressional Ways and Means Committee to scope the threat of the COV1D-19 pandemic to the Caribbean US territories. This competitive revision leverages the Yale Transdisciplinary Collaborative Center for Health Disparities Research focused on Precision Medicine (Yale-TCC; NIH/NIMHD U54MD010711; MPI: Nunez-Smith), which supports broader scientific engagement across ECHORN members. ECHORN was founded in 2011 as a consortium of researchers and non-academic stakeholder partners, using a participatory action research approach, to address the epidemic of non-communicable diseases in the region. The Yale-TCC is a community-engaged and stakeholder-driven network with a consortium comprised of 60 individuals representing 35 organizations spanning academia, research, health policy, faith-based organizations, community-based organizations, and civic societies. The Yale-TCC Governing Board guides prioritization. The goal of the proposed community-engaged research was to, in concert with the RADx-UP consortium, understand factors that have led to the disproportionate disease burden and deploy interventions that improve the reach, access, uptake and impact of COVID-19 testing technologies and strategies across FQHCs, local CBOs, and clinical laboratories in the USVl and PR. Rigorous quasi-experimental designs were used to evaluate the proposed testing intervention projects. This was achieved through the following specific aims:\nAim 1: Enhance testing implementation strategies in the USVI and PR utilizing community-based assets and cultural responsiveness to address barriers to full participation in the testing continuum from diagnosis through to seif-isolation. An initial partnership with 3 FQHCs (two in USVI and one in PR) and 2 CBOs (one in USVI and one in PR) was leveraged to refine and implement a multi-component intervention to increase testing, contact tracing, and safe and effective quarantine and isolation, with a focus on the most vulnerable populations. An interrupted time series study design was used to analyze the effect of the intervention on the primary implementation outcome of reach. Secondary Implementation outcomes of adoption, fidelity, acceptability, and sustainability were assessed, as is the secondary effectiveness outcome of ER utilization. Community partners were engaged throughout the intervention refinement, implementation, and evaluation process. Aim 2: Assess the diffusion and uptake of FDA authorized and approved testing technologies across existing and emerging testing models. Through stakeholder and community engagement meetings, intervention components that provide the necessary education/health promotion information, training, and resources that were needed to address barriers at the FQHC, CBO, and community-level to adopt, implement, and disseminate new testing technologies were determined. Sustainability of this model for integration of future technologies or vaccines was addressed and assessed." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_62> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/12814> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_185> <http://schema.org/sameAs> <https://doi.org/10.60773/s244-bp16> .
<https://okn.wobd.org/grant/1R01AI146165-01A1> <http://schema.org/funder> <https://ror.org/043z4tv69> .
<https://okn.wobd.org/grant/8P20GM103395-12> <http://schema.org/funder> <https://ror.org/04q48ey07> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_215> <http://schema.org/identifier> "phs003504" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_77> <http://schema.org/datePublished> "2023-08-29"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/2UL1TR000427-06> <http://schema.org/name> "Institutional Clinical and Translational Science Award" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_65> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_166> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR002319-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_129> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_99> <http://schema.org/dateCreated> "2021-11-16"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_49> <http://schema.org/datePublished> "2022-07-20"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_124> <http://schema.org/sameAs> <https://doi.org/10.60773/7h8k-bz16> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_210> <http://schema.org/funding> <https://okn.wobd.org/grant/1P30DK098722-01A1> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_40> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_130> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<http://purl.obolibrary.org/obo/MONDO_0004975> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_60> <http://schema.org/author> <https://okn.wobd.org/person/montefiore> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_122> <http://schema.org/description> "Non-Native Hawaiian Pacific Islanders (PI), defined as indigenous people having origins in Guam, the Commonwealth of the Northern Mariana Islands, American Samoa, Federated States of Micronesia, Republic of the Marshall Islands and Republic of Palau, have among the highest COVID-19-associated morbidity and mortality rates in the U.S. PI also suffer from medical co-morbidities known to increase their risk of severe COVID-19. In addition, PI have poor access to health care, inadequate or no health insurance, live in multi-generational or multi-family overcrowded housing, and have low-paying service jobs that expose them to the infected public. In Hawaii, PI comprise only 4% of the State's population but account for more than 20% of COVID-19 cases and deaths. The long-term goal was to reduce COVID-19 disparities among PI. The overall objective was to use culturally resonant community-engagement strategies to increase the reach and uptake of COVID-19 testing to better understand SARS-CoV-2 infection patterns among PI in Hawaii and on Guam. The multi-disciplinary investigative team comprises of physicians and community health workers, community-engaged researchers and basic and applied scientists. Strong support from the institution, community, and local government attest to the urgency of this RADx-UP Community-Engagement Testing Research Project." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_67> <http://schema.org/dateModified> "2024-01-18"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/77" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_166> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<http://schema.org/dateModified> <http://www.w3.org/2000/01/rdf-schema#domain> <http://schema.org/Thing> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_65> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_76> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_79> <http://schema.org/description> "The overall goal of Reaching Communities through the Design of Information Visualizations (ReDIVis) Toolbox for Return of COVID-19 Results (RCR) was to decrease health disparities related to COVID-19 by enabling widespread use of culturally congruent and health literate infographics to return the results of SARS-CoV-2 diagnostic and antibody testing in a manner that supports comprehension of the results, informs decision-making, and motivates appropriate behaviors. In collaboration with a community partner, the Association to Benefit Children, mixed-methods research design was used to achieve the following specific aims: 1. Advance understanding of the factors that influence comprehension and use of the results of SARS- CoV-2 diagnostic and antibody testing in underserved and vulnerable populations. 2. Collaborate with underserved and vulnerable populations to design infographics for returning the results of SARS-CoV-2 diagnostic and antibody testing in a format that maximizes comprehension, informs decision making, and motivates action. 3. Develop, implement, evaluate, and disseminate the ReDIVis Toolbox for returning the results of SARS-CoV-2 diagnostic and antibody testing. ReDIVis Toolbox-RCR builds upon substantial preliminary work in community engagement, lay-person science, system development and evaluation, and information visualization as well as existing infrastructure: (a) a research cohort of Latino adults, and (b) the Visualization Design Studio of the Precision in Symptom Self-Management Center. Informed by seven public health ethics principles, ReDIVis Toolbox-RCR research activities (focus groups, interviews, surveys, participatory design sessions, usability testing) resulted in the web-based ReDIVis Toolbox that includes: (a) infographics in English and Spanish for returning SARS-CoV-2 test results; (b) documents to support design, implementation, and evaluation of infographics; and (c) software to enable the creation of tailored culturally congruent and health literate infographics. Within the defined areas of research interests in NOT-OD-20-119, ReDIVis Toolbox-RCR directly responds to the need for SARS-CoV-2 test results templates and toolkits designed in collaboration with communities and strategies and resources to increase use and utility of test results. In addition, ReDIVis Toolbox-RCR research activities allowed for advanced understanding of the social, ethical, and behavioral implications of how test results are interpreted and used; specifically, how the results influence decision-making and COVID-19 mitigation behaviors (e.g., social distancing, self-isolation, mask wearing, and vaccination, when available). Moreover, this study involved interaction with other RADx-UP grantees to enhance the generalizability of the ReDIVis Toolbox." .
<https://okn.wobd.org/grant/1R01AG066749-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_96> <http://schema.org/author> <https://okn.wobd.org/person/brigham_womens_hospital> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_58> <http://schema.org/url> "https://radxdatahub.nih.gov/study/58" .
<https://okn.wobd.org/grant/1R01HL105704-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_71> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/grant/1U01HG010971-01> <http://schema.org/endDate> "2024-07-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/north_miami_high_school> <http://schema.org/name> "North Miami High School" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_150> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_166> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_201> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/18dv-6j23> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/92" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_86> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1P30CA042014-01> <http://schema.org/endDate> "1989-06-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01DA055491-01> <http://schema.org/identifier> "1R01DA055491-01" .
<https://okn.wobd.org/grant/8G12MD007595-04> <http://schema.org/name> "Xavier's RCMI Cancer Research Program" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_58> <http://schema.org/sameAs> "10.60773/gr4a-3m47" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_58> <http://schema.org/sameAs> <https://doi.org/10.60773/gr4a-3m47> .
<https://okn.wobd.org/person/georgia_institute_of_technology> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/person/inc_nys_department_of_health> <http://schema.org/name> "Inc./NYS Department of Health" .
<https://okn.wobd.org/person/monell_chemical_senses_center> <http://schema.org/name> "Monell Chemical Senses Center" .
<https://okn.wobd.org/grant/1U19AI142733-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/person/arch_creek_elementary> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_160> <http://schema.org/sameAs> <https://doi.org/10.60773/8yg5-8e14> .
<https://okn.wobd.org/grant/1R01AI088364-01> <http://schema.org/funder> <https://ror.org/043z4tv69> .
<https://okn.wobd.org/grant/1ZIANR000035-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9784517" .
<https://okn.wobd.org/grant/1P30AI042853-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_82> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/grant/1R01AI123105-01A1> <http://schema.org/startDate> "2016-02-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_61> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/grant/1R01GM138385-01A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_152> <http://schema.org/datePublished> "2023-08-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_45> <http://schema.org/description> "In North Carolina and nationally, Black and Hispanic/Latinx communities have been disproportionately affected by COVID-19 due to multi-level risk factors and barriers to testing, prevention, and care, but have not benefited from a clinical and public health response commensurate with the magnitude of the problem. To address this, a proven implementation strategy from the global HIV response community-based task shifting was adapted to reach underserved and vulnerable Black and Hispanic/Latinx communities with COVID-19 testing and linkage to care, vaccination, and other preventative measures in rural central North Carolina, and to evaluate the effects of this strategy on important health service and implementation outcomes. This project improved testing access for underserved communities being missed by current testing approaches, and generated new insights into a promising implementation strategy that could be leveraged to enhance ongoing pandemic response efforts and delivery of COVID-19 vaccines and other prevention interventions." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_124> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/7h8k-bz16> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_35> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/person/morehouse_school_of_medicine> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_55> <http://schema.org/description> "Children have been disproportionately less impacted by the Corona Virus Disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) compared to adults. However, severe illnesses including Multisystem Inflammatory Syndrome (MIS-C) and respiratory failure have occurred in a small proportion of children with SARS-CoV-2 infection. Nearly 80% of children with MIS-C are critically ill with a 2-4% mortality rate. Currently, there are no modalities to characterize the spectrum of disease severity and predict which child with SARS-CoV-2 exposure will likely develop severe illness including MIS-C. Thus, there is an urgent need to develop a diagnostic modality to distinguish the varying phenotypes of disease and risk stratify disease. The epigenetic changes in microRNA (miRNA) profiles that occur due to an infection can impact disease severity by altering immune response and cytokine regulation which may be detected in body fluids including saliva. The long-term goal of this study was to improve outcomes of children with SARS-CoV-2 by early identification and treatment of those at risk for severe illness. The central hypothesis was that a model that integrates salivary biomarkers with social and clinical determinants of health would predict disease severity in children with SARS-CoV-2 infection. This central hypothesis was pursued through four specific, phased aims. The first two aims from the R61 phase were: 1) Defining and comparing the salivary molecular host response in children with varying phenotypes (severe and non-severe) SARS-CoV-2 infections, and 2) Developing and validating a sensitive and specific model to predict severe SARS-CoV-2 illness in children. The R33 phase pursued the following two aims: 3) Development of a portable, rapid device that quantifies salivary miRNAs with comparable accuracy to predicate technology (qRT-PCR), and 4) Development of an artificial intelligence (AI) assisted cloud and mobile system for early recognition of severe SARS-CoV-2 infection in children. The above aims were pursued using an innovative combination of salivaomics and bioinformatics, analytic techniques of AI and clinical informatics. This research is significant because development of a sensitive model to risk stratify disease is expected to improve outcomes of children with severe SARS-CoV-2 infection via early recognition and timely intervention. The outcome of this study is a better understanding of the epigenetic regulation of host immune response to the viral infection which is expected to lead to personalized therapy in the future. The results have immediately had a positive impact and will lead to the creation of patient profiles based on individual risk factors which can enable early identification of severe disease and appropriate resource allocation during the pandemic." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_220> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/grant/1R01HG009518-01A1> <http://schema.org/startDate> "2018-08-10"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_216> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/hwkn-r448> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_147> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/person/children_s_national_research_institute> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_75> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_66> <http://schema.org/url> "https://radxdatahub.nih.gov/study/66" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_271> <http://schema.org/sameAs> "10.60773/gwn0-p070" .
<https://okn.wobd.org/grant/2P2CHD050924-11> <http://schema.org/startDate> "2005-07-11"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_205> <http://schema.org/identifier> "phs003361" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_173> <http://schema.org/url> "https://radxdatahub.nih.gov/study/173" .
<https://okn.wobd.org/grant/1UL1TR002345-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/1K23AI121485-01A1> <http://schema.org/funder> <https://ror.org/043z4tv69> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_47> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_144> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_99> <http://schema.org/sameAs> <https://doi.org/10.60773/nxck-yd76> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_109> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_208> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/person/tufts_medicine> <http://schema.org/name> "Tufts Medicine" .
<https://okn.wobd.org/grant/1UL1TR001863-01> <http://schema.org/identifier> "1UL1TR001863-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_213> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_77> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/grant/1UM1HG008898-01> <http://schema.org/name> "Genomic Architecture of Common Disease in Diverse Populations" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_39> <http://schema.org/date> "2024-04-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_41> <http://schema.org/identifier> "phs002544" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_180> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01MH115676-01A1> <http://schema.org/url> "https://reporter.nih.gov/project-details/9543791" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_138> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/10239> .
<https://okn.wobd.org/grant/1T32AI007291-01A1> <http://schema.org/identifier> "1T32AI007291-01A1" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_188> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_176> <http://schema.org/author> <https://okn.wobd.org/person/sable_palm_elementary> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_210> <http://schema.org/sameAs> <https://doi.org/10.60773/ybnk-xd66> .
<https://okn.wobd.org/grant/1P30ES030285-01> <http://schema.org/endDate> "2024-03-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_92> <http://schema.org/identifier> "phs002647" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_174> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/grant/1P20GM121342-01A1> <http://schema.org/name> "SC COBRE for Translational Research Improving Musculoskeletal Health (SC-TRIMH)" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_70> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/tpfh-0630> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_74> <http://schema.org/name> "Early Detection, Containment, and Management of COVID-19 in Dialysis Facilities Using Multi-Modal Data Sources" .
<https://okn.wobd.org/grant/1R35GM119774-01> <http://schema.org/identifier> "1R35GM119774-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_74> <http://schema.org/description> "With older age and multiple comorbidities, dialysis patients are at high risk for serious complications, even death, from COVID-19. There is a large disproportionate representation of minorities, especially Blacks and Hispanics. Over 85% of hemodialysis patients travel three times a week to dialysis facilities to receive life-sustaining treatments and cannot shelter in place. There is a critical need to characterize COVID-19 transmission pathways in dialysis patients and clinics, identify potential coronavirus carriers, and develop procedures to curb the spread. With regular medical encounters, a large amount of data has been collected for each patient over time. These data have not been fully utilized for COVID-19 prediction and control in dialysis clinics. This study sought to leverage demographic, clinical, treatment, laboratory, socioeconomic, serological, metabolomic, wearable and machine-integrated sensors, and COVID-19 surveillance data to develop mathematical and statistical models and implement them in a large number of dialysis clinics. The mathematical and statistical modeling using multiple data resources helped to understand how COVID-19 spreads in dialysis facilities, identify potential COVID-19 patients before symptoms appear, and identify potential asymptomatic COVID-19 patients. Novel mathematical and statistical models were developed that fully utilize the high dimensional multimodal data available. This study capitalized on the intrinsic advantages of hemodialysis clinics to implement and validate the proposed prediction models. There was a firm belief that this cross-disciplinary effort would improve patient and staff safety while delivering high-quality, individualized care to a high-risk population." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_121> <http://schema.org/author> <https://okn.wobd.org/person/university_of_massachusetts_chan_medical_school_and_northwestern_university> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_46> <http://schema.org/description> "Black communities in the US are experiencing three converging public health crises: COVID-19, systemic racism, and community and police violence. Black Americans are significantly less likely to receive a needed COVID-19 test and have higher rates of COVID-19 infection and death than white Americans. Additionally, Black communities have experienced a surge in gun violence in 2020 and continue to be victims of police harassment and violence, resulting in large-scale social justice demonstrations. The convergence of these epidemics has created a syndemic, wherein racism, violence, and COVID-19 cluster in predominantly Black and low-income communities. This study aimed to characterize this syndemic to understand how personal and systemic racism and violence in Black communities may influence COVID-19 testing decisions. This mixed-method study with Black residents of Chicago, IL resulted in community-driven recommendations to enhance COVID-19 testing and prevention strategies and address this emerging syndemic. The potential mediating pathways of medical mistrust, psychological trauma and stress, and economic injustice were examined in this study. Additionally, a strengths-based approach was taken to understand potential protective factors including neighborhood cohesion, social support, and access to health care. The specific aims of the study were to: 1) Qualitatively examine how experiences of racial discrimination, community violence, and police violence influence trust in, and engagement with, healthcare systems and contribute to decisions around COVID-19 testing and mitigation strategies (e.g., social distancing) among Black individuals in Chicago (N=S0); 2) Quantitatively assess the prevalence and correlates of COVID-19 testing among Black residents in Chicago (N = 500) and characterize the COVID-19, racism, and violence syndemic; and 3) In partnership with a Community Advisory Council, use an integrative translational workshop approach and intervention mapping techniques to develop community and data-driven recommendations and an intervention blueprint for local health departments, researchers, and public health organizations to improve COVID-19 testing among Black Americans. This study resulted in policy and research recommendations, community resources, and a 'shovel-ready' intervention blueprint to enhance COVID-19 testing and address this emerging syndemic." .
<https://okn.wobd.org/grant/1U54CA132384-01A1> <http://schema.org/identifier> "1U54CA132384-01A1" .
<https://okn.wobd.org/grant/5R01DK035385-02> <http://schema.org/identifier> "5R01DK035385-02" .
<https://www.uniprot.org/taxonomy/9606> <http://schema.org/name> "Homo sapiens" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_190> <http://schema.org/sameAs> "10.60773/a4fj-3408" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_220> <http://schema.org/dateCreated> "2024-02-07"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/93" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_128> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/c9fp-qk33> .
<https://ror.org/04q48ey07> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Organization> .
<https://okn.wobd.org/grant/1P30NS047101-01> <http://schema.org/endDate> "2008-07-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_214> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0013600> .
<https://okn.wobd.org/grant/9P30AI050410-04> <http://schema.org/funder> <https://ror.org/043z4tv69> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_170> <http://schema.org/description> "The COVID-19 pandemic is the most devastating infectious disease outbreak in a century, particularly in underserved and minoritized communities. In 2020 alone, it will cost a million lives. It continues to wreak economic havoc worldwide. Therefore, it is critical to develop new tools that can mitigate the spread of SARS-CoV- 2, the virus that causes COVID-19. Rapid screening tools can identify potentially infected individuals who can then be isolated/quarantined from the uninfected and directed towards further testing and treatment. Unfortunately, definitive viral testing for SARS-CoV-2 has proven difficult to implement in many countries, including the US, due to technical, financial and governmental hurdles to universal access and timely processing. Symptom-based screening offers a valuable, albeit imperfect, complement to viral testing that can help identify many individuals with the disease for isolation as well as treatment. A major challenge with symptomatic testing is that COVID-19 is highly protean: the heterogeneity of symptoms means no single symptom or constellation of symptoms is definitive diagnostically. Still, there is growing evidence that sudden partial or complete olfactory loss, even more than other symptoms such as fever or dry cough, is the single best predictor of COVID-19. In this project, objective, self-administered smell tests were developed and implemented for the purpose of identifying individuals with COVID-19 prior to, or in the absence of, viral testing, as well as for use in population-level surveillance of COVID-19 spread. Several kinds of objective tests were used in clinical or laboratory settings to assess an individual's olfactory ability, including those that test the ability to identify or discriminate odors as well as procedures to determine the lowest concentration an individual can reliably perceive (i.e., odor detection threshold). Each approach had technical and logistical advantages and disadvantages, and each captured different aspects of olfactory dysfunction. Regarding COVID-19, it is unknown what type of measure had the highest specificity or sensitivity. Aim 1 relied on the use of self-administered objective testing of odor identification and odor detection threshold in SARS-CoV-2-tested individuals to determine which olfactory measure was the best predictor of COVID-19. Aim 2 used objective smell testing to assess whether population monitoring of olfactory loss in university, municipal or other community settings can serve as a sentinel of COVID-19 community spread. Together, these studies provided a rapid, remote-friendly, cost-effective, scalable, non-intrusive method to screen for COVID-19 at the individual level and to assess prevalence in communities, especially those that have been traditionally underserved by the health care system and public health infrastructure." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_41> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_172> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_113> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_83> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_161> <http://schema.org/name> "Broad-Spectrum Detection of VOC and Non-VOC Biomarkers from Patient Exhalant Using a Biomimetic Multiplexed eNose Biosensor for COVID-19 Diagnosis" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_33> <http://schema.org/datePublished> "2022-01-07"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/2U54MD007601-31> <http://schema.org/funder> <https://ror.org/0493hgw16> .
<https://okn.wobd.org/person/children_s_hospital_los_angeles> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/person/louisiana_state_university_of_health_sciences_center> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_210> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005550> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_49> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/6U48DP006395-01M001> <http://schema.org/startDate> "2019-09-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_172> <http://schema.org/author> <https://okn.wobd.org/person/umass_lowell> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_195> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_137> <http://schema.org/author> <https://okn.wobd.org/person/emory_university> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_31> <http://schema.org/url> "https://radxdatahub.nih.gov/study/31" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_201> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_183> <http://schema.org/dateCreated> "2022-09-16"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_74> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_157> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_163> <http://schema.org/name> "Identifying and Addressing Critical Social, Ethical, and Behavioral Factors Associated with COVID-19 Testing and Vaccination Among Spanish Speakers" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_109> <http://schema.org/identifier> "phs002700" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_201> <http://schema.org/datePublished> "2024-07-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1UL1TR002345-01> <http://schema.org/name> "Washington University Institute of Clinical and Translational Sciences" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_119> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1P30CA042014-01> <http://schema.org/name> "CANCER CENTER SUPPORT GRANT--UTAH REGIONAL CANCER CENTER" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_36> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_32> <http://schema.org/description> "The goal of this project was to develop both contact tracing and secure data exchange tools. The contact tracing solution securely combines data from a variety of sources (including manual self-report data, mobile device surveys) to enable tracing of contacts with individuals that have tested positive for COVID-19 or have been exposed to COVID-19. The data exchange solution is a secure mechanism that empowers users to control the data they share in the course of their return to work, including the ability to provide a verifiable health status claim. These tools were used by an employer to evaluate the risk of allowing individuals to return to normal activities and also the ability to trace user contact with individuals diagnosed with, or suspected of having contracted, COVID-19." .
<https://okn.wobd.org/grant/1R01HD106120-01> <http://schema.org/name> "Retinoic acid signaling in decidualization" .
<https://okn.wobd.org/grant/1P30AI094189-01A1> <http://schema.org/funder> <https://ror.org/043z4tv69> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_144> <http://schema.org/identifier> "phs002651" .
<https://okn.wobd.org/grant/1R01NS076465-01> <http://schema.org/identifier> "1R01NS076465-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_132> <http://schema.org/author> <https://okn.wobd.org/person/frederiksted_health_care_st_croix> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_80> <http://schema.org/author> <https://okn.wobd.org/person/association_for_utah_community_health> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_61> <http://schema.org/name> "A Multimodal Platform for Oral Screening of COVID-19" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_69> <http://schema.org/description> "To help diversify the approaches that can be used to sensitively detect SARS-CoV-2 and improve response resilience, an established virus detection system that has already shown the ability to detect viruses such as Ebola and Marburg viruses were pivoted and a focused assay for SARS-CoV-2 was developed. In parallel, rapidly scalable sensor chips and an automated reader was prototyped to enable deployment of rapid and sensitive POC viral diagnostics assays based on a simple interferometric reflectance imaging sensor (IRIS) platform. The multiplexed and configurable assays using robust universal DNA functionalized sensor chips, proposed diagnostic was performed in the presence of influenza. A patient with flu-like symptoms could be diagnosed with flu or COVID-19, or both as feared that these infections can occur concurrently. The study also prototyped a high-throughput system that tests samples directly in microwell plates to run 2,000 tests/day per instrument." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_152> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR001442-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_195> <http://schema.org/name> "Test Us At Home" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_58> <http://schema.org/description> "The COVID-19 pandemic has caused unprecedented societal suffering and economic disruption. Although current COVID-19 diagnostic testing technologies are critical for curbing the spread of the virus and preventing future outbreaks, they are not practical for field use. Current diagnostic tests are cumbersome to perform because they use aqueous solutions, require multiple steps, and hours-to-days to obtain results. Therefore, there is an urgent need to develop a diagnostic approach that is non-invasive, portable, and can rapidly provide test results. The overall goal of the project was to develop a mobile breath analysis technology for rapid screening for COVID-19 using a handheld breath collection tool and a portable GC with a photoionization detector (PID). The handheld tool was a closed system for trapping target volatile organic compounds (VOCs) on a microfabricated chip. The captured VOCs were eluted with a solvent and then analyzed using a portable GC-PID instrument. Artificial intelligence (AI) and machine learning algorithms were applied to recognize the VOC pattern that correlates with COVID-19 infection. The central innovation was the microfabricated chip that captured VOCs in exhaled breath and thus served as a preconcentrator, which enabled analysis of the captured VOCs by the portable GC-PID. The hypothesis was that VOC metabolome in exhaled breath was directly related to the body's reaction to tSARS-CoV-2 infection, and the changes of VOC profile in exhaled breath relative to healthy controls were used to detect both symptomatic and asymptomatic COVID-19 patients. The University of Louisville was uniquely suited to rapidly transition the microchip technology to field use because of the PI and Co-PI's experience in breath analysis and translational research, and the project team's experience in virology, infectious diseases, biostatistics, and artificial intelligence as well as the state-of-the-art facilities that include a MicroNano Technology Center, Biosafety Level 3 Regional Biocontainment Lab, and an NIH-funded REACH program." .
<https://okn.wobd.org/grant/1P30DK045735-01> <http://schema.org/name> "DIABETES ENDOCRINOLOGY RESEARCH CENTER" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_28> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/grant/2U54MD007595-11> <http://schema.org/url> "https://reporter.nih.gov/project-details/9615236" .
<https://okn.wobd.org/person/unc_chapel_hill_note_data_are_only_collected_and_managed_by_jhu> <http://schema.org/name> "UNC Chapel Hill (Note: data are only collected and managed by JHU)." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_178> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2901879> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_205> <http://schema.org/url> "https://radxdatahub.nih.gov/study/205" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_195> <http://schema.org/dateCreated> "2023-03-24"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_82> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_199> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_68> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_217> <http://schema.org/name> "Increasing Representation of Black Communities in COVID-19 Home Testing and Surveillance Data" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_173> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/347537> .
<https://okn.wobd.org/grant/8P51OD011132-52> <http://schema.org/url> "https://reporter.nih.gov/project-details/8306086" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_119> <http://schema.org/description> "This prospective clinical study sought to examine the performance of the device, a sample-to-answer nucleic acid PCR amplification platform solution for the point-of-care (POC) detection of SARS-CoV-2, compared to the Roche 6800 Cobas PCR for SARS-CoV-2 assay. Secondary outcomes include usability and interpretability of results among POC device operators. The goal of this study was to extend the existing EUA approval that the device has (symptomatic participants and healthcare provider obtained specimens) to use among asymptomatic persons and using self-collected mid-turbinate specimens. Note: no device performance data were included in the dataset." .
<http://purl.obolibrary.org/obo/MONDO_0005046> <http://schema.org/name> "immune system disorder" .
<https://okn.wobd.org/grant/1ZIANR000035-01> <http://schema.org/identifier> "1ZIANR000035-01" .
<https://okn.wobd.org/grant/1P30GM131944-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9703201" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_84> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1UG3OD023365-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9263719" .
<https://okn.wobd.org/person/university_of_illinois_urbana_champaign_and_northwestern_university> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_55> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://ror.org/004a2wv92> <http://schema.org/alternateName> "El Instituto Nacional de Investigación Dental y Craneofacial" .
<https://okn.wobd.org/person/the_university_of_chicago_department_of_pediatrics> <http://schema.org/name> "The University of Chicago Department of Pediatrics" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_162> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/NCIT_C136265> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_168> <http://schema.org/datePublished> "2024-08-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_187> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_74> <http://schema.org/date> "2024-01-18"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_119> <http://schema.org/sameAs> <https://doi.org/10.60773/2seb-yr47> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_155> <http://schema.org/name> "Assessing Vaccine Hesitancy and a Pharmacist Led Intervention Model to Increase COVID-19 Vaccine Uptake Among African Americans" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_127> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/tufts_medicine> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/grant/1DP2AI138242-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://ror.org/04byxyr05> <http://schema.org/identifier> "https://ror.org/04byxyr05" .
<https://okn.wobd.org/grant/1UL1TR001442-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/person/emory_university> <http://schema.org/name> "Emory University" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_86> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_38> <http://schema.org/datePublished> "2022-11-07"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_221> <http://schema.org/dateCreated> "2024-03-28"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_146> <http://schema.org/dateCreated> "2022-04-18"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_156> <http://schema.org/funding> <https://okn.wobd.org/grant/1U24TR001608-01> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/158" .
<https://okn.wobd.org/grant/9P30AI050410-04> <http://schema.org/identifier> "9P30AI050410-04" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_121> <http://schema.org/description> "The purpose of this feasibility study was to gather knowledge that will inform a future larger study using at-home SARS-CoV-2 testing and digital tools. This study will: 1) Test the feasibility of daily home SARS-CoV-2 testing using the Quidel QuickVue® device; 2) Test whether a smartphone app (CareEvolution MyDataHelps™) designed to support at-home testing is acceptable and usable; and 3) Examine other key process metrics and variables important to the design of a larger randomized trial. In particular, the feasibility of the Quidel QuickVue® home test and the digital app will be assessed through data on the number of home SARS-CoV-2 tests performed and number of home SARS-CoV-2 tests transmitted through the mobile health app. Secondary outcomes of importance are: (1) participant self-reported overall usability of the app-supported at-home testing system; (2) participant self-reported acceptability of the at-home test and smartphone app using the net promoter scale; (3) participant self-reported quality of the CareEvolution MyDataHelps™ app using uMARS (Mobile app rating scale); and (4) concordance between self-interpretation and study-team interpretation of self-test SARS-CoV-2 results. This was a feasibility study that enrolled an observational cohort into an intervention-only arm of future cluster RCT." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_67> <http://schema.org/author> <https://okn.wobd.org/person/university_of_pennsylvania> .
<https://www.uniprot.org/taxonomy/2971083> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_96> <http://schema.org/author> <https://okn.wobd.org/person/unc_chapel_hill_note_data_are_only_collected_and_managed_by_jhu> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_76> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/1835-3770> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_32> <http://schema.org/name> "NIH Digital Health Solutions for COVID-19: IBM COVID-19 Contact Tracing and Data Exchange Tools" .
<https://okn.wobd.org/grant/1P30ES005022-01> <http://schema.org/name> "RESEARCH IN ENVIRONMENTAL HEALTH SCIENCES" .
<https://okn.wobd.org/grant/1T32EB009380-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/1T32DA007292-01A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/146" .
<http://purl.obolibrary.org/obo/NCIT_C136265> <http://schema.org/name> "Carfilzomib/Dexamethasone Regimen" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_43> <http://schema.org/description> "The recent emergence of SARS-CoV-2 and resultant pandemic of COVID-19 disease has overwhelmed global health systems and led to over 200,000 American deaths to date. While initial reports suggested that SARS-CoV-2 infection in children was generally benign, a novel post-inflammatory syndrome known as multisystem inflammatory syndrome in children (MIS-C) has now been described. MIS-C in children is characterized by fever, systemic inflammation, and end-organ involvement, and the majority of patients are IgG seropositive for SARS-CoV-2. Because the clinical features of MIS-C overlap with other infections and inflammatory disorders, new strategies for diagnosis of MIS-C in febrile children are urgently needed. The immediate objective of this study was to determine the reproducible changes in breath, urine, and salivary volatile composition in children diagnosed with MIS-C. These discovery studies were integrated with clinical and immunological profiling to develop and validate a novel and much-needed MIS-C diagnostic, which was expected to have a major impact on care of febrile children. The long-term goal of this study was to develop a diagnostic strategy to distinguish children with MIS-C from children with other causes of fever." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_108> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_173> <http://schema.org/sameAs> "10.60773/nsxy-2f26" .
<https://okn.wobd.org/grant/1K08AI130381-01A1> <http://schema.org/endDate> "2023-12-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_76> <http://schema.org/url> "https://radxdatahub.nih.gov/study/76" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/75" .
<https://okn.wobd.org/grant/1R01AI129709-01A1> <http://schema.org/name> "Non-inferiority study of adjuvanted vs. high dose flu vaccine in residents of long term care" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_177> <http://schema.org/datePublished> "2022-11-07"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_144> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01MH113094-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_208> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/grant/1R25EB020393-01A1> <http://schema.org/url> "https://reporter.nih.gov/project-details/9044390" .
<http://schema.org/author> <http://www.w3.org/2000/01/rdf-schema#domain> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_167> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/11709> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_62> <http://schema.org/sameAs> <https://doi.org/10.60773/qggp-bp06> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_40> <http://schema.org/dateModified> "2024-04-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_179> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_49> <http://schema.org/funding> <https://okn.wobd.org/grant/1T32EB009380-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_206> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_67> <http://schema.org/identifier> "phs002588" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_42> <http://schema.org/url> "https://radxdatahub.nih.gov/study/42" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_128> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_148> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/r2zx-gw24> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_43> <http://schema.org/identifier> "phs002603" .
<https://okn.wobd.org/grant/2T32CA009140-11> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_144> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/grant/75N93021C00015-0-9999-2> <http://schema.org/endDate> "2022-03-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100163> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_42> <http://schema.org/name> "Direct Bioelectronic Detection of SARS-CoV-2 From Saliva Using Single-Molecule Field-Effect Transistor Array" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_30> <http://schema.org/dateModified> "2022-12-09"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.obolibrary.org/obo/MONDO_0100096> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_115> <http://schema.org/identifier> "phs002713" .
<https://okn.wobd.org/grant/1UL1TR002736-01> <http://schema.org/identifier> "1UL1TR002736-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_175> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_167> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_33> <http://schema.org/dateModified> "2024-01-04"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_219> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_97> <http://schema.org/description> "The overarching goal of this study was to determine the acceptability, feasibility, efficacy, and scalability of back-to-early childhood education (ECE) testing in young children (3-5 years). Whether outdoor garden-based education can help close the education gap experienced by children who have been out of school during the pandemic will also be determined. The subject population was comprised of three groups of people: (1) ECE-enrolled children, (2) their parents, and (3) ECE personnel. The enrollment goal for this study was ~800 children between the ages of 3 and 5, with the average age of 4 years to be evenly distributed by sex from 40 ECE sites in Phoenix, Maricopa County, AZ. One parent of each child, most of whom (~90%) will be women, were also enrolled. It was expected that most children and parents in the sample will be Hispanic and many to be Spanish language dominant. Approximately 40 ECE personnel were enrolled. An additional 800 child and parent dyads were recruited." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_141> <http://schema.org/sameAs> <https://doi.org/10.60773/86zb-bq66> .
<https://okn.wobd.org/grant/1P01AI118688-01A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_183> <http://schema.org/url> "https://radxdatahub.nih.gov/study/183" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_60> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_159> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_217> <http://schema.org/sameAs> <https://doi.org/10.60773/ewfr-hd70> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_61> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2901879> .
<https://okn.wobd.org/grant/1R01DK107585-01A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/1T32HD044355-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/6650562" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_160> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/springside_chestnut_hill_academy> <http://schema.org/name> "Springside Chestnut Hill Academy)" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_54> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_28> <http://schema.org/identifier> "phs002682" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_191> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_35> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2901879> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_170> <http://schema.org/date> "2022-12-09"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01GM138385-01A1> <http://schema.org/startDate> "2020-06-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_271> <http://schema.org/date> "2024-09-13"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://ror.org/004a2wv92> <http://schema.org/identifier> "https://ror.org/004a2wv92" .
<https://okn.wobd.org/person/texas_children_s_hospital> <http://schema.org/name> "Texas Children's Hospital" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_76> <http://schema.org/sameAs> "10.60773/1835-3770" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_132> <http://schema.org/author> <https://okn.wobd.org/person/st_thomas_east_end_medical_center_st_thomas> .
<https://okn.wobd.org/person/outreach_community_health_ctr> <http://schema.org/name> "Outreach Community Health Ctr" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_182> <http://schema.org/author> <https://okn.wobd.org/person/morgan_state_university> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_137> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01MH115676-01A1> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_29> <http://schema.org/dateModified> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_190> <http://schema.org/author> <https://okn.wobd.org/person/university_of_washington> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_152> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005550> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_70> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/694009> .
<https://okn.wobd.org/grant/1K08AI130381-01A1> <http://schema.org/startDate> "2019-01-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_90> <http://schema.org/description> "Ohio includes a very diverse population, with many minority, underserved, and vulnerable communities (MUVP). The need to increase testing in Ohio's MUVP is great; testing rates are only at 2.0 per 1000, with positivity rates indicating active community spread. With rapidly rising infection rates, ways to curb infection and morbidity/mortality are needed, especially in the most vulnerable populations. The RADx-UP Initiative Large Network proposal, RADx-UP Ohio, leveraged the vast community partnership networks of the Ohio Center for Clinical and Translational Science Award and the OSU Comprehensive Cancer Center to identify reasons for and intervene to reduce disparities in COVID-19 education, testing, contact tracing, follow-up and treatment among MUVP in Ohio in a bi-directional academic-state-community partnership. This complemented the work of Ohio Department of Health (ODH) emergency response to this pandemic. This research process is guided by a socio-ecological model based on the Social Determinants of Health, the Proctor Model for Implementation Science and a Community-Based Participatory Research (CBPR) framework and prior preliminary work of the team, using an implementation science framework and overall program evaluation. The goal of this RADx-UP Large Network Proposal (RADx-UP Ohio) was to address and reduce the disparities in COVID-19 education, testing, contact testing, follow-up and treatment (COVID-19 testing components) among minority, underserved, and vulnerable populations through the delivery of a CBPR-integrated program that focused on individual, social and community health system and broader contextual-level barriers related to disparities in COVID-19 testing components, built upon a long-standing academic-community-government partnership. The specific aims were to: (1) Implement a multi-level intervention, built on effective interventions of the team, to increase the impact of COVID testing in MUVP in 12 selected counties informed by community partner input that will increase uptake of COVID-19 testing, knowledge of COVID-19 testing and results, and follow-up including contact tracing for positives; (2) Assess the impact and sustainability of the intervention in different MUVP in Ohio; and (3) Interact with public health entities to disseminate successful strategies. The interventions were culturally appropriate and tailored to the needs of each MUVP in the 12 selected counties using an implementation science design, with counties randomized in a 3-wave step wedge design. RADx-UP Ohio included the following Units: Community Engagement and Intervention; Testing; Statistics and Data Management; Human Subjects, and Evaluation. RADx-UP Ohio used a hub and spoke model where the units provided expertise to support the activities of the 4 regional teams, each of which included CHWs from each of the 3 individual counties with at least one community stakeholder to provide community context and ensure authentic partnerships are maintained." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_210> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005015> .
<https://okn.wobd.org/grant/3OT2HL156812-01S2> <http://schema.org/startDate> "2020-06-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_180> <http://schema.org/funding> <https://okn.wobd.org/grant/1DP2DA040254-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_109> <http://schema.org/name> "Nanobody-Based Electrochemical Biosensor for Real-Time Detection of Aerosolized SARS-CoV2" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_71> <http://schema.org/author> <https://okn.wobd.org/person/centro_de_estudios_en_infectología_pediátrica> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_121> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/grant/1T32DA007292-01A1> <http://schema.org/identifier> "1T32DA007292-01A1" .
<https://okn.wobd.org/grant/1UM1AI106716-01> <http://schema.org/name> "LC - IMPAACT Leadership Group" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_187> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://schema.org/funder> <http://www.w3.org/2000/01/rdf-schema#domain> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_200> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_127> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/y7xk-ma85> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_188> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2901879> .
<https://okn.wobd.org/grant/8UL1TR000002-07> <http://schema.org/identifier> "8UL1TR000002-07" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_73> <http://schema.org/identifier> "phs002648" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/author> <https://okn.wobd.org/person/kapi_olani_medical_specialists> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_75> <http://schema.org/identifier> "phs002662" .
<https://okn.wobd.org/grant/1R01AI163029-01> <http://schema.org/identifier> "1R01AI163029-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_79> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2901879> .
<http://schema.org/startDate> <http://www.w3.org/2000/01/rdf-schema#domain> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_59> <http://schema.org/name> "Touchscreen-Compatible, Real-Time Electrochemical Sensing of SARS-CoV-2" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_186> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/grant/1P30AI045008-01> <http://schema.org/identifier> "1P30AI045008-01" .
<https://okn.wobd.org/grant/1U54CA260492-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/10221904" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_163> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/204" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_130> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/141" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_63> <http://schema.org/author> <https://okn.wobd.org/person/university_of_illinois_at_urbana_champaign_and_louisiana_state_university> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_116> <http://schema.org/description> "In the U.S., women who use illicit drugs (WWUD) have disproportionately high rates of infectious (e.g., HIV, HCV), chronic, and pulmonary diseases that elevate their risk for COVID-19. Their health and disease profile is driven by enduring social conditions (e.g., scarcity of income, food insecurity, access to health services, housing, discrimination). These prevailing social conditions can also undermine WWUDs' ability to protect themselves from COVID-19 (e.g., washing hands, social distancing). Drug procurement and use, which are largely social processes, further challenge these self-protection measures. Testing and future vaccination is vital to reducing COVID-19 among this high-risk population, necessitating accessible testing schemes. Here, a mixed methods study was conducted that draws upon the Andersen Behavioral Model10 and is grounded in eco-social theory. Specifically, the Baltimore-based study aimed to: 1) explore predisposing social factors (e.g., housing, food security), individual-level factors (e.g., drug use, mental health), and beliefs (e.g., medical mistrust) that are facilitators and barriers of COVID-19 testing and perceived risks (e.g., income generation, violence) resulting from a diagnosis through in-depth interviews among WWUD (N=15) and a cultural domain analysis (N=45); 2) gain an understanding of the enabling community-level environment (e.g., medical and social service agencies that currently serve WWUD, existing city-wide COVID-19 testing sites) that could facilitate or hinder WWUDs' COVID-testing uptake through observations (N=8-10) and key informant interviews (N=10); and examine predisposing social factors, individual-level factors, and beliefs that are associated with COVID-19 testing and retesting among a cohort (N=250) of WWUD at baseline and 3-month follow-up. Optional testing offered at both study visits were a self-administered, rapid antigen test. The role of medical mistrust in shaping women's' use of healthcare services were examined, as well as experiences of stigma and discrimination in healthcare settings, particularly among Black participants. In Baltimore, this mistrust was particularly pronounced, with Johns Hopkins Hospital having a long history of mistrust in the Black community owing to experimentation and deception of research engagement. The study was guided by a community advisory board (CAB) who informed its design and implementation as well as engaged in disseminating the results at community meetings to inform COVID-testing scale up." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_133> <http://schema.org/dateModified> "2023-06-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_30> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/bsnf-k280> .
<https://okn.wobd.org/person/university_of_massachusetts_chan_medical_school_and_northwestern_university> <http://schema.org/name> "University of Massachusetts Chan Medical School and Northwestern University" .
<https://okn.wobd.org/grant/1UL1TR002001-01> <http://schema.org/endDate> "2020-05-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_214> <http://schema.org/funding> <https://okn.wobd.org/grant/1P30GM131944-01> .
<http://schema.org/DataCatalog> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2000/01/rdf-schema#Class> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_172> <http://schema.org/identifier> "phs003027" .
<https://okn.wobd.org/grant/1U01CA260539-01> <http://schema.org/endDate> "2022-08-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_134> <http://schema.org/url> "https://radxdatahub.nih.gov/study/134" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_195> <http://schema.org/description> "Objective: To evaluate performance of Ag-RDT for detection of SARS-CoV-2 in relation to onset of infection for symptomatic and asymptomatic participants. Design, Setting, and Participants: Prospective cohort study conducted from October 2021 to February 2022 among participants > 2 years-old from across the US who enrolled using a smartphone app. During each testing encounter, participants self-collected one nasal swab and performed Ag-RDT at home; at-least fifteen minutes later, a second nasal swab was self-collected and shipped for SARS-CoV-2 RT-PCR at a central lab. Both nasal swabs were collected 7 times at 48-hour intervals (over approximately 14 days) followed by an extra nasal swab collection with home Ag-RDT test 48-hours after their last PCR sample. Each participant was assigned to one of the three emergency use authorized (EUA) Ag-RDT tests used in this study. This analysis was limited to participants who were asymptomatic and tested negative by antigen and molecular tests on their first day of study participation." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_176> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0004975> .
<https://okn.wobd.org/grant/1R01ES028615-01> <http://schema.org/endDate> "2017-12-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_194> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_97> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_195> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2901879> .
<https://www.uniprot.org/taxonomy/2971083> <http://schema.org/name> "Vector NC" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_203> <http://schema.org/description> "The COVID-19 pandemic disproportionately impacts Latinos in the US. COVID-19 testing remains critical for tracking and slowing the spread of the virus and preventing future outbreaks, particularly in communities disproportionately affected by COVID-19 and where vaccination coverage is suboptimal. The goal of this project was to expand the RADx-UP Phase 1 COVID-19 testing project \"Vive Sin Duda\" to implement and evaluate innovative implementation strategies to increase reach, access, and uptake of COVID-19 home-based self-testing (HST) among low-income Latinos in Maryland. This study implemented and evaluated two distribution approaches: 1) Network-based; and 2) Social marketing. The study also incorporated data driven iterative changes to optimize a community health worker (CHW)-led short message service (SMS) platform to support HST and linkage to COVID-19 care, vaccination, and other services (e.g., cash and food assistance). Primary and secondary outcomes include: 1) Reach and uptake of HST; and 2) Linkage to care for those who test positive or vaccination for unvaccinated people who test negative. Leveraging existing community coalition, testing and vaccination clinics, and a team of bilingual and bicultural CHWs, the team was well poised to implement a COVID-19 HST program and measure its impact. The research provided important new information to improve access and uptake of innovative COVID-19 testing technology. It also filled critical knowledge gaps to guide the translation of evidence-based interventions into widespread adoption by RADx-UP consortium members." .
<https://okn.wobd.org/person/mit> <http://schema.org/name> "MIT" .
<https://ror.org/043z4tv69> <http://schema.org/alternateName> "National Institute of Allergy & Infectious Diseases" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_220> <http://schema.org/date> "2024-07-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_57> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/grant/1S10OD018499-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_63> <http://schema.org/datePublished> "2022-06-06"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_185> <http://schema.org/dateCreated> "2022-10-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1U54CA156732-01> <http://schema.org/startDate> "2010-09-27"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1P30AI027763-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_49> <http://schema.org/sameAs> <https://doi.org/10.60773/7gn8-9w03> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_49> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005711> .
<http://purl.obolibrary.org/obo/MONDO_0010691> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_124> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_93> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/grant/1P30AI073961-01> <http://schema.org/startDate> "2007-06-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01DA013806-01> <http://schema.org/startDate> "2000-09-20"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_117> <http://schema.org/dateModified> "2024-01-18"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://ror.org/04byxyr05> <http://schema.org/alternateName> "National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health & Human Development" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_144> <http://schema.org/funding> <https://okn.wobd.org/grant/1U01AI069918-01> .
<https://okn.wobd.org/grant/1T32GM128596-01> <http://schema.org/startDate> "2018-07-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/30" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_108> <http://schema.org/author> <https://okn.wobd.org/person/monell_chemical_senses_center> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_122> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_183> <http://schema.org/date> "2022-11-07"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_173> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/1986198> .
<https://ror.org/04pw6fb54> <http://schema.org/parentOrganization> "National Institutes of Health" .
<https://okn.wobd.org/grant/1F30DK123915-01> <http://schema.org/endDate> "2023-09-04"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_52> <http://schema.org/sameAs> "10.60773/6y92-jm05" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_28> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2901879> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_150> <http://schema.org/dateModified> "2024-04-10"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://ror.org/04byxyr05> <http://schema.org/alternateName> "NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_215> <http://schema.org/sameAs> <https://doi.org/10.60773/5aar-0w08> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_90> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/212" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_43> <http://schema.org/sameAs> <https://doi.org/10.60773/wyqe-xw03> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_78> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR003017-01> .
<http://schema.org/species> <http://www.w3.org/2000/01/rdf-schema#range> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/grant/1UL1TR001878-01> <http://schema.org/funder> <https://ror.org/04pw6fb54> .
<https://okn.wobd.org/grant/1P30GM131944-01> <http://schema.org/startDate> "2019-08-13"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/163" .
<https://okn.wobd.org/person/physiq> <http://schema.org/name> "physIQ" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_34> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_149> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_41> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_160> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_174> <http://schema.org/name> "Safer at School Early Alert Project HUB" .
<https://okn.wobd.org/grant/1R35GM119774-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9142825" .
<https://okn.wobd.org/person/indiana_university_of_school_of_medicine> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/grant/1S10OD025082-01> <http://schema.org/endDate> "2019-04-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_160> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/8yg5-8e14> .
<https://okn.wobd.org/person/bristol_myers_squibb_children_s_hospital_robert_wood_johnson_university_hospital> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_60> <http://schema.org/author> <https://okn.wobd.org/person/nyu> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_60> <http://schema.org/dateModified> "2024-01-18"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1P30CA042014-01> <http://schema.org/identifier> "1P30CA042014-01" .
<https://okn.wobd.org/grant/1UG3OD023365-01> <http://schema.org/name> "Pre-adolescent and Late-adolescent Follow-up of the CHARGE Study Children" .
<https://ror.org/00adh9b73> <http://schema.org/alternateName> "NIH National Institute of Diabetes and Digestive and Kidney Diseases" .
<https://okn.wobd.org/grant/1R01DK121072-01A1> <http://schema.org/funder> <https://ror.org/00adh9b73> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_204> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_66> <http://schema.org/datePublished> "2022-07-21"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_129> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_181> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/long_beach> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/147" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_119> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/grant/3T32GM083937-01A1S1> <http://schema.org/endDate> "2011-07-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_45> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/NCIT_C35016> .
<https://okn.wobd.org/grant/1U19AI142733-01> <http://schema.org/funder> <https://ror.org/043z4tv69> .
<https://okn.wobd.org/grant/1U01AI122285-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_210> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_138> <http://schema.org/name> "NIEHS Diagnostic-Prognostic RNAseq" .
<https://okn.wobd.org/grant/1U19AI142733-01> <http://schema.org/startDate> "2019-03-05"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_122> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/NCIT_C154635> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_187> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/eg9v-8e46> .
<https://okn.wobd.org/grant/1R03DK117252-01> <http://schema.org/funder> <https://ror.org/00adh9b73> .
<https://okn.wobd.org/person/technology_and_research_trust_san_juan> <http://schema.org/name> "Technology and Research Trust (San Juan" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_88> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_134> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_112> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_123> <http://schema.org/dateCreated> "2022-01-06"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_123> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_163> <http://schema.org/datePublished> "2023-12-07"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_168> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_125> <http://schema.org/sameAs> "10.60773/an3v-wq86" .
<https://okn.wobd.org/person/granite_school_district> <http://schema.org/name> "Granite School District" .
<https://okn.wobd.org/grant/1UL1TR001085-01> <http://schema.org/identifier> "1UL1TR001085-01" .
<https://okn.wobd.org/grant/1R01AI125416-01> <http://schema.org/endDate> "2021-05-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_210> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/grant/1R01AI123105-01A1> <http://schema.org/endDate> "2021-01-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/name> "SF-RAD: Development and Proof-of-Concept Implementation of the South Florida Miami RADx-rad SARS-CoV-2 Wastewater-Based Surveillance Infrastructure" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_175> <http://schema.org/dateCreated> "2022-08-19"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_69> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/person/umass_lowell> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_137> <http://schema.org/funding> <https://okn.wobd.org/grant/1U19AI135995-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_75> <http://schema.org/sameAs> <https://doi.org/10.60773/v9jf-fj56> .
<https://okn.wobd.org/grant/1P30CA240139-01> <http://schema.org/name> "The Sylvester Cancer Center Support Grant" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_205> <http://schema.org/funding> <https://okn.wobd.org/grant/2UL1TR000427-06> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_92> <http://schema.org/sameAs> "10.60773/a7c6-ff66" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_79> <http://schema.org/dateModified> "2024-04-10"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_191> <http://schema.org/identifier> "phs003128" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_184> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_194> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_150> <http://schema.org/funding> <https://okn.wobd.org/grant/8UL1TR000042-07> .
<https://okn.wobd.org/person/university_of_missouri_kansas_city> <http://schema.org/name> "University of Missouri - Kansas City" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_168> <http://schema.org/date> "2024-08-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_73> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_141> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://ror.org/00fj8a872> <http://schema.org/alternateName> "Office of the Director, NIH" .
<https://okn.wobd.org/grant/1U01DA053941-01> <http://schema.org/endDate> "2022-06-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_96> <http://schema.org/datePublished> "2023-08-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_96> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005550> .
<https://okn.wobd.org/grant/6U48DP006395-01M001> <http://schema.org/endDate> "2024-09-29"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_42> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2901879> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_149> <http://schema.org/sameAs> <https://doi.org/10.60773/v97k-6w36> .
<https://okn.wobd.org/grant/1U54HL108460-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/8012935" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_202> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_274> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_49> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_213> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/114727> .
<https://okn.wobd.org/grant/8G12MD007595-04> <http://schema.org/endDate> "2014-07-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_36> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/grant/5R01DK035385-02> <http://schema.org/funder> <https://ror.org/00adh9b73> .
<https://okn.wobd.org/grant/1P30CA240139-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9789579" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_172> <http://schema.org/author> <https://okn.wobd.org/person/oregon_health_science_university> .
<https://okn.wobd.org/grant/1P30AI036214-01> <http://schema.org/endDate> "1999-03-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_47> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_189> <http://schema.org/funding> <https://okn.wobd.org/grant/1U54GM104940-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_115> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/project_vida> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_217> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/grant/1U19NS112953-01> <http://schema.org/funder> <https://ror.org/01s5ya894> .
<https://okn.wobd.org/person/see_attached_list> <http://schema.org/name> "See attached list" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_126> <http://schema.org/identifier> "phs002740" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_79> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/3gd9-km98> .
<http://purl.obolibrary.org/obo/NCIT_C189188> <http://schema.org/name> "Infected with SARS-CoV-2" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_36> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/grant/1U54GM115677-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_155> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R21AI133331-01> <http://schema.org/identifier> "1R21AI133331-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_153> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_59> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/funding> <https://okn.wobd.org/grant/1R25EB020393-01A1> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_99> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/NCIT_C154635> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_90> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_177> <http://schema.org/date> "2022-11-07"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_174> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005550> .
<https://okn.wobd.org/person/health_research> <http://schema.org/name> "Health Research" .
<https://okn.wobd.org/grant/1UL1TR002541-01> <http://schema.org/funder> <https://ror.org/04pw6fb54> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/28" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_35> <http://schema.org/dateModified> "2024-01-03"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/funding> <https://okn.wobd.org/grant/1U54HL108460-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_202> <http://schema.org/dateCreated> "2023-07-27"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_117> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_60> <http://schema.org/author> <https://okn.wobd.org/person/dartnet> .
<https://okn.wobd.org/grant/1R01DA055491-01> <http://schema.org/name> "Brain Myeloid Cells are Sources of HIV-associated Damage and Viral Dispersal" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_30> <http://schema.org/sameAs> "10.60773/bsnf-k280" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_136> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_121> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2901879> .
<https://okn.wobd.org/grant/4UH3OD023365-03> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/8G12MD007595-04> <http://schema.org/url> "https://reporter.nih.gov/project-details/8309874" .
<https://okn.wobd.org/grant/1P30GM114737-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_52> <http://schema.org/url> "https://radxdatahub.nih.gov/study/52" .
<https://okn.wobd.org/person/albany_area_primary_health_care> <http://schema.org/name> "Albany Area Primary Health Care" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_173> <http://schema.org/dateCreated> "2022-08-19"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_274> <http://schema.org/sameAs> <https://doi.org/10.60773/8e0v-pk44> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_151> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/1tqv-dv25> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0016168> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_39> <http://schema.org/url> "https://radxdatahub.nih.gov/study/39" .
<https://okn.wobd.org/grant/1R01GM138385-01A1> <http://schema.org/funder> <https://ror.org/04q48ey07> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_156> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR002319-01> .
<https://okn.wobd.org/person/the_university_of_chicago_department_of_pediatrics> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/grant/1UL1TR002319-01> <http://schema.org/endDate> "2022-02-28"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://ror.org/04byxyr05> <http://schema.org/alternateName> "NICHD" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/155" .
<https://okn.wobd.org/person/association_to_benefit_children> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_46> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.obolibrary.org/obo/MONDO_0006663> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_53> <http://schema.org/url> "https://radxdatahub.nih.gov/study/53" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_162> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_132> <http://schema.org/author> <https://okn.wobd.org/person/puerto_rico_science> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_180> <http://schema.org/name> "Improving Testing for COVID-19 in Skilled Nursing Facilities: IMPACT-C" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_38> <http://schema.org/identifier> "phs002538" .
<https://okn.wobd.org/grant/1P30MH058107-01> <http://schema.org/endDate> "2002-08-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_137> <http://schema.org/funding> <https://okn.wobd.org/grant/8P51OD011132-52> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_60> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/person/uc_davis_children_s_hospital> <http://schema.org/name> "UC Davis Children's Hospital" .
<https://okn.wobd.org/grant/1U01CA260539-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/1UL1TR002319-01> <http://schema.org/identifier> "1UL1TR002319-01" .
<https://okn.wobd.org/grant/1P30AI027767-01> <http://schema.org/endDate> "1993-08-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_157> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_129> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0010691> .
<http://purl.obolibrary.org/obo/MONDO_0004981> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://ror.org/00baak391> <http://schema.org/parentOrganization> "National Institutes of Health" .
<https://okn.wobd.org/grant/1R01EB025022-01> <http://schema.org/funder> <https://ror.org/00372qc85> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_87> <http://schema.org/sameAs> "10.60773/ydsc-2z38" .
<https://okn.wobd.org/person/henry_ford_hospital_centers_detroit> <http://schema.org/name> "Henry Ford Hospital Centers - Detroit" .
<https://okn.wobd.org/grant/1P30ES023513-01A1> <http://schema.org/startDate> "2015-05-05"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_161> <http://schema.org/identifier> "phs002924" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_213> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/1986198> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_161> <http://schema.org/dateModified> "2022-05-19"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/organization/national_heart_lung_and_blood_institute> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Organization> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_203> <http://schema.org/url> "https://radxdatahub.nih.gov/study/203" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_143> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/university_of_massachusetts_chan_medical_school_and_northwestern_university> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_215> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/grant/1UL1TR001860-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9261031" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_187> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://ror.org/04pw6fb54> <http://schema.org/name> "National Center for Advancing Translational Sciences" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_199> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_113> <http://schema.org/datePublished> "2023-08-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_71> <http://schema.org/sameAs> "10.60773/jcap-3849" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_68> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_63> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/694009> .
<http://purl.obolibrary.org/obo/MONDO_0016168> <http://schema.org/name> "cryopyrin-associated periodic syndrome" .
<https://okn.wobd.org/grant/3P50HD103525-01S1> <http://schema.org/url> "https://reporter.nih.gov/project-details/10232657" .
<https://okn.wobd.org/grant/1R01MH117406-01> <http://schema.org/startDate> "2018-07-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_32> <http://schema.org/url> "https://radxdatahub.nih.gov/study/32" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/694009> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_199> <http://schema.org/sameAs> "10.60773/ad5b-vx98" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_147> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/grant/1S10OD026929-01> <http://schema.org/name> "Illumina NovaSeq 6000 Sequencing System" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_77> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1P30DK045735-01> <http://schema.org/startDate> "1993-01-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/cook_county_hhs> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://ror.org/00fq5cm18> <http://schema.org/parentOrganization> "National Institutes of Health" .
<https://okn.wobd.org/grant/1R01AI146165-01A1> <http://schema.org/url> "https://reporter.nih.gov/project-details/9972395" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_155> <http://schema.org/funding> <https://okn.wobd.org/grant/2U54MD007595-11> .
<https://ror.org/004a2wv92> <http://schema.org/alternateName> "NIDCR" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_197> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_34> <http://schema.org/datePublished> "2024-04-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.obolibrary.org/obo/MONDO_0005377> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_79> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1ZIAAI001175-01> <http://schema.org/name> "Immunopathogenesis of Fungal Infections" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_36> <http://schema.org/author> <https://okn.wobd.org/person/inc_and_university_of_illinois_hospital_and_health_system> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_85> <http://schema.org/datePublished> "2023-08-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_186> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_44> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/219" .
<http://purl.obolibrary.org/obo/MONDO_0013600> <http://schema.org/name> "insomnia" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_49> <http://schema.org/url> "https://radxdatahub.nih.gov/study/49" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_96> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_54> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_221> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_206> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_185> <http://schema.org/sameAs> "10.60773/s244-bp16" .
<https://okn.wobd.org/grant/8UL1TR000042-07> <http://schema.org/endDate> "2016-06-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01GM120553-01> <http://schema.org/funder> <https://ror.org/04q48ey07> .
<https://ror.org/00j4k1h63> <http://schema.org/name> "National Institute of Environmental Health Sciences" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_214> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/children_s_hospital_of_michigan> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_179> <http://schema.org/name> "Identifying COVID-19 Vaccine Deserts Using Machine Learning and Geospatial Analyses to Target Community-Engaged Testing for Vulnerable Rural Populations to Prevent Localized Outbreaks" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_191> <http://schema.org/dateCreated> "2022-11-28"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/oregon_health_science_university> <http://schema.org/name> "Oregon Health & Science University" .
<https://www.uniprot.org/taxonomy/11709> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_134> <http://schema.org/sameAs> <https://doi.org/10.60773/9ema-x262> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_143> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR002001-01> .
<https://okn.wobd.org/grant/1P30ES005022-01> <http://schema.org/funder> <https://ror.org/00j4k1h63> .
<https://okn.wobd.org/grant/1K08AR073339-01> <http://schema.org/name> "The Reprogramming of Regulatory T cells to a Th17 Phenotype in Systemic Juvenile Idiopathic Arthritis" .
<https://okn.wobd.org/grant/1R01ES021006-01A1> <http://schema.org/endDate> "2015-06-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_170> <http://schema.org/identifier> "phs002631" .
<https://okn.wobd.org/grant/1P30MH058107-01> <http://schema.org/startDate> "1997-09-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_155> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_174> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_114> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/grant/1P30AI064518-01> <http://schema.org/identifier> "1P30AI064518-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_70> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_192> <http://schema.org/identifier> "phs003126" .
<https://okn.wobd.org/grant/1KL2TR003108-01> <http://schema.org/identifier> "1KL2TR003108-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_206> <http://schema.org/dateCreated> "2023-07-27"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_126> <http://schema.org/funding> <https://okn.wobd.org/grant/1U24TR001608-01> .
<https://okn.wobd.org/grant/1U19NS112953-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9814744" .
<https://okn.wobd.org/grant/9P30AI050410-04> <http://schema.org/endDate> "2006-07-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_175> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/grant/2T32CA009140-11> <http://schema.org/endDate> "1990-06-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_153> <http://schema.org/description> "The overall goal of the Obesity Health Disparities Research Center (OHDRC) COVID-19 Testing Model of Vulnerable Populations: From Community Engagement to Follow-Up was to implement a three-component mobile community-based testing model and evaluate its impact for improved reach, access, acceptance, uptake, and appropriate follow-up to COVID-19 testing. The proposed model, guided by the Community Based Participatory Research (CBPR) framework, integrated a Social Determinants of Health (SDH) approach throughout all aims to strengthen community engagement, identify areas of greatest need of testing, and enhance navigation services to address unmet follow-up healthcare and social needs. The project built on a successful feasibility pilot that provided testing to African American and Hispanic residents of Jefferson County, Alabama. This project tested the effectiveness of this neighborhood mobile testing model. Study findings provided evidence that can help to increase testing and follow-up among vulnerable populations, and consequently, attenuate the current stark disparities in COVID-19 outcomes." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_167> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_182> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005550> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_206> <http://schema.org/datePublished> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1P30CA045508-01> <http://schema.org/name> "CANCER CENTER SUPPORT GRANT" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_99> <http://schema.org/author> <https://okn.wobd.org/person/progressive_community_health_ctr> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_125> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_51> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_212> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_117> <http://schema.org/datePublished> "2022-11-07"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_140> <http://schema.org/description> "Nationally, Latinx individuals have four times the rate of SARS-CoV-2 diagnoses compared to Non-Hispanic Whites. Furthermore, Latinx populations may face barriers in accessing SARS-CoV-2 tests, receiving test results, interpreting test results, and getting appropriate follow-up care. Improved understanding of the sources of health equity differences for Latinx populations can be used to better guide allocation of resources and provide essential data for provider organizations seeking to support those in the most need. Through this RADx-UP project, a statewide research and monitoring infrastructure was established in partnership with community clinics. This study developed community health teams (\"Promotoras Teams\") with the largest Latinx community organization in Rhode Island to address identified barriers to COVID-19 testing through patient navigation, health literacy support, and follow-up care. The overall goals of this study were to improve testing uptake and the understanding of SARS-CoV-2 outcomes among Latinx populations. This study built on partnerships with community clinics that serve a high proportion of Latinx individuals (>50%) in Rhode Island. This study placed particular emphasis on disparities in care faced by Latinx populations and factors that have been identified as impacting health equity in Rhode Island (integrated healthcare, community resilience, physical environment, socioeconomics, and community trauma). The insights gained from the quantitative and qualitative approaches were used guide the implementation of community campaigns to improve testing among Latinx populations that are in identified locations with lower per capita testing than other parts of the state (\"testing deserts\"). This RADx-UP project utilized a unique approach and infrastructure to monitor SARS-CoV-2 testing rates, including the use of the statewide Health Information Exchange (HIE) in Rhode Island that connects data across primary care, urgent care, specialty care, and acute care clinical environments. The HIE contains clinical data for most people receiving care in Rhode Island including SARS-CoV-2 test results from major laboratories and other facilities (e.g., CVS MinuteClinic). These quantitative data were combined with qualitative data and organized according to the Consolidated Framework for Implementation Research framework to guide the mixed-methods explanatory sequential design. The specific aims of this project were to: (1) Identify COVID-19 hotspots and testing deserts using a near-real time geographic information system monitoring system; (2) Determine community and provider barriers that impact access to SARS-CoV-2 testing; and, (3) Implement community-based approaches to improve SARS-CoV-2 testing. This RADx-UP project developed a community-based infrastructure to enable structured, longitudinal relationships with a historically underserved patient population. Such insights provide essential data for a population-level decision support system, testing prioritization, and for future consideration of vaccine-based prevention strategies." .
<https://okn.wobd.org/grant/3T32GM083937-01A1S1> <http://schema.org/startDate> "2009-08-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01HG009120-01A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_108> <http://schema.org/sameAs> "10.60773/3v5j-f685" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_161> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_176> <http://schema.org/sameAs> <https://doi.org/10.60773/dk7k-jh11> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_143> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0011918> .
<https://ror.org/006zn3t30> <http://schema.org/parentOrganization> "National Institutes of Health" .
<https://okn.wobd.org/grant/1R01AI141630-01A1> <http://schema.org/name> "Modulation of Macrophage Polarization by Heterotrimeric G proteins: Implications of Gastrointestinal Inflammation" .
<https://okn.wobd.org/grant/7P30DK034987-01A1> <http://schema.org/startDate> "1985-09-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1U54GM104940-01> <http://schema.org/startDate> "2012-08-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_138> <http://schema.org/date> "2024-08-16"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/university_of_illinois_at_urbana_champaign_and_louisiana_state_university> <http://schema.org/name> "University of Illinois at Urbana Champaign and Louisiana State University" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/author> <https://okn.wobd.org/person/uab_children_s_of_alabama> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_205> <http://schema.org/name> "COVID-19 Testing and Prevention in Correctional Settings" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_36> <http://schema.org/author> <https://okn.wobd.org/person/physiq> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/186" .
<https://okn.wobd.org/person/north_jersey_community_research_initiative> <http://schema.org/name> "North Jersey Community Research Initiative" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_144> <http://schema.org/author> <https://okn.wobd.org/person/fiu_research_clinic> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_271> <http://schema.org/identifier> "phs003686" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/192" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_180> <http://schema.org/funding> <https://okn.wobd.org/grant/1U01CA260539-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_43> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01AI121250-01A1> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_46> <http://schema.org/identifier> "phs002582" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_37> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/grant/1P30CA240139-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/1U24TR001608-01> <http://schema.org/identifier> "1U24TR001608-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_32> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/grant/1P30DK092950-01> <http://schema.org/endDate> "2016-07-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_213> <http://schema.org/sameAs> <https://doi.org/10.60773/pp0p-gj15> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_59> <http://schema.org/dateModified> "2022-12-09"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_194> <http://schema.org/description> "This RADx-UP Phase II proposal, “Social network diffusion of COVID-19 prevention for diverse Criminal Legal Involved Communities”, implemented a situation appropriate COVID-19 testing and vaccination social network diffusion intervention – C3 – building upon RADx-UP Phase I lessons and successful social network prevention interventions developed previously by the research team. C3 Criminal Legal Involved (CLI) populations encompassed those non-incarcerated who have experienced recent arrest, incarceration, probation, parole or diversion programs such as drug courts. While increases in COVID-19 testing have been observed among this group, there remain members with limited testing history as well as individuals who are vaccine hesitant. COVID-19 prevention messaging can no longer be simplified to “everyone test and/or everyone vaccinate” as testing and vaccination decisions among community members are sensitive to personal histories (i.e., prior infection), local infection rates (i.e., low rates) and testing/vaccination availability. As COVID-19 prevention efforts have become more complicated (i.e., test if exposed), people tend to focus on the messenger, and particularly those that are close to them. Personal connections and communications within existing personal network structures, such as families, friends and other trusted acquaintances represent the cornerstone to increase situation appropriate testing and overcoming COVID-19 vaccine hesitancy. C3 built upon RADx-UP I, by using a network diffusion approach facilitated through motivational interviewing purposefully geared to mobilize one’s own organic social network to increase context appropriate testing and vaccine uptake. Through this process, the study maximized the primary benefit and impact of this type of intervention which also has the intended effect of increasing likelihood that the messenger themselves will undergo the same behavior change that they have been trained to promote. The study leveraged infrastructure developed in RADx-UP Phase I, which included 4 high-impact sites across the Central US from Phase I: Baton Rouge LA, Little Rock AR, Indianapolis IN, and Chicago IL. The study utilized established engagement efforts already in place and continue to fully integrate communities in the strategic application of the intervention. The study used the RE-AIM (Reach, Effectiveness, Adoption, Implementation, and Maintenance) framework to guide implementation. C3 aims to: Aim 1a. Test the efficacy (3-month situation appropriate testing or vaccination) of a network diffusion intervention (C3) versus an existing COVID-19 testing and vaccine linkage to care intervention among: 1) primary study participants (primary outcome); and 2) secondary study participants connected to primary participants (secondary outcome) using a RCT design. Aim 1b. Explore the mechanisms for differential intervention effects at the individual and network-level that may increase situation appropriate testing and/or vaccination uptake. Aim 2. Examine key RE-AIM components in real time tied to the implementation of the network diffusion intervention (C3)." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_155> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/NCIT_C154635> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_271> <http://schema.org/datePublished> "2024-09-13"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_44> <http://schema.org/name> "Community Driven Approach to Mitigate COVID-19 Disparities in Hawaii's Vulnerable Populations" .
<https://okn.wobd.org/grant/1R01AI140442-01> <http://schema.org/identifier> "1R01AI140442-01" .
<https://okn.wobd.org/grant/1U54CA156732-01> <http://schema.org/name> "U Mass Boston / DFHCC U54 Partnership (1 of 2)" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_86> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_69> <http://schema.org/datePublished> "2024-09-04"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_61> <http://schema.org/sameAs> <https://doi.org/10.60773/a1js-pv10> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_109> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/694009> .
<https://okn.wobd.org/grant/1U01CA260539-01> <http://schema.org/name> "Early Drivers of Humoral Immunity to SARS-CoV-2 Infections" .
<https://okn.wobd.org/grant/1F30DK123915-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_180> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01AI129709-01A1> .
<https://okn.wobd.org/grant/1P30ES030283-01A1> <http://schema.org/endDate> "2025-03-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/173" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/66" .
<https://okn.wobd.org/grant/1R01HG009518-01A1> <http://schema.org/identifier> "1R01HG009518-01A1" .
<https://okn.wobd.org/grant/1P30AI042853-01> <http://schema.org/funder> <https://ror.org/043z4tv69> .
<https://okn.wobd.org/grant/1R01MH115676-01A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_215> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/5aar-0w08> .
<https://okn.wobd.org/grant/1R25EB020393-01A1> <http://schema.org/endDate> "2018-06-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_40> <http://schema.org/url> "https://radxdatahub.nih.gov/study/40" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_186> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_127> <http://schema.org/funding> <https://okn.wobd.org/grant/3P50HD103525-01S1> .
<https://okn.wobd.org/person/joe_dimaggio_children_s_hospital> <http://schema.org/name> "Joe Dimaggio Children's Hospital" .
<https://okn.wobd.org/grant/1UM1HG008898-01> <http://schema.org/identifier> "1UM1HG008898-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_214> <http://schema.org/sameAs> <https://doi.org/10.60773/1qf8-w396> .
<https://okn.wobd.org/grant/1U54CA132384-01A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_133> <http://schema.org/sameAs> "10.60773/n1eh-8t78" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_153> <http://schema.org/sameAs> <https://doi.org/10.60773/6tcr-xa14> .
<https://okn.wobd.org/grant/1P30AI027763-01> <http://schema.org/funder> <https://ror.org/043z4tv69> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_59> <http://schema.org/description> "This study involved the development of an assay for detecting SARS-CoV-2. Data that included signal for given virus or S protein concentration, as well as binding constants for molecular recognition agents, was generated." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_99> <http://schema.org/identifier> "phs002644" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01AI155696-01> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/27" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_97> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/6kbx-7v76> .
<http://schema.org/includedInDataCatalog> <http://www.w3.org/2000/01/rdf-schema#domain> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_181> <http://schema.org/url> "https://radxdatahub.nih.gov/study/181" .
<https://okn.wobd.org/grant/1UL1TR003017-01> <http://schema.org/funder> <https://ror.org/04pw6fb54> .
<https://okn.wobd.org/grant/1R01AI125416-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_140> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_140> <http://schema.org/funding> <https://okn.wobd.org/grant/1T32GM128596-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_137> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0016168> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_73> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_82> <http://schema.org/description> "The global SARS-CoV-2 pandemic that causes the severe respiratory illness COVID-19 is the worst health crisis the United States has faced in a century. Although this highly contagious virus has infected millions of Americans, the disease burdens are disproportionately born to historically underserved populations such as Latinx communities. Nationally, Latinx people with COVID-19 are hospitalized at four times the rate of Whites and have much higher rates of morbidity and mortality. This disparity is notable in Oregon, where the 13% of the population that is Latinx represents approximately 44% of COVID-19 cases. An urgent need exists to reach Oregon's Latinx community with public health and prevention messages to increase testing. This project implemented a culturally-tailored community outreach and testing program to increase the reach, access, and uptake of testing in Latinx communities in Oregon. The project brought together a world-class team of prevention scientists, public health experts, Latinx researchers, community partners, and biologists who have been working together to conduct SARS-CoV-2 diagnostic testing since March, soon after the pandemic first arrived in the U.S. This team established a CLIA-certified laboratory and honed molecular testing protocols, hired and trained laboratory personnel and a field research team, procured diagnostic testing equipment and supplies, and partnered with county public health offices and hospitals throughout the state to conduct testing. The team also conducted a comprehensive community assessment using community-based participatory methods to gather Latinx community feedback on modes of communication, health messages, and testing protocols, and staffed multiple county-led testing sites serving Latinx communities. Using these resources and expertise as a foundation, a two-arm randomized controlled trial implemented community-level interventions to increase testing rates and health behaviors. Thirty-nine testing sites across 9 counties were randomized to receive one of two outreach interventions, Basic Outreach versus Promotores de Salud. Promotores de Salud was a culturally-informed intervention that included psychoeducation about COVID-19, motivational strategies, emotional support, and information support to engage individuals to attend a testing site. In addition, the study included a booster intervention for those who attend a Promotoras de Salud testing site. In the booster intervention, participants received an in-person Promotores de Salud intervention and a written pamphlet with information about health behaviors. Participants randomized to the control condition only received the written pamphlet. Participants in the research study were assessed via a survey at the time of testing and 1 month later. Site- and community-level assessments occurred at three timepoints in the study: immediate, mid-term, and primary outcomes, to measure the effects of the randomization and the on-site promotores intervention. Individual-level data were collected from 1,200 participants at two timelines when they were at a testing visit, and approximately one month later. Over time, this project helped communities institutionalize optimal local testing frameworks supported by laboratory facilities for testing capacity, technical support for testing logistics, and collection of data on health behaviors, testing rates, and sustainability. The resulting structures and systems were poised for future scale-up to other vulnerable communities and/or for other public health purposes (e.g., vaccination campaigns). This project aimed for a major reduction in COVID-19 health disparities in underserved populations." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/author> <https://okn.wobd.org/person/joe_dimaggio_children_s_hospital> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_118> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_219> <http://schema.org/dateCreated> "2024-01-04"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_115> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_65> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/10239> .
<https://okn.wobd.org/grant/8UL1TR000002-07> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/1UL1TR002378-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9514466" .
<https://okn.wobd.org/grant/1R01MH113094-01> <http://schema.org/identifier> "1R01MH113094-01" .
<https://ror.org/043z4tv69> <http://schema.org/alternateName> "NIAID" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_196> <http://schema.org/sameAs> <https://doi.org/10.60773/6hh3-jr12> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_144> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_42> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_129> <http://schema.org/name> "Addressing COVID-19 Testing Disparities in Vulnerable Populations Using a Community JITAI (Just in Time Adaptive Intervention) Approach-A UTHealth CTSA Program" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_45> <http://schema.org/name> "Adapting Community-Based Task-Shifting for the COVID-19 Response Among Underserved Populations in Piedmont, North Carolina (ACT UP)" .
<https://okn.wobd.org/person/kapi_olani_medical_specialists> <http://schema.org/name> "Kapi'olani Medical Specialists" .
<https://okn.wobd.org/grant/1P30AI073961-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_29> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_41> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/w5vb-c640> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_90> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_180> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/grant/8UL1TR000002-07> <http://schema.org/url> "https://reporter.nih.gov/project-details/8278511" .
<https://okn.wobd.org/grant/1T32EB009380-01> <http://schema.org/funder> <https://ror.org/00372qc85> .
<https://okn.wobd.org/grant/1R35GM141535-01> <http://schema.org/startDate> "2021-07-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_128> <http://schema.org/url> "https://radxdatahub.nih.gov/study/128" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_125> <http://schema.org/datePublished> "2023-12-07"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_113> <http://schema.org/identifier> "phs002708" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_214> <http://schema.org/funding> <https://okn.wobd.org/grant/1U54GM138062-01A1> .
<https://okn.wobd.org/grant/1K01MH112436-01> <http://schema.org/identifier> "1K01MH112436-01" .
<https://okn.wobd.org/person/barnes_jewish_hospital> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/grant/1R01CA249054-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_209> <http://schema.org/sameAs> "10.60773/96jm-wg84" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_27> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_75> <http://schema.org/funding> <https://okn.wobd.org/grant/1T32GM128596-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_201> <http://schema.org/sameAs> "10.60773/18dv-6j23" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_178> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/person/harm_reduction_coalition_san_diego_onpoint> <http://schema.org/name> "Harm Reduction Coalition San Diego - Onpoint" .
<https://okn.wobd.org/grant/8P51OD011132-52> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_189> <http://schema.org/identifier> "phs003125" .
<https://okn.wobd.org/grant/1R01AI135992-01> <http://schema.org/startDate> "2018-01-24"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1U54HL108460-01> <http://schema.org/endDate> "2015-06-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/51" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/grant/1P30AI036214-01> <http://schema.org/name> "AIDS RESEARCH" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_153> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1UL1TR003107-01> <http://schema.org/funder> <https://ror.org/04pw6fb54> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_27> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/grant/1UG3OD023365-01> <http://schema.org/startDate> "2016-09-21"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_78> <http://schema.org/sameAs> "10.60773/ddc6-ar41" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_199> <http://schema.org/name> "COVID-19 Treatment Cascade Optimization Study" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_121> <http://schema.org/identifier> "phs002739" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_176> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/university_of_connecticut> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_178> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://www.uniprot.org/taxonomy/2901879> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_75> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/v9jf-fj56> .
<https://okn.wobd.org/grant/7P30DK034987-01A1> <http://schema.org/name> "CORE CENTER IN DIARRHEAL DISEASES" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_150> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR002538-01> .
<https://okn.wobd.org/grant/1P30ES023513-01A1> <http://schema.org/identifier> "1P30ES023513-01A1" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_129> <http://schema.org/funding> <https://okn.wobd.org/grant/1P30ES030285-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_183> <http://schema.org/datePublished> "2022-11-07"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_60> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR003017-01> .
<https://okn.wobd.org/grant/7R01HG010040-02> <http://schema.org/name> "Advanced computational methods in analyzing high-throughput sequencing data" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_81> <http://schema.org/name> "COVID-19 Testing and Linkage to Care with African American Church and Health Agency Partners" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/author> <https://okn.wobd.org/person/the_university_of_chicago_department_of_pediatrics> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_46> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_59> <http://schema.org/sameAs> "10.60773/wd0m-eh53" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_180> <http://schema.org/dateCreated> "2022-09-06"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/yale_university> <http://schema.org/name> "Yale University" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_31> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_100> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_205> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR002373-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_149> <http://schema.org/identifier> "phs002825" .
<https://okn.wobd.org/grant/1U01AI122285-01> <http://schema.org/funder> <https://ror.org/043z4tv69> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_39> <http://schema.org/datePublished> "2024-04-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/centro_de_estudios_en_infectología_pediátrica> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_38> <http://schema.org/description> "This study was a prospective observational study, and had lasted approximately 7 months in duration. Participants were asked to complete a weekly survey online asking about their influenza-like-illness (ILI) experience over the past 7 days. The primary objective of this study was to collect a population-wide, longitudinal dataset of ILI events (with onset and recovery dates) and the associated symptoms, behaviors, and medical information associated with each event." .
<https://okn.wobd.org/person/division_of_cardiology> <http://schema.org/name> "Division of Cardiology" .
<https://okn.wobd.org/grant/1K08AR073339-01> <http://schema.org/identifier> "1K08AR073339-01" .
<https://okn.wobd.org/grant/1R01DA037628-01A1> <http://schema.org/url> "https://reporter.nih.gov/project-details/8815875" .
<https://okn.wobd.org/grant/1R01MH113094-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9162321" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_116> <http://schema.org/sameAs> <https://doi.org/10.60773/pkzs-t351> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_181> <http://schema.org/identifier> "phs003051" .
<https://ror.org/04xeg9z08> <http://schema.org/name> "National Institute of Mental Health" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/87" .
<http://purl.obolibrary.org/obo/NCIT_C3038> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_72> <http://schema.org/dateModified> "2022-12-09"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_61> <http://schema.org/author> <https://okn.wobd.org/person/mit> .
<https://ror.org/00j4k1h63> <http://schema.org/parentOrganization> "National Institutes of Health" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_178> <http://schema.org/sameAs> "10.60773/5061-0a66" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_110> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_172> <http://schema.org/datePublished> "2022-08-29"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_116> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_78> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/grant/1U01CA260539-01> <http://schema.org/startDate> "2020-09-18"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1K01MH112436-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9271555" .
<https://okn.wobd.org/person/san_ysidro_health_centers> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/72" .
<https://okn.wobd.org/grant/1R01AI088364-01> <http://schema.org/endDate> "2015-03-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1DP2GM137418-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_184> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_185> <http://schema.org/datePublished> "2023-08-29"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_71> <http://schema.org/sameAs> <https://doi.org/10.60773/jcap-3849> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_58> <http://schema.org/datePublished> "2022-06-07"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_215> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_187> <http://schema.org/identifier> "phs003123" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/40" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_109> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/kt6c-e369> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_80> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_167> <http://schema.org/dateCreated> "2022-06-13"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_192> <http://schema.org/description> "Throughout the COVID-19 pandemic in the U.S., persons in jails have borne a share of disease 3-fold or greater than that seen in the general population. While many cases have been imported from surrounding communities, crowding in these congregate settings has led to rapid in-house transmission, especially since testing in jails has been sparse. Vaccine hesitancy among staff and those detained mean the population is ill prepared for new waves of infection, perhaps from virus variants. Better surveillance could warn systems earlier, and allow jails to stem the tide of a new outbreak. At least half, if not more, of infected persons shed coronavirus in their stool. Monitoring wastewater is a promising practice that only a few jails have adopted. The overarching goal was to introduce or refine Wastewater Based Surveillance (WBS) as an evidence-based strategy for SARS-CoV-2 surveillance in the jails of Atlanta, Chicago, suburban Boston and Washington DC. It was adapted to the needs of jail settings and evaluated the implementation with the Consolidated Framework for Implementation Research. Implementation teams were formed of both correctional staff and formerly incarcerated individuals. Project aims: (1) To assess the barriers to and facilitators of implementing WBS for SARS-CoV-2 detection in 4 jail demonstration sites. Guided by CFIR, an informational webinar was held followed by focus groups. Four were with leaders at each of the jails; these discussed the site-specific context in which WBS was introduced or refined. A fifth, cross-site focus group of jail workers, and a sixth, cross-site group of persons with lived jail experience, reflected on characteristics of WBS approaches and implementation strategies in jail settings. (2) To measure implementation outcomes associated with WBS and use these outcomes to inform key stakeholders, using a knowledge to action framework. The study examined uptake, acceptability, appropriateness and feasibility of WBS as a sensitive early warning system and a way of quantifying SARS-CoV-2 levels to monitor trends in COVID-19 prevalence. Feasibility, the suitability of how WBS data are acted upon, was of utmost importance. The study used the Knowledge to Action process model, leveraging implementation outcomes to further engage stakeholders and characterize the adaptions needed to successfully implement WBS in jails. (3, Pilot) To study the process and the perceived effectiveness of incorporating diverse stakeholders, including the formerly incarcerated, on the WBS implementation team. The study used the Research Engagement Survey Tool (REST), to survey early in the implementation process and eight months later, individuals on the implementation team who have lived experience in jail; all other consenting implementation team members were surveyed once early in the implementation process. Successfully completing the aims determined factors that promote WBS implementation to improve disease." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_150> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/grant/1UL1TR001863-01> <http://schema.org/endDate> "2021-05-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01GM120553-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/75N93021C00016-0-9999-4> <http://schema.org/startDate> "2021-04-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1K08AR073339-01> <http://schema.org/funder> <https://ror.org/006zn3t30> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_97> <http://schema.org/sameAs> "10.60773/6kbx-7v76" .
<https://okn.wobd.org/grant/1U54HL108460-01> <http://schema.org/name> "iDASH: Integrating Data for Analysis, Anonymization, and Sharing" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_200> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1P30ES030283-01A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/1R03DK117252-01> <http://schema.org/identifier> "1R03DK117252-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_178> <http://schema.org/url> "https://radxdatahub.nih.gov/study/178" .
<https://okn.wobd.org/person/fiu_research_clinic> <http://schema.org/name> "FIU Research Clinic" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_73> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/grant/1UL1TR000460-01A1> <http://schema.org/name> "Miami Clinical and Translational Science Institute" .
<https://okn.wobd.org/grant/1UL1TR003017-01> <http://schema.org/name> "New Jersey Alliance for Clinical Translational Science: NJ ACTS" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/36" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_116> <http://schema.org/funding> <https://okn.wobd.org/grant/1P30AI094189-01A1> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_88> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_68> <http://schema.org/sameAs> "10.60773/67qn-0273" .
<https://okn.wobd.org/grant/1U54GM138062-01A1> <http://schema.org/url> "https://reporter.nih.gov/project-details/10281542" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_150> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/grant/1R01DE026471-01A1> <http://schema.org/identifier> "1R01DE026471-01A1" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_29> <http://schema.org/sameAs> <https://doi.org/10.60773/vjdg-pt27> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_168> <http://schema.org/description> "Self-report of sudden loss of smell or taste substantially increases the odds of being infected with SARS-CoV-2. However, self-report of smell function is an unreliable predictor of smell loss. The study created a self-administered easy to use \"at home\" 5-minute objective smell test to uncover alterations in smell function unbeknownst to many individuals and confer increased risk of infection by SARS- CoV-2. The new smell test consists of a physical smell card containing peel and sniff odor labels and a web- based application. Each participant accessed the web-based app on their own smartphone, tablet, or computer. The study developed a native app to conduct longitudinal COVID Smell Test (Aim 1), collect data on asymptomatic health care workers, symptomatic patients, and undergraduates (Aim 2) and develop algorithms for the longitudinal smell test for personalized thresholds, differentiate smell loss from COVID relative to influenza (Aim 3). The Longitudinal COVID Smell Test was accessible, affordable, and readily scalable. Effective screening with the COVID smell test better informed students and employees if they should not report to school or work and seek an evaluation by a healthcare professional." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_140> <http://schema.org/sameAs> <https://doi.org/10.60773/3zgp-q276> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_149> <http://schema.org/funding> <https://okn.wobd.org/grant/1U24TR001608-01> .
<https://okn.wobd.org/grant/2U54MD007601-31> <http://schema.org/identifier> "2U54MD007601-31" .
<https://okn.wobd.org/grant/1UL1TR001878-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/205" .
<https://okn.wobd.org/person/the_community_action_place> <http://schema.org/name> "The Community Action Place" .
<https://ror.org/00j4k1h63> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Organization> .
<https://okn.wobd.org/grant/1P01HL114471-01A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_169> <http://schema.org/url> "https://radxdatahub.nih.gov/study/169" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_157> <http://schema.org/funding> <https://okn.wobd.org/grant/1DP2GM137418-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_51> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1UL1TR002538-01> <http://schema.org/funder> <https://ror.org/04pw6fb54> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_185> <http://schema.org/identifier> "phs003082" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_187> <http://schema.org/name> "C2SPARC: Implementing Mobile, POC COVID-19 Testing in Partnership with a Community-Based Organization to Reach Women Who Use Drugs" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_218> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/grant/1R01DK121072-01A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/person/harm_reduction_coalition_san_diego_onpoint> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_112> <http://schema.org/sameAs> "10.60773/jv00-r132" .
<https://okn.wobd.org/person/barnes_jewish_hospital> <http://schema.org/name> "Barnes Jewish Hospital" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_134> <http://schema.org/datePublished> "2023-08-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_163> <http://schema.org/description> "Latinx communities are disproportionately affected by the COVID-19 pandemic, with Spanish-speaking Latinx communities carrying even heavier burdens of infection, hospitalization, and mortality. Major barriers to COVID-19 testing and vaccination exist, and a profound need remains to understand and address the social, ethical, and behavioral implications (SEBI) of COVID-19 testing and vaccination within Latinx communities. The well-established community-academic partnership proposed a rigorous mixed-methods, community-based participatory research (CBPR) study to better understand the SEBI of COVID-19 testing and vaccination and to refine and test a novel and culturally congruent intervention to increase COVID-19 testing and vaccination within Spanish-speaking Latinx communities. In Aim 1, the study conducted individual in-depth interviews with health providers and representatives from Latinx-serving community-based organizations and focus groups with Spanish-speaking Latinx community members to expand understanding of the individual, interpersonal, institutional, community, and policy factors influencing COVID-19 testing and vaccination within Spanish-speaking Latinx communities. In Aim 2, the study integrated findings from other relevant COVID-19 studies and from Aim 1 to refine a Spanish-language intervention known as Nuestra Salud Segura (Our Safe Health) designed to increase COVID-19 testing and vaccination among Spanish-speaking Latinx persons. Nuestra Salud Segura harnessed the complementary strengths of peer navigation and mHealth. The study also tested the intervention using a longitudinal group-randomized trial design assessing participants at: (1) baseline and (2) immediate post intervention. The study anticipated that participants in the intervention group, relative to their counterparts in the delayed-intervention group, would demonstrate increased COVID-19 testing and vaccination. In Aim 3, the study developed and disseminated practice, research, intervention, and policy priorities and recommendations to increase COVID-19 testing and vaccination, reduce COVID-19 disparities, and promote health equity in Spanish-speaking Latinx communities by conducting an empowerment theory-based community forum. This CBPR study advanced prevention science and practice through increased understanding of the SEBI of COVID-19 testing and vaccination and testing an innovative intervention to promote and support COVID-19 testing and vaccination among a particularly underserved and vulnerable population -Spanish-speaking Latinx communities in the United States." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_190> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_52> <http://schema.org/datePublished> "2022-11-07"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_124> <http://schema.org/sameAs> "10.60773/7h8k-bz16" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_61> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_161> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2901879> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_153> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_59> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/274" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_101> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/grant/3T32GM083937-01A1S1> <http://schema.org/identifier> "3T32GM083937-01A1S1" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_35> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_179> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_85> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_136> <http://schema.org/sameAs> "10.60773/1e6t-6b11" .
<https://okn.wobd.org/grant/1R01AI140442-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9607342" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/funding> <https://okn.wobd.org/grant/1P30AI073961-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_48> <http://schema.org/name> "Multi-Modal Wireless COVID Monitoring and Infection Alerts for Concentrated Populations" .
<https://okn.wobd.org/grant/1P30DK092950-01> <http://schema.org/identifier> "1P30DK092950-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_128> <http://schema.org/dateCreated> "2022-01-12"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_196> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/135" .
<https://okn.wobd.org/grant/1R01HL140898-01> <http://schema.org/startDate> "2018-01-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/upmc_children_s_hospital_of_pittsburgh> <http://schema.org/name> "UPMC Children's Hospital of Pittsburgh" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_128> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005550> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_173> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_189> <http://schema.org/name> "Engaging Church Health Ministries to Decrease SARS-CoV-2 Vaccine Hesitancy in Underserved Populations in Baton Rouge" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_118> <http://schema.org/identifier> "phs002737" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_37> <http://schema.org/dateModified> "2024-04-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_185> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_214> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01MD016593-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_179> <http://schema.org/sameAs> <https://doi.org/10.60773/8s4e-d179> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_66> <http://schema.org/date> "2024-01-18"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_77> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/grant/1T32HD044355-01> <http://schema.org/name> "Institutional Training for Pediatricians" .
<https://okn.wobd.org/grant/1R01AI155696-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/10100201" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_132> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_194> <http://schema.org/dateCreated> "2023-03-24"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/41" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_214> <http://schema.org/funding> <https://okn.wobd.org/grant/8UL1TR000042-07> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_192> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/funding> <https://okn.wobd.org/grant/1R21AI129851-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_79> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/grant/1R01HL140898-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9472184" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_148> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_63> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_152> <http://schema.org/description> "The project aimed to increase access and uptake of COVID-19 testing and vaccination among people who inject drugs (PWID), a population highly vulnerable to COVID-19. This RADx-UP project, LinkUP, was nested within the San Diego component of the parent grant, La Frontera, which was funded by National Institute on Drug Abuse (NIDA) in April, 2020. To date, 31% of La Frontera PWID have tested SARS-CoV-2 antibody+, of whom 65% had not previously been tested for COVID-19. Only 3% had been vaccinated by May, 2021, and 45% were vaccine hesitant. The specific aims were: AIM1: To prospectively evaluate the prevalence, predictors and barriers to COVID-19 testing among PWID. AIM2: To prospectively assess incidence, predictors, and barriers to COVID-19 vaccination among PWID. AIM3: To adapt and pilot an intervention offered at a mobile syringe services program (SSP) to improve uptake of COVID-19 testing and vaccination among PWID. AIM4: To compare COVID testing and vaccination rates before and after the state introduces a) COVID-19 rapid testing, and b) COVID-19 vaccination at the SSP, which represents a natural experiment. AIM5: To prospectively assess the impact of COVID-19 testing and vaccination on PWID's behaviors. To meet Aims 1 and 2, interviews were conducted with 400 PWID in La Frontera. Results were made available in Fall 2021. Based on these findings and input from the Community and Scientific Advisor Board (CASB), the study selected and adapted a brief intervention to improve COVID-19 testing and vaccination uptake among PWID at the mobile van of the community partner, OnPoint. The OnPoint peer counselors also offered on-site rapid COVID-19 antigen testing and confirmatory PCR and referrals to the closest COVID-19 vaccination center until vaccine was offered at OnPoint by the state. The study evaluated COVID-19 vaccine update independently through ongoing La Frontera study visits, that included self-reported interview data and linage of electronic health records with the San Diego County COVID-19 database, by analyzing SARS-CoV-2 antibody patterns to differentiate between natural infection and vaccine-induced immunity. Results were used to estimate effect sizes for a future efficacy trial and shared with the RADx-UP consortium, policymakers, and program planners. Since there are 185 SSPs across the country, the study informed efforts to enable SSPs to become important 'touchpoint' to reach marginalized PWID, strengthening the nation's pandemic preparedness infrastructure to reduce COVID-19 health disparities." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_172> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/cghr-4117> .
<https://okn.wobd.org/grant/1R21AI129851-01> <http://schema.org/name> "Mapping the RNA modification N6-methyladenosine during Zika virus infection" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_152> <http://schema.org/funding> <https://okn.wobd.org/grant/1T32AI007384-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_188> <http://schema.org/date> "2024-08-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_101> <http://schema.org/funding> <https://okn.wobd.org/grant/1P30AI094189-01A1> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_79> <http://schema.org/name> "Reaching Communities through the Design of Information Visualizations (ReDIVis) Toolbox for Return of COVID-19 Results (RCR)" .
<https://okn.wobd.org/person/csula> <http://schema.org/name> "CSULA" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_84> <http://schema.org/sameAs> <https://doi.org/10.60773/sh92-7q42> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_79> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/person/northwestern_university> <http://schema.org/name> "Northwestern University" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_221> <http://schema.org/url> "https://radxdatahub.nih.gov/study/221" .
<https://okn.wobd.org/grant/1F30DK123915-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9908956" .
<https://okn.wobd.org/grant/1R01AI107301-01> <http://schema.org/name> "Genetic viral and host adaptations to breach species barriers of HCV" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_192> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/grant/1R01MH117406-01> <http://schema.org/funder> <https://ror.org/04xeg9z08> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_192> <http://schema.org/name> "Conducting Correctional COVID Research and Implementing Novel, Ethically Sound, Sustainable Surveillance Systems (CRAINES)" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/191" .
<https://okn.wobd.org/grant/5T32GM007618-08> <http://schema.org/startDate> "1978-07-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_28> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_195> <http://schema.org/sameAs> <https://doi.org/10.60773/0va3-6933> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_83> <http://schema.org/author> <https://okn.wobd.org/person/better_community_development> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_218> <http://schema.org/name> "Impact of COVID-19 Testing and Mitigation on Equitable Return-to-School in the Second Largest U.S. School District" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_90> <http://schema.org/identifier> "phs002643" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_67> <http://schema.org/author> <https://okn.wobd.org/person/florida_international_university> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_29> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_139> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://ror.org/040gcmg81> <http://schema.org/name> "National Cancer Institute" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_49> <http://schema.org/funding> <https://okn.wobd.org/grant/1S10OD023527-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_87> <http://schema.org/datePublished> "2023-08-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_36> <http://schema.org/date> "2024-04-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.obolibrary.org/obo/MONDO_0005015> <http://schema.org/name> "diabetes mellitus" .
<https://www.uniprot.org/taxonomy/10239> <http://schema.org/name> "Viruses" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_74> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_80> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_156> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/grant/2UL1TR000457-06> <http://schema.org/url> "https://reporter.nih.gov/project-details/8467203" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_80> <http://schema.org/sameAs> <https://doi.org/10.60773/dp9b-t353> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_132> <http://schema.org/author> <https://okn.wobd.org/person/technology_and_research_trust_san_juan> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_81> <http://schema.org/sameAs> "10.60773/fc6a-gf05" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_210> <http://schema.org/author> <https://okn.wobd.org/person/morehouse_school_of_medicine> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_143> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_200> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_187> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_140> <http://schema.org/url> "https://radxdatahub.nih.gov/study/140" .
<https://okn.wobd.org/grant/1U54CA156732-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_134> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/9ema-x262> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_210> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_159> <http://schema.org/url> "https://radxdatahub.nih.gov/study/159" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_126> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR002319-01> .
<https://okn.wobd.org/grant/1UL1TR003167-01> <http://schema.org/endDate> "2024-06-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_176> <http://schema.org/author> <https://okn.wobd.org/person/north_miami_middle_school> .
<https://ror.org/01s5ya894> <http://schema.org/parentOrganization> "National Institutes of Health" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_144> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/gvj9-b203> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_176> <http://schema.org/description> "This project explored the feasibility of strategic COVID-19 testing protocols in at-risk urban school settings with the goal of increasing a sense of safety for parents and staff, and elucidating information that could assist the district in adopting a testing protocol which would increase time students and staff spend in school physically versus quarantined or in virtual learning environments. This study hypothesized that the data collected via this study would support a testing protocol for students to return to school sooner than the current 10-day quarantine period required by the Miami-Dade school district. Using the information gathered from Study 1, two types of protocols were expected: 1) For students showing symptoms (isolation room protocol-see sample below); 2) For students exposed (either in the classroom or outside of school)." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_207> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR001863-01> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/166" .
<https://okn.wobd.org/grant/1P30GM114737-01> <http://schema.org/funder> <https://ror.org/04q48ey07> .
<https://okn.wobd.org/grant/1UL1TR002541-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<http://purl.obolibrary.org/obo/MONDO_0005249> <http://schema.org/name> "pneumonia" .
<https://okn.wobd.org/grant/1S10OD018499-01> <http://schema.org/name> "CyTOF Mass Cytometer" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_58> <http://schema.org/date> "2024-01-18"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1U19NS112953-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_152> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1UL1TR000460-01A1> <http://schema.org/url> "https://reporter.nih.gov/project-details/8467155" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/121" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_121> <http://schema.org/dateCreated> "2022-01-06"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_199> <http://schema.org/author> <https://okn.wobd.org/person/north_jersey_community_research_initiative> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_169> <http://schema.org/dateModified> "2024-01-18"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_159> <http://schema.org/description> "African American and Latinx communities nationally and in California not only bear a disproportionate burden of COVID-19 positive cases and deaths but are also not taking part in COVID-19 testing for a wide range of understudied reasons. This can have profound implications in safety net health care settings that care for the most vulnerable patients. The Los Angeles County Department of Health Services (LACDHS) is the second largest publicly operated county safety net health care system in the United States, serving more than 750,000 patients annually. Timely access to health care in this under-resourced, high-need setting has been an ongoing challenge for its majority Latinx and African American patients. With the current pandemic, COVID-19 testing for patients has become integral to receiving critical health care, from treatment for symptomatic disease to the first step in providing procedural care. However, the range of reasons why patients refuse COVID-19 testing and vaccinations is little understood. To this end, the study proposed to explore the obstacles to COVID-19 testing and vaccinations to provide COVID-19 specific training to LACDHS Community Health Workers (CHWs) from these same communities to effectively address: a) the primary goal of increasing COVID-19 testing and vaccinations for individual patients, and b) developing a sustained public health presence in these communities to build trust and preparedness for critical COVID-19 related future needs. Trained CHWs can help to more effectively overcome obstacles to COVID-19 testing and vaccinations, including historical barriers of mistrust, provide COVID-19 health education, help address social determinants of health and help facilitate technological literacy to improve patient access to testing and care in a telehealth environment. The proposal used a multidisciplinary, mixed-methods approach including unsupervised machine learning and qualitative interviews to systematically explore barriers and facilitators to COVID-19 testing/vaccinations among vulnerable safety net patients. The study then trained clinically-based, ethnically/linguistically matched CHWs to implement a hypothesis-driven intervention consisting of six group classes and six personalized patient encounters with African American and Latinx safety net patients. This study had the following specific aims: Aim 1- Utilize machine learning methods to assess whether there are characteristics that define two sets of African American and Latinx safety net patients, a) those who engage in or refuse COVID-19 testing and b) those who engage in or refuse COVID-19 vaccinations; Aim 2 - Conduct in-depth interviews with African American and Latinx patients who either declined or accepted COVID-19 testing and/or vaccinations to explore contextual, behavioral, and attitudinal factors shaping patient circumstances and concerns; Aim 3 - Develop, implement, and pre-test a CHW intervention with the information from Aims 1 and 2, utilizing a randomized control design among African American and Latinx safety net patients to assess the effect of the CHW hypothesis-driven intervention on trust, self-efficacy, and intent to participate in COVID-19 testing/ re-testing and vaccinations." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_114> <http://schema.org/datePublished> "2022-07-25"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/pediatric_research_in_inpatient_settings_pris_network> <http://schema.org/name> "Pediatric Research in Inpatient Settings (PRIS) Network" .
<https://okn.wobd.org/person/the_community_action_place> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_149> <http://schema.org/funding> <https://okn.wobd.org/grant/1P30CA042014-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_195> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/0va3-6933> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_175> <http://schema.org/sameAs> "10.60773/9d1x-h432" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_147> <http://schema.org/sameAs> <https://doi.org/10.60773/02m0-qe56> .
<https://okn.wobd.org/grant/5T32HL007227-10> <http://schema.org/identifier> "5T32HL007227-10" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_55> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0004975> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_194> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_192> <http://schema.org/dateCreated> "2022-11-28"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_110> <http://schema.org/sameAs> <https://doi.org/10.60773/rqhz-1a60> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_99> <http://schema.org/name> "Randomized COVID-19 Testing in Vulnerable Communities and Risk Tool Creation (FightCOVIDMKE)" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01CA249054-01> .
<https://okn.wobd.org/grant/1P30AI094189-01A1> <http://schema.org/startDate> "2012-05-02"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/this_was_a_decentralized_study_run_on_evidation_s_achievement_platform> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/grant/1UL1TR001873-01> <http://schema.org/identifier> "1UL1TR001873-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_115> <http://schema.org/funding> <https://okn.wobd.org/grant/6U48DP006395-01M001> .
<http://purl.obolibrary.org/obo/MONDO_0008383> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_120> <http://schema.org/datePublished> "2022-08-12"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_176> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/dk7k-jh11> .
<https://okn.wobd.org/grant/1UL1TR003107-01> <http://schema.org/name> "Expanding Translational Research in Arkansas" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/author> <https://okn.wobd.org/person/texas_children_s_hospital> .
<https://okn.wobd.org/grant/1S10OD026929-01> <http://schema.org/endDate> "2020-08-20"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1U54GM104942-01> <http://schema.org/name> "West Virginia IDEA-CTR" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_126> <http://schema.org/description> "The School TLC Study developed and implemented COVID-19 testing approaches in highly disadvantaged public school settings that addressed barriers to testing and returning to in-person school among vulnerable populations. The study included a COVID-19 test preference study and formative needs assessment to inform ongoing testing approach and services to support in-person schooling. In addition, the study augmented testing with tailored medical consultation and communication strategies in school settings and examined whether these services benefit in-person learning above and beyond testing. Methods included a verbal test preference questionnaire, parent surveys and interviews, and staff interviews. Secondary data sources included test enrollment rates and absenteeism rates." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_146> <http://schema.org/url> "https://radxdatahub.nih.gov/study/146" .
<https://ror.org/00fj8a872> <http://schema.org/alternateName> "Office of the NIH Director" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_88> <http://schema.org/name> "Transforming Community Engagement to Increase SARS-CoV-2 Testing in Underserved Populations in Baton Rouge (TEST UP-BR)" .
<https://okn.wobd.org/person/association_for_utah_community_health> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_140> <http://schema.org/name> "Developing a Realtime Monitoring System and Program to Improve COVID-19 Testing for Latinx Populations" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_156> <http://schema.org/identifier> "phs002904" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_100> <http://schema.org/sameAs> "10.60773/sx9p-ww84" .
<https://okn.wobd.org/person/children_s_national_health_system> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_39> <http://schema.org/dateModified> "2024-04-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://ror.org/040gcmg81> <http://schema.org/alternateName> "Instituto Nacional del Cáncer" .
<https://okn.wobd.org/grant/1R01CA193776-01> <http://schema.org/name> "Improving risk allocation and developing novel therapies for children with T-ALL" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_145> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/author> <https://okn.wobd.org/person/children_s_hospital_of_orange_county> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_77> <http://schema.org/sameAs> <https://doi.org/10.60773/amzc-p035> .
<https://okn.wobd.org/person/and_johns_hopkins_university_school_of_medicine_washington_university> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_61> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/a1js-pv10> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_174> <http://schema.org/funding> <https://okn.wobd.org/grant/1K01MH112436-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_70> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_143> <http://schema.org/name> "Testing for COVID-19 in High Risk Children with Intellectual and Developmental Disabilities (COV-IDD)" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_71> <http://schema.org/date> "2024-01-18"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01CA249054-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9947324" .
<https://okn.wobd.org/grant/1R01AI135992-01> <http://schema.org/name> "Automation and Evaluation of Real-Time Transmission Network-Based HIV Prevention Services in New York City" .
<https://okn.wobd.org/grant/1P01HL114471-01A1> <http://schema.org/endDate> "2018-06-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01HL105704-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/8024631" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_122> <http://schema.org/dateCreated> "2022-01-06"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1P30ES030283-01A1> <http://schema.org/name> "University of Louisville Center for Integrative Environmental Health Sciences" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_160> <http://schema.org/identifier> "phs002917" .
<http://purl.obolibrary.org/obo/MONDO_0005447> <http://schema.org/name> "testicular cancer" .
<https://okn.wobd.org/person/albany_area_primary_health_care> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/person/valley_childrens_healthcare> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_203> <http://schema.org/sameAs> "10.60773/tkr8-r227" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_209> <http://schema.org/dateCreated> "2023-08-02"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_153> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/6tcr-xa14> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_203> <http://schema.org/identifier> "phs003364" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_83> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1UL1TR001442-01> <http://schema.org/name> "UC San Diego Clinical and Translational Research Institute" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_42> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_220> <http://schema.org/sameAs> <https://doi.org/10.60773/cpws-7m93> .
<https://okn.wobd.org/person/texas_children_s_hospital> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/grant/1P30AI094189-01A1> <http://schema.org/endDate> "2017-04-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_188> <http://schema.org/name> "Exosome-Based Non-Traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS-CoV-2" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_53> <http://schema.org/sameAs> "10.60773/prf9-6708" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_118> <http://schema.org/name> "Accurate, Sensitive and Affordable POC and At Home Testing Device" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_203> <http://schema.org/sameAs> <https://doi.org/10.60773/tkr8-r227> .
<http://purl.obolibrary.org/obo/NCIT_C37935> <http://schema.org/name> "Cough" .
<https://okn.wobd.org/person/northwestern_university> <http://schema.org/name> " Northwestern University" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/85" .
<https://okn.wobd.org/grant/1UL1TR000460-01A1> <http://schema.org/startDate> "2012-06-27"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_42> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_221> <http://schema.org/dateModified> "2024-03-29"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_29> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/grant/1R01HG009120-01A1> <http://schema.org/url> "https://reporter.nih.gov/project-details/9256914" .
<https://okn.wobd.org/grant/1R01HD091218-01> <http://schema.org/name> "Mechanisms of Zika Virus Maternal-Fetal Transmission" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_205> <http://schema.org/datePublished> "2023-11-09"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_143> <http://schema.org/funding> <https://okn.wobd.org/grant/3P50HD103525-01S1> .
<https://okn.wobd.org/grant/8P20GM103429-11> <http://schema.org/url> "https://reporter.nih.gov/project-details/8261896" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0000465> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_191> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_85> <http://schema.org/identifier> "phs002616" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_37> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_27> <http://schema.org/sameAs> "10.60773/hz9w-yy91" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_213> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/grant/1UL1TR002378-01> <http://schema.org/name> "Georgia Clinical & Translational Science Alliance (GaCTSA)" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_180> <http://schema.org/description> "Purpose: To assess beliefs, attitudes and intentions of skilled nursing facility staff, residents and family members concerning COVID-19 testing and vaccination, via survey and using mixed methods. Design and Methods: E-surveys were developed and distributed to measure attitudes about SARS-CoV-2 testing and vaccine uptake among skilled nursing facility (SNF) workers and families. The surveys were distributed in over 50 SNFs across the U.S., with results from 4838 respondents compiled." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_63> <http://schema.org/sameAs> <https://doi.org/10.60773/e8nb-ns15> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_170> <http://schema.org/url> "https://radxdatahub.nih.gov/study/170" .
<https://ror.org/00fq5cm18> <http://schema.org/alternateName> "Instituto Nacional sobre el Abuso de Drogas" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_40> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/grant/1R01DA055491-01> <http://schema.org/endDate> "2026-04-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_209> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/progressive_community_health_ctr> <http://schema.org/name> "Progressive Community Health Ctr" .
<https://okn.wobd.org/grant/1R01AI125416-01> <http://schema.org/funder> <https://ror.org/043z4tv69> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_182> <http://schema.org/funding> <https://okn.wobd.org/grant/8UL1TR000042-07> .
<https://okn.wobd.org/grant/1P20GM121342-01A1> <http://schema.org/endDate> "2023-07-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1U54GM138062-01A1> <http://schema.org/startDate> "2021-09-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01EB025022-01> <http://schema.org/startDate> "2017-09-12"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_181> <http://schema.org/dateCreated> "2022-09-06"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_196> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2901879> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_196> <http://schema.org/description> "The study sought to understand how and why people perform SARS-CoV-2 testing and report their results to the public health department. Participants participated in this study for three months and received home-delivery of rapid antigen and PCR-collection kits if they report to be at-risk for SARS-CoV-2 infection i.e. recently became symptomatic or were exposed to someone who tested positive. This study also collected wearable device data from participants to understand if signals from wearable devices can help detect onset of SARS-CoV-2 infection." .
<https://okn.wobd.org/grant/3OT2HL156812-01S2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_111> <http://schema.org/dateCreated> "2022-01-06"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_75> <http://schema.org/url> "https://radxdatahub.nih.gov/study/75" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_215> <http://schema.org/date> "2024-03-04"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_160> <http://schema.org/dateCreated> "2022-05-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_148> <http://schema.org/description> "Hispanics living in the United States have been negatively affected by the COVID-19 pandemic in a disproportionate manner, including significantly higher infection and hospitalization rates compared with non-Hispanic whites. The El Paso, TX metropolitan area has a substantial Hispanic population that has been profoundly affected by the current SARS-CoV-2 pandemic, especially the vulnerable residents of rural El Paso County. Many of these residents suffer from marked cumulative disadvantages with limited healthcare, poor access to public transportation, work as essential workers in low-paying frontline jobs, and demonstrate a persistent hesitancy to interact with unfamiliar medical systems and processes, resulting in \"SARS-CoV-2 testing deserts\". There is a critical need to increase the number of individuals being tested for SARS-CoV-2 in El Paso County, however, success in this space requires an integrated and personalized approach whereby residents are engaged with and informed by trusted co-ethnics and local organizations. The aims strategically integrated University of Texas at El Paso (UTEP), non-profit, business, and public partners, coupled with culturally-centric familial and Community Health Worker (CHWs) networks, as catalysts to: 1) reduce testing deficiencies by providing SARS-CoV-2 testing information, navigation strategies to testing sites, and implementing local pop-up testing sites, and 2) provide foundational data for understanding testing barriers and developing platforms for assessing future COVID-19 vaccine uptake willingness for El Paso residents. The UTEP Border Biomedical Research Center (BBRC), and associated Coronavirus Testing Program that provides CLIA-certified testing, was central to completion of the integrated approaches, and the established capability of the investigative team to interact with community partners and recruit participants was a prominent strength of the plan. The studies tested the novel hypothesis that improving the reach, acceptance, uptake and sustainability of SARS-CoV-2 testing for the most marginalized populations of El Paso County is dependent on implementing strategies that target the cultural, social and behavioral factors characteristic of this population. The multifaceted approach enhanced the testing capacity in the El Paso region, reduced testing hesitancy, increased coronavirus testing numbers for vulnerable populations within specific testing deserts, and exerted a sustained influence on the health status of the region by integrating the extensive collaborative networks that are essential for addressing the persistent negative social determinants of health." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_99> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<http://purl.obolibrary.org/obo/MONDO_0010528> <http://schema.org/name> "anosmia" .
<https://ror.org/00372qc85> <http://schema.org/name> "National Institute of Biomedical Imaging and Bioengineering" .
<https://okn.wobd.org/person/children_s_hospital_boston> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_112> <http://schema.org/dateCreated> "2022-01-06"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://ror.org/04pw6fb54> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Organization> .
<https://okn.wobd.org/grant/1R01HD091218-01> <http://schema.org/identifier> "1R01HD091218-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_137> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/NCIT_C143827> .
<https://okn.wobd.org/person/north_miami_beach_high_school> <http://schema.org/name> "North Miami Beach High School" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_167> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/1986198> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_121> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_169> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/grant/1DP2GM137418-01> <http://schema.org/name> "Resolving epigenetic instability during pluripotent state transitions: a roadmap for exploiting the biomedical potential of dynamic human stem cell states" .
<https://okn.wobd.org/person/monell_chemical_senses_center> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_126> <http://schema.org/funding> <https://okn.wobd.org/grant/8UL1TR000042-07> .
<https://okn.wobd.org/grant/1U19AI135995-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_127> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_48> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://ror.org/00372qc85> <http://schema.org/parentOrganization> "National Institutes of Health" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_115> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/grant/1R01HD091218-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9289300" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_137> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01HL105704-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_29> <http://schema.org/sameAs> "10.60773/vjdg-pt27" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_205> <http://schema.org/sameAs> <https://doi.org/10.60773/kkcm-b102> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/author> <https://okn.wobd.org/person/children_s_hospital_colorado> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_100> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/sx9p-ww84> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_166> <http://schema.org/funding> <https://okn.wobd.org/grant/8UL1TR000042-07> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_74> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/author> <https://okn.wobd.org/person/louisiana_state_university_of_health_sciences_center> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_121> <http://schema.org/sameAs> <https://doi.org/10.60773/v1k1-md20> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_172> <http://schema.org/author> <https://okn.wobd.org/person/northwestern_university> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/sameAs> "10.60773/vaeg-ht26" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_90> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_180> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_62> <http://schema.org/datePublished> "2024-08-16"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_42> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/0pp8-qx15> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_152> <http://schema.org/identifier> "phs002821" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_72> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/sqkn-3a50> .
<https://okn.wobd.org/grant/1K08AI130381-01A1> <http://schema.org/url> "https://reporter.nih.gov/project-details/9666325" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_35> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/grant/1UL1TR003017-01> <http://schema.org/endDate> "2024-02-29"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_160> <http://schema.org/datePublished> "2023-08-29"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/2P2CHD050924-11> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_100> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/person/the_university_of_texas_health_science_center_houston> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_215> <http://schema.org/url> "https://radxdatahub.nih.gov/study/215" .
<https://okn.wobd.org/grant/1T32DA007292-01A1> <http://schema.org/endDate> "1998-07-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DataCatalog> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_142> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_152> <http://schema.org/author> <https://okn.wobd.org/person/harm_reduction_coalition_san_diego_onpoint> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_179> <http://schema.org/identifier> "phs003049" .
<http://purl.obolibrary.org/obo/MONDO_0005287> <http://schema.org/name> "developmental disability" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_218> <http://schema.org/sameAs> "10.60773/xf2h-5k20" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_93> <http://schema.org/identifier> "phs002649" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_132> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_122> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/grant/1K23AI121485-01A1> <http://schema.org/identifier> "1K23AI121485-01A1" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_83> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_168> <http://schema.org/sameAs> <https://doi.org/10.60773/xb7r-qw92> .
<https://okn.wobd.org/person/puerto_rico_science> <http://schema.org/name> "Puerto Rico Science" .
<https://okn.wobd.org/grant/1R01DA055491-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_208> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_35> <http://schema.org/name> "NIH Digital Health Solutions for COVID-19: Team SAE" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_90> <http://schema.org/sameAs> "10.60773/pz40-d968" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_62> <http://schema.org/description> "A substantial and growing body of evidence demonstrated that COVID-19 is transmitted by human-emitted airborne particles; therefore, it was critical to rapidly screen individuals to determine whether they are at risk of transmitting the disease to others before they enter large venues (e.g., airports, schools) and smaller ones where extended exposure or close proximity is expected (e.g., dental offices, hair salons). Given the large number of asymptomatic cases of the disease, the infrared thermometers and health questionnaires frequently used to screen individuals are plainly inadequate. Existing SARS-CoV-2 detection technology is time-consuming and complicated to use, expensive and not portable, and therefore ill-suited to use as point-of-care (POC) screening tools. Tests recently approved by the FDA under the Emergency Use Authorization face some of the same challenges. The goal of this project was to develop and test a novel breathalyzer for detecting aerosolized SARS-CoV-2 directly from exhaled breath in near real-time by marrying a proven, cutting-edge aerosol sampling technology with a novel and inexpensive virus detector. The innovation was directly detecting virus in the breath, while other breathalyzers depend on indirect detection (VOCs and AI algorithms) to infer the presence of the virus. In this Fast-track STTR project, Aerosol Devices Inc (ADev) modified its commercial bioaerosol collector, which was used to sample from the ambient environment, to enable it to collect viruses from breath samples into a concentrated liquid sample. The University of Minnesota (UMN) modified its Magnetic Particle Spectrometer (MPS), a version of which has previously been used to detect Influenza A H1N1 virus, so that the liquid samples from the collector could be analyzed to detect SARS-CoV-2. Specific aims included developing the hardware for transforming an ambient sampler into a breath sampler, designing a rapid means of decontaminating the collector between tests, integrating the collector and the detector into a robust package, functionalizing magnetic nanoparticles with SARS-CoV-2 antibodies, increasing the signal/noise ratio of the MPS electronics, reducing the assay time, improving the analytical sensitivity/specificity, measuring the clinical sensitivity/specificity and comparing to RT-qPCR in pre-clinical testing. The technology platform proposed was flexible and extensible and was tailored to detect other pathogens (e.g., rhinoviruses, respiratory syncytial virus, parainfluenza virus, other coronaviruses, etc.). This flexibility was valuable since (1) this will not be the last pandemic (new pathogens in the future) and (2) development could pivot to a different pathogen if a vaccine or other control measures bring the current COVID-19 pandemic under control before this SARS-CoV-2 breathalyzer was made commercially available." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_80> <http://schema.org/datePublished> "2023-08-29"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_37> <http://schema.org/author> <https://okn.wobd.org/person/this_was_a_decentralized_study_run_on_evidation_s_achievement_platform> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_51> <http://schema.org/sameAs> "10.60773/6e21-bq61" .
<https://okn.wobd.org/grant/5T32HL007227-10> <http://schema.org/name> "PATHOPHYSIOLOGY OF MYOCARDIAL DISEASE" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_122> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_45> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01AI088364-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_208> <http://schema.org/datePublished> "2024-03-04"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_120> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_140> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/3zgp-q276> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_97> <http://schema.org/url> "https://radxdatahub.nih.gov/study/97" .
<https://ror.org/006zn3t30> <http://schema.org/alternateName> "The National Institute of Arthritis and Musculoskeletal and Skin Diseases" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_35> <http://schema.org/url> "https://radxdatahub.nih.gov/study/35" .
<https://okn.wobd.org/person/university_of_southern_maine> <http://schema.org/name> "University of Southern Maine" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_65> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_74> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/NCIT_C154635> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_33> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/grant/1R35GM119774-01> <http://schema.org/startDate> "2016-08-23"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01MD016593-01> <http://schema.org/funder> <https://ror.org/0493hgw16> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_149> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_113> <http://schema.org/name> "Community-Driven Optimization of COVID-19 Testing to Reach and Engage Underserved Areas for Testing Equity (CO-CREATE)" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_144> <http://schema.org/name> "Community-Engaged Research on COVID-19 Testing Among Underserved and/or Vulnerable Populations" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_114> <http://schema.org/sameAs> "10.60773/ws7v-2r18" .
<https://okn.wobd.org/grant/1U54CA260492-01> <http://schema.org/name> "Johns Hopkins Excellence in Pathogenesis and Immunity Center for SARS-CoV-2 (JH-EPICS)" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_59> <http://schema.org/funding> <https://okn.wobd.org/grant/1DP1AI158186-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_143> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_170> <http://schema.org/dateModified> "2022-12-09"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_76> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_184> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/person/iowa_state_university> <http://schema.org/name> "Iowa State University" .
<https://okn.wobd.org/grant/1ZIAAI001175-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/8556078" .
<https://okn.wobd.org/grant/1P30ES023513-01A1> <http://schema.org/funder> <https://ror.org/00j4k1h63> .
<https://okn.wobd.org/grant/1P30GM114737-01> <http://schema.org/name> "Pacific Center for Emerging Infectious Diseases Research" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_38> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/grant/1R01HG011274-01> <http://schema.org/funder> <https://ror.org/00baak391> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_152> <http://schema.org/sameAs> <https://doi.org/10.60773/w25v-9n49> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_49> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/7gn8-9w03> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_87> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_83> <http://schema.org/sameAs> <https://doi.org/10.60773/mx0a-y046> .
<https://okn.wobd.org/grant/1K08AR073339-01> <http://schema.org/startDate> "2018-04-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_178> <http://schema.org/author> <https://okn.wobd.org/person/northwestern_university_and_john_hopkins_university> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_209> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/grant/1P01HL114471-01A1> <http://schema.org/url> "https://reporter.nih.gov/project-details/8476658" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/160" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_170> <http://schema.org/sameAs> "10.60773/cwrf-q204" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_81> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_214> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR002538-01> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/123" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/datePublished> "2022-11-07"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_69> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_87> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_177> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/50dx-sm74> .
<https://okn.wobd.org/grant/1R01MH115676-01A1> <http://schema.org/identifier> "1R01MH115676-01A1" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_177> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_134> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_112> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/grant/1UL1TR003107-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/1R01GM089784-01A1> <http://schema.org/startDate> "2010-04-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_137> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01MH117406-01> .
<https://okn.wobd.org/grant/1UL1TR001863-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9261061" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_168> <http://schema.org/dateModified> "2024-01-18"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_44> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/114" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/176" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_173> <http://schema.org/sameAs> <https://doi.org/10.60773/nsxy-2f26> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_143> <http://schema.org/funding> <https://okn.wobd.org/grant/2UL1TR000427-06> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_84> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/sh92-7q42> .
<https://okn.wobd.org/grant/1UL1TR003107-01> <http://schema.org/endDate> "2024-06-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_206> <http://schema.org/sameAs> "10.60773/jrhz-2h83" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_130> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_43> <http://schema.org/dateModified> "2022-12-09"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_220> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/person/pediatric_rheumatology_covid_consortium_prcc_hackensack_meridian> <http://schema.org/name> "Pediatric Rheumatology COVID Consortium (PRCC- Hackensack Meridian" .
<https://okn.wobd.org/grant/1R56HL149881-01A1> <http://schema.org/endDate> "2023-08-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_134> <http://schema.org/sameAs> "10.60773/9ema-x262" .
<http://purl.obolibrary.org/obo/MONDO_0005148> <http://schema.org/name> "type 2 diabetes mellitus" .
<https://ror.org/043z4tv69> <http://schema.org/name> "National Institute of Allergy and Infectious Diseases" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_190> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/grant/1DP2DA040254-01> <http://schema.org/funder> <https://ror.org/00fq5cm18> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_97> <http://schema.org/funding> <https://okn.wobd.org/grant/1U24TR001608-01> .
<https://www.uniprot.org/taxonomy/2839062> <http://schema.org/name> "Transformation" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_185> <http://schema.org/name> "Localized Mobile Health Approach to Boosting COVID-19 Testing and Vaccine Literacy, Access, and Uptake Among Women with Criminal Legal System Involvement" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_139> <http://schema.org/sameAs> <https://doi.org/10.60773/wtx3-4882> .
<https://okn.wobd.org/grant/1DP2GM137418-01> <http://schema.org/funder> <https://ror.org/04q48ey07> .
<https://okn.wobd.org/grant/1U54GM115516-01A1> <http://schema.org/name> "Northern New England Clinical and Translational Research Network" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_72> <http://schema.org/url> "https://radxdatahub.nih.gov/study/72" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_204> <http://schema.org/name> "Supported Employment to Create a Community Culture of Rapid Testing Among People Who Inject Drugs: PeerConnect2Test" .
<https://okn.wobd.org/grant/1R01HL149450-01A1> <http://schema.org/name> "Foam cells as drug targets in tuberculosis" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_197> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_150> <http://schema.org/datePublished> "2023-08-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://ror.org/006zn3t30> <http://schema.org/alternateName> "NIAMS" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_169> <http://schema.org/identifier> "phs002551" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_141> <http://schema.org/description> "The COVID-19 pandemic has disproportionately affected the already underserved Latinx communities. The overall goal of the testing research project was to decrease disparities in the morbidity and mortality patterns for COVID-19 through engaged partnerships with several communities in central California that are both historically underserved and vulnerable to COVID-19, namely the Latinx. These communities currently are experiencing infection rates that are three times higher than whites, and are among the highest in the U.S. They also are among the most socially and economically disadvantaged, have high rates of co-morbidities such as diabetes and asthma, live in overcrowded housing, and reside in some of the most polluted areas of the country. A high proportion are undocumented and employed in food production, especially farm labor, performing essential work that has been a backbone of the California economy, while simultaneously being marginalized. This research built upon long-term existing partnerships with an array of community-based organizations and trusted leaders in Latinx communities to develop interventions that address the barriers to SARS-CoV2 diagnostics, as part of a larger strategy to reduce transmission and control the pandemic in the Latinx population of central California. Because of the dynamic changes in incidence, shifting hubs of transmission, and policy changes from authorities, a comparator trial of different community- developed interventions was needed to provide information on which actions are feasible, acceptable, and effective. Hence, comparisons were made between the Latinx population and whites in the same counties, and among Latinx persons from counties having different interventions, with adjustment for infection incidence rates and trajectories, as well as local policy changes and government interventions. This study pursued the overall goal with the following specific aims: 1) Determine the epidemiology of COVID-19 infections, COVID-19 related mortality, and SARS-CoV-2 testing rates in selected Latinx and white non-Latinx communities of targeted California counties, 2) Develop strategies to increase testing and reduce rates of infection in the targeted areas in collaboration with community partners and, 3) Disseminate information and knowledge gained from this project back to partnering communities, other grantees from this and other COVID-19 initiatives by full participation in RADx-UP Coordinating Data and Collection Center (CDCC), to the broad public, and to policy- makers. Experience and knowledge gained through achievement of these aims set a firm foundation for subsequent research on COVID-19 and health disparities and helped to prepare communities to meet the challenges of future public health crises." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_68> <http://schema.org/identifier> "phs002600" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_202> <http://schema.org/description> "The study examined ways of understanding and responding to sources of mistrust and misinformation about COVID-19. The research also refined community-engaged research approaches to enhance the process of building and sustaining trust with communities. A central theme of the proposed research was to develop processes and resources to assure individuals have the tools and information to make well-informed choices about how they respond to COVID-19. The ultimate goal was to begin to address the long-term, deeply embedded issues of trust and injustice that have detrimentally impacted the health of communities of color." .
<https://okn.wobd.org/grant/5T32HL007227-10> <http://schema.org/url> "https://reporter.nih.gov/project-details/3540381" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_118> <http://schema.org/author> <https://okn.wobd.org/person/oregon_rural_practice_based_research_network> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_78> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01HL149450-01A1> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_76> <http://schema.org/identifier> "phs002520" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_174> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_197> <http://schema.org/sameAs> "10.60773/k8wj-0k62" .
<https://okn.wobd.org/grant/1R01CA249054-01> <http://schema.org/endDate> "2025-03-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://ror.org/004a2wv92> <http://schema.org/alternateName> "NIH National Institute of Dental and Craniofacial Research" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_213> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2901879> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_214> <http://schema.org/dateCreated> "2023-08-03"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_149> <http://schema.org/datePublished> "2023-12-07"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_177> <http://schema.org/author> <https://okn.wobd.org/person/sipa> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_179> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0004975> .
<https://okn.wobd.org/grant/1DP2AI138242-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9350514" .
<https://okn.wobd.org/person/david_geffen_school_of_medicine_at_ucla> <http://schema.org/name> "David Geffen School of Medicine at UCLA" .
<https://okn.wobd.org/grant/1UL1TR002001-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9314023" .
<https://okn.wobd.org/person/the_jackson_laboratory> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_113> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_221> <http://schema.org/name> "Faithful Response II: COVID-19 Rapid Test-to-Treat with African American Churches" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_122> <http://schema.org/sameAs> "10.60773/bxqp-9045" .
<https://okn.wobd.org/grant/1R01AI151059-01> <http://schema.org/identifier> "1R01AI151059-01" .
<https://okn.wobd.org/grant/1P30DK092950-01> <http://schema.org/startDate> "2011-09-20"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1P30CA042014-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_133> <http://schema.org/url> "https://radxdatahub.nih.gov/study/133" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_125> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005550> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/date> "2023-10-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_51> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005550> .
<https://okn.wobd.org/grant/1UL1TR002345-01> <http://schema.org/identifier> "1UL1TR002345-01" .
<https://okn.wobd.org/grant/1P30DK098722-01A1> <http://schema.org/endDate> "2020-07-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://ror.org/00fq5cm18> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Organization> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_169> <http://schema.org/sameAs> <https://doi.org/10.60773/y2n3-k036> .
<https://okn.wobd.org/grant/1R01HL149450-01A1> <http://schema.org/startDate> "2019-08-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_147> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/02m0-qe56> .
<https://okn.wobd.org/grant/1U01HG010971-01> <http://schema.org/name> "Center for Human Reference Genome Diversity" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_130> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01ES028615-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_74> <http://schema.org/sameAs> <https://doi.org/10.60773/073r-9g87> .
<https://okn.wobd.org/grant/1UL1TR002373-01> <http://schema.org/startDate> "2017-09-21"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1P30CA240139-01> <http://schema.org/startDate> "2019-07-10"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/57" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_274> <http://schema.org/author> <https://okn.wobd.org/person/the_university_of_texas_health_science_center_houston_the_university_of_texas_health_science_center_at_tyler> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_201> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_187> <http://schema.org/sameAs> "10.60773/eg9v-8e46" .
<https://okn.wobd.org/grant/1P30GM131944-01> <http://schema.org/name> "IBR-COBRE Phase III" .
<https://okn.wobd.org/grant/1DP2AI138242-01> <http://schema.org/identifier> "1DP2AI138242-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_140> <http://schema.org/sameAs> "10.60773/3zgp-q276" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/author> <https://okn.wobd.org/person/upmc_children_s_hospital_of_pittsburgh> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_53> <http://schema.org/name> "Minimal False-Alarm Touch-Based Detection of SARS-CoV-2 Virus Particles Using Poly-Aptamers" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_204> <http://schema.org/sameAs> <https://doi.org/10.60773/66qd-hj95> .
<https://okn.wobd.org/grant/2U54MD007595-11> <http://schema.org/funder> <https://ror.org/0493hgw16> .
<https://ror.org/04pw6fb54> <http://schema.org/alternateName> "NIH's National Center for Advancing Translational Sciences" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_78> <http://schema.org/funding> <https://okn.wobd.org/grant/1P30ES005022-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_147> <http://schema.org/dateCreated> "2022-04-18"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_181> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.obolibrary.org/obo/MONDO_0005044> <http://schema.org/name> "hypertensive disorder" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/identifier> "phs002553" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_151> <http://schema.org/datePublished> "2023-08-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1T32EB028092-01A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://ror.org/01y3zfr79> <http://schema.org/alternateName> "National Institute of Nursing Research National Institutes of Health" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_218> <http://schema.org/dateCreated> "2024-01-04"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_44> <http://schema.org/description> "The long-term goal of this project was to eliminate COVID-19 disparities among Hawaii's racial/ethnically diverse yet vulnerable populations including Native Hawaiian and other Pacific Islanders (NHPI) living in rural and underserved communities. This relied on integrating innovative SARS-CoV-2 testing capacity with novel community-specific messaging and education. Compounded by long-standing health disparities and socioeconomic challenges, NHPIs suffer from increased infection and mortality rates attributed to COVID-19. To date, NHPIs rank among the highest disproportionately burdened by SARS-CoV-2 in the U.S. With the nation's highest Rt, a basic reproductive metric indicating the degree of viral spread, Hawaii's disaggregated NHPI data reveal further disparities. Preliminary testing data collected by the Waianae Coast Comprehensive Health Center (WCCHC), Hawaii's largest federally funded community health center, indicated a significant deficiency in testing uptake, especially among Pacific Islanders. Under-representative coverage of testing among youth (ages 5-19 years old) in NHPI communities was observed, despite their higher than average infection rate. Other factors, including slow testing turnaround time and untested asymptomatic cases, complicated efforts to contain further community spread. Given the looming public health concerns around the re-opening of businesses and schools, these gaps highlighted the critical need for innovative approaches to effecting behavioral change coupled with novel testing strategies to enhance access to all community members, including school-aged children/youth. Fortunately, existing partnerships in Hawaii's culturally diverse populations offered a unique opportunity to augment the COVID-19 response with community knowledge and resilience. It was hypothesized that community-contextualized messaging disseminated by novel healthcare-school partnerships, coupled with a robust community and patient-centered testing strategy, would increase reach, access, uptake, and impact for COVID-19 testing in vulnerable populations. To test this hypothesis, the multidisciplinary team: (1) evaluated SARS-CoV-2 testing data, identified gaps and barriers in testing, and augmented community testing capacity to increase uptake, and (2) optimized and implemented community-informed COVID-19 messaging and education with a novel community healthcare-school network partnership in the NHPI population across Hawaii. Building on the parent Ola HAWAII grant, this project leveraged existing Community Engagement, Biostatistics, and Administrative Cores with the NHIP partnerships to augment the RADx-UP Coordinating and Data Collection Center for common evaluation metrics on COVID-19 testing-related outcomes and implementation. This project provided the foundation for an engaged community network primed for disseminating anticipated vaccines in Hawaii's highest risk populations. Given the urgency to both improve public health safety and re-open schools, results from this project offered insights into an integrated model or toolkit from which health clinics and schools in underserved and vulnerable communities across the country might actively participate in abating the pandemic." .
<https://okn.wobd.org/person/university_of_missouri_kansas_city> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_78> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://ror.org/04byxyr05> <http://schema.org/alternateName> "NIH/NICHD" .
<https://okn.wobd.org/grant/1UL1TR002538-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/1U01DA053941-01> <http://schema.org/startDate> "2021-01-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1P30CA045508-01> <http://schema.org/endDate> "1990-07-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.obolibrary.org/obo/NCIT_C35041> <http://schema.org/name> "Stress" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_67> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/person/fresenius_medical_care_north_america> <http://schema.org/name> "Fresenius Medical Care North America" .
<https://okn.wobd.org/grant/1UL1TR003142-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/1UL1TR002014-01> <http://schema.org/startDate> "2016-09-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1P30DK045735-01> <http://schema.org/identifier> "1P30DK045735-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_54> <http://schema.org/name> "Development of an Automated Diagnostic Platform for SARS-CoV-2 Monitoring in Vulnerable Areas" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_101> <http://schema.org/identifier> "phs002660" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_52> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/grant/2UL1TR000427-06> <http://schema.org/endDate> "2017-05-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_173> <http://schema.org/description> "As the coronavirus disease 2019 (COVID-19) pandemic evolved, equitable access to SARS-CoV testing and contact tracing was critical to ongoing pandemic surveillance. Even as COVID-19 infection rates, hospitalizations, and deaths were declining overall, testing was necessary to identify people who may benefit from COVID-19 therapies, to encourage isolation and quarantine of close contacts to prevent spread, to monitor for real-world vaccine effectiveness, and to learn about how the virus may be spreading within communities. For those communities disproportionately affected by COVID-19, testing may be simultaneously more important and yet more challenging because of the social, ethical, and behavioral implications (SEBI) of a positive test. Fears of positive tests leading to lost wages, employment disruption, privacy breaches, or housing instability can deter testing and contact tracing. In some communities, structural barriers, mistrust, or other factors may have contributed to vaccine hesitancy or lower rates of vaccination - circumstances that create greater potential for bias, discrimination, and stigmatization of communities where future COVID-19 outbreaks or may occur. The goal of REACH-OUT (Research, Engagement and Action on COVID-19 Health Outcomes via Testing) was to improve the reach, uptake and sustainability of COVID-19 testing among 5 underserved and socially- or medically-vulnerable populations via a community-based, participatory action research approach. The project built upon the strong community engagement network infrastructure built by the Colorado Community Engagement Alliance Against COVID-19 Disparities (CO-CEAL) and an existing Phase I SEBI grant (CONCERTS; Community Organizations for Natives: COVID-19 Epidemiology, Research, Testing, and Services). It broadened and deepened these efforts to address the next phase of the pandemic. This unique partnership between communities and multidisciplinary academic researchers with expertise in bioethics, mixed methods research, intervention design, and public health evaluation: (1) engaged communities to rapidly understand key cultural beliefs, communication preferences, and community-level resources that can be leveraged to overcome social, ethical, and behavioral barrier to COVID-19 testing using mixed methods; (2) co-created and implemented a menu of culturally-concordant strategies at the individual, interpersonal, health system, and/or community levels to increase testing rates, contact tracing, and access to COVID-19 support services using an Intervention Mapping approach; and (3) evaluated the processes and testing outcomes from REACH-OUT to inform the COVID-19 response and responses to future pandemics (including evaluation of the engagement process itself). The study focused on 5 populations (American Indian/Alaska Native; Urban LatinX; Rural LatinX; Urban Black or African American; and Black/Refugee), enabling the team to draw comparative insights about the barriers in common and unique to each and - in coordination with other SEBI projects - to generalize the findings to other communities throughout the US." .
<https://okn.wobd.org/grant/1T32EB028092-01A1> <http://schema.org/endDate> "2025-07-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1U19AI142733-01> <http://schema.org/endDate> "2024-02-29"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_201> <http://schema.org/dateCreated> "2023-07-27"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_77> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/amzc-p035> .
<http://purl.obolibrary.org/obo/MONDO_0005148> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/grant/1UL1TR003142-01> <http://schema.org/endDate> "2024-06-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_172> <http://schema.org/author> <https://okn.wobd.org/person/university_of_kansas_medical_center> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_114> <http://schema.org/url> "https://radxdatahub.nih.gov/study/114" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_159> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<http://purl.obolibrary.org/obo/MONDO_0005287> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_158> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/person/north_miami_high_school> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_119> <http://schema.org/name> "Rapid Manufacturing Scale-up for Compact Point-of-Care EUA SARS-CoV-2 RT-PCR Test" .
<https://okn.wobd.org/person/children_s_national_research_institute> <http://schema.org/name> "Children's National Research Institute" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_53> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_130> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/grant/1R01GM120553-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9160590" .
<https://ror.org/00fq5cm18> <http://schema.org/name> "National Institute on Drug Abuse" .
<https://okn.wobd.org/grant/1P30CA240139-01> <http://schema.org/endDate> "2024-06-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/97" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_138> <http://schema.org/datePublished> "2024-08-16"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_271> <http://schema.org/sameAs> <https://doi.org/10.60773/gwn0-p070> .
<https://okn.wobd.org/grant/1U01AI122285-01> <http://schema.org/startDate> "2016-04-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1UM1AI106716-01> <http://schema.org/funder> <https://ror.org/04byxyr05> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_182> <http://schema.org/name> "Social, Ethical, and Behavioral Factors in the Return to School Among Underserved Communities in Maryland" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_211> <http://schema.org/identifier> "phs003375" .
<http://purl.obolibrary.org/obo/MONDO_0100130> <http://schema.org/name> "adult acute respiratory distress syndrome" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_139> <http://schema.org/datePublished> "2023-08-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1ZIANR000035-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_111> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_127> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_162> <http://schema.org/identifier> "phs002945" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_176> <http://schema.org/author> <https://okn.wobd.org/person/fulford_elementary> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_82> <http://schema.org/date> "2024-04-10"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01AI123105-01A1> <http://schema.org/identifier> "1R01AI123105-01A1" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_68> <http://schema.org/funding> <https://okn.wobd.org/grant/1P30ES023513-01A1> .
<https://okn.wobd.org/grant/1R01CA193776-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/8862616" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_34> <http://schema.org/date> "2024-04-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_28> <http://schema.org/description> "There are two device studies under the 2183 banner. The 2183b study used an enhanced visual display compared to the original study (2183a), so it has been renamed. These prospective clinical studies sought to examine the performance of the 2183 device (a and b), a lateral flow immunoassay for the point-of-care (POC) detection of SARS-CoV-2 nucleocapsid protein antigen, compared to the Roche 6800 Cobas PCR for SARS-CoV-2 assay. The goal of the 2183b study was for EUA approval for the device to be used among symptomatic persons by trained healthcare personnel collected mid-turbinate specimens. Note: no device performance data will be included in the data files." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_156> <http://schema.org/dateCreated> "2022-05-06"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_219> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/w561-ag09> .
<https://ror.org/00fq5cm18> <http://schema.org/alternateName> "Instituto Nacional sobre el Abuso de Drogas de Estados Unidos" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/32" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_133> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_203> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/tkr8-r227> .
<https://okn.wobd.org/grant/1U01AI069918-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/7118353" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_166> <http://schema.org/author> <https://okn.wobd.org/person/st_louis> .
<https://okn.wobd.org/organization/national_center_for_chronic_disease_prev_and_health_promo> <http://schema.org/name> "National Center for Chronic Disease Prev and Health Promo" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_65> <http://schema.org/dateModified> "2022-12-09"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_175> <http://schema.org/sameAs> <https://doi.org/10.60773/9d1x-h432> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_207> <http://schema.org/sameAs> <https://doi.org/10.60773/yry0-5j59> .
<https://okn.wobd.org/grant/1R01AI140442-01> <http://schema.org/funder> <https://ror.org/043z4tv69> .
<https://okn.wobd.org/grant/1R01HG009120-01A1> <http://schema.org/endDate> "2022-02-28"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_207> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_55> <http://schema.org/identifier> "phs002549" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/46" .
<https://okn.wobd.org/grant/1R01ES028615-01> <http://schema.org/identifier> "1R01ES028615-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_51> <http://schema.org/description> "COVID-19 is expected to become one of the largest mass casualty events in the history of the United States (U.S.). Assessment of the true burden of disease in the population is needed for the prevention and mitigation of this and future viral disease outbreaks. Testing of new cases (via swabs/saliva) and those previously exposed (via serum) has limited reach in the population. However, an alternative approach relying on the analysis of community wastewater can screen up to 70% of the U.S. population on a weekly basis at < 0.01% of the cost of clinical screening of individuals. As a population-wide infectious disease surveillance tool, wastewater-based epidemiology (WBE) can be used to complement current surveillance methods to better understand disease burden and how these burdens differ across communities. The goal of this RADx-rad supplement was to implement and evaluate a near real-time WBE framework for SARS-CoV-2 by (i) assessing in near real-time community spread of the new coronavirus, (ii) significantly increasing the fraction of the U.S. population screened, the frequency at which this testing is being completed (weekly) and the geospatial resolution of screening (from city-wide to neighborhood-specific), (iii) comparing novel coronavirus levels in wastewater with the burdens of infection, disease, and mortality reported by local health systems, (iv) harvesting high throughput sequence (HTS) data on SARS-CoV-2 variants across the U.S., (v) optimizing pipelines for HTS analysis, and (vi) immediately sharing any new knowledge gained with the RADx-rad Data Coordinating Center (DCC), research community, and the general public via an expansion of the online dashboard that was pioneered by the team in collaboration with the City of Tempe, AZ. Previously developed, peer-reviewed strategies were leveraged for population-wide virus monitoring via reverse transcription real-time polymerase chain reaction (RT-qPCR), HTS, sequence analysis, and data communication originally developed for the parent award to quickly provide a data stream and scientific resource for managing the COVID-19 epidemic in the U.S. In Aim 1, a wastewater-based epidemiology (WBE) bioinformatics framework for SARS-CoV-2 was developed at the national, city, and intra-sewershed or neighborhood-level to produce RT-qPCR and SARS-CoV-2 RNA-seq data for studying the distribution of viral levels and genetic polymorphisms in the community. In Aim 2, a WBE bioinformatics framework for translating SARS-CoV-2 data from RT-qPCR and high-throughput sequencing into information for monitoring population health was be evaluated. Successful completion of this biomedical informatics project provided the U.S. with an early warning system for SARS-CoV-2 detection and a tracking aid for public health epidemiologists seeking to reduce morbidity and mortality from infectious diseases like COVID-19 in the U.S." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_33> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2901879> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_44> <http://schema.org/identifier> "phs002526" .
<https://okn.wobd.org/grant/1R01EB025022-01> <http://schema.org/endDate> "2020-06-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_87> <http://schema.org/name> "Improving the Response of Local Urban and Rural Communities to Disparities in COVID-19 Testing" .
<https://okn.wobd.org/grant/1TL1TR001871-01> <http://schema.org/startDate> "2016-07-18"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_186> <http://schema.org/url> "https://radxdatahub.nih.gov/study/186" .
<https://okn.wobd.org/person/albert_einstein_college_of_medicine> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_199> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_47> <http://schema.org/datePublished> "2024-09-04"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1U54CA132379-01A1> <http://schema.org/endDate> "2013-08-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_214> <http://schema.org/description> "This community-based participatory study implemented and refined a SARS-CoV-2 testing program that increased testing uptake, fostered the return to face-to- face classroom instruction, promoted school-based mitigation measures, and empowered students as change agents.\nGoal and Specific Aims: The primary goal of this study was to empower schools as community assets in the safe return of students to in-person learning by establishing them as sites of sustainable phased antigen testing programs and as health navigators for disseminating information regarding mitigation procedures such as vaccination. Specific aims: (1) to optimize and disseminate the unique school-based SARS-CoV-2 testing approach that trains and incorporates students to support testing and become change agents; (2) to evaluate the efficacy of this approach of testing uptake, infectivity, vaccine hesitancy, as well as attitudes and behaviors related to face-to-face instruction among populations enriched with NHPIs; (3) to compare outcomes, including sustainability and scalability, with other DOH pilot programs. Communities Engaged: Asian Americans, Children, Native Hawaiians, Older Adults, Pacific Islanders. Setting: Community Health Centers, Rural, School, Urban. State Served: Hawaii. Languages: English, Hawaiian, Ilokano, Tagalog, Chuukese, Marshallese. Community outreach: Print media, Internet/social media, in-person/online community presentations or meetings, focus groups and/or surveys, partnerships with community-based organizations." .
<https://okn.wobd.org/grant/1R01HD091218-01> <http://schema.org/funder> <https://ror.org/04byxyr05> .
<https://okn.wobd.org/grant/1P30CA045508-01> <http://schema.org/identifier> "1P30CA045508-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_182> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR002538-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_153> <http://schema.org/sameAs> "10.60773/6tcr-xa14" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_85> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://ror.org/00baak391> <http://schema.org/alternateName> "NHGRI" .
<https://okn.wobd.org/grant/1R01DA037628-01A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_177> <http://schema.org/dateModified> "2022-11-07"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/68" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/197" .
<http://purl.obolibrary.org/obo/MONDO_0019526> <http://schema.org/name> "erythema elevatum diutinum" .
<https://ror.org/01s5ya894> <http://schema.org/alternateName> "NIH/National Institute of Neurological Disorders and Stroke" .
<https://ror.org/03q21mh05> <http://schema.org/alternateName> "NCI" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_151> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_158> <http://schema.org/identifier> "phs002906" .
<https://ror.org/049v75w11> <http://schema.org/identifier> "https://ror.org/049v75w11" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_69> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_210> <http://schema.org/description> "The Georgia Center for Diabetes Translation Research Center (P30DK111024) proposed to leverage its interdisciplinary expertise (clinicians, implementation and behavioral scientists, public health, technology, and diabetes experts) and collaborations (community, academic, government, and health system partners) to rapidly scale a COVID-19 testing program for adults and children who are at high risk due to background metabolic disease (i.e., diabetes, obesity, or elevated risk of diabetes). The Rapid Optimization of COVID-19 Testing for People Affected by Diabetes program adapted, optimized, and iteratively evaluated and refined a testing and education strategy delivered through the network of Federally-Qualified Health Center (FQHC) partners. This study focused on Georgia, a national epicenter of diabetes, which is experiencing rapidly escalating COVID-19 cases, morbidity, and mortality. Yet, the state has not accelerated testing opportunities, leaving critically underserved subgroups at high-risk without access to testing. Building on technologies and innovations designed by the team, this study addressed access gaps, optimized resource allocation to meet high risk groups where it suits them best, and supported people at the time of and after their test results. Guided by the EPIS framework, the implementation program learned how to scale the strategy, combining approaches to reach high-risk groups through testing enhancement at FQHC partner sites and other community testing centers with a \"test your bubble\" approach to provide opportunities for all household members to get tested. To achieve this, geospatial analyses were conducted to identify localities of testing deserts within counties with high densities of people at risk for COVID-19 infection, hospitalization, and mortality (Aim 1; Exploration); engage community and clinic stakeholders to formatively understand what barriers and facilitators influence testing and what strategies are well-received by users (Aim 2; Preparation); develop models that provide real-time guidance on whom to test, where to test, and when to test (Aim 3; Preparation); and deploy and evaluate the program at testing site partners using rapid-cycle testing in a pre-post effectiveness-implementation type 2 hybrid study (Aim 4; Implementation). Sustainability will be measured through continuous quality improvement efforts (Aims 2, 4) and future research. Data from this study motivated further programs and studies of how to scale serological testing and vaccination (in the future) and has huge relevance for underserved areas of other states. The study evaluated this program in terms of its reach, effectiveness, adoption, implementation, and maintenance (REAIM). The team had extensive experience applying these transformative innovations to reach populations. The project team leveraged partnerships with the Georgia Department of Public Health, nationally-recognized expertise via the NIH-funded Rapid Acceleration of Diagnostics Validation Core at Emory University, National COVID-19 Resiliency Network at Morehouse's School of Medicine, and the Georgia Clinical and Translation Science Alliance's Community Engagement Program." .
<https://okn.wobd.org/person/joe_dimaggio_children_s_hospital> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/grant/1R01GM138385-01A1> <http://schema.org/name> "Annotation of cell types in human colon tissue using Boolean analysis" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/125" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01HL124209-01A1> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_151> <http://schema.org/dateCreated> "2022-04-19"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_109> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/grant/1R01AI107301-01> <http://schema.org/startDate> "2013-07-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01AI146165-01A1> <http://schema.org/startDate> "2020-01-13"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_208> <http://schema.org/date> "2024-03-04"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_128> <http://schema.org/description> "COVID-19, the disease caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), led to a global pandemic and exacerbated existing health inequities among vulnerable populations. Despite higher rates of COVID-19 in Black and Latinx individuals compared to White individuals, rates of testing in predominately non-White, low-income communities were significantly lower than in high-income areas. Strategies to increase COVID-19 testing rates in underserved populations were urgently needed. Self-testing, where individuals collect their own samples, was feasible for the detection of SARS-CoV-2. Self-testing increased testing convenience and privacy and was effectively leveraged to expand testing for other infections, such as HIV, in key populations across a broad spectrum of contexts. However, self-testing may be limited to those with access to health services, without reaching individuals underserved by existing medical systems. One promising approach to increase test uptake was the secondary distribution of self-testing kits, where an individual distributes tests to contacts in their social network and encourages them to self-test. A significant advantage of a secondary distribution strategy was that by decentralizing a health care process, individuals were more likely to access services if delivered by social network peers, rather than health professionals. In addition, secondary distribution enhanced contact tracing efforts, as individuals diagnosed with COVID-19 could have distributed self-tests to close contacts to identify additional cases. Given high levels of COVID-19 misinformation, stigma, and medical mistrust among vulnerable populations, this peer-driven test distribution strategy holds significant promise in increasing the reach of COVID-19 testing among underserved populations. In collaboration with the community-based partner, Public Health Management Corporation, the study conducted a 1:1 randomized trial with 1048 individuals cared for at Federally Qualified Health Centers to evaluate whether secondary distribution of SARS-CoV-2 self-tests increases test uptake compared with referrals among underserved populations in Philadelphia (Aim 1). The study will assess whether the secondary distribution of self-tests to close contacts among individuals with COVID-19 facilitates case detection (Aim 2). Additionally, the study will use a mixed methods strategy to identify key social, ethical, economic, and behavioral barriers and facilitators to secondary distribution to inform its future modifications, implementation, and scale-up (Aim 3). This study will engage in the relationship with community partners to reach underserved individuals with housing instability, immigrants, and those with significant medical comorbidities including HIV, viral hepatitis, and substance use disorders, in order to increase COVID-19 test uptake in these populations. As more rapid and user-friendly diagnostic tests emerged, this secondary distribution model may have become even more impactful. The project may establish a new paradigm for expanding COVID-19 testing and contact tracing." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_92> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://schema.org/parentOrganization> <http://www.w3.org/2000/01/rdf-schema#domain> <http://schema.org/Organization> .
<https://okn.wobd.org/grant/1F30DK123915-01> <http://schema.org/identifier> "1F30DK123915-01" .
<https://okn.wobd.org/grant/1K08AI130381-01A1> <http://schema.org/identifier> "1K08AI130381-01A1" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01HL140898-01> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/179" .
<https://okn.wobd.org/grant/1K01MH112436-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_135> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_54> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/12814> .
<https://okn.wobd.org/grant/1R35GM119850-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_166> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR002538-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_41> <http://schema.org/datePublished> "2022-01-26"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/indiana_university> <http://schema.org/name> "Indiana University" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_132> <http://schema.org/sameAs> <https://doi.org/10.60773/q2xk-0f98> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/206" .
<https://okn.wobd.org/grant/1K12HD000850-01> <http://schema.org/identifier> "1K12HD000850-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_47> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_139> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1U19AI135995-01> <http://schema.org/startDate> "2018-02-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_192> <http://schema.org/sameAs> <https://doi.org/10.60773/ewt6-jf83> .
<https://okn.wobd.org/grant/1R01ES021006-01A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/1U54CA132379-01A1> <http://schema.org/url> "https://reporter.nih.gov/project-details/7595292" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_182> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://ror.org/0493hgw16> <http://schema.org/identifier> "https://ror.org/0493hgw16" .
<https://okn.wobd.org/grant/1P30AI027763-01> <http://schema.org/name> "SAN FRANCISCO CENTER FOR AIDS RESEARCH" .
<https://okn.wobd.org/grant/1S10OD026929-01> <http://schema.org/startDate> "2019-08-21"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/2T32CA009140-11> <http://schema.org/funder> <https://ror.org/03q21mh05> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_141> <http://schema.org/name> "Organizations to Reduce, Advance, and Lead for Equity (ORALE) Against COVID-19" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_271> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/grant/1U24TR001608-01> <http://schema.org/funder> <https://ror.org/04pw6fb54> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_188> <http://schema.org/dateModified> "2022-11-28"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/4UH3OD023365-03> <http://schema.org/endDate> "2023-08-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_116> <http://schema.org/dateCreated> "2022-01-06"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_77> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01DA037628-01A1> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_200> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_175> <http://schema.org/identifier> "phs003032" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_69> <http://schema.org/date> "2024-09-04"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_88> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_45> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<http://schema.org/distribution> <http://www.w3.org/2000/01/rdf-schema#domain> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_47> <http://schema.org/dateModified> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_101> <http://schema.org/dateModified> "2024-04-10"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_93> <http://schema.org/name> "Communities Fighting COVID!" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_143> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR002345-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_111> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_54> <http://schema.org/sameAs> <https://doi.org/10.60773/7th6-st50> .
<http://purl.obolibrary.org/obo/MONDO_0000465> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_161> <http://schema.org/datePublished> "2024-08-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_40> <http://schema.org/description> "SAFER-COVID provided a set of self-management tools to consumers to track symptoms, test results, vaccine record, and environmental factors such as exposure to others. Consumers could choose to integrate data from wearables and EHR records for self-management. These data were used to enable multiple use cases such as return-to-work, activity risk assessment, and self-management within SAFER-COVID." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_42> <http://schema.org/date> "2022-12-09"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_123> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_51> <http://schema.org/identifier> "phs002527" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/210" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_126> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_127> <http://schema.org/identifier> "phs002759" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_123> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_180> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005240> .
<https://okn.wobd.org/grant/1P30AI027767-01> <http://schema.org/startDate> "1988-09-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_115> <http://schema.org/name> "Using Health Communication to Increase COVID-19 Testing and Vaccination in Underserved Populations" .
<https://okn.wobd.org/grant/1U24TR001608-01> <http://schema.org/endDate> "2023-06-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_189> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_44> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_133> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_141> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_55> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_66> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/q345-4e35> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_30> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_63> <http://schema.org/identifier> "phs002573" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_182> <http://schema.org/dateCreated> "2022-09-16"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_39> <http://schema.org/identifier> "phs002539" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_124> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_195> <http://schema.org/identifier> "phs003237" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_216> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/grant/1R35GM141535-01> <http://schema.org/identifier> "1R35GM141535-01" .
<https://okn.wobd.org/grant/1UL1TR001866-01> <http://schema.org/startDate> "2016-07-05"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_110> <http://schema.org/description> "This study was designed to develop aptamer-based electrochemical detection platform with SARS-CoV-2 as the model system to demonstrate performance. As this study was a technology development, the data generated did not involve human samples or human subjects. The project's goals were relayed as a data summary in the form of a presentation recapping the study journey and performance characteristics including: LOD, sensitivity, specificity, throughput, etc. of the minimal viable prototype platform developed as a result of this technology-based development project supported by the NIH." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_45> <http://schema.org/datePublished> "2024-04-11"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_145> <http://schema.org/funding> <https://okn.wobd.org/grant/1U54CA132379-01A1> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_72> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<http://purl.obolibrary.org/obo/MONDO_0010691> <http://schema.org/name> "Norrie disease" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/136" .
<https://okn.wobd.org/person/henry_ford_hospital_centers_detroit> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_175> <http://schema.org/datePublished> "2023-08-29"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_167> <http://schema.org/datePublished> "2023-08-29"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_126> <http://schema.org/datePublished> "2024-04-11"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_132> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/grant/1UL1TR001866-01> <http://schema.org/endDate> "2021-05-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_148> <http://schema.org/name> "COVID-19: Implementing Community-Based Approaches to Increase SARS-CoV-2 Testing Among an Underserved and Vulnerable Hispanic Population" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_203> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_119> <http://schema.org/datePublished> "2022-08-12"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_211> <http://schema.org/sameAs> "10.60773/wydm-qa91" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_65> <http://schema.org/url> "https://radxdatahub.nih.gov/study/65" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_71> <http://schema.org/author> <https://okn.wobd.org/person/nyu_grossman_school_of_medicine> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_212> <http://schema.org/description> "Community health workers (CHWs) played an essential role in addressing multi-level, community barriers to accessing COVID-19 information, testing, risk mitigation, and vaccination; however, little is known about how CHWs managed their roles in light of enormous social, community, and political challenges. In May 2020, the Orange County Health Equity COVID-19 Community- Academic Partnership formed with community-based health equity leaders and health equity academic partners to elevate the need for and guide local COVID-19 equity response and recovery initiatives. Equitable recovery must address larger civic engagement needs, and CHWs were essential to navigating rising anti-immigrant attitudes, and promoting civic engagement for census complete count and elections turnout in addition to COVID-19 education and chronic disease management." .
<https://okn.wobd.org/grant/1P30CA045508-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/3101830" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_203> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/grant/1R01AI140442-01> <http://schema.org/endDate> "2023-04-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/2UL1TR000427-06> <http://schema.org/startDate> "2007-09-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_71> <http://schema.org/funding> <https://okn.wobd.org/grant/1U19AI142733-01> .
<http://purl.obolibrary.org/obo/NCIT_C16880> <http://schema.org/name> "Mortality Rate" .
<https://okn.wobd.org/grant/1UM1AI106716-01> <http://schema.org/startDate> "2014-01-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_120> <http://schema.org/identifier> "phs002738" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_137> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/694009> .
<http://purl.obolibrary.org/obo/MONDO_0800175> <http://schema.org/name> "cardiogenic shock" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_173> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/nsxy-2f26> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_144> <http://schema.org/sameAs> <https://doi.org/10.60773/gvj9-b203> .
<https://okn.wobd.org/grant/1UL1TR002319-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9474341" .
<https://okn.wobd.org/person/university_of_texas_southwestern> <http://schema.org/name> "University of Texas Southwestern" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_207> <http://schema.org/url> "https://radxdatahub.nih.gov/study/207" .
<https://okn.wobd.org/person/morgan_state_university> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/person/renal_research_institute> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_113> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/nvkn-xv26> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_181> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/funding> <https://okn.wobd.org/grant/1ZIAAI001175-01> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/140" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_82> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/NCIT_C16880> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_55> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR002014-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_76> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_124> <http://schema.org/dateModified> "2023-08-24"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/5T32HL007227-10> <http://schema.org/endDate> "1986-06-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_204> <http://schema.org/dateCreated> "2023-07-27"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_210> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/grant/1R01GM120553-01> <http://schema.org/identifier> "1R01GM120553-01" .
<http://purl.obolibrary.org/obo/MONDO_0004992> <http://schema.org/name> "cancer" .
<https://okn.wobd.org/grant/1U54HL108460-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_188> <http://schema.org/datePublished> "2024-08-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_38> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/person/association_to_benefit_children> <http://schema.org/name> "Association to Benefit Children" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_134> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<http://purl.obolibrary.org/obo/MONDO_0004981> <http://schema.org/name> "atrial fibrillation" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/78" .
<https://okn.wobd.org/person/university_of_hawaii_at_manoa_and_university_of_guam> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/grant/1P30DK063720-01> <http://schema.org/endDate> "2008-01-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1P42ES010337-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/6079261" .
<https://okn.wobd.org/grant/1R01HL124209-01A1> <http://schema.org/url> "https://reporter.nih.gov/project-details/8840380" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/37" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_57> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/1986198> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_65> <http://schema.org/sameAs> "10.60773/vprs-gc97" .
<https://okn.wobd.org/grant/1R01GM120553-01> <http://schema.org/startDate> "2016-08-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_114> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_160> <http://schema.org/url> "https://radxdatahub.nih.gov/study/160" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_55> <http://schema.org/dateModified> "2024-01-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_173> <http://schema.org/datePublished> "2023-08-29"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/st_thomas_east_end_medical_center_st_thomas> <http://schema.org/name> "St. Thomas East End Medical Center (St. Thomas" .
<https://okn.wobd.org/grant/1DP1AI158186-01> <http://schema.org/name> "Unraveling the bat humoral immune response against zoonotic viruses to guide the design of next-generation therapeutics" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01CA234614-01A1> .
<https://okn.wobd.org/grant/5T32HL007227-10> <http://schema.org/startDate> "1976-07-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_126> <http://schema.org/dateCreated> "2022-01-12"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_59> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/694009> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_99> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/nxck-yd76> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_36> <http://schema.org/datePublished> "2024-04-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/2T32CA009140-11> <http://schema.org/identifier> "2T32CA009140-11" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_117> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/md02-q556> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_129> <http://schema.org/author> <https://okn.wobd.org/person/the_university_of_texas_health_science_center_at_tyler> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_54> <http://schema.org/author> <https://okn.wobd.org/person/clemson_university> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_60> <http://schema.org/author> <https://okn.wobd.org/person/pediatric_rheumatology_covid_consortium_prcc_hackensack_meridian> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_177> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_169> <http://schema.org/sameAs> "10.60773/y2n3-k036" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_211> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_69> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2901879> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_175> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_92> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_156> <http://schema.org/funding> <https://okn.wobd.org/grant/8UL1TR000042-07> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_96> <http://schema.org/funding> <https://okn.wobd.org/grant/9P30AI050410-04> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_44> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_210> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/ybnk-xd66> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_75> <http://schema.org/description> "West Virginia (WV) is rated by Becker's Hospital Review as the state with the sixth most vulnerable population to the novel coronavirus (SARS-CoV-2) while a second group at Wallethub, using three key domains (medical, housing, and financial), rates WV as the most vulnerable state to SARS-CoV-2 impact. Central to the state's extreme vulnerability is the high prevalence of obesity, cardiovascular disease including hypertension, chronic lung disease due to smoking and environmental exposure (e.g., mining), diabetes mellitus, and cancer. Additionally, WV is among the three states having the highest proportion of persons >age 65 years (20%). Through school and university closures in March 2020, along with shutdown of non-essential businesses, WV had relatively few COVID-19 cases and deaths until July 2020 when transmissibility (Rt) skyrocketed. Testing remains problematic in WV for multiple reasons, including inadequate testing supplies, accessibility to testing sites (given the rurality of the state and lack of widespread public transportation), shortages of personal protective equipment for staff, and lack of insurance coverage for surveillance testing and for uninsured persons. The West Virginia Clinical and Translational Science Institute (WVCTSI) submitted this application in partnership with multiple organizations with which they have existing collaborative relationships, including: 1) the WV Practice Based Research Network (PBRN), a 107 site primary care network spanning the state, 2) the WV Department of Health and Human Resources, 3) the WV National Guard, 4) West Virginia University (WVU) Health Sciences Center and College of Engineering, and 5) the Communities of Color. Vulnerable populations included individuals in rural communities and African American populations as well as those with comorbidities known to increase risk of severe COVID-19. Given the high prevalence of substance use disorder (SUD) in WV, a cross-cutting theme was ensuring persons with SUD are included in all proposed strategies to increase SARS-CoV-2 testing. COVID-19 testing disparities were addressed through achievement of the following specific aims, all of which use nucleic acid polymerase chain reaction testing on nasal or nasopharyngeal swabs: 1) Enhance COVID-19 testing among rural primary care offices located across WV, 2) Intensify COVID-19 testing through mobile vans in areas forecasted to experience a near-term increase in COVID-19 incidence, and 3) Increase COVID-19 testing in Black or African American communities through a dedicated mobile van and home testing. Evaluation of implemented strategies included assessing numbers of tests performed, uptake of home testing, satisfaction surveys, and structured interviews among Black or African Americans enrolled in the home testing study." .
<https://okn.wobd.org/grant/5T32GM007618-08> <http://schema.org/name> "MEDICAL SCIENTIST" .
<https://ror.org/00baak391> <http://schema.org/identifier> "https://ror.org/00baak391" .
<https://okn.wobd.org/grant/1UL1TR003142-01> <http://schema.org/identifier> "1UL1TR003142-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_137> <http://schema.org/sameAs> <https://doi.org/10.60773/8yrw-qt94> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_59> <http://schema.org/sameAs> <https://doi.org/10.60773/wd0m-eh53> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_109> <http://schema.org/funding> <https://okn.wobd.org/grant/75N93021C00016-0-9999-4> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/60" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_54> <http://schema.org/author> <https://okn.wobd.org/person/university_of_hawaii> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_194> <http://schema.org/sameAs> <https://doi.org/10.60773/z740-hc64> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_190> <http://schema.org/date> "2024-04-10"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_139> <http://schema.org/url> "https://radxdatahub.nih.gov/study/139" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_31> <http://schema.org/name> "NIH Digital Health Solutions for COVID-19: Clear2Go - A Digital Identity Wallet for Health Status" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_145> <http://schema.org/sameAs> <https://doi.org/10.60773/swwm-cp96> .
<https://okn.wobd.org/grant/1T32AI007291-01A1> <http://schema.org/url> "https://reporter.nih.gov/project-details/3531135" .
<http://schema.org/healthCondition> <http://www.w3.org/2000/01/rdf-schema#domain> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_78> <http://schema.org/description> "The COVID-19 pandemic disproportionately impacts members of under-represented minority (URM) communities. Unfortunately, URM and other vulnerable communities remain profoundly under-tested. As such, new approaches are needed to disseminate and accomplish testing that could be generalized across the US. New Jersey can serve as a unique, virtual testing laboratory, ranking 11th in the US in population, 2nd in the US (after NY) in the per capita rate of COVID-19 deaths, and 5th in total cases, while representing a highly diverse state with substantial Black and Latinx minority populations. Rutgers has assembled cohorts of healthcare workers (HCWs) to monitor the spread of COVID-19 and to enroll subjects for clinical and vaccine trials. While building these cohorts, it was recognized that many URMs serve as HCWs or personal care aides often in lower-income roles, and these workers were more often infected compared with those with higher income occupations. Given these observations, it is posited that HCWs in occupations at lower incomes would facilitate testing among their households and their communities. In a sense, these HCWs served as ambassadors to catalyze community-based COVID-19 testing. NJ HEROES TOO (New Jersey Healthcare Essential WoRker Outreach and Education Study - Testing Overlooked Occupations) proposed to approach URM HCWs who have been identified as index individuals who will act as ambassadors to help expand testing in their households and extended networks. In Aim 1, an innovative, HCW-centric outreach intervention strategy was (co-)designed, developed, and implemented to engage Black and Latinx minority communities. Community perceptions about COVID-19 testing, treatment, and vaccination were explored to design COVID-19 testing materials and messages that were culturally tailored to address concerns of Black and Latinx minority communities. In Aim 2, a mixed methods study was conducted to evaluate the effectiveness and cost of: (1) the HCW-focused outreach intervention strategy versus (2) standard community engaged outreach, working with community based organizations (CBOs). Contextual factors (individual, family, and community) affecting COVID-19 testing implementation outcomes and scalability were explored. The primary outcome was uptake of COVID-19 testing in the targeted populations. The novel Rutgers Clinical Genomics Laboratory/RUCDR saliva test, the first FDA-authorized diagnostic test using saliva to detect SARS-CoV-2 for non-invasive, home based self-testing was used. The hypothesis was that a participatory outreach strategy approach focused on identified index HCWs would mobilize quicker uptake of testing within community settings than best-practice CBO recruitment approaches. It was also hypothesized that recruitment through index HCWs would be more successful for hard to reach participants compared to a traditional CBO approach. The strategy focusing on HCWs could easily be expanded to other front-line and essential workers, making the strategy generalizable and sustainable." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_45> <http://schema.org/sameAs> <https://doi.org/10.60773/c65t-e596> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_47> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2901879> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_60> <http://schema.org/description> "This study's objective was to understand which children are at highest risk for having severe consequences from SARS-CoV-2 infection. The study used clinical, epidemiologic, and sociodemographic data alongside specific biomarkers and created machine learning models designed to predict severe consequences. In order to accomplish this, a network of various networks and sites were established to examine subjects who have previously had infections or complications and subjects with active infections or complications, through both prospective enrollment and collection of data and biospecimens as well as through retrospective analyses of diverse datasets." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_207> <http://schema.org/sameAs> "10.60773/yry0-5j59" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_116> <http://schema.org/sameAs> "10.60773/pkzs-t351" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_33> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01DK113642-01A1> <http://schema.org/identifier> "1R01DK113642-01A1" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_177> <http://schema.org/author> <https://okn.wobd.org/person/ocapica> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_69> <http://schema.org/sameAs> "10.60773/dnv2-mx89" .
<https://okn.wobd.org/grant/1R56HL149881-01A1> <http://schema.org/identifier> "1R56HL149881-01A1" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_133> <http://schema.org/author> <https://okn.wobd.org/person/henry_ford_hospital_centers_detroit> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_71> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/jcap-3849> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_221> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/person/and_william_and_mary_college> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_196> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://ror.org/049v75w11> <http://schema.org/alternateName> "NIA" .
<https://okn.wobd.org/grant/1R01HL149450-01A1> <http://schema.org/url> "https://reporter.nih.gov/project-details/9839149" .
<https://okn.wobd.org/grant/1R01HD106120-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/122" .
<https://okn.wobd.org/grant/1UL1TR002319-01> <http://schema.org/name> "Institute of Translational Health Sciences" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_183> <http://schema.org/description> "The purpose of this proposal was to identify individual, community (population) and structural factors associated with lower rates of COVID-19 testing in Northern New England (NNE), with a focus on underserved and vulnerable populations. This study included several COVID-19 medically and/or socially vulnerable populations: communities with high levels of social vulnerability; community-dwelling older adults; individuals with medical comorbidities known to increase risk of severe COVID-19 and, particularly, rural and remote communities. Analytically, the study qualitatively estimated individual, population and structural factors associated with higher or lower probability of having been tested for COVID-19 by combining comprehensive all-payer claims data across two states with state-level COVID-19 testing data and the CDC vulnerable community index. This study also assessed the geospatial distribution of disparities in COVID-19 testing in NNE using geographic information system methods to examine factors like testing center density and distance on testing rates. The study exploited differences in structure between Vermont and Maine to identify system level factors, including provider accessibility, testing availability and provider payment rules. The key outcomes were COVID-19 testing, hospitalizations and excess mortality among underserved and vulnerable populations in NNE. This study augmented the quantitative analysis with focus groups to identify additional barriers to testing. This study conducted multiple focus groups with individuals from vulnerable populations to identify barriers to COVID-19 testing. Once the individual, community (population) and structural factors that create barriers to COVID-19 testing and excess mortality were identified, potential interventions were tested in two different ways, First, the study developed and deployed a Discrete Choice Experiment (DCE) both in vulnerable communities in NNE and in a nationally representative sample of rural adults to test optimal strategies to increase testing using hypothetical scenarios. Second, the study tested the effect of targeted communication using a rural communication network using optimal communication strategies to facilitate increased testing and test if the communications change individual behavior and reduce health disparities. This study was conducted in partnership with the Department of Health in both Vermont and Maine and numerous community partners. This mixed methods project combined data from qualitative and quantitative analyses to identify barriers to COVID-19 testing with a focus on individuals and communities with high social vulnerability. Approaches to reduce testing disparities using experimental and interventional data were then tested." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_191> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR002538-01> .
<https://okn.wobd.org/grant/1UL1TR002378-01> <http://schema.org/identifier> "1UL1TR002378-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_113> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/142" .
<https://okn.wobd.org/grant/1P30AI027767-01> <http://schema.org/identifier> "1P30AI027767-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_40> <http://schema.org/name> "NIH Digital Health Solutions for COVID-19: SAFER-COVID - Integration of Testing and Digital Health" .
<https://ror.org/01s5ya894> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Organization> .
<https://okn.wobd.org/person/division_of_cardiology> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_202> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/16th_street_community_health_ctr> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_133> <http://schema.org/dateCreated> "2022-01-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_66> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01AG066749-01> .
<https://okn.wobd.org/person/sognef_inc> <http://schema.org/name> "Sognef Inc" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_196> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_59> <http://schema.org/url> "https://radxdatahub.nih.gov/study/59" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_38> <http://schema.org/author> <https://okn.wobd.org/person/this_was_a_decentralized_study_run_on_evidation_s_achievement_platform> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_28> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/54ae-xy13> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_77> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01AI140442-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_135> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/grant/1R01NS076465-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/1K01MH112436-01> <http://schema.org/endDate> "2022-04-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_173> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_201> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/grant/1UL1TR001085-01> <http://schema.org/startDate> "2013-09-26"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_100> <http://schema.org/description> "The epidemic of novel coronavirus disease 2019 (COVID-19) has caused an unprecedented public health crisis in the United States. African Americans (AA) have been disproportionately impacted, as systemic inequities have contributed to increased exposure and vulnerability to COVID-19. Evidence suggests that AAs are delaying testing and care for COVID-19, which increases risk of transmission and poor outcomes. In Chicago, segregated AA neighborhoods have experienced some of the highest COVID-19 mortality rates in the city, yet large portions of these neighborhoods remain testing deserts. Providing trusted, accessible, community-based testing in underserved AA communities is critical to ensuring that individuals receive an early diagnosis, thereby reducing the risk of further transmission and improving clinical outcomes. This study leveraged the Alive Church Network (ACN), a long-standing, community-driven coalition of African American pastors and public health researchers that was developed as a sustainable infrastructure to address health inequities in chronic disease in segregated AA neighborhoods in Chicago. The ACN was designed to address lack of access to health care, cultural insensitivity, and lack of trust, which are the root cause of disparities in chronic disease as well as infectious disease, including COVID-19. The project utilized the ACN infrastructure to create a network of church-based testing sites in a segregated and underserved AA neighborhood in Chicago that provided COVID-19 testing and education as well as linkage to healthcare and social resources. Thirteen ACN pastors who served predominantly AA congregations in the West Side of Chicago formed a coalition to promote community-wide COVID-19 testing in local churches. Residents of all ages received COVID-19 education and free SARS-CoV- 2 PCR testing with rapid turn-around of results from an on-site clinical team, as well as connection to local resources to address social needs, including food, housing, and medical care. The specific aims of this study were: (1) Conduct a rapid needs assessment to identify barriers to and facilitators of COVID-19 testing to inform a tailored outreach and intervention strategy to increase COVID-19 testing among high-risk AAs; (2 – Primary Aim) Evaluate the impact of the ACN COVID-19 testing intervention on uptake of testing among residents of target high poverty AA neighborhoods in Chicago; (3) Use the RE-AIM framework to assess the reach, adoption, implementation, maintenance and cost of the ACN COVID-19 testing intervention. The primary analysis used an interrupted time series framework, which is a quasi-experimental approach, to test whether the ACN testing intervention was successful at increasing uptake of testing by at least 20% among residents in the target neighborhoods. Completion of these aims provided crucial evidence about the public health utility of this approach and informed efforts to scale this intervention to increase testing uptake in other vulnerable urban areas in Chicago and nationally." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_214> <http://schema.org/sameAs> "10.60773/1qf8-w396" .
<https://okn.wobd.org/grant/1R01AI121250-01A1> <http://schema.org/startDate> "2016-06-08"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1T32CA203702-01A1> <http://schema.org/url> "https://reporter.nih.gov/project-details/9280411" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_185> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/sameAs> "10.60773/tca1-nb16" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_60> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_81> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_111> <http://schema.org/dateModified> "2024-04-10"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_219> <http://schema.org/name> "Project IMPROVE: Implementing Community-Engaged Intervention Research to Increase Rapid SARS-CoV-2 Self-Testing Among Diverse Underserved and Vulnerable Asian Americans" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_128> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_35> <http://schema.org/identifier> "phs002534" .
<https://okn.wobd.org/grant/1R01CA234614-01A1> <http://schema.org/endDate> "2024-07-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://ror.org/04byxyr05> <http://schema.org/alternateName> "Eunice Kennedy Shriver National Institute of Child Health & Human Development" .
<https://okn.wobd.org/person/kids_frankford_friends> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_148> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_172> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_78> <http://schema.org/name> "NJ HEROES TOO: New Jersey Healthcare Essential Worker Outreach and Education Study Testing Overlooked Occupations" .
<http://purl.obolibrary.org/obo/NCIT_C16880> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/grant/1R01AI123538-01A1> <http://schema.org/endDate> "2021-12-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_202> <http://schema.org/author> <https://okn.wobd.org/person/african_women_s_cancer_awareness_association_awcaa> .
<https://okn.wobd.org/person/inc_and_university_of_illinois_hospital_and_health_system> <http://schema.org/name> "Inc. and University of Illinois Hospital and Health System" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_60> <http://schema.org/funding> <https://okn.wobd.org/grant/1P30ES005022-01> .
<https://ror.org/012pb6c26> <http://schema.org/alternateName> "NIH/National Heart, Lung and Blood Institute" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/44" .
<https://okn.wobd.org/grant/1R01DA013806-01> <http://schema.org/endDate> "2005-07-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_210> <http://schema.org/dateCreated> "2023-08-02"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/inc> <http://schema.org/name> "Inc" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_178> <http://schema.org/identifier> "phs003026" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_67> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/organization/national_heart_lung_and_blood_institute> <http://schema.org/name> "National Heart Lung and Blood Institute" .
<https://okn.wobd.org/grant/1R01AI151059-01> <http://schema.org/name> "Metagenomic profiling of urinary cell-free DNA to monitor urinary tract infection after kidney transplantation" .
<https://okn.wobd.org/grant/1P30ES005022-01> <http://schema.org/endDate> "1993-08-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_80> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/5P30CA008748-20> <http://schema.org/name> "CANCER CENTER SUPPORT GRANT" .
<https://okn.wobd.org/grant/1P01CA214274-01A1> <http://schema.org/name> "Mechanism-Based Targeting of Mantle Cell Lymphoma" .
<https://okn.wobd.org/grant/1UL1TR000460-01A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/1P30AI094189-01A1> <http://schema.org/url> "https://reporter.nih.gov/project-details/8281943" .
<https://okn.wobd.org/grant/1F30DK123915-01> <http://schema.org/name> "The Role of RFX6 in Type 1 Diabetes" .
<https://okn.wobd.org/grant/1K12HD000850-01> <http://schema.org/endDate> "1991-11-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R21AI129851-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9277824" .
<https://okn.wobd.org/grant/1P30AI064518-01> <http://schema.org/funder> <https://ror.org/043z4tv69> .
<https://okn.wobd.org/grant/1P30AI027763-01> <http://schema.org/identifier> "1P30AI027763-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_28> <http://schema.org/author> <https://okn.wobd.org/person/umass_chan_medical_school_and_northwestern_university> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_52> <http://schema.org/identifier> "phs002542" .
<https://okn.wobd.org/grant/1P30DK045735-01> <http://schema.org/funder> <https://ror.org/00adh9b73> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_90> <http://schema.org/sameAs> <https://doi.org/10.60773/pz40-d968> .
<https://okn.wobd.org/grant/8P20GM103395-12> <http://schema.org/startDate> "2001-09-24"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_210> <http://schema.org/funding> <https://okn.wobd.org/grant/1P30DK045735-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_119> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/grant/1R01DE026471-01A1> <http://schema.org/startDate> "2017-07-03"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/children_s_national_health_system> <http://schema.org/name> "Children's National Health System" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_53> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_86> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_211> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/person/st_louis> <http://schema.org/name> "St. Louis" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_195> <http://schema.org/sameAs> "10.60773/0va3-6933" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_39> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<http://schema.org/description> <http://www.w3.org/2000/01/rdf-schema#domain> <http://schema.org/Thing> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_147> <http://schema.org/funding> <https://okn.wobd.org/grant/1U54CA156732-01> .
<https://okn.wobd.org/grant/1UL1TR002345-01> <http://schema.org/endDate> "2022-02-28"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_30> <http://schema.org/url> "https://radxdatahub.nih.gov/study/30" .
<https://ror.org/006zn3t30> <http://schema.org/name> "National Institute of Arthritis and Musculoskeletal and Skin Diseases" .
<https://okn.wobd.org/grant/1P30AI064518-01> <http://schema.org/startDate> "2005-07-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_163> <http://schema.org/identifier> "phs002946" .
<https://okn.wobd.org/grant/75N93021C00015-0-9999-2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/1ZIAAI001222-01> <http://schema.org/funder> <https://ror.org/043z4tv69> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_162> <http://schema.org/sameAs> "10.60773/277p-e595" .
<https://okn.wobd.org/grant/1R01MD016593-01> <http://schema.org/identifier> "1R01MD016593-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_55> <http://schema.org/name> "Severity Predictors Using Immunology and Transcriptomics in Saliva Using Multi Neural Network Intelligence in SARS-CoV2 Infection in Children (SPITS MISC)" .
<https://okn.wobd.org/person/mercy_hospital_st_louis> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/grant/1U01HG010961-01> <http://schema.org/identifier> "1U01HG010961-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_211> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_55> <http://schema.org/author> <https://okn.wobd.org/person/upmc_children_s_hospital_of_pittsburgh_university_of_pittsburgh> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_82> <http://schema.org/dateModified> "2024-04-10"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1T32EB028092-01A1> <http://schema.org/url> "https://reporter.nih.gov/project-details/9936810" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_205> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_175> <http://schema.org/author> <https://okn.wobd.org/person/albany_area_primary_health_care> .
<https://okn.wobd.org/person/miller_children_s_hospital> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_34> <http://schema.org/dateModified> "2024-04-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://schema.org/sameAs> <http://www.w3.org/2000/01/rdf-schema#domain> <http://schema.org/Thing> .
<https://ror.org/01y3zfr79> <http://schema.org/name> "National Institute of Nursing Research" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_145> <http://schema.org/identifier> "phs002869" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_179> <http://schema.org/datePublished> "2023-08-29"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_41> <http://schema.org/date> "2023-09-27"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1UL1TR002541-01> <http://schema.org/endDate> "2023-04-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_187> <http://schema.org/description> "Through the RADx-UP Phase I study, correlates of point-of-care COVID-19 testing (POCT) uptake at baseline and reuptake at a 3-month follow-up visit among WWUD (N=250) in Baltimore, MD were examined. In this Phase II, C2SPARC study, this study examined POCT uptake in both research and service delivery contexts. Specifically, the study proposed adding a 6-month visit (C2SPARC visit) among the CARE cohort in order to examine trends in POCT uptake over time. Secondly, in partnership with the SPARC Center, a leading harm reduction organization that serves WWUD, the study proposed designing and implementing POCT on their nighttime mobile outreach van that provides harm reduction supplies (e.g., condoms, naloxone, syringes), basic necessities (e.g., food, clothing), and trauma informed micro-counseling. C2SPARC leveraged long-term community partnerships (see letters of support), an existing Community Advisory Board (CAB), and a well-established research infrastructure. The study employed Andersen's Behavioral Model10 (Aim 1), PRISM (Practical, Robust, Implementation, and Sustainability Model)11 (Aim 2), and the Theoretical Framework of Acceptability (TFA)12 (Aim 3) to meet the following aims. 1. To examine predisposing (e.g., social - homelessness, food insecurity; individual - drug use, race/ ethnicity, health beliefs) and enabling (prior COVID-19 testing, vaccine uptake) factors that predict uptake of POCT over a six-month period in WWUD (N=250) in Baltimore, Maryland. 2. To collaborate with the SPARC Center to develop and implement POCT on their mobile outreach van that primarily serves WWUD in Baltimore City, Maryland. 3. To examine the feasibility (e.g., testing uptake) and acceptability (e.g., participant burden, testing self-efficacy) of mobile POCT among WWUD (N=250) who are clients of SPARC outreach. Through Aim 1, the study examined a range of predisposing (social and individual) and enabling factors that predict POCT uptake over a six-month period. By leveraging Phase I's existing cohort and data collection, the C2SPARC visit doubles the follow-up length, allowing for longitudinal data analysis. Predictors of POCT uptake are shaped by Andersen's Behavioral framework and informed by the extensive prior research with the study population. The C2SPARC visit leveraged the existing Phase I CARE research infrastructure, which is built on 15 years of community-engaged field research among WWUD and female sex workers (FSW) who use drugs. This additional data collection wave deepened the understanding of the drivers of COVID-19 testing uptake among this highly marginalized population in the context of a rapidly evolving testing and vaccine landscape. Through Aim 2, the study investigators partnered with the SPARC Center to develop, pilot, and implement a POCT service two nights per week on their outreach van (see Preliminary Studies). This implementation process was informed by Aim 1 findings and by formative qualitative data collection including key informant interviews with outreach staff (N=5) and systematic observations (N=6) of the SPARC outreach van, guided by the PRISM framework. Through Aim 3, the study investigators assessed the program feasibility (i.e., testing uptake) of POCT on SPARC outreach through analyzing SPARC outreach administrative data. The study employed the TFA framework to measure acceptability of COVID-19 testing via a brief anonymous survey administered to SPARC clients (N=250) when POCT is offered. C2SPARC was innovative in leveraging the Phase I cohort in examining drivers of POCT uptake longitudinally, which then informed the implementation of POCT on a highly subscribed mobile outreach van. Further, situating POCT in the context of existing relationships with trusted service providers was urgently needed. The study's impact and sustainability was further enhanced by the engagement of a seasoned CAB. C2SPARC was responsive to NOT-OD-21-103 in that it expanded the RADx-UP Phase I study to build enhanced point-of-care infrastructures that can be sustained beyond the current pandemic. Study results were quickly disseminated to the target population, service providers, and policy makers through products (i.e., fact sheets, manuscripts) and events (i.e., community forums) to inform community-based testing and eventual vaccination programs targeting WWUD and similarly marginalized populations." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_76> <http://schema.org/description> "This study employed a community-based participatory research approach guided by the Social Ecological Model to target testing strategies that had the greatest impact for the Latinx and Marshallese communities in Northwest Arkansas. The specific aims were: Aim 1: leverage and fully engage long-standing community-based partnerships to increase COVID-19 testing and prepare for future vaccination trials; Aim 2: implement and evaluate access and uptake strategies of two community-driven COVID-19 testing approaches to understand effectiveness and impact for vulnerable populations; and Aim 3: fully collaborate with the RADx-UP CDCC and other RADx-UP sites. These study aims were built directly on the collaborative needs assessment and recommendations from the Community and Scientific Advisory Board." .
<https://okn.wobd.org/person/wayne_state_university> <http://schema.org/name> "Wayne State University" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_215> <http://schema.org/datePublished> "2024-03-04"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1P01AI118688-01A1> <http://schema.org/identifier> "1P01AI118688-01A1" .
<https://okn.wobd.org/person/nyu_grossman_school_of_medicine> <http://schema.org/name> "NYU Grossman School of Medicine" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_183> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_156> <http://schema.org/name> "ReSET: Restarting Safe Education and Testing for Children with Medical Complexity" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_116> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/pkzs-t351> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_114> <http://schema.org/sameAs> <https://doi.org/10.60773/ws7v-2r18> .
<https://okn.wobd.org/grant/1F30DK123915-01> <http://schema.org/startDate> "2019-09-05"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1U54HL108460-01> <http://schema.org/funder> <https://ror.org/012pb6c26> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_101> <http://schema.org/name> "A Community-Led Approach to Enhance COVID-19 Testing Among Vulnerable Latinos" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_144> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://ror.org/04xeg9z08> <http://schema.org/alternateName> "Mental Health NIMH" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_179> <http://schema.org/url> "https://radxdatahub.nih.gov/study/179" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_158> <http://schema.org/dateCreated> "2022-05-06"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_110> <http://schema.org/dateModified> "2022-01-05"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01AI121250-01A1> <http://schema.org/url> "https://reporter.nih.gov/project-details/9175786" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_62> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/grant/1R01ES021006-01A1> <http://schema.org/startDate> "2012-08-16"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_84> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://ror.org/00fq5cm18> <http://schema.org/identifier> "https://ror.org/00fq5cm18" .
<https://okn.wobd.org/grant/1P30AI042853-01> <http://schema.org/startDate> "1998-09-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01AI153044-01A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_185> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/s244-bp16> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_140> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_93> <http://schema.org/url> "https://radxdatahub.nih.gov/study/93" .
<https://okn.wobd.org/person/university_of_texas_southwestern> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01AI141630-01A1> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/221" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_70> <http://schema.org/funding> <https://okn.wobd.org/grant/75N93021C00015-0-9999-2> .
<https://okn.wobd.org/grant/1R01MH113094-01> <http://schema.org/funder> <https://ror.org/00fj8a872> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_163> <http://schema.org/dateCreated> "2022-06-10"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_122> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005550> .
<https://okn.wobd.org/person/yale_university> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_186> <http://schema.org/identifier> "phs003083" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_129> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/NCIT_C16880> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/86" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_220> <http://schema.org/description> "This project aimed to identify the facilitators and barriers to COVID-19 and Influenza vaccine uptake, as well as the factors influencing potential participation in future intervention research among underserved adult populations in San Diego county. This study originally included an intervention component which was removed due to several major logistical, and participant challenges in order to continue to enroll participants to complete the study survey and gain valuable information about the factors that can facilitate recruitment of study participants into future interventions studies. For example, questions were added to the survey regarding reasons why potential participants would or not participate in future interventions. This information will inform the development of future vaccination intervention studies." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_177> <http://schema.org/url> "https://radxdatahub.nih.gov/study/177" .
<https://okn.wobd.org/grant/1S10OD026929-01> <http://schema.org/identifier> "1S10OD026929-01" .
<https://okn.wobd.org/grant/1UL1TR001866-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_206> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_29> <http://schema.org/name> "DNA Star SARS-CoV-2 Rapid Test" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_27> <http://schema.org/description> "When faced with a pandemic such as SARS-Coronavirus-2 (SARS-CoV-2), the virus responsible for COVID-19, timely risk assessment and action are required to prevent public health impacts to entire communities. Because infected individuals may not have access to testing or may be asymptomatic and contraction can mean death, a proactive approach to detect the virus is needed to develop public health strategy to mitigate virus spread. Recent studies have detected SARS-CoV-2 genetic material in sewage and demonstrate a positive correlation between the concentration of viral markers and reported cases. The Coronavirus Sewershed Surveillance Project (CSSP) was a collaborative effort to monitor sewersheds for genetic indicators of COVID-19 in wastewater to provide additional, population-level information about virus circulation that is not captured by clinical testing. Untreated wastewater (influent) samples were screened weekly from select sewersheds and targeted micro-sewersheds for detection and \"true\" prevalence. Congregate facilities provided unique opportunities for study because they are controlled populations where the precise number and timing of infections can be defined. Detailed monitoring of congregate facilities will be utilized to define the precise per patient contribution and longevity of SARS-CoV-2 RNA to wastewater by 1) increasing the number of facilities tested, 2) altering the frequency at which samples are collected, and 3) comparing sewershed data collected to clinical patient case data. Although SARS-CoV-2 contribution/patient varies among communities, there have been clear outlier communities that produce little or no genetic material in the wastewater despite the presence of known outbreaks. The reason for this lost signal is not known, so factors that contribute to SARS-CoV-2 signal suppression in wastewater were defined by 1) defining the physical nature of the genetic material in the sewershed to better understand the types of factors that could suppress signal, 2) expanding testing within sewersheds with suppressed signal as well as from additional facilities with similar population and industry demographics as those with suppressed signal to narrow the sources of signal suppression, 3) performing exhaustive chemical characterization comparing wastewater from locations that are suppressed to those that are not to identify candidate compounds that could be causing suppression, and 4) obtaining or generating candidate inhibitors and testing their ability to suppress signal from viral genetic material in a controlled experimental setting. The utility of using wastewater RNA to determine what viral variants are circulating in a community was further examined. Towards this the research team: 1) evaluated different methods for characterizing genetic material in wastewater such as variant specific qPCR and targeted high throughput sequencing, 2) developed methods for evaluating existing and emerging variants from wastewater, and 3) designed platforms for communicating wastewater variant results to the public." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_167> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2901879> .
<http://schema.org/date> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01AI123538-01A1> <http://schema.org/funder> <https://ror.org/043z4tv69> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_77> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_116> <http://schema.org/url> "https://radxdatahub.nih.gov/study/116" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_114> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/ws7v-2r18> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_66> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_62> <http://schema.org/sameAs> "10.60773/qggp-bp06" .
<https://okn.wobd.org/grant/1R01HG011274-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/10034316" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_188> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/person/ucsf_benioff_children_s_hospital_oakland_san_francisco> <http://schema.org/name> "UCSF Benioff Children's Hospital-Oakland/San Francisco" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_112> <http://schema.org/funding> <https://okn.wobd.org/grant/1U54GM115516-01A1> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_29> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/vjdg-pt27> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_143> <http://schema.org/sameAs> "10.60773/q8pd-9n90" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/author> <https://okn.wobd.org/person/division_of_cardiology> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_212> <http://schema.org/url> "https://radxdatahub.nih.gov/study/212" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_75> <http://schema.org/name> "Developing Novel Strategies to Increase COVID-19 Testing Among Underserved and Vulnerable Populations in West Virginia Through Community and State Partnerships" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/name> "Characterization of Multisystem Inflammatory Syndrome in Children and Its Relationship to Kawasaki Disease" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_142> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_153> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_188> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_271> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_179> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_58> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/gr4a-3m47> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_60> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100163> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_122> <http://schema.org/sameAs> <https://doi.org/10.60773/bxqp-9045> .
<https://www.uniprot.org/taxonomy/2901879> <http://schema.org/name> "Severe acute respiratory syndrome coronavirus" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_274> <http://schema.org/identifier> "phs003687" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_83> <http://schema.org/author> <https://okn.wobd.org/person/university_of_arkansas_for_medical_sciences> .
<https://okn.wobd.org/grant/1R01GM089784-01A1> <http://schema.org/identifier> "1R01GM089784-01A1" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_204> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_206> <http://schema.org/author> <https://okn.wobd.org/person/university_of_illinois_urbana_champaign_and_northwestern_university> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_82> <http://schema.org/sameAs> <https://doi.org/10.60773/wbd9-yd79> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_108> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_108> <http://schema.org/dateCreated> "2022-01-06"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/8UL1TR000042-07> <http://schema.org/name> "The University of Rochester Clinical and Translational Science Institute" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_150> <http://schema.org/funding> <https://okn.wobd.org/grant/3P50HD103525-01S1> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_188> <http://schema.org/identifier> "phs003124" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_48> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_177> <http://schema.org/author> <https://okn.wobd.org/person/thai_cdc> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_96> <http://schema.org/sameAs> <https://doi.org/10.60773/yrkh-gy81> .
<https://okn.wobd.org/grant/1U54GM104940-01> <http://schema.org/name> "Louisiana Clinical and Translational Science Center" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_188> <http://schema.org/sameAs> "10.60773/yn52-cp83" .
<https://okn.wobd.org/grant/1R01DK107585-01A1> <http://schema.org/startDate> "2016-09-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/umass_chan_medical_school> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/grant/1R01DK107585-01A1> <http://schema.org/identifier> "1R01DK107585-01A1" .
<https://okn.wobd.org/grant/1U54CA132379-01A1> <http://schema.org/name> "Comprehensive SDSU-UCSD Cancer Center Partnership (2 of 2)" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/author> <https://okn.wobd.org/person/university_of_nebraska_medical_center> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_204> <http://schema.org/datePublished> "2024-03-04"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01AI163029-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/10278180" .
<https://okn.wobd.org/grant/1R01GM089784-01A1> <http://schema.org/url> "https://reporter.nih.gov/project-details/7897045" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_213> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_108> <http://schema.org/date> "2024-01-18"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_99> <http://schema.org/datePublished> "2023-08-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_99> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005550> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/70" .
<https://okn.wobd.org/grant/1U01AI069918-01> <http://schema.org/funder> <https://ror.org/043z4tv69> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_176> <http://schema.org/author> <https://okn.wobd.org/person/arch_creek_elementary> .
<https://okn.wobd.org/person/unc_chapel_hill_note_data_are_only_collected_and_managed_by_jhu> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/220" .
<https://okn.wobd.org/grant/2T32CA009140-11> <http://schema.org/url> "https://reporter.nih.gov/project-details/3532581" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_111> <http://schema.org/url> "https://radxdatahub.nih.gov/study/111" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_195> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/person/mercy_hospital_st_louis> <http://schema.org/name> "Mercy Hospital St. Louis" .
<https://okn.wobd.org/person/kapi_olani_medical_specialists> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_160> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_218> <http://schema.org/identifier> "phs003515" .
<https://okn.wobd.org/grant/1R01HG011274-01> <http://schema.org/identifier> "1R01HG011274-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_43> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/wyqe-xw03> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_132> <http://schema.org/sameAs> "10.60773/q2xk-0f98" .
<http://purl.obolibrary.org/obo/MONDO_0005044> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_82> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_111> <http://schema.org/description> "The rapid spread of the SARS-CoV-2 virus has greatly impacted underserved populations. This project aimed to understand social and behavioral determinants of COVID-19 testing and variations within sub-groups of this population. In partnership with the largest federally qualified health center in the United States, a survey was administered and a randomized experiment was conducted on 2,160 individuals (540 families) to evaluate the effectiveness of risk-based messaging and incentives that promote repeated testing for SARS-CoV-2 antibodies. In a 2x2 (Messaging x Incentive) factorial experiment, participants were randomized to receive personalized messaging promoting repeated testing. Messaging focused upon either (1a) household risk or (1b) personal risk of COVID-19. They were also randomly assigned to an incentive condition that (2a) insures against losing baseline rewards for initial testing, or (2b) that enters them into a bonus lottery with a small chance to win $150 if they complete both tests. Both the insurance and lottery conditions carry the same incentive costs. Previous work in similar populations demonstrated that adherence to planned health behaviors is higher with insurance-based incentives than cash payments of equal value. This experiment compared insurance-based incentives to lottery incentives that have been shown to be effective in multiple contexts. Finally, whether social and behavioral determinants of health result in heterogeneous treatment effects that can inform customization of incentive offerings in future programs devoted to increasing uptake of testing or vaccinations among underserved populations was evaluated." .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/124" .
<https://okn.wobd.org/grant/2T32CA009140-11> <http://schema.org/startDate> "1975-07-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_137> <http://schema.org/identifier> "phs002781" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_43> <http://schema.org/sameAs> "10.60773/wyqe-xw03" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_274> <http://schema.org/date> "2024-09-13"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.obolibrary.org/obo/MONDO_0004995> <http://schema.org/name> "cardiovascular disorder" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_137> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/author> <https://okn.wobd.org/person/the_ann_robert_h_lurie_children_s_hospital_of_chicago> .
<https://okn.wobd.org/grant/1P01HL114471-01A1> <http://schema.org/name> "Novel Molecular Mechanisms Promote GPCR-Induced Bronchodilation in Asthma" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_213> <http://schema.org/datePublished> "2024-04-11"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_30> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_188> <http://schema.org/dateCreated> "2022-11-28"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_80> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/grant/1R01AI163029-01> <http://schema.org/name> "Inborn errors of immunity in patients with life-threatening COVID-19" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_124> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_28> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_186> <http://schema.org/description> "This study planned to offer SARS-CoV-2 screening tests at selected dialysis facilities in order to: reduce transmission, and detect early cases and prevent serious illness among patients receiving dialysis. Patients receiving dialysis have an 8-fold higher risk for hospitalization and 15-fold higher risk for death from COVID-19 compared with the general population. Patients receiving dialysis also disproportionately belong to racial/ethnic minority and economically disadvantaged groups. Thus, the goals of this project were to increase availability of highly sensitive and specific testing for SARS-CoV-2 infection in a medically vulnerable and disadvantaged population. The study planned to perform a pragmatic cluster (facility-level) randomized study to test the patient level acceptability of two strategies for offering test-based screening offered at the dialysis facility. This study offered anterior nares, rtPCR tests at a static frequency (aim 1) versus a dynamic frequency anchored to county COVID-19 spread (aim 2). After a pilot in four facilities, this study planned to scale up the study to 62 dialysis facilities within US Renal Care. After a 3-month period of testing, the study assessed the following outcomes: Patient level test acceptability (primary outcome), Facility level Deaths, and Facility level Hospitalization. The overall goal was to identify a highly acceptable universal testing strategy for patients receiving dialysis, and prevent serious complications from SARS-CoV-2 by identifying cases early." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_62> <http://schema.org/date> "2024-08-16"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_217> <http://schema.org/dateCreated> "2024-01-04"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_34> <http://schema.org/url> "https://radxdatahub.nih.gov/study/34" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_72> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/grant/1R01GM138385-01A1> <http://schema.org/identifier> "1R01GM138385-01A1" .
<http://schema.org/url> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2000/01/rdf-schema#Literal> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_202> <http://schema.org/sameAs> <https://doi.org/10.60773/sfgj-td47> .
<https://okn.wobd.org/grant/1R01DA013806-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/6292035" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_48> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR003142-01> .
<https://okn.wobd.org/person/university_of_nebraska_medical_center> <http://schema.org/name> "University of Nebraska Medical Center" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_108> <http://schema.org/sameAs> <https://doi.org/10.60773/3v5j-f685> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_74> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_47> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_118> <http://schema.org/url> "https://radxdatahub.nih.gov/study/118" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_130> <http://schema.org/description> "This project employed sentinel and community-based epidemiological surveillance and participatory research methods to evaluate whether a person-centered, rapid COVID-19 testing intervention (at-home swab and send, or on-site point of care testing), coupled with a novel mHealth COVID-19 Literacy and Outreach Suite of apps and videos, would serve to increase the acceptance, access, reach, uptake, and impact of COVID-19 testing at UI Health and in the 14 FQHC practice sites and their corresponding catchment areas. The social, ethical, economic, and behavioral drivers and consequences of this outreach and testing approaches were evaluated according to the degree to which participants contributed to the co-creation of study-related messaging. The study leveraged existing infrastructures to expand testing uptake and analyzed (by PCR) viral load at infection onset/exposure and following onset/exposure to determine viral dynamics and identify individuals at early and late stages of infection. NIH PhenX self-report measures were used to test intervention effects on testing and retesting uptake, time-to-diagnosis, COVID-19 knowledge, healthcare access and seeking, disclosure, medical adherence, and practice of home self-isolation, quarantine, and other infection control behaviors. All data acquisition, collection and curation approaches were informed by the CDCC, including AboutML-informed consent approaches and with the other RADx-UP studies and relevant federal agencies. The central hypothesis of this study argued that a persuasive mHealth Suite of apps and videos (co-created with community members) combined with person-centered COVID-19 testing choices (remote at home nasal swab versus on-site nasal swab), will lead to higher COVID-19 testing uptake in 7000 adults and children living in the geographic catchment areas of the 14 Mile Square Health Center practice sites (as compared with baseline rates of testing uptake in the same geographic catchment area). This relationship was mediated by a number of social, economic, and behavioral determinants of health, including self-reported COVID-19-related knowledge, COVID-19 social capital, COVID-19 racial/ethnic bias and stigma, and COVID-19 preventative and risk behaviors. Analysis of mediators was limited to the adult sample. This was accomplished utilizing a repeated measure, pre-post-test mediational design. Interviews were conducted over the phone on Day 1 and Day 28 of a 28-day study period, to track outcomes. With improved access to testing and care, self-management strategies of COVID-19 and increased knowledge, a higher percentage of people living in underserved neighborhoods will have access to testing and necessary follow-up care and are expected to develop a stronger sense of empowerment over their own healthcare decisions related to COVID-19. Three groups were recruited to participate in this study. The first group was recruited from the 14 Mile Square Health Center (MSHC) practice sites. The second group was recruited through contact tracing of COVID-19 test positives from MSHC. The third group was recruited from the community through posted study ads and flyers online, which first contained the study contact number and eventually contained an invitation to find out about the study through the mobile health (mHealth) suite of apps and videos. In addition to nasal swab testing for COVID-19, participants had access to smartphone apps to track symptoms, improve knowledge of COVID-19, and learn self-management skills while at home. Participants who were not initially identified via a call or in-person visit to Mile Square Health Clinic were given the opportunity to partake in rapid, COVID-19 nasal swab self-collection at home. Research members shared the data collected from the biological specimens, interviews, and apps with the Illinois Department of Public Health. The final goal of this study was the prevention of COVID-19 transmission through increased COVID-19 literacy and empowerment, combined with early intervention via rapid diagnosis, contact tracing, and earlier access to treatment." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_112> <http://schema.org/name> "Understanding Factors Influencing COVID-19 Testing and Vaccination in Immigrant Low-Income and Homeless Populations and Testing Targeted Interventions" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_62> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/147711> .
<https://ror.org/00372qc85> <http://schema.org/alternateName> "NIBIB" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/190" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_206> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/195" .
<https://okn.wobd.org/grant/1U24TR001608-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/1R01CA193776-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_206> <http://schema.org/sameAs> <https://doi.org/10.60773/jrhz-2h83> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_57> <http://schema.org/url> "https://radxdatahub.nih.gov/study/57" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_170> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_101> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/person/inc> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_181> <http://schema.org/name> "Using the Multiphase Optimization Strategy (MOST) to Optimize an Intervention to Increase COVID-19 Testing for Black and Latino/Hispanic Frontline Essential Workers" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_156> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR002538-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_93> <http://schema.org/date> "2024-04-10"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/the_university_of_texas_health_science_center_at_tyler> <http://schema.org/name> "The University of Texas Health Science Center at Tyler" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_207> <http://schema.org/name> "Supporting the Health and Well-Being of Children with Intellectual and Developmental Disability During COVID-19 Pandemic" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_183> <http://schema.org/dateModified> "2022-11-07"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/3OT2HL156812-01S2> <http://schema.org/endDate> "2025-02-28"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_144> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01AI107301-01> <http://schema.org/funder> <https://ror.org/043z4tv69> .
<https://okn.wobd.org/grant/1U01AI069918-01> <http://schema.org/name> "North American AIDS Cohorts Collaboration on Research and Design" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_141> <http://schema.org/datePublished> "2023-08-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_101> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_79> <http://schema.org/author> <https://okn.wobd.org/person/association_to_benefit_children> .
<https://okn.wobd.org/grant/1R01DA055491-01> <http://schema.org/startDate> "2021-07-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_63> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_71> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_172> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_180> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1U54GM115516-01A1> <http://schema.org/identifier> "1U54GM115516-01A1" .
<https://okn.wobd.org/grant/8UL1TR000002-07> <http://schema.org/endDate> "2016-06-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/author> <https://okn.wobd.org/person/maria_fareri_children_s_hospital_at_westchester_medical_center> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_113> <http://schema.org/funding> <https://okn.wobd.org/grant/1P42ES010337-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_151> <http://schema.org/funding> <https://okn.wobd.org/grant/1P30AI027767-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_181> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/person/university_of_michigan> <http://schema.org/name> "University of Michigan" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_78> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/grant/1ZIAAI001222-01> <http://schema.org/identifier> "1ZIAAI001222-01" .
<https://okn.wobd.org/grant/1S10OD026929-01> <http://schema.org/funder> <https://ror.org/00fj8a872> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_33> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_202> <http://schema.org/author> <https://okn.wobd.org/person/be_health_empowered_bhe_group> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_108> <http://schema.org/url> "https://radxdatahub.nih.gov/study/108" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_43> <http://schema.org/funding> <https://okn.wobd.org/grant/1K12HD047349-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_217> <http://schema.org/sameAs> "10.60773/ewfr-hd70" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_129> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR003167-01> .
<https://okn.wobd.org/person/booker_t_washington_high_school> <http://schema.org/name> "Booker T. Washington High School." .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/67" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_134> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_143> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005287> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_173> <http://schema.org/identifier> "phs003030" .
<https://okn.wobd.org/person/university_of_pennsylvania> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_133> <http://schema.org/sameAs> <https://doi.org/10.60773/n1eh-8t78> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_58> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_215> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_33> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_212> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/grant/2U54MD007595-11> <http://schema.org/startDate> "2009-09-24"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_201> <http://schema.org/name> "You & Me: Test and Treat" .
<https://okn.wobd.org/grant/1P30DK092950-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/8192916" .
<https://ror.org/012pb6c26> <http://schema.org/name> "National Heart, Lung, and Blood Institute" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_125> <http://schema.org/identifier> "phs002745" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_29> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_219> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/grant/1UL1TR003017-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/1R01GM122080-01> <http://schema.org/funder> <https://ror.org/04q48ey07> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_166> <http://schema.org/author> <https://okn.wobd.org/person/and_johns_hopkins_university_school_of_medicine_washington_university> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_70> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_48> <http://schema.org/sameAs> <https://doi.org/10.60773/dwzp-am60> .
<https://okn.wobd.org/grant/1R35GM141535-01> <http://schema.org/funder> <https://ror.org/04q48ey07> .
<https://okn.wobd.org/grant/2U54MD007601-31> <http://schema.org/name> "Ola HAWAII" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_156> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/grant/1R01MH115676-01A1> <http://schema.org/endDate> "2023-01-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/117" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_84> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2901879> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_43> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100163> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_219> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_215> <http://schema.org/dateModified> "2024-03-04"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/2R37AI051652-06> <http://schema.org/name> "Biomolecular Markers for Safe Minimization of Immunosuppression" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_140> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2901879> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/funding> <https://okn.wobd.org/grant/1U01HG010971-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_61> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01DA037628-01A1> <http://schema.org/identifier> "1R01DA037628-01A1" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_87> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_156> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/grant/1UL1TR001085-01> <http://schema.org/endDate> "2018-04-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1UL1TR001866-01> <http://schema.org/funder> <https://ror.org/04pw6fb54> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_152> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_112> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/university_of_kansas> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/person/this_was_a_decentralized_study_run_on_evidation_s_achievement_platform> <http://schema.org/name> "This was a decentralized study run on Evidation's Achievement platform" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_219> <http://schema.org/description> "Low-Income Asian Americans (AA) with limited English proficiency (LEP) represent a meaningful proportion of low-wage frontline workers in essential service industries. Many also live in multigenerational households with crowded conditions and with their elderly relatives in ethnic neighborhoods, areas that have experienced high rates of COVID-19 infection. Unfortunately, AAs have encountered numerous barriers to COVID-19 testing across individual, provider/health system and community/societal levels, including anti-Asian racism and discrimination, fear of safety at test sites and on public transportation, lack of health insurance, lack of culturally and language-appropriate COVID-19 information and navigation, and limited access to COVID-19 testing sites. As a result, AAs have the lowest COVID-19 testing rate across all racial/ethnic groups. This is particularly concerning in light of the recent surge in cases due to the BA.2 variant and lifting of COVID restrictions, which has led to increases in COVID-19 infections and hospitalizations especially among vulnerable populations. FDA-approved over-the-counter (OTC) COVID-19 diagnostic tests offer a valuable evidence-based strategy for empowering vulnerable AAs (who are hesitant or otherwise unable to obtain in-person PCR testing) to complete self-testing. Although prior studies have demonstrated the feasibility of COVID-19 self-testing in communities with access barriers, no intervention study has focused on vulnerable low-income frontline workers and seniors with LEP across diverse AA ethnic groups (Chinese, Vietnamese, Korean, Filipino, Indian, and other South Asian Americans), the fastest growing US population. Thus, the overall goal of this application was to implement a community-engaged multifaceted intervention (IMPROVE intervention) to increase access to and uptake of rapid COVID-19 self-testing across diverse AA populations. Guided by the NIMHD Research Framework and Social Cognitive Theory to address sociocultural/environmental and individual/interpersonal influences for COVID self-testing, the central hypothesis was that trusted messengers (community health navigators, heath providers, and peer advocates) were essential to reducing testing barriers and increasing uptake of COVID-19 self-testing. The Specific Aims were to: (1) Engage community partners to implement a pragmatic cluster-randomized trial in 12 CBO sites to evaluate the effectiveness of the community-engaged and evidence-based IMPROVE intervention in increasing access to and uptake of COVID-19 self-testing (primary outcome) and changes in mitigation behaviors including adherence to mask wearing and COVID-19 vaccination (secondary outcomes) in underserved and vulnerable ethnic AAs (N=1200 AAs); and (2) Evaluate Intervention Reach, Effectiveness, Adoption, Implementation and Maintenance using the RE-AIM framework to facilitate IMPROVE intervention dissemination to more CBOs and enhance its sustainability over time. The primary outcomes included COVID-19 self-testing uptake (number of tests done and locations) and access to COVID-19 self-testing (difficulties of getting tested in the community, and access to at-home self-test kits, difficulties in using self-test kits). The secondary outcomes included changes in COVID-19 mitigation behaviors, including COVID-19 testing, COVID-19 testing intention if testing not performed, COVID-19 vaccine uptake (dosage and brands of vaccine received, to be verified via self-report or vaccine card upload), and intention/hesitancy; mask-wearing and other mitigation strategies, and treatment received and difficulties if positive. The project was one of the first to evaluate an evidence-based community-engaged approach to reducing systemic barriers and filled gaps in research on COVID-19 self-testing and mitigation adherence in above-stated ethnic AA vulnerable populations." .
<http://schema.org/dateCreated> <http://www.w3.org/2000/01/rdf-schema#domain> <http://schema.org/Thing> .
<https://okn.wobd.org/person/university_of_florida> <http://schema.org/name> "University of Florida" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_138> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01NS076465-01> .
<https://okn.wobd.org/grant/1T32CA203702-01A1> <http://schema.org/endDate> "2022-06-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_271> <http://schema.org/description> "The goal of this project was to use a flexible and sustainable approach that promotes responsiveness to both the needs of the community and the changing pandemic context while reducing COVID-19 testing disparities. This project refined, and tested three implementation strategies prioritized by the Community and Scientific Advisory Board (CSAB). These three strategies include: (1) current, walk-up free testing, (2) promotores-led COVID-19 test counseling and preventive care reminders, (3) vending machines that dispense FDA-authorized self-testing kits." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_101> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0004981> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_46> <http://schema.org/url> "https://radxdatahub.nih.gov/study/46" .
<https://okn.wobd.org/grant/1K12HD000850-01> <http://schema.org/funder> <https://ror.org/04byxyr05> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_172> <http://schema.org/description> "This biorepository was established to obtain, store, and share body fluid samples for SARS-CoV-2 research. Samples were obtained at the study sites. The overall study duration was open ended to allow ongoing enrollment and indefinite storage of samples. There was no limit to the number of volunteers who could consent to participate in the study. The time frame for enrollment of volunteers and endpoints of the study were open ended, and duration of participation was only limited by withdrawal of consent to store data or samples. Participants were asked to complete a survey through the Eureka digital study platform. The survey collected demographic information, delineated the types of samples provided, and collected information about experience with COVID-19 (e.g., symptoms or exposures). Samples were collected in a location equipped for safely obtaining specimens from potentially SARS-CoV-2-infected participants, e.g., ED or inpatient units, ambulatory clinics, or COVID-19 community screening events." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_184> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_194> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/person/indiana_university> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_62> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/qggp-bp06> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_214> <http://schema.org/url> "https://radxdatahub.nih.gov/study/214" .
<https://okn.wobd.org/grant/1R01DE026471-01A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_117> <http://schema.org/identifier> "phs002729" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_34> <http://schema.org/name> "Digital Health Solutions for COVID-19: COVID Community Action and Research Engagement (COVID-CARE)" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_145> <http://schema.org/funding> <https://okn.wobd.org/grant/1U54CA132384-01A1> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_142> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/ywfr-4e53> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_191> <http://schema.org/sameAs> <https://doi.org/10.60773/wrsw-vq98> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_78> <http://schema.org/funding> <https://okn.wobd.org/grant/1U01AI122285-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_140> <http://schema.org/dateCreated> "2022-01-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_37> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_85> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_174> <http://schema.org/description> "Schools serve important community roles beyond academic education. In historically marginalized communities they are trusted providers for a range of support services for families in need. The tradeoff between these crucial benefits of in-person learning against the risk of SARS-CoV-2 transmission in school settings has been hotly debated throughout much of 2020 and 2021. The stakes are particularly high in historically marginalized communities which rely most heavily on school services, but have also been hit the hardest by COVID-19 primarily due to structural issues. The Safer at School Early Alert (SASEA) program was co-developed by the University of California, San Diego, the County of San Diego, and 15 partner schools serving socially vulnerable students in 5 school districts across San Diego County. SASEA utilized daily wastewater and surface (floor) environmental monitoring to detect asymptomatic SARS-CoV-2 infections among students and staff on campus. Positive environmental signals were immediately followed by targeted responsive testing for a whole school (in the case of wastewater) or classroom (for a positive surface sample). This project developed the Safer at School Early Alert School-Neighborhood Asset Portal (SASEA- SNAP), an online school environmental monitoring report dashboard with resources to address structural barriers to COVID-19 diagnostic testing in historically marginalized communities (Aim 1). This study also created a toolkit to allow any school to rapidly adapt the template to their specific setting. In Aims 2 and 3, the study used a randomized stepped wedge trial to compare SASEA (control) vs SASEA-SNAP (intervention) in 50 schools across 4 diverse school clusters in San Diego County. The primary outcome (Aim 2) was higher rates of diagnostic testing in intervention schools. The secondary outcome (Aim 3) was increased risk mitigation behaviors in school community members when environmental surveillance data suggested a potential case on campus. In Aim 4, the study used parent-child narrative interviews with 40 parent-student pairs to understand how children perceive COVID-19 risk at school, assess differences in perceptions of testing barriers between intervention and control sites, and better understand how children understand the process of environmental surveillance and responsive testing." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_129> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/grant/1U54GM104942-01> <http://schema.org/funder> <https://ror.org/04q48ey07> .
<https://okn.wobd.org/grant/1U01AI069918-01> <http://schema.org/startDate> "2006-07-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_146> <http://schema.org/sameAs> "10.60773/qhrd-7c61" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_195> <http://schema.org/url> "https://radxdatahub.nih.gov/study/195" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_197> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_40> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/grant/8P20GM103429-11> <http://schema.org/startDate> "2001-09-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/nyu> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_84> <http://schema.org/description> "Racial minorities have disproportionate risk for SARS-CoV-2 diagnoses and adverse outcomes including death. Burden of disease in Black populations is likely underestimated due to sub-optimal access to, and usage of, SARS-CoV-2 testing. Serosurveys, which use probability-based methods to select persons for SARS-CoV-2 testing and an accompanying survey, have potential to improve understanding of population-level burden of disease and risk factors for infection. However, early results from U.S.-based serosurveys indicate sub-optimal participation rates among Black populations, which results in their under-representation in burden of disease estimates and a limited understanding of risk factors for infection. The current project aimed to identify barriers and motivations for participation in population-based SARS-CoV-2 serosurveys among diverse Black sub-populations (e.g., by gender, age, and education level). Understanding factors that influence Black people's decision-making about serosurvey participation and how these factors differ by socio-demographic characteristics enabled tailored recommendations for increasing Black populations' participation in serosurveys and representation in burden of disease estimates. The interdisciplinary team of epidemiologists, behavioral scientists, and community health advocates/practitioners used qualitative and quantitative methods in the context of serosurveys to understand how influences on decision-making are related to actual decisions about participation in SARS-CoV-2 antibody testing. The qualitative interview guide was informed by the family of value expectancy theories and was developed in collaboration with a community advisory board (CAB), who also helped to identify community constituents for participation in qualitative interviews. Key themes from the qualitative interviews, and language used by respondents, informed a quantitative survey instrument, which assessed relative strengths of influences on serosurvey participation and how they differ socio-demographically across Black sub-populations. The Specific Aims of this study were: (1) Convene a community advisory board (CAB) comprising leaders from organizations serving Black communities in Atlanta (e.g., professional, faith-based, health and social services); (2) In the context of a SARS-CoV-2 serosurvey, conduct 50 semi-structured interviews about barriers and motivations for serosurvey and vaccine participation with Black persons from 3 diverse neighborhoods, representing a range of socio-demographic characteristics; (3) Determine the distribution of barriers and motivations for serosurvey participation across socio-demographic subgroups of 2,000 Black persons using a quantitative survey. Recommendations for increasing participation of black communities in SARS-CoV-2 serosurveys were provided, which is critical as SARS-CoV-2 serosurveys were likely to be used for on-going disease surveillance in the U.S. and to inform both resource allocation and design and monitoring of prevention and control strategies." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_151> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/grant/1R01AI123105-01A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/1T32AI007291-01A1> <http://schema.org/funder> <https://ror.org/043z4tv69> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_54> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/grant/1ZIAAI001222-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/1U54CA156732-01> <http://schema.org/funder> <https://ror.org/040gcmg81> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_81> <http://schema.org/datePublished> "2024-04-11"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://schema.org/affiliation> <http://www.w3.org/2000/01/rdf-schema#domain> <http://schema.org/Person> .
<https://okn.wobd.org/person/university_of_utah_health_care> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/person/fulford_elementary> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_141> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/86zb-bq66> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_61> <http://schema.org/description> "This project developed a multiplexed sensor platform based on nanomaterials capable of rapid simultaneous detection of multiple components of viral particles in a field applicable electrochemical device. The device had synthetic biosensors that, in a multimodal, rapid, accurate, inexpensive, field-deployable test, detected multiple of SARS-CoV-2 biomarkers." .
<https://ror.org/0493hgw16> <http://schema.org/alternateName> "National Center on Minority Health and Health Disparities" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_192> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_163> <http://schema.org/sameAs> "10.60773/v1h1-pp81" .
<https://okn.wobd.org/grant/1U01HG010961-01> <http://schema.org/funder> <https://ror.org/00baak391> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_196> <http://schema.org/datePublished> "2023-05-25"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1P30GM131944-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/1R21AI129851-01> <http://schema.org/endDate> "2019-08-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_169> <http://schema.org/name> "Marshallese: Alternate Surveillance for COVID-19 in a Unique Population" .
<https://okn.wobd.org/grant/1P01CA214274-01A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/5R01DK035385-02> <http://schema.org/url> "https://reporter.nih.gov/project-details/3233691" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_47> <http://schema.org/sameAs> <https://doi.org/10.60773/vbbc-kt11> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_168> <http://schema.org/url> "https://radxdatahub.nih.gov/study/168" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_135> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_71> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_81> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/fc6a-gf05> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_113> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0004975> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_145> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_216> <http://schema.org/name> "Enhancing SARS-CoV-2 Rapid Testing Acceptance in Latinx Communities" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_157> <http://schema.org/author> <https://okn.wobd.org/person/mercy_hospital_st_louis> .
<https://okn.wobd.org/grant/1UL1TR001860-01> <http://schema.org/startDate> "2016-07-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/capitol_area_reentry_program> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/grant/1K08AI130381-01A1> <http://schema.org/name> "Deconvolution of pro- and anti-viral responses to Dengue virus and Zika Virus infections" .
<https://okn.wobd.org/person/columbia_university> <http://schema.org/name> "Columbia University" .
<https://okn.wobd.org/grant/1R01AI123538-01A1> <http://schema.org/url> "https://reporter.nih.gov/project-details/9309328" .
<http://schema.org/alternateName> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2000/01/rdf-schema#Literal> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_82> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_146> <http://schema.org/sameAs> <https://doi.org/10.60773/qhrd-7c61> .
<https://okn.wobd.org/grant/4R33HD105590-03> <http://schema.org/identifier> "4R33HD105590-03" .
<https://okn.wobd.org/grant/1R01CA234614-01A1> <http://schema.org/funder> <https://ror.org/040gcmg81> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_139> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/grant/1P42ES010337-01> <http://schema.org/startDate> "2000-07-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_75> <http://schema.org/funding> <https://okn.wobd.org/grant/1U54GM115677-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_145> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_70> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01AI140442-01> .
<https://okn.wobd.org/grant/1UL1TR002014-01> <http://schema.org/endDate> "2020-05-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1T32HD044355-01> <http://schema.org/startDate> "2003-06-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_32> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/funding> <https://okn.wobd.org/grant/4R33HD105590-03> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_132> <http://schema.org/name> "Community-Engaged Research to Improve the COVID-19 Testing Cascade Among Underserved Populations in the US Caribbean Territories" .
<https://okn.wobd.org/person/albert_einstein_college_of_medicine> <http://schema.org/name> "Albert Einstein College of Medicine" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_46> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/grant/1R35GM141535-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/10199488" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_125> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_148> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005447> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_187> <http://schema.org/datePublished> "2023-08-29"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_61> <http://schema.org/date> "2022-12-09"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_51> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<http://schema.org/DataDownload> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2000/01/rdf-schema#Class> .
<https://okn.wobd.org/grant/1T32CA203702-01A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/1UL1TR003017-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9831333" .
<https://okn.wobd.org/grant/1P30AI060354-01> <http://schema.org/name> "Harvard Medical School Center for AIDS Research" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_121> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/v1k1-md20> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_148> <http://schema.org/url> "https://radxdatahub.nih.gov/study/148" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_217> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/100" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_79> <http://schema.org/url> "https://radxdatahub.nih.gov/study/79" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_183> <http://schema.org/sameAs> <https://doi.org/10.60773/38sx-dw45> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_176> <http://schema.org/url> "https://radxdatahub.nih.gov/study/176" .
<https://okn.wobd.org/grant/1T32GM128596-01> <http://schema.org/endDate> "2023-06-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_184> <http://schema.org/url> "https://radxdatahub.nih.gov/study/184" .
<https://okn.wobd.org/grant/1U54GM104940-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/8339627" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/138" .
<https://okn.wobd.org/grant/1UL1TR003167-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9938025" .
<http://purl.obolibrary.org/obo/MONDO_0005354> <http://schema.org/name> "chronic hepatitis C virus infection" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_186> <http://schema.org/datePublished> "2023-08-29"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/8P20GM103395-12> <http://schema.org/endDate> "2014-02-28"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/northwestern_university_and_john_hopkins_university> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_83> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_209> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_204> <http://schema.org/date> "2024-03-04"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_39> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_217> <http://schema.org/description> "Black communities in the U.S. have disproportionately experienced adverse outcomes attributable to the COVID-19 pandemic. While COVID-19 cases and deaths have declined in recent months, emergent variants continue to pose threats to the health of Black communities and others. COVID-19 testing has recently shifted from primarily point-of-care testing to widespread use of rapid home antigen tests. Home testing may be preferable to clinic-based testing for Black persons, many of whom have a high degree of well-founded, historically based mistrust of the medical system, but very little is currently known about knowledge, attitudes, and behaviors surrounding COVID-19 home testing among Black people. In addition to challenges related to affordability and accessibility of home testing, the privacy afforded by home testing comes at the expense of surveillance information. Home tests are rarely reported to public health surveillance, and specimens are unavailable for genetic sequencing and variant detection. This results in a substantial gap in public health knowledge about COVID-19 burden of disease and circulating variants, which may be particularly problematic for Black communities with higher risk for adverse outcomes. This project was a pre-post intervention study based in Black communities in Atlanta, GA to assess willingness of research participants to use a COVID-19 rapid home test and to simultaneously mail a self-collected anterior nares sample to a commercial laboratory for confirmatory PCR testing. The project provided culturally competent oral and illustrated written communication messages encouraging continued COVID-19 vigilance and home testing alongside self-collection of a specimen for mail-off testing. These messages were packaged with a home test kit for rapid testing and self collecting and mailing a second specimen to a laboratory. If a subset of home testers were willing to self-collect and mail a specimen for confirmatory testing, multiplier methods were used to estimate burden of disease and circulating variants among home testers. However, people with medical mistrust might not have elected to share biological specimens for surveillance purposes. The study aimed to understand motivations and barriers for using this type of testing modality in Black communities while also assessing general knowledge, attitudes, and behaviors related to home testing. Specific aims were: (1) Develop culturally appropriate, empowering communications strategies underscoring the importance of home COVID-19 testing for individual and public health; (2) Assess knowledge, attitudes, and behaviors regarding COVID-19 rapid home testing among sociodemographically diverse Black communities; (3) Assess willingness to provide, in conjunction with a rapid home test, a self-collected specimen to a laboratory for confirmatory COVID-19 testing; (4) Conduct in-depth interviews with persons completing (N=10) and not completing (N=10) the study-provided home test to further improve communications strategies using participants' open-ended reflections on intervention effectiveness." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_128> <http://schema.org/datePublished> "2023-08-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/fox_subacute_care> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/person/st_louis> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_194> <http://schema.org/name> "COVID-19 Testing and Vaccination Social Network Diffusion for Diverse Criminal Legal Involved Communities" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_178> <http://schema.org/author> <https://okn.wobd.org/person/university_of_massachusetts_chan_medical_school> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_47> <http://schema.org/identifier> "phs002522" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_176> <http://schema.org/dateCreated> "2022-08-19"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1T32GM128596-01> <http://schema.org/identifier> "1T32GM128596-01" .
<http://purl.obolibrary.org/obo/NCIT_C35041> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_190> <http://schema.org/datePublished> "2023-08-29"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_150> <http://schema.org/url> "https://radxdatahub.nih.gov/study/150" .
<https://okn.wobd.org/grant/1P30GM131944-01> <http://schema.org/identifier> "1P30GM131944-01" .
<https://okn.wobd.org/grant/1T32EB028092-01A1> <http://schema.org/name> "TRAINING IN REGENERATIVE MEDICINE" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_168> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/xb7r-qw92> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_120> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<http://schema.org/species> <http://www.w3.org/2000/01/rdf-schema#domain> <http://schema.org/Dataset> .
<https://okn.wobd.org/grant/1U54GM115516-01A1> <http://schema.org/url> "https://reporter.nih.gov/project-details/9361849" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_37> <http://schema.org/url> "https://radxdatahub.nih.gov/study/37" .
<http://purl.obolibrary.org/obo/MONDO_0044339> <http://schema.org/name> "lumbar disk degenerative disorder" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_53> <http://schema.org/sameAs> <https://doi.org/10.60773/prf9-6708> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_207> <http://schema.org/identifier> "phs003359" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_99> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_112> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://ror.org/00baak391> <http://schema.org/alternateName> "The National Human Genome Research Institute" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_45> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_133> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005550> .
<https://okn.wobd.org/grant/1R56HL149881-01A1> <http://schema.org/startDate> "2020-09-23"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R35GM119850-01> <http://schema.org/funder> <https://ror.org/04q48ey07> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_200> <http://schema.org/sameAs> <https://doi.org/10.60773/b47b-ek03> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_190> <http://schema.org/funding> <https://okn.wobd.org/grant/1U24TR001608-01> .
<https://okn.wobd.org/grant/1K12HD047349-01> <http://schema.org/endDate> "2009-06-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/umass_chan_medical_school_and_northwestern_university> <http://schema.org/name> "UMass Chan Medical School and Northwestern University" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_155> <http://schema.org/sameAs> "10.60773/gkzn-9x83" .
<https://okn.wobd.org/grant/1R01AI153044-01A1> <http://schema.org/funder> <https://ror.org/043z4tv69> .
<https://okn.wobd.org/grant/1UL1TR001873-01> <http://schema.org/endDate> "2021-05-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_128> <http://schema.org/identifier> "phs002760" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_60> <http://schema.org/datePublished> "2022-11-07"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_111> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_210> <http://schema.org/funding> <https://okn.wobd.org/grant/1P30DK063720-01> .
<https://okn.wobd.org/grant/6U48DP006395-01M001> <http://schema.org/url> "https://reporter.nih.gov/project-details/10005877" .
<https://okn.wobd.org/grant/4UH3OD023365-03> <http://schema.org/startDate> "2016-09-21"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_99> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/grant/1UL1TR003017-01> <http://schema.org/identifier> "1UL1TR003017-01" .
<https://okn.wobd.org/grant/5T32GM007618-08> <http://schema.org/url> "https://reporter.nih.gov/project-details/3537743" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_75> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/the_university_of_texas_health_science_center_houston_the_university_of_texas_health_science_center_at_tyler> <http://schema.org/name> "The University of Texas Health Science Center Houston, The University of Texas Health Science Center at Tyler" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_157> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_137> <http://schema.org/funding> <https://okn.wobd.org/grant/1DP2AI138242-01> .
<https://okn.wobd.org/grant/1ZIAAI001175-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_47> <http://schema.org/date> "2024-09-04"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1U01AI069918-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_54> <http://schema.org/funding> <https://okn.wobd.org/grant/1P20GM121342-01A1> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_62> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_96> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01DK121072-01A1> <http://schema.org/url> "https://reporter.nih.gov/project-details/9887203" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/174" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_73> <http://schema.org/sameAs> <https://doi.org/10.60773/wx0n-5518> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_166> <http://schema.org/name> "Supporting the Health and Well-Being of Children with Intellectual and Developmental Disability During the COVID-19 Pandemic" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_192> <http://schema.org/date> "2023-02-21"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_167> <http://schema.org/name> "Motivational Enhancement to Augment Contingency Management for SARS-CoV-2 Testing and Vaccination Utilization Among Syringe Exchange Clients" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_74> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_113> <http://schema.org/sameAs> <https://doi.org/10.60773/nvkn-xv26> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_158> <http://schema.org/sameAs> "10.60773/enx6-h124" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_214> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_93> <http://schema.org/description> "Given observed disparities in COVID-19 morbidity, hospitalization, and mortality across race, ethnicity, and socioeconomic status, there is a great need to increase testing access and uptake with rapid return of test results. Therefore, a community health worker (CHW)-led approach to facilitate COVID-19 testing for underserved populations, with a focus on increasing testing access, uptake, and impact among Latinx, African American, Filipino, and immigrant communities using different testing implementation strategies was proposed. This project utilized COVID-19 contact tracing and community partner infrastructure to reach individuals aged 6 and above exposed or at risk of COVID-19 exposure. Mobile and home-based testing strategies for increasing testing uptake among contacts, referred high-risk friends and family, and the broader community were evaluated. The specific aims of this project were to: 1) Implement COVID-19 testing integrated into community health worker contact tracing home visits and compare the subsequent uptake of testing for referred high-risk friends and family in a mobile testing vs. home-based testing approach; 2) Using a community-led rapid cycle research process, identify effective strategies to promote uptake of COVID-19 testing through mobile/pop-up testing for Latinx, African American, Filipino, and immigrant populations exposed or at risk of exposure to COVID-19; 3) Gather CHW and community insights to establish best practices for future scale-up and sustainability. The project contributed to health disparity reductions in COVID-19 morbidity and mortality and produce high impact through core strengths in drawing on local knowledge, the team's existing community partnerships, use of culturally-competent community healthcare workers, point-of-care rapid and inexpensive testing, and the use of geospatial data to prioritize locations for mobile pop-up testing. This focus on underserved populations with high COVID-19 exposures informed both future testing and vaccination efforts." .
<https://okn.wobd.org/grant/1UM1HG008898-01> <http://schema.org/startDate> "2016-01-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_48> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/author> <https://okn.wobd.org/person/indiana_university_of_school_of_medicine> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_220> <http://schema.org/identifier> "phs003544" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_172> <http://schema.org/sameAs> "10.60773/cghr-4117" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_141> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/grant/1P30ES030283-01A1> <http://schema.org/identifier> "1P30ES030283-01A1" .
<https://okn.wobd.org/grant/1T32EB028092-01A1> <http://schema.org/startDate> "2020-08-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01ES021006-01A1> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_133> <http://schema.org/identifier> "phs002747" .
<https://okn.wobd.org/grant/1UL1TR001866-01> <http://schema.org/identifier> "1UL1TR001866-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_213> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/pp0p-gj15> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_83> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/mx0a-y046> .
<https://okn.wobd.org/grant/4UH3AI122309-03> <http://schema.org/name> "Statins as Adjunctive, Host-Directed Therapy for TB" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_32> <http://schema.org/date> "2024-04-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_271> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/gwn0-p070> .
<https://okn.wobd.org/grant/1U54HL108460-01> <http://schema.org/identifier> "1U54HL108460-01" .
<https://okn.wobd.org/grant/1R01GM122080-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/75N93021C00015-0-9999-2> <http://schema.org/identifier> "75N93021C00015-0-9999-2" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_69> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_93> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_178> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1U01AI122285-01> <http://schema.org/identifier> "1U01AI122285-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_39> <http://schema.org/author> <https://okn.wobd.org/person/this_was_a_decentralized_study_run_on_evidation_s_achievement_platform> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_196> <http://schema.org/url> "https://radxdatahub.nih.gov/study/196" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_146> <http://schema.org/funding> <https://okn.wobd.org/grant/1U24TR001608-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_128> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_170> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/NCIT_C189188> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_205> <http://schema.org/funding> <https://okn.wobd.org/grant/1U24TR001608-01> .
<https://ror.org/00adh9b73> <http://schema.org/identifier> "https://ror.org/00adh9b73" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/180" .
<https://okn.wobd.org/grant/1ZIANR000035-01> <http://schema.org/name> "Sensory Science and Metabolism; Molecular and Neuronal Mechanisms" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_220> <http://schema.org/dateModified> "2024-03-27"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_73> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/wx0n-5518> .
<https://okn.wobd.org/grant/1UG3OD023365-01> <http://schema.org/endDate> "2018-08-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/203" .
<https://okn.wobd.org/grant/1R35GM119850-01> <http://schema.org/name> "Unraveling the mammalian secretory pathway through systems biology and algorithm development" .
<https://okn.wobd.org/grant/1R01DA055491-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/10327225" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_78> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_143> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_178> <http://schema.org/sameAs> <https://doi.org/10.60773/5061-0a66> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_139> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/wtx3-4882> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_57> <http://schema.org/date> "2023-10-18"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1UL1TR001863-01> <http://schema.org/funder> <https://ror.org/04pw6fb54> .
<https://okn.wobd.org/person/greynolds_park_elementary> <http://schema.org/name> "Greynolds Park Elementary" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_69> <http://schema.org/dateModified> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_157> <http://schema.org/description> "Pregnant women are a vulnerable and high-risk population, as COVID-19 is associated with an increased risk of preterm birth, cesarean section, and maternal intensive care. The objectives of this study were to: (a) evaluate the full impact of SARS-CoV-2 in pregnancy to inform testing strategies, (b) examine the factors that impede testing during pregnancy, and (c) use study data to devise implementation strategies that improve SARS-CoV-2 testing in pregnancy and prenatal care during the pandemic. To do so, this study proposed to prospectively enroll two cohorts of pregnant women: 1) exposed (SARS-CoV-2 positive), and 2) unexposed (SARS-CoV-2 negative as defined by antibody testing at the beginning of pregnancy, every trimester, and at delivery). Women who initially enroll as unexposed but later test positive for SARS-CoV-2 antibodies crossed over to the exposed cohort. In total, an estimated 179 pregnant women were followed per cohort. In Aim 1, the study evaluated patients' and providers' perceptions of SARS-CoV-2 testing during pregnancy and the influence of COVID-19 on maternal care-seeking behavior and anxiety via surveys and semi-structured interviews. The study hypothesized suboptimal uptake of testing among pregnant women due to the fear of repercussions from a positive test. In Aim 2, the study determined the effect of SARS-CoV-2 infection during pregnancy on the risk of preterm birth and other adverse pregnancy outcomes in symptomatic and asymptomatic disease. The study hypothesized that SARS-CoV-2 infection will increase the risk of preterm birth by 12%, regardless of disease severity. In Aim 3, the study estimated the risk of mother-to-fetus SARS-CoV-2 transmission and viral presence in umbilical cord blood, placenta, and amniotic fluid by assaying for viral RNA in the neonate, cord blood, and placenta. The study hypothesized that SARS-CoV-2 can be transmitted from mother to fetus. Collectively, Aims 1-3 were interpreted by investigators, a Scientific Advisory Board (experts in obstetrics, infectious disease, implementation science, disparities) and Community Advisory Board (an obstetric social worker, pregnant women, and a director of a community obstetrics clinic) who applied data to devising targeted implementation strategies designed for rapid community dissemination to improve testing and prenatal care. In sum, this study filled knowledge gaps on the impact of SARS-CoV-2 infection and current utilization of diagnostic testing in pregnancy. Further, it created implementation strategies to overcome barriers to testing, increase uptake, and promote acceptance and sustainability of testing. Lastly, this study helped determine optimal testing strategies by examining the necessity of testing for asymptomatic disease, informed prenatal care plans by assessing the full impact of infection, and contributed to the ability to counsel women and create prenatal care plans if they are pregnant or considering pregnancy." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_47> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_29> <http://schema.org/description> "A Novel Saliva-Based Aptamer Detection Assay for SARS-CoV-2 Infection (RFA-OD-20-021 STTR Application) Automated, rapid diagnostics with little sample collection and preparation are needed to identify and trace affected persons in times when hyper-infectious pathogens cause pandemics. Frequent, low cost and highly scalable testing is the only way to gain visibility on the magnitude of the pandemic and ultimately control the spread of the disease. Therefore, a unique system that can cheaply and readily detect SARS-CoV-2 in saliva samples will be developed. The development of a system that uses saliva present an opportunity to readily test patients using a sample that is easily collected and harbors high concentration of viral particles. The SARS-CoV-2 pandemic has predominantly affected individuals with pre-existing conditions such as clotting disorders, diabetes, hypertension or other chronic diseases. Patients with these pre-existing conditions who then are infected have exacerbated symptoms and complications that can lead to death. For example, many patients that have succumbed to SARS-CoV-2 infection have developed blood clots that have impaired pulmonary or cardiac function and ultimately cardiac failure. A rapid diagnostic using easily collected samples (e.g. saliva) would allow for infections to be identified sooner, therapies to be administered quicker, treatment to be monitored, and ultimately leading to fewer individuals that succumb to the infection. A novel DNA Star biosensing approach based on the fact that viruses, such as SARS- CoV-2, express unique spatial patterns of antigens on their surfaces, facilitating multivalent binding to host cells for infection, was outlined. These configurations of epitopes drive the high sensitivity and specificity of this assay. Based on this naturally occurring binding mechanism, a rational design approach producing pattern matching designer DNA architecture for viral sensing was developed. A proof-of-concept Dengue virus (DENV) rapid diagnostics was developed to demonstrate its power: DENV surface antigens present the most complex geometric pattern among all known pathogens, a DNA star linked 10-aptamers nanostructure that offers polyvalent, spatial DENV-epitope pattern matching interactions has provided high DENV-binding avidity and specificity, increasing affinity by ~1,000× — compared to the conventional aptamer approach which relies on monovalent aptamer-epitope interactions. These POCT diagnostics detected intact DENV virions in patient samples with PCR equivalent sensitivity in <2 mins at a cost <$0.15. Current RT-PCR molecular test are suited to large, centralized laboratories, and difficult to scale for rapid testing of samples and delivery of results to clinicians and patients. Immunoassay tests have lower sensitivity, and patients need to develop a response to the virus in order to detect the antibody response. The DNA star biosensor-based rapid diagnostics provided the infrastructure for real time SARS-CoV-2 diagnostics that is easy to use (instrument-free), faster (sample to results in minutes) and cost effective (~$3 per test)." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_78> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/NCIT_C189188> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_194> <http://schema.org/datePublished> "2023-08-29"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01AI107301-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/1R01AI107301-01> <http://schema.org/identifier> "1R01AI107301-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_197> <http://schema.org/name> "Test Us At Home Daily" .
<https://okn.wobd.org/grant/1P30DK092950-01> <http://schema.org/name> "Washington University Center for Diabetes Translation Research " .
<https://okn.wobd.org/dataset/radx_data_hub/radx_149> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/v97k-6w36> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_97> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<http://schema.org/MonetaryGrant> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2000/01/rdf-schema#Class> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_149> <http://schema.org/funding> <https://okn.wobd.org/grant/8UL1TR000042-07> .
<https://okn.wobd.org/grant/1P01AI118688-01A1> <http://schema.org/startDate> "2016-06-08"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_206> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/jrhz-2h83> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_88> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/dartnet> <http://schema.org/name> "DARTNet" .
<https://okn.wobd.org/grant/1UL1TR002001-01> <http://schema.org/startDate> "2016-08-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_162> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_145> <http://schema.org/url> "https://radxdatahub.nih.gov/study/145" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_169> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_152> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_43> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0016168> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/108" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_114> <http://schema.org/dateCreated> "2022-01-06"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01AI151059-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9945606" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_45> <http://schema.org/url> "https://radxdatahub.nih.gov/study/45" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_84> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/3P50HD103525-01S1> <http://schema.org/endDate> "2025-05-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1S10OD018499-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/8734834" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_161> <http://schema.org/date> "2024-08-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_215> <http://schema.org/description> "In Puerto Rico, the COVID-19 burden in the elderly population is significant. 23% of the confirmed COVID-19 cases and 75% of the deaths have been reported in this group with a low testing rate (3.4 per 100,000) in those > 65 years. The knowledge, beliefs, attitudes, and practices about the risk of infection from COVID-19, symptoms, testing and vaccination, remain a public health concern in Puerto Rico. In 2019, 21.3% of the population living in PR were elderly (> 65 years) with 43.3% living in poverty, were isolated, and medically vulnerable due to their chronic diseases. Isolation for elders has been exacerbated due to the high migration rates of their family members that culturally cared and lookout for them. The Puerto Rico Community Action Research and Engagement (PR-CARE) initiative aimed to focus on the elderly communities in PR who are disadvantaged by geography, sexual and/or gender identification, homelessness and/or income to identify how multiple factors serve to disadvantage this at-risk population in COVID-19 testing and vaccine uptake. PR-CARE sought to identify factors that shape how vulnerable elderly populations in PR recognize and address issues that impact their health and wellness, using the lens of social, ethical, behavioral, structural, historical, and policy issues. The well-established community partner network, using a mixed methods research strategy, had the goal of examining how social determinants of health, in addition to critical policy and environmental factors, address testing and vaccine access and uptake in elderly (> 65 years old) populations in Puerto Rico who suffer from high levels of social vulnerability (i.e., homeless), who were geographically isolated (i.e., living in isolated or rural areas), living in poverty, and gender or sexual diverse (i.e., L.G.B.T.T.Q.I.A.+). In close partnership with three community-based organizations (Coai, Inc. Coalicion de Coaliciones and OSAN) and community promoters or community leaders, this project committed to promoting appropriate access to research findings for the advancement of scientific knowledge. The strategies were guided by four theoretical frameworks: Community Engagement Continuum, Intersectionality-Informed Approach, Andersen's Behavioral Model of Health, and Historical Trauma. These models enable portraying a critical array of multi-domain determinants of health to understand health disparities and healthcare utilization, specifically COVID-19 testing, and vaccinations, in vulnerable elderly communities. Following an explanatory sequential mixed-method approach of surveys, policy review and interviews, PR-CARE aimed to improve the understanding of factors that shape how policy makers, decision makers, and communities make decisions related to health behaviors, especially those related to COVID-19 testing and vaccination uptake. Aims were: 1) assess federal and Puerto Rico Commonwealth policy implications on COVID-19 testing in low-resourced and socially vulnerable elderly in Puerto Rico; 2) examine individual and social determinants of health that influence the uptake of the COVID-19 diagnostics among low-resourced and socially vulnerable elderly in Puerto Rico and 3) combine results from the systematic policy review and key informants (Aim 1: qualitative) and elderly individuals (Aim 2: quantitative and qualitative) to identify challenges, barriers and effective strategies and language to support and improve COVID-19 testing and other related health outcomes in this vulnerable population. The community engagement research that comprised PR-CARE worked to expand the scope, reach, access to and uptake of COVID-19 testing for vulnerable elderly populations in Puerto Rico, focusing on the elderly communities in PR who were disadvantaged by geography, sexual and/or gender identification, homelessness and/or income. Concurrently, it identified and created permanent pathways in health policy that increase the availability of health services for vulnerable populations, promoting health equity using the lens of social, ethical, and behavioral implications." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_142> <http://schema.org/dateCreated> "2022-02-25"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_158> <http://schema.org/sameAs> <https://doi.org/10.60773/enx6-h124> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_179> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/NCIT_C16880> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_146> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_167> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/author> <https://okn.wobd.org/person/children_s_hospital_boston> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_274> <http://schema.org/name> "Addressing COVID-19 Testing Disparities in Vulnerable Populations Using a Community JITAI (Just in Time Adaptive Intervention) Approach: RADx-UP Phase III" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_68> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01AI123105-01A1> .
<https://okn.wobd.org/grant/1U54GM115677-01> <http://schema.org/endDate> "2021-04-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_271> <http://schema.org/name> "CO-CREATE-Ex: Community-engaged Optimization of COVID-19 Rapid Evaluation And  TEsting Experiences" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_191> <http://schema.org/description> "This project was a prospective, mixed-methods cohort study of children who were eligible, enrolled, or who previously participated in the Nebraska Migrant Education Program (MEP) and their families who consented to enroll in an mHealth-targeted, in-home SARS-CoV-2 testing and community aid program. Participant caregivers performed household-level SARS-CoV-2 infection risk screening at least twice weekly and surveys for social determinants of health challenges (household challenges) every other week. Positive SARS-CoV-2 risk screens prompted enrolled students and family members to perform in-home nasal swab antigen testing and reported their results to the study team. Positive household challenges surveys prompted families to indicate their interest in receiving assistance from a community navigator. Follow-up qualitative interviews of students and adult family members occurred for families with positive responses on mHealth screening, positive SARS-CoV-2 antigen test results, and for families who decline to perform testing when prompted." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_129> <http://schema.org/dateCreated> "2022-01-12"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_47> <http://schema.org/url> "https://radxdatahub.nih.gov/study/47" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_185> <http://schema.org/url> "https://radxdatahub.nih.gov/study/185" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_169> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/y2n3-k036> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_137> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://ror.org/00adh9b73> <http://schema.org/name> "National Institute of Diabetes and Digestive and Kidney Diseases" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_156> <http://schema.org/sameAs> <https://doi.org/10.60773/61bs-2j03> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_176> <http://schema.org/datePublished> "2023-08-29"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_189> <http://schema.org/url> "https://radxdatahub.nih.gov/study/189" .
<https://okn.wobd.org/person/university_of_california_san_diego> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_142> <http://schema.org/url> "https://radxdatahub.nih.gov/study/142" .
<https://okn.wobd.org/grant/1U54GM104942-01> <http://schema.org/endDate> "2017-06-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_216> <http://schema.org/dateCreated> "2024-01-04"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_204> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/66qd-hj95> .
<https://okn.wobd.org/grant/2UL1TR000427-06> <http://schema.org/funder> <https://ror.org/04pw6fb54> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_66> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/7P30DK034987-01A1> <http://schema.org/funder> <https://ror.org/00adh9b73> .
<http://purl.obolibrary.org/obo/NCIT_C189188> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/152" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_118> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1P42ES010337-01> <http://schema.org/funder> <https://ror.org/00j4k1h63> .
<https://okn.wobd.org/grant/1TL1TR001871-01> <http://schema.org/name> "NRSA Training Core" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_274> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/8e0v-pk44> .
<https://ror.org/04xeg9z08> <http://schema.org/parentOrganization> "National Institutes of Health" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_83> <http://schema.org/author> <https://okn.wobd.org/person/capitol_area_reentry_program> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_176> <http://schema.org/funding> <https://okn.wobd.org/grant/1U24TR001608-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_109> <http://schema.org/description> "Coronavirus 2019 (COVID-19) has afflicted 6.2 million Americans and killed 190,000 as of early September 2020 (WHO website); a roughly 3% mortality. Between a shortage in testing and unidentified asymptomatic individuals, the actual number of those infected could be 6 to 24-fold higher than that reported. SARS-CoV-2 (CoV-2), the virus underlying the disease, results in a range of symptoms; in select cases a severe respiratory illness that impedes breathing could lead to hospitalization and death. CoV-2 is transmitted person-to-person via inhalation of the virus through mucosal membranes of the nose and throat from transfer after touching a contaminated surface or by inhaling aerosolized virus. Unfortunately, COVID-19 was likely to be prevalent well into 2021 and beyond. The ability to test for CoV-2 must be increased. First, testing is needed to diagnose individuals that are symptomatic or asymptomatic to reduce community spread. And second, monitoring gathering areas for airborne virus that could inform the decision to shutdown a space or implement disinfection and mitigation of an area. This study examined an electrochemical biosensor in two detection devices, 1) a diagnostic breathalyzer for instant detection of CoV-2 and 2) an airborne detector for real-time, continuous surveillance of a large space. A novel ultra-sensitive, antibody-based electrochemical biosensor to detect CoV-2 repeat binding domain (RBD) spike protein was developed. The technology was based on a micro-immunoelectrode (MIE) biosensor pioneered by the Cirrito laboratory to study protein dynamics in the setting of neurodegeneration. The biosensor used voltammetry to measure the oxidation of tyrosine amino acids; oxidation was the release of electrons that the biosensor measures as a change in current. Antibodies were covalently attached to the electrode surface to provide selectivity. This prototype CoV-2 biosensor was sensitive to 2 femtogram/ml, compared to several current CoV-2 antigen tests that are sensitive to the low picogram/ml range. The proposal (Aim 1) optimized the CoV-2 biosensor to detect CoV-2 viral particles, as well as test several parameters to increase sensitivity and longevity. In Aim 2, a test breathalyzer was built that will utilize a nebulizer to generate virus laden air containing aerosol droplets similar to a breath that contain defined concentrations of CoV-2 viral particles. Aim 3 tested the airborne biosensor in a realistic environment. Co-I Chakrabarty's laboratory had unique capabilities of mimicking real-world environmental conditions, especially in the context of atmospheric aerosols, necessary for testing and optimizing the biosensor's performance for field deployment. Atmospheric conditions included relative humidity (RH) and temperature, as well as common airborne pollutants found indoors. Finding novel means to detect the CoV-2, as well as create a platform to detect other and future pathogens, which would enable the ability to limit the viral spread throughout the community in the current and future pandemics." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_214> <http://schema.org/funding> <https://okn.wobd.org/grant/3P50HD103525-01S1> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/153" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_44> <http://schema.org/sameAs> "10.60773/eya4-rh89" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_202> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_59> <http://schema.org/identifier> "phs002565" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_205> <http://schema.org/sameAs> "10.60773/kkcm-b102" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_108> <http://schema.org/author> <https://okn.wobd.org/person/yale_university> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_170> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_208> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_61> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/grant/1U01AI122285-01> <http://schema.org/endDate> "2019-03-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/john_hopkins_university> <http://schema.org/name> "John Hopkins University;" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_120> <http://schema.org/url> "https://radxdatahub.nih.gov/study/120" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_151> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_168> <http://schema.org/sameAs> "10.60773/xb7r-qw92" .
<https://okn.wobd.org/grant/1P01HL114471-01A1> <http://schema.org/identifier> "1P01HL114471-01A1" .
<https://ror.org/006zn3t30> <http://schema.org/alternateName> "National Institute of Arthritis & Musculoskeletal & Skin Diseases" .
<https://okn.wobd.org/grant/1R01AI153044-01A1> <http://schema.org/endDate> "2025-03-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_57> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2901879> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_122> <http://schema.org/name> "Puipuia le Ola: Increasing Reach and Uptake of COVID-19 Testing Among Pacific Islanders in Hawaii and Guam" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_167> <http://schema.org/sameAs> <https://doi.org/10.60773/83zk-vv89> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/143" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_203> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_59> <http://schema.org/datePublished> "2022-06-06"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_172> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_46> <http://schema.org/sameAs> "10.60773/1qmd-nt62" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_208> <http://schema.org/dateModified> "2024-03-04"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_221> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_148> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005550> .
<https://ror.org/004a2wv92> <http://schema.org/alternateName> "Instituto Nacional de Investigación Dental y Craneofacial" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_101> <http://schema.org/funding> <https://okn.wobd.org/grant/1U54CA260492-01> .
<http://purl.obolibrary.org/obo/MONDO_0010528> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_188> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/yn52-cp83> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/167" .
<https://okn.wobd.org/grant/1S10OD023527-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9274502" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_173> <http://schema.org/name> "REACH-OUT: Research, Engagement and Action on COVID-19 Health Outcomes via Testing" .
<https://okn.wobd.org/person/university_of_arkansas_for_medical_sciences> <http://schema.org/name> "University of Arkansas for Medical Sciences" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_120> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2901879> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_147> <http://schema.org/description> "This competitive revision submitted to the RADx-UP Initiative (NOT-20-121) aimed to extend the infrastructure of P50 Implementation Science Center for Cancer Control Equity (ISCCCE) to accelerate COVID testing in 9 hotspot communities in MA. ISCCCE is a strong partnership with the Massachusetts League of Community Health Centers, in which the team co-designed studies to increase implementation of evidence-based practices focused on equity. Together, this study was extremely well-positioned to extend the community-engaged efforts to COVID-19 testing, and to build an infrastructure that would support future COVID-related mitigation and prevention efforts in the vulnerable communities that the community health centers (CHCs) serve. This project included 6 community health center- community partnerships in nine vulnerable communities that continue to be COVID hot spots. These communities collectively had 1.3 million residents. Partner CHCs focused on COVID-19 testing for diagnostic purposes in symptomatic individuals, with limited outreach testing in high-risk communities. This project expanded the scope of testing to include prospective surveillance activities using dedicated testing and outreach teams. Accelerated testing efforts focused on CHC patients and community members who had significant social and medical vulnerabilities to COVID, per the NOSI, including those living in congregate housing, people experiencing homelessness, those with substance use disorders, low wage essential workers, and those with limited English proficiency. The partnership was well-integrated into the State's testing and contact tracing strategy, and well-positioned to leverage those resources. The study drew on a strongly community-engaged, equity-focused approach to implementation, and on Mass League's extensive experience in HIV testing and contact tracing. This study used an interrupted time series design to evaluate the impact of the enhanced outreach efforts on testing rates overall and on priority populations in the context of different phases of re-opening and restrictions. This study also used an exploratory sequential mixed methods approach to conduct a series of community-engaged pilot studies to address key barriers to testing and different approaches to return of results. The Human Participant Research Unit, co-led by academic and community-based investigators, guided the partnership's work through an ethics and equity lens. The study supported the CHC-community partnerships through the Testing Capacity and Innovation Team, which provided infectious disease expertise and technical guidance on COVID testing. The Community Communications Team used educational and communication design strategies to develop culturally and linguistically appropriate materials to support the testing activities." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_115> <http://schema.org/description> "Many low-income Americans, racial and ethnic minorities, and other marginalized groups live in information-poor environments, disproportionately exposed to misinformation about COVID-19, and distrusting medical, government, and scientific institutions and leaders. These and other social, cultural, and behavioral factors pose significant obstacles to public health efforts to increase population testing and vaccination in a pandemic. Testing and vaccination efforts must be paired with an understanding of the needs and cultures of different communities, and the contexts in which people live must be considered, especially among groups hit hardest by the COVID-19 pandemic. The study approach was built on strong evidence from the team's decades-long program of health communication research to eliminate disparities, especially proven message tactics such as cultural values, disparity framing, and narratives, that was applied to the COVID-19 context. Specifically, a multi-method content analysis of 43,000+ COVID-19 testing inquiries to 2-1-1 callers was conducted with the following aims: Aim 1) Survey and interview over 500 2-1-1 callers and phone operators; Aim 2) Develop and evaluate in randomized A-B testing new COVID-19 testing messages among 300 2-1-1 callers; and Aim 3) Taken together, these activities identified essential contexts and content for communicating about COVID-19 testing to vulnerable populations, and Aim 3 integrated this knowledge into proven message tactics and determined their impact on interest in, and intention to be tested, and other key outcomes. The existing partnership with 2-1-1 was central to this research. Of the 24 priority populations identified in the NOSI, 2-1-1s serve a higher proportion of callers from nearly every group compared to their proportion of the U.S. population, including 60-80% racial or ethnic minorities, 40-55% with household income below $10,000, and 1 in 4 who have not completed high school. During COVID-19, 2-1-1s in 36 states have fielded 964,286 COVID-19 requests. These first-hand accounts from underserved Americans concerned about, or affected by, COVID-19 must inform communication efforts, and the infrastructure of 2-1-1 was well suited to support rapid testing of promising approaches." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_168> <http://schema.org/author> <https://okn.wobd.org/person/university_of_maryland> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_177> <http://schema.org/dateCreated> "2022-08-19"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_78> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_170> <http://schema.org/author> <https://okn.wobd.org/person/arizona_state_university> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_143> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/q8pd-9n90> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_100> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1T32DA007292-01A1> <http://schema.org/url> "https://reporter.nih.gov/project-details/2119721" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_136> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_75> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_191> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/wrsw-vq98> .
<https://www.uniprot.org/taxonomy/11709> <http://schema.org/name> "Human immunodeficiency virus 2" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_161> <http://schema.org/url> "https://radxdatahub.nih.gov/study/161" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_139> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_58> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_151> <http://schema.org/url> "https://radxdatahub.nih.gov/study/151" .
<https://ror.org/00372qc85> <http://schema.org/identifier> "https://ror.org/00372qc85" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_37> <http://schema.org/identifier> "phs002537" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_155> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_126> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR002538-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_207> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/yry0-5j59> .
<http://schema.org/identifier> <http://www.w3.org/2000/01/rdf-schema#domain> <http://schema.org/Thing> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_71> <http://schema.org/author> <https://okn.wobd.org/person/inc_nys_department_of_health> .
<https://okn.wobd.org/grant/1P30GM114737-01> <http://schema.org/startDate> "2015-07-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_70> <http://schema.org/url> "https://radxdatahub.nih.gov/study/70" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/271" .
<https://okn.wobd.org/person/capitol_area_reentry_program> <http://schema.org/name> "Capitol Area Reentry Program" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_183> <http://schema.org/name> "Evidence-based Interventions - Individual, Community, and Structural Factors That Predict Lower Rates of COVID-19 Screening Testing in Underserved and Vulnerable Populations" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_87> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_176> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/130" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_27> <http://schema.org/datePublished> "2022-11-07"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_209> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_175> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0011122> .
<https://okn.wobd.org/person/john_hopkins_university> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_29> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/12637> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_161> <http://schema.org/sameAs> <https://doi.org/10.60773/w35s-2a90> .
<https://okn.wobd.org/grant/75N93021C00015-0-9999-2> <http://schema.org/funder> <https://ror.org/043z4tv69> .
<https://okn.wobd.org/grant/1R01HD091218-01> <http://schema.org/endDate> "2022-03-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_52> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/grant/1UL1TR001866-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9261077" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_210> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR002378-01> .
<https://okn.wobd.org/person/ascension_wisconsin> <http://schema.org/name> "Ascension Wisconsin" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_113> <http://schema.org/sameAs> "10.60773/nvkn-xv26" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_46> <http://schema.org/sameAs> <https://doi.org/10.60773/1qmd-nt62> .
<https://okn.wobd.org/grant/1R01HL124209-01A1> <http://schema.org/name> "Defining the roles of RIPK1 and RIPK3 in emergency hematopoiesis" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_274> <http://schema.org/sameAs> "10.60773/8e0v-pk44" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/author> <https://okn.wobd.org/person/children_s_hospital_of_michigan> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_30> <http://schema.org/datePublished> "2022-07-21"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1P20GM121342-01A1> <http://schema.org/funder> <https://ror.org/04q48ey07> .
<https://okn.wobd.org/grant/1U19AI142733-01> <http://schema.org/name> "Modulation of Lung Immune Responses to Viral Infection" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_211> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005550> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_160> <http://schema.org/sameAs> "10.60773/8yg5-8e14" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_92> <http://schema.org/datePublished> "2023-08-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_81> <http://schema.org/identifier> "phs002578" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_70> <http://schema.org/funding> <https://okn.wobd.org/grant/1K23AI121485-01A1> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_101> <http://schema.org/url> "https://radxdatahub.nih.gov/study/101" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_178> <http://schema.org/datePublished> "2022-09-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_138> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://ror.org/00j4k1h63> <http://schema.org/identifier> "https://ror.org/00j4k1h63" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_161> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_42> <http://schema.org/dateModified> "2022-12-09"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1U19AI135995-01> <http://schema.org/endDate> "2023-01-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_32> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_114> <http://schema.org/identifier> "phs002709" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_166> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_158> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_76> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01AI123105-01A1> <http://schema.org/funder> <https://ror.org/043z4tv69> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_68> <http://schema.org/funding> <https://okn.wobd.org/grant/1UG3OD023365-01> .
<https://okn.wobd.org/grant/1P30MH062246-01> <http://schema.org/endDate> "2006-08-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1UL1TR002001-01> <http://schema.org/name> "The University of Rochester's Clinical and Translational Science Institute" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_185> <http://schema.org/description> "People with criminal legal system involvement (CLSI) have experienced five times as many COVID-19 infections and have three times the risk of death compared to general population in the U.S. Heavily impacted by COVID-19 and squarely within NIH health disparities populations, people with CLSI are often poor and disproportionately from racial and ethnic minority groups. Despite the increased risk of COVID-19, it is expected that only one-half of people with CLSI will get vaccinated. Ongoing COVID-19 testing in communities and among groups that are not vaccinated will be key to containing the pandemic. The messaging that COVID-19 testing will still be important may not be getting through to people who are at risk - a critical driver of disparities. This team had a unique opportunity to boost testing literacy, access, and uptake using mobile health (mHealth) technologies (text and Web) to reach women with CLSI in community settings who are part of the existing Tri-City Cohort drawn from geographically and socio-politically diverse cities: Birmingham, AL, Kansas City, MO/KS, and Oakland, CA. This application was highly responsive to the RADx-UP Phase II call for research that tests interventions to reduce COVID-19 disparities among underserved populations. The team was positioned to embed the study into an existing Web-based women's health literacy intervention platform (www.shewomen.org, 2R01CA181047) for women leaving jail. The study was also able to immediately push the mHealth COVID-19 testing literacy intervention to 508 women that have already recruited to a three-city cervical health study of women with CLSI (R01CA226838), and to promptly make this scalable intervention widely available to people with CLSI. The study engaged the women as stakeholders to study regional and individual differences in COVID-19 testing and vaccine literacy, access, and uptake. This study used findings to rapidly develop an mHealth intervention focused on COVID-19 literacy, and then pushed the intervention to CLSI women in the three cities to boost COVID-19 literacy, testing, access, and uptake, and vaccination. Findings were used to develop dissemination strategies with stakeholders to push the mHealth intervention to the two million women and 11 million men who interface with the criminal legal system annually in the U.S." .
<https://okn.wobd.org/grant/1R35GM138152-01> <http://schema.org/startDate> "2020-09-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1P30DK063720-01> <http://schema.org/name> "Diabetes Research and Training Center" .
<https://okn.wobd.org/grant/1S10OD026929-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9709001" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_31> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/grant/1P30AI073961-01> <http://schema.org/identifier> "1P30AI073961-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_274> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_175> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_108> <http://schema.org/author> <https://okn.wobd.org/person/university_of_dayton> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_167> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/grant/1K12NS098482-01> <http://schema.org/endDate> "2021-07-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1U54GM115516-01A1> <http://schema.org/startDate> "2017-07-03"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/valley_childrens_healthcare> <http://schema.org/name> "Valley Childrens Healthcare" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/42" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_32> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_71> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/NCIT_C3137> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_143> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005046> .
<https://okn.wobd.org/grant/1R01AI107301-01> <http://schema.org/endDate> "2018-06-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1UL1TR002541-01> <http://schema.org/name> "The Harvard Clinical and Translational Science Center" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_158> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/grant/5P30CA008748-20> <http://schema.org/identifier> "5P30CA008748-20" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_175> <http://schema.org/description> "The Georgia Center for Diabetes Translation Research Center (P30DK111024) proposed to collaborate with the RADx-UP Diabetes rural community partner and utilized locally developed and tested Georgia CEAL (1OT2HL156812-01/16-312-0217571-66105L) COVID-19 communication materials to enhance COVID-19 testing in addition to vaccine confidence and uptake in underserved populations most severely affected by COVID-19 disease (i.e., African Americans and Latinos with diabetes, prediabetes, and their household contacts (\"bubble). The 1-year project implemented and evaluated a brief Community Health Worker (CHW) intervention through the Albany Area Primary Health Care, a rural Federally Qualified Health Center (FQHC). The primary goal of this study was to maximize effective outreach, education, and communication through CHWs in order to facilitate improved COVID-19 vaccine confidence and uptake in underserved and vulnerable communities. CHWs were deployed to the homes of adults with increased risk of morbidity and mortality (i.e., African Americans or Latinos with uncontrolled diabetes or prediabetes, age <50 years, and non-COVID-19 vaccinated) in order to educate them about diabetes, COVID-19 and related vaccines. Health assessments, including blood glucose measurement, were conducted on the indexed patient and offered to all other adult family members in the household (i.e., \"bubble\"). Adults with Type 2 diabetes likely live in households with other adults who have or are at increased risk for diabetes (i.e., prediabetes and obesity). It was expected that they would also share similar COVID-19 exposure risk. The specific aims were to: 1) Evaluate a community-driven education program to increase and enhance COVID-19 vaccine confidence and uptake in individuals with uncontrolled diabetes and their families (i.e., their \"bubble\") and 2) Evaluate a community-driven education program to improve diabetes self-management behaviors and related outcomes (e.g., blood glucose) in individuals with uncontrolled diabetes in rural, Southwest Georgia." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_162> <http://schema.org/url> "https://radxdatahub.nih.gov/study/162" .
<https://okn.wobd.org/grant/8P51OD011132-52> <http://schema.org/startDate> "1997-05-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_85> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_126> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_163> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_170> <http://schema.org/datePublished> "2022-07-22"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_71> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/umass_lowell> <http://schema.org/name> "UMass Lowell" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_167> <http://schema.org/sameAs> "10.60773/83zk-vv89" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_96> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_135> <http://schema.org/url> "https://radxdatahub.nih.gov/study/135" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/49" .
<https://ror.org/040gcmg81> <http://schema.org/parentOrganization> "National Institutes of Health" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_156> <http://schema.org/datePublished> "2023-08-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_119> <http://schema.org/dateCreated> "2022-01-06"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_60> <http://schema.org/funding> <https://okn.wobd.org/grant/1U01AI122285-01> .
<https://ror.org/012pb6c26> <http://schema.org/alternateName> "NHLBI" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_151> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/grant/1UL1TR002373-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9514389" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_214> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/grant/1R21AI133331-01> <http://schema.org/startDate> "2017-06-26"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_192> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/ewt6-jf83> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_84> <http://schema.org/name> "Increasing Representation of Black Communities in SARS-CoV-2 Serosurveys by Understanding Barriers and Motivations for Participation (Represent ATL)" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_147> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1T32HD044355-01> <http://schema.org/funder> <https://ror.org/04byxyr05> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_192> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_88> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/grant/1R01DA055491-01> <http://schema.org/funder> <https://ror.org/00fq5cm18> .
<https://okn.wobd.org/grant/1UL1TR001085-01> <http://schema.org/funder> <https://ror.org/04pw6fb54> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_158> <http://schema.org/name> "A Nurse-Community Health Worker-Family Partnership Model: Addressing Uptake of COVID-19 Testing and Control Measures" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/194" .
<https://okn.wobd.org/grant/1P30CA240139-01> <http://schema.org/funder> <https://ror.org/040gcmg81> .
<https://ror.org/04byxyr05> <http://schema.org/alternateName> "Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_37> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/1986198> .
<https://okn.wobd.org/person/university_of_michigan> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://ror.org/0493hgw16> <http://schema.org/alternateName> "NIMHD" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_87> <http://schema.org/sameAs> <https://doi.org/10.60773/ydsc-2z38> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_144> <http://schema.org/funding> <https://okn.wobd.org/grant/1P30AI064518-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_177> <http://schema.org/author> <https://okn.wobd.org/person/csula> .
<https://okn.wobd.org/grant/4UH3OD023365-03> <http://schema.org/name> "Pre-adolescent and Late-adolescent Follow-up of the CHARGE Study Children" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_196> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_190> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR002319-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_167> <http://schema.org/url> "https://radxdatahub.nih.gov/study/167" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_76> <http://schema.org/datePublished> "2023-08-29"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_70> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_192> <http://schema.org/author> <https://okn.wobd.org/person/cook_county_hhs> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/187" .
<https://okn.wobd.org/grant/1K12NS098482-01> <http://schema.org/startDate> "2016-08-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://www.uniprot.org/taxonomy/2697049> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/person/university_of_kansas> <http://schema.org/name> "University of Kansas" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_139> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/grant/1R01AI153044-01A1> <http://schema.org/startDate> "2021-04-09"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/j_f_k_middle_school> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_66> <http://schema.org/dateModified> "2024-01-18"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01CA193776-01> <http://schema.org/startDate> "2015-05-04"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_173> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/grant/1S10OD025082-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9494292" .
<https://okn.wobd.org/grant/1K12HD000850-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/3088221" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_146> <http://schema.org/description> "By leveraging the infrastructure and community partnerships formed through the ABC Science Collaborative, this project assessed the effectiveness of rapid surveillance testing in reducing within-school transmission and restoring trust among Black and Latino families to return to in-person school, as well as assess the uptake of school-based testing and time to safe school return after SARS-CoV-2 exposure." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_71> <http://schema.org/url> "https://radxdatahub.nih.gov/study/71" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_157> <http://schema.org/funding> <https://okn.wobd.org/grant/1T32EB028092-01A1> .
<https://okn.wobd.org/person/johns_hopkins_school_of_medicine> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_185> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_174> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_55> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/person/emory_university> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_188> <http://schema.org/url> "https://radxdatahub.nih.gov/study/188" .
<https://okn.wobd.org/grant/1P30GM114737-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/8883300" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_182> <http://schema.org/funding> <https://okn.wobd.org/grant/3P50HD103525-01S1> .
<https://okn.wobd.org/grant/1R01HD106120-01> <http://schema.org/startDate> "2021-08-09"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_110> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/rqhz-1a60> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_216> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/grant/1UG3OD023365-01> <http://schema.org/funder> <https://ror.org/00fj8a872> .
<https://okn.wobd.org/person/north_miami_middle_school> <http://schema.org/name> "North Miami Middle School" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01GM138385-01A1> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/144" .
<https://okn.wobd.org/grant/3T32GM083937-01A1S1> <http://schema.org/funder> <https://ror.org/04q48ey07> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_214> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/1qf8-w396> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_65> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/grant/1T32EB028092-01A1> <http://schema.org/funder> <https://ror.org/00372qc85> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_43> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_132> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR001866-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_145> <http://schema.org/datePublished> "2023-08-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_99> <http://schema.org/author> <https://okn.wobd.org/person/froedtert_medical_college_of_wisconsin_clinics_15> .
<https://okn.wobd.org/grant/1ZIAAI001222-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9566783" .
<https://okn.wobd.org/grant/1P30GM131944-01> <http://schema.org/funder> <https://ror.org/04q48ey07> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_143> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR002373-01> .
<https://okn.wobd.org/grant/1UM1AI106716-01> <http://schema.org/identifier> "1UM1AI106716-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_68> <http://schema.org/name> "Portable GC Detector for COVID Diagnostics" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_200> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/116" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_150> <http://schema.org/identifier> "phs002878" .
<https://okn.wobd.org/grant/1T32GM128596-01> <http://schema.org/name> "Predoctoral Training Program in Biological Data Science at Brown University" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/identifier> "phs002525" .
<https://okn.wobd.org/grant/9P30AI050410-04> <http://schema.org/funder> <https://ror.org/00fq5cm18> .
<https://okn.wobd.org/grant/4R33HD105590-03> <http://schema.org/name> "Diagnosing and predicting risk in children with SARS-CoV-2- related illness" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_177> <http://schema.org/sameAs> "10.60773/50dx-sm74" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_196> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/6hh3-jr12> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_122> <http://schema.org/datePublished> "2023-08-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_116> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_146> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR002319-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_72> <http://schema.org/sameAs> "10.60773/sqkn-3a50" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_72> <http://schema.org/description> "The goals of this Emergency Competitive Revision were to develop (Aim 1) and deploy (Aim 2) a novel, objective, psychophysical smell and taste screening test to detect the onset of COVID-19 in at-risk populations. Complementary to the temperature screening procedures currently in use, this tool was predicted to promote early identification of COVID onset, leading to better prognoses and the early implementation of protocols to prevent community spread. A hard-candy containing different combinations of tastants and flavors that were easy to distribute to a large population were used. During the development phase (Aim 1), this novel test was compared with the NIH toolbox to assess the acceptability and efficacy of the two methods. It was expected that the hard-candy assessment would be at least as efficacious in detecting chemosensory loss but more acceptable to subjects. Aim 2 entailed daily self-monitoring of chemosensory function in at-risk populations with data tracked through a secure online portal. The novelty of this confectionary-based test was that it provided standard stimuli that can yield objective measures of both the qualitative and quantitative aspects of smell (aroma and flavor) and taste (sweet and sour). Moreover, both orthonasal and retronasal olfactory function were independently assessed. The test can be self-administered and the familiar, pleasant nature of the stimuli facilitated a high compliance rate, allowing for continuous monitoring over prolonged periods. Moreover, the test was rapid and inexpensive. Data were incorporated into a predictive model for COVID-19 and assessed using AOC analyses of sensitivity and specificity. OSU is a leading large public land grant university with a varied population of students, faculty, and support staff that includes all health care specialties. These characteristics, along with the University-mandated regular PCR testing of students and staff made it a perfect site to perform this urgent research." .
<https://okn.wobd.org/grant/1P30AI027767-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<http://schema.org/Dataset> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2000/01/rdf-schema#Class> .
<https://okn.wobd.org/person/iowa_state_university> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/person/university_of_pennsylvania> <http://schema.org/name> "University of Pennsylvania" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_117> <http://schema.org/name> "Improved Scalability, Sensitivity, and Interpretability of Pathogen Detection, Including SARS-CoV-2, in Wastewater using High-Throughput, Highly Multiplexed Digital Array PCR Technology" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_191> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_197> <http://schema.org/sameAs> <https://doi.org/10.60773/k8wj-0k62> .
<https://okn.wobd.org/grant/4UH3AI122309-03> <http://schema.org/endDate> "2020-08-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_55> <http://schema.org/datePublished> "2022-07-21"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://www.uniprot.org/taxonomy/12814> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_112> <http://schema.org/sameAs> <https://doi.org/10.60773/jv00-r132> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_166> <http://schema.org/funding> <https://okn.wobd.org/grant/3P50HD103525-01S1> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_168> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/grant/1P30GM114737-01> <http://schema.org/identifier> "1P30GM114737-01" .
<https://okn.wobd.org/grant/1T32GM128596-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/person/university_of_hawaii> <http://schema.org/name> "University of Hawaii" .
<https://okn.wobd.org/grant/1P30GM114737-01> <http://schema.org/endDate> "2020-06-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_116> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_205> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_207> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_62> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/114727> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_221> <http://schema.org/sameAs> <https://doi.org/10.60773/9br0-er28> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_192> <http://schema.org/sameAs> "10.60773/ewt6-jf83" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_108> <http://schema.org/description> "Smell loss is a predominant symptom of COVID-19, and initial evidence based on self-reports suggests that chemosensory loss is a sensitive predictor of COVID-19 in the general population, more so than fever. However, given the natural lack of awareness of chemosensory changes, self-reports underestimate the true prevalence of smell loss in patients with COVID-19 by 20% compared to an objective test. Therefore, this study examined testing and deploying a rapid and objective measure of smell ability, the SCENTinel test, inspired by the NIH Toolbox Odor Identification Test. SCENTinel was an inexpensive, convenient, and robust smell test for COVID-19 surveillance of the population that quickly and easily assesses three smell loss factors: odor detection, odor intensity, and odor identification. It was designed for practical use in several contexts, including high-density areas such as community medical sites, universities, subacute care facilities, and both industrial and nonindustrial workplaces. The multi-disciplinary team had expertise in understanding taste and smell, developing and validating chemosensory tests, as well as studying the broad symptomatology of COVID-19. This project aimed to a) fine-tune SCENTinel's ability to predict a positive COVID-19 diagnostic test; b) examine marginal smell loss as a sign of the earliest phases of COVID-19, before a positive diagnostic test; and c) assess the test's psychometric validity with test-retest reliability measures and validation against the NIH Toolbox Odor Identification Test. Together, these aims established a standardized protocol for use of SCENTinel as a rapid and objective smell test that can easily be incorporated into onsite COVID-19 testing centers, schools, and workplaces nationwide. Furthermore, it provided key insights into early-onset chemosensory symptoms in relation to a confirmed COVID-19 diagnosis, providing a crucially needed means to contain the spread of COVID-19." .
<https://okn.wobd.org/grant/1P30ES030285-01> <http://schema.org/funder> <https://ror.org/00j4k1h63> .
<http://purl.obolibrary.org/obo/MONDO_0011122> <http://schema.org/name> "obesity disorder" .
<https://ror.org/04byxyr05> <http://schema.org/alternateName> "Eunice Kennedy Shriver National Institute of Child Health and Human Development at the National Institutes of Health" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_76> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_121> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_190> <http://schema.org/dateModified> "2024-04-10"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1UL1TR002373-01> <http://schema.org/name> "Institutional Clinical AND Translational Science Award" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_205> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_118> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_153> <http://schema.org/name> "Obesity Health Disparities Research Center (OHDRC) COVID-19 Testing Model Among Vulnerable Populations From Community Engagement to Follow-Up" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_182> <http://schema.org/description> "The goal of this study was to use surveys to characterize social, ethical, and behavioral factors associated with parents of K-8 students' willingness to return their children to in-person school (or to remain in school), and their support for and compliance with COVID-19 infection control and prevention strategies in eight underserved school systems in Maryland." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_204> <http://schema.org/identifier> "phs003362" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_220> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/cpws-7m93> .
<https://okn.wobd.org/grant/1U01CA260539-01> <http://schema.org/identifier> "1U01CA260539-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_38> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_162> <http://schema.org/date> "2022-12-09"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.obolibrary.org/obo/MONDO_0005109> <http://schema.org/name> "HIV infectious disease" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_70> <http://schema.org/date> "2022-12-09"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_162> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/277p-e595> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_220> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_86> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_149> <http://schema.org/description> "Racial/ethnic minority and low socioeconomic status (SES) populations suffer profound health inequities across a wide variety of conditions as well as a disproportionate burden of the negative health consequences of the COVID-19 pandemic. Latinos make up ~14% of the Utah population vs. ~21% of Utah's COVID-19 cases (50% higher) and the case rate is over 3-fold higher in neighborhoods characterized by high vs. low deprivation. In the Utah 2020-2021 school year, there have been 36,484 school-associated cases of COVID-19. The ongoing partnerships with the Utah Department of Health (UDOH) allowed access to real-time information on \"hotspot schools\" across the state. One of the Utah school district partners, Granite School District (n=85 schools), had the 3rd highest number of cases of COVID-19 and 45% of its schools have a student population with >50% eligible to receive free/reduced lunch and 60% have a student population that is >50% ethnic minority. Schools bear a large part of the burden of managing COVID-19 testing and communicating with parents about testing their children. Few schools in Utah have information technology systems in place to support systematic communication with parents about student COVID-19 testing and tracking testing outcomes. Through the existing RADx-UP grant (UL1TR002538-03S4), the team developed a text messaging and health navigator infrastructure that was deployed in federally-qualified health centers across Utah. The study chose to use text messaging because it is widely available in underserved communities, with 97% of individuals with an annual income <$30,000 and 96% with educational attainment of high school or less having a phone that can text. This project addressed key testing challenges in schools by building on existing collaborations with school districts and with UDOH on COVID-19 testing and existing infrastructure. This study worked closely with schools and the Utah public health system to implement and test a shovel-ready and scalable health information technology approach that delivers automated text messages (TMs) to staff and students' parents around COVID-19 testing. In addition, students in some schools received a health navigator (HN) follow-up to ensure that tests are completed. HN were community members who have been trained in case management. Families were offered the recently FDA-approved in-home serial testing approach if accessing in-person testing was a challenge. Within the context of a cluster-randomized trial, this study employed a rapid cycle design to test interventions on a small scale, using short time frames (<1month) and iterative evaluation cycles. This approach was extremely successful in the current RADx-UP project, SCALE-UP Utah. The proposed trial compared the efficacy of TM versus TM+HN. This project had several potential impacts on COVID-19 testing for elementary and middle school students in disadvantaged school settings: 1] SCALE-UP Counts provided critical data on the impact of pragmatic and scalable approaches to increasing COVID-19 testing and reducing COVID-19-related health inequities among students and their families. 2] The rapid cycle research approach utilized in this project allowed the team to quickly disseminate effective interventions to other schools and adapt interventions to changing testing policies and local outbreaks and rates. 3] The use of HNs who are members of the students' communities maximized the team's ability to integrate communities' cultural factors and strengths and to promote the acceptability of the testing support provided. 4] SCALE-UP Counts hold a significant impact on community transmission of COVID-19 due to the provision of testing to students' immediate household members. Rates of household transmission were 50-75% and thus, ensuring testing for households is essential towards decreasing community spread. 5] The interventions were made readily available for adoption by other disadvantaged school settings and the data will advance population health and implementation science." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_108> <http://schema.org/author> <https://okn.wobd.org/person/kids_frankford_friends> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_75> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0004995> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_112> <http://schema.org/description> "In collaboration with community partners, a public health intervention was created and impact of the intervention was evaluated in the area of Cumberland County, Maine, to provide outreach, testing, and vaccination education to a large community of immigrants from sub-Saharan Africa, the Middle East, and Central America, higher-risk low-income people accessing a public health facility (with a sexually transmitted infections clinic, needle exchange, and a free clinic), and individuals experiencing homelessness. This included a longitudinal study to understand beliefs about and knowledge of COVID-19, and barriers and beliefs about testing and vaccination. Results informed a community-developed and based intervention to engage the cohort and other members of these populations in testing and vaccine education, and evaluated the impact of this intervention on testing and vaccination uptake in immigrant, low-income, and homeless communities. The Specific Aims were: (Aim 1) To understand patient perceptions of, fears about, and experiences with COVID-19 testing in immigrant, low-income, and homeless populations; (Aim 2a) To use the data from Aim 1 to develop and pilot test public health messaging in these immigrant, low-income, and homeless populations, and to develop a strategy for a testing program; (Aim 2b) To use the data from Aims 1 and 2a to develop, pilot test, and implement a walk-up, COVID-19 testing program to increase testing uptake in these immigrant, low-income, and homeless populations; and (Aim 3) To evaluate the impact of a public health messaging and testing program developed in Aim 2b on rapid COVID-19 testing uptake." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_36> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_139> <http://schema.org/name> "Lupus Education Alliance Program (LEAP)" .
<https://okn.wobd.org/grant/1R01GM089784-01A1> <http://schema.org/name> "COMBINED COMPUTATIONAL AND EXPERIMENTAL ANALYSES OF GENE REGULATION BY MICRORNAS" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/73" .
<https://okn.wobd.org/grant/1K01MH112436-01> <http://schema.org/startDate> "2017-05-24"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_191> <http://schema.org/sameAs> "10.60773/wrsw-vq98" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/author> <https://okn.wobd.org/person/david_geffen_school_of_medicine_at_ucla> .
<http://schema.org/name> <http://www.w3.org/2000/01/rdf-schema#domain> <http://schema.org/Thing> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_39> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/1986198> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_66> <http://schema.org/identifier> "phs002585" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_207> <http://schema.org/dateCreated> "2023-07-27"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_101> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01HG009518-01A1> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_140> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0006663> .
<https://okn.wobd.org/grant/1P30MH062246-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_274> <http://schema.org/datePublished> "2024-09-13"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_111> <http://schema.org/datePublished> "2023-08-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_54> <http://schema.org/url> "https://radxdatahub.nih.gov/study/54" .
<https://ror.org/006zn3t30> <http://schema.org/alternateName> "NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_218> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/sameAs> <https://doi.org/10.60773/vaeg-ht26> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_101> <http://schema.org/description> "Latinos are among the most heavily impacted communities by the COVID-19 pandemic in the US, with more than 3 times higher infection rate than non-Hispanic whites. To address this disparity, this team of investigators and community partners established a multi-pronged approach that leveraged the skill set of trusted bilingual/bicultural peer navigators (or promotoras) to address social determinants of health (SDOH) that create barriers to testing (such as lack of insurance, immigration status, stigmatization or loss of job/ income), and to expand access to free COVID-19 testing in community settings. Preliminary findings show that leveraging the promotora model for timely delivery of results (within 48 hours), paired with rapid linkage of COVID-19 positive patients to critical services (including clinical follow-up, food delivery, cash assistance, and/or isolation hotel), and referral of contacts for testing, increased acceptability and uptake of COVID-19 testing in a heavily impacted Latino community. The overall goal of this Phase I Testing Research Project called Juntos (Together) was to work closely with community partners to systematically evaluate and refine current COVID-19 testing strategies, and to implement and evaluate innovative customized strategies to rapidly increase reach, access, acceptance, uptake, and sustainment of FDA-authorized/approved diagnostics (especially viral tests) for this highly vulnerable and health care marginalized community. Leveraging community partnerships and prior experience implementing an HIV testing campaign, a customized Juntos COVID- 19 testing campaign was developed and evaluated to address specific common concerns in the Latino community and link users to existing Johns Hopkins COVID-19 community testing sites and to new options, including home-based and/or self- testing kits and rapid tests (Aim 1). Assessment of the overall impact of the Juntos COVID-19 Testing Project will rely on the latest in causal inference methods for evaluating population-level health interventions and a synthetic control analysis will be implemented to compare testing uptake and positivity rate among Latinos in Baltimore City (intervention site) as compared to control zip codes across Maryland. (Aim 2). Finally, informed by Consolidated Framework for Implementation Research (CFIR) and RE-AIM framework, the implementation determinants, mechanisms, and outcomes of existing and novel Juntos testing interventions will be assessed to inform future broad-scale implementation (Aim 3). A multi-disciplinary team with methodological expertise in implementation science, community-based research, and laboratory medicine, has been assembled, and the mature and long-standing collaboration with partners at Esperanza Center, Casa de Maryland, the Mayor's Office of Immigrant Affairs, and religious leaders will be leveraged." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_112> <http://schema.org/datePublished> "2023-08-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.obolibrary.org/obo/MONDO_0005550> <http://schema.org/name> "infectious disease" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_99> <http://schema.org/url> "https://radxdatahub.nih.gov/study/99" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_101> <http://schema.org/datePublished> "2023-08-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://ror.org/00fq5cm18> <http://schema.org/alternateName> "NIDA" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_60> <http://schema.org/author> <https://okn.wobd.org/person/yale_pediatric_genomics_discovery_program> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/88" .
<https://ror.org/00j4k1h63> <http://schema.org/alternateName> "The National Institute of Environmental Health Sciences" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_84> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/35" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_218> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/grant/1P01CA214274-01A1> <http://schema.org/identifier> "1P01CA214274-01A1" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_117> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_57> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_71> <http://schema.org/dateModified> "2024-01-18"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1U54GM115677-01> <http://schema.org/startDate> "2016-07-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_60> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01HL149450-01A1> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_186> <http://schema.org/dateCreated> "2022-10-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_140> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/grant/2UL1TR000457-06> <http://schema.org/endDate> "2017-05-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R25EB020393-01A1> <http://schema.org/startDate> "2015-09-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_207> <http://schema.org/description> "Children with intellectual and developmental disabilities (IDD) are at major risk of irreversible harm from the Coronavirus Infectious Diseases 2019 (COVID-19) pandemic, particularly those from underserved populations. Not only are they at dramatically higher risk of becoming infected with Severe Acute Respiratory SyndromeCoronavirus-2 (SARS-CoV-2) and death from COVID-19, but children with IDD are vulnerable to the negative impact of school closure. School districts provide critical services beyond the education, including nutritional, social, therapy (physical, occupational, and speech-language) and healthcare services. Risks are heightened for children with IDD, as they are often unable to wear masks, practice social distancing and/or implement effective hand hygiene. Access to rapid and reliable SARS-CoV-2 testing is essential for children with IDD and school staff in order to safely return to school. Members of the research team have developed an innovative, scalable, low-cost method for SARS-CoV-2 testing using saliva samples. Investigators at the Washington University Intellectual and Developmental Disabilities Research Center (IDDRC@WUSTL), in collaboration with the University of Missouri-Kansas City Institute of Human Development and the Kennedy Krieger Institute in Maryland (which includes an IDDRC, the Maryland Center for Developmental Disabilities, and the Kennedy Krieger School Programs), are ideally positioned to determine the best implementation strategies to maximize use of a saliva-based SARS-CoV-2 diagnostic test for vulnerable children and school staff in a school setting. The IDDRC@WUSTL has a long-standing relationship with the Special School District (SSD) of St. Louis County, whose mission is to serve children with IDD, and the national network of the Association of University Centers on Disabilities (AUCD). First, the most effective messaging and implementation strategies to maximize weekly SARS-CoV-2 testing in a school setting were determined. In this adaptive clinical trial, 52,000 diagnostic tests to students and school staff at SSD, whose student population is 48% Black were administered. Second, the study measured national attitudes among parents/guardians of children with IDD and school staff regarding the impact of COVID-19 and the importance of SARS-CoV-2 testing. At the successful completion of this project, the study improved the acceptance, adoption, and process for SARS-CoV-2 diagnostic testing in a school-based setting to enable delivery of critical educational activities for children with IDD in an underserved community. By identifying the most effective methods for SARS-CoV-2 testing in a vulnerable population of children with IDD, the study established a blueprint for wider adoption of COVID-19 mitigation efforts, such as vaccination." .
<https://okn.wobd.org/grant/1R01DE026471-01A1> <http://schema.org/endDate> "2022-06-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1P30AI042853-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/2595903" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_75> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0006663> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/versionDate> "2025-03-26"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_32> <http://schema.org/datePublished> "2024-04-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_157> <http://schema.org/dateCreated> "2022-05-06"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_66> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_41> <http://schema.org/name> "AFS/SERS Saliva-Based SARS-CoV-2 Earliest Infection and Antibodies Detection" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_122> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/3P50HD103525-01S1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/person/university_of_iowa> <http://schema.org/name> "University of Iowa" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/120" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_182> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/person/university_of_utah_health_care> <http://schema.org/name> "University of Utah Health Care" .
<https://ror.org/004a2wv92> <http://schema.org/name> "National Institute of Dental and Craniofacial Research" .
<https://okn.wobd.org/grant/1R01HG009120-01A1> <http://schema.org/funder> <https://ror.org/00baak391> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_59> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/wd0m-eh53> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_66> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://ror.org/04byxyr05> <http://schema.org/parentOrganization> "National Institutes of Health" .
<https://okn.wobd.org/person/wayne_state_university> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<http://schema.org/infectiousAgent> <http://www.w3.org/2000/01/rdf-schema#domain> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/funding> <https://okn.wobd.org/grant/1U01DA053941-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_178> <http://schema.org/description> "This was a sub-study of the COVID-19 Test At Home Study. The objective was to gather data on performance of Quidel QuickVue for detection of SARS-CoV-2. This sub-study was used to provide data to Quidel to supplement their existing EUA application for an at-home test. In this study, asymptomatic participants with known close contact to someone who was positive for SARS-CoV-2 infection within the past seven days was asked to self-administer a Quidel QuickVue test and receive a comparator PCR test at the study site on the first day of the study. Thereafter, participants received a test-kit to perform Quidel QuickVue test daily at home, preferably in the morning, for five consecutive days. Participants were asked to return to the study site on day 2 for a second PCR test and on the final day (study day 6). However, if any of the home-tests from days 3-5 resulted as positive or participants developed symptoms and their PCR test result was negative on days 1-2, they were asked to come to the study-site for a comparator PCR test earlier than day 6. Participants were given two additional days to return to the study site if they were unable to come on day 6 for an exit PCR; for those participants, they performed an additional Quidel QuickVue test at home before the standard test at the study site. This means that if they came in on day 6, then no at home test was performed on days 7 and 8. If they came in on day 7 then they performed a test at home on day 7. If they came in on day 8 then they performed a test at home on days 7 and 8. The primary objective of this sub-study was to evaluate the performance (positive percent agreement and negative percent agreement) of the Quidel QuickVue test when self-administered by participants in an unsupervised setting at the study site in comparison to a comparator PCR test performed the same day by study staff. Secondary objectives of this sub-study were to: 1) evaluate the performance (positive percent agreement and negative percent agreement) of the Quidel QuickVue test when self-administered by participants at home in comparison to a comparator PCR performed at the beginning and end of the study and 2) Compare self-reported interpretation of QuickVue test result with interpretation made by a study staff in-person (on day 1) and digitally (days 2-6)." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_83> <http://schema.org/author> <https://okn.wobd.org/person/indiana_university> .
<https://okn.wobd.org/grant/1U54GM115516-01A1> <http://schema.org/funder> <https://ror.org/04q48ey07> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_208> <http://schema.org/sameAs> "10.60773/86j7-he45" .
<https://okn.wobd.org/grant/1UL1TR001873-01> <http://schema.org/funder> <https://ror.org/04pw6fb54> .
<https://okn.wobd.org/grant/1UL1TR002319-01> <http://schema.org/funder> <https://ror.org/04pw6fb54> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_190> <http://schema.org/author> <https://okn.wobd.org/person/fred_hutchinson_cancer_research_center> .
<https://okn.wobd.org/person/and_william_and_mary_college> <http://schema.org/name> "and William and Mary College" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_55> <http://schema.org/sameAs> "10.60773/fp1q-f015" .
<https://okn.wobd.org/person/howard_university> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/grant/1T32EB009380-01> <http://schema.org/endDate> "2014-06-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1P30AI036214-01> <http://schema.org/startDate> "1994-04-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://ror.org/049v75w11> <http://schema.org/parentOrganization> "National Institutes of Health" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_110> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/person/san_ysidro_health_centers> <http://schema.org/name> "San Ysidro Health Centers" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_119> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/2seb-yr47> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_169> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_60> <http://schema.org/author> <https://okn.wobd.org/person/maria_fareri_children_s_hospital_westchester_medical_center> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_152> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/grant/1R01AI123538-01A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_61> <http://schema.org/sameAs> "10.60773/a1js-pv10" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_123> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_190> <http://schema.org/url> "https://radxdatahub.nih.gov/study/190" .
<https://okn.wobd.org/grant/1R01GM122080-01> <http://schema.org/name> "Deciphering the Regulatory Role of Small RNAs on Alternative Splicing  " .
<https://okn.wobd.org/grant/7P30DK034987-01A1> <http://schema.org/url> "https://reporter.nih.gov/project-details/3102072" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_127> <http://schema.org/funding> <https://okn.wobd.org/grant/1U24TR001608-01> .
<https://okn.wobd.org/grant/1R01GM138385-01A1> <http://schema.org/endDate> "2024-05-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01GM122080-01> <http://schema.org/endDate> "2020-07-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_153> <http://schema.org/url> "https://radxdatahub.nih.gov/study/153" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_166> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<http://schema.org/dateModified> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2001/XMLSchema#dateTime> .
<http://purl.obolibrary.org/obo/MONDO_0003265> <http://schema.org/name> "adjustment disorder" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_97> <http://schema.org/funding> <https://okn.wobd.org/grant/8UL1TR000042-07> .
<https://okn.wobd.org/grant/1R03DK117252-01> <http://schema.org/endDate> "2020-03-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_51> <http://schema.org/date> "2023-06-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_88> <http://schema.org/sameAs> <https://doi.org/10.60773/7x5v-ym43> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_121> <http://schema.org/date> "2024-04-09"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01HG009518-01A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://ror.org/04pw6fb54> <http://schema.org/alternateName> "NCATS" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_111> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005377> .
<https://okn.wobd.org/grant/5P30CA008748-20> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_86> <http://schema.org/sameAs> "10.60773/s0km-xf55" .
<https://okn.wobd.org/person/long_beach> <http://schema.org/name> "Long Beach" .
<https://okn.wobd.org/grant/1U01HG010971-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9905992" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_99> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R21AI133331-01> <http://schema.org/funder> <https://ror.org/043z4tv69> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_92> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/grant/1S10OD026929-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_141> <http://schema.org/identifier> "phs002791" .
<https://okn.wobd.org/grant/1R01AI125416-01> <http://schema.org/identifier> "1R01AI125416-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_99> <http://schema.org/description> "Fight COVID MKE used randomized COVID antibody testing in Milwaukee County, Wisconsin to measure the population proportion infected and how this proportion varies over time and with patient demographic and health characteristics. Through partnerships with 20 primary care health centers and with local churches and community agencies to conduct community outreach and engagement, the study oversampled minority, poor, and elderly populations to obtain more precise estimates for these groups. Fight COVID MKE gathered patient-reported health data and leverage extensive data linkages from Wisconsin state data partners to assess the risks of infection progressing to symptoms, hospitalization, ICU stay, or death and to calculate population infection rates as a function of patient and community characteristics. A web-based risk assessment tool was developed in English and Spanish to allow individuals, families, and health care professionals to assess individual risk and advise high-risk individuals on risk mitigation as well as vaccination." .
<https://okn.wobd.org/grant/1T32EB009380-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/7643569" .
<https://okn.wobd.org/grant/1U19AI135995-01> <http://schema.org/name> "Consortium for Viral Systems Biology (CViSB)" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_68> <http://schema.org/datePublished> "2022-08-02"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_67> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_81> <http://schema.org/sameAs> <https://doi.org/10.60773/fc6a-gf05> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_84> <http://schema.org/datePublished> "2023-12-07"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_127> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_179> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/8s4e-d179> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_52> <http://schema.org/name> "Wastewater Assessment for Coronavirus in Kentucky: Implementing Enhanced Surveillance Technology" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_92> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_28> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_151> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/347537> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_82> <http://schema.org/url> "https://radxdatahub.nih.gov/study/82" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_216> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2901879> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_203> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_92> <http://schema.org/description> "This project used a geographically diverse quantitative survey to assess patterns and disparities in COVID-19 testing and preventive behaviors longitudinally across 6 months, as well as the impact of multilevel factors, including stigma and policy. Informed by the results of this survey, and guided by the Information, Motivation, and Behavioral Skills (IMB) Model, a mixed-methods approach was used to iteratively develop a community engaged, health messaging intervention tailored towards SGMY and REMY to increase testing and preventive behaviors, provisionally titled Prev_Cvd. This text messaging intervention was pilot tested by 100 REMY and SGMY to refine content and determine feasibility and acceptability. Given the lack of messaging guidelines for this population, this was the first evidence-based messaging intervention for COVID-19 prevention among YYA. Developing and pilot testing such an intervention with active input from the community will allow for the intervention, if effective, to be rapidly scaled up and widely implemented to address disparities in COVID-19 among YYA and reduce overall transmission." .
<https://okn.wobd.org/grant/1UL1TR001442-01> <http://schema.org/identifier> "1UL1TR001442-01" .
<https://okn.wobd.org/grant/1U54CA132384-01A1> <http://schema.org/startDate> "2008-09-29"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1U54GM104942-01> <http://schema.org/identifier> "1U54GM104942-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_208> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_80> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://ror.org/00fj8a872> <http://schema.org/identifier> "https://ror.org/00fj8a872" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_137> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005249> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_143> <http://schema.org/dateCreated> "2022-02-25"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_117> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_82> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/wbd9-yd79> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_74> <http://schema.org/dateModified> "2024-01-18"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_124> <http://schema.org/datePublished> "2022-11-10"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/113" .
<https://okn.wobd.org/grant/8P20GM103395-12> <http://schema.org/url> "https://reporter.nih.gov/project-details/8231369" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_132> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2901879> .
<https://okn.wobd.org/grant/1UL1TR001863-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0008383> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_194> <http://schema.org/sameAs> "10.60773/z740-hc64" .
<https://okn.wobd.org/grant/1R01HD106120-01> <http://schema.org/identifier> "1R01HD106120-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_96> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/yrkh-gy81> .
<https://okn.wobd.org/grant/3T32GM083937-01A1S1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_218> <http://schema.org/description> "This project showed how COVID-19 surveillance testing influences secondary infection and school attendance and how it influences disparities in these outcomes associated with student characteristics, including poverty, race and ethnicity. The project studied how surveillance testing influences disparities in parent perceptions of safety, decisions to return in-person, and daily attendance." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_92> <http://schema.org/name> "Supporting COVID-19 Prevention and Testing for Marginalized and Minoritized Youth and Young Adults" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_217> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/ewfr-hd70> .
<https://okn.wobd.org/grant/1DP2DA040254-01> <http://schema.org/endDate> "2020-08-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_97> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_80> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/dp9b-t353> .
<https://okn.wobd.org/person/arizona_state_university> <http://schema.org/name> "Arizona State University" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_145> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005550> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_68> <http://schema.org/date> "2024-01-18"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_63> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_203> <http://schema.org/dateCreated> "2023-07-27"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/ascension_wisconsin> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_41> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_207> <http://schema.org/author> <https://okn.wobd.org/person/and_johns_hopkins_university_school_of_medicine> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01HL105704-01> <http://schema.org/name> "Broad Detection of Infectious Agents in Blood by Microarrays and Deep Sequencing" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_60> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/grant/1P30AI064518-01> <http://schema.org/name> "Center for AIDS Research (CFAR)" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_144> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/NCIT_C101788> .
<https://okn.wobd.org/grant/1R01AI155696-01> <http://schema.org/name> "Macrophage Polarization in Response to Infections and Inflammation" .
<https://okn.wobd.org/grant/4R33HD105590-03> <http://schema.org/funder> <https://ror.org/00fj8a872> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_144> <http://schema.org/funding> <https://okn.wobd.org/grant/1P30MH058107-01> .
<https://okn.wobd.org/grant/1U54CA156732-01> <http://schema.org/endDate> "2015-08-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/university_of_maryland_school_of_medicine> <http://schema.org/name> "University of Maryland School of Medicine" .
<https://okn.wobd.org/grant/6U48DP006395-01M001> <http://schema.org/funder> <https://okn.wobd.org/organization/national_center_for_chronic_disease_prev_and_health_promo> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_115> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_115> <http://schema.org/dateCreated> "2022-01-06"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_99> <http://schema.org/author> <https://okn.wobd.org/person/16th_street_community_health_ctr> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_71> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01AI151059-01> .
<https://okn.wobd.org/grant/8P20GM103429-11> <http://schema.org/name> "Partnerships for Biomedical Research in Arkansas" .
<https://okn.wobd.org/grant/1DP2DA040254-01> <http://schema.org/startDate> "2015-07-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_271> <http://schema.org/url> "https://radxdatahub.nih.gov/study/271" .
<https://okn.wobd.org/person/outreach_community_health_ctr> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_43> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01CA193776-01> .
<https://okn.wobd.org/grant/1R01AI107301-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/8562610" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_180> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_150> <http://schema.org/description> "San Diego State University (SDSU), a designated Hispanic-serving institution, partnered with Sweetwater Union High School District, an independent public school district serving 90% ethnic minority and a high proportion of socioeconomically disadvantaged students, and other community partners, to generate evidence for effective and feasible COVID-19 testing for middle school students and staff as part of broader COVID mitigation strategies including vaccination to return students back to school safely. Specific aims were to: 1) determine if providing free at-home COVID-19 rapid antigen testing kits produces equivalent participation in school screening testing as on-site school testing; 2) evaluate if a family-based model of making testing available to family members enhances participation; 3) study implementation of the program to inform scale-up to additional schools; and 4) identify resources needed to ensure ongoing high participation rates." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_79> <http://schema.org/author> <https://okn.wobd.org/person/columbia_university> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_209> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_39> <http://schema.org/name> "Large Scale Flu Surveillance Study (LSFS)" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_191> <http://schema.org/funding> <https://okn.wobd.org/grant/3P50HD103525-01S1> .
<https://okn.wobd.org/person/oregon_rural_practice_based_research_network> <http://schema.org/name> "Oregon Rural Practice-based Research Network" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_35> <http://schema.org/datePublished> "2022-11-07"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/granite_school_district> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_73> <http://schema.org/description> "There are limited studies on the spread of SARS-CoV-2 infection in rural essential workers. This gap-in-knowledge were addressed to develop and implement novel pandemic strategies to keep open rural essential workplaces, such as coal mines. The long-term goal of the study was to mitigate the spread of the pandemic in miners, a population of high-risk, rural essential workers who are susceptible and vulnerable to COVID-19, and who are predominantly racial/ethnic minorities in New Mexico (NM). The study objective was to provide proof-of-principle for frequent point-of-care molecular testing as a workplace surveillance tool to monitor and prevent the spread of SARS-CoV-2 infection in this unique population. The central hypothesis was that frequent workplace molecular surveillance is an effective method to reduce SARS-CoV-2 infection and discover novel host risk factors. The site of molecular surveillance (intervention site) was a surface mine in McKinley County, NM, located just outside the Navajo Nation, comprised of 66% minority miners. Miners at the intervention site will provide nasal swabs every alternate work shift, which were analyzed with the Abbott ID Now, COVID-19 test, i.e., the 'index' test. The control mine located at Campbell County, Wyoming, has similar mine characteristics as the intervention mine. The rationale for this study was to establish the suitability of longitudinal molecular surveillance to prevent and control SARS-CoV-2 infection in this unique population by completing the following aims. Specific Aim 1: To determine the acceptance rate to frequent point-of-care molecular workplace surveillance among miners. Hypothesis 1: Miners will have a cumulative acceptance rate of frequent testing at 85%, with the added objective of exploring difference in acceptance by miner characteristics. Specific Aim 2: To determine the ability to detect the presence of SARS-CoV-2 by point-of-care molecular workplace surveillance in a real-world setting of miners. Hypothesis 2: The sensitivity of the index test in a real-world study setting is a) comparable to that described by others in controlled settings, and b) positively associated with viral load in upper respiratory specimens. Specific Aim 3: To determine the effectiveness and implementation costs of frequent point-of-care molecular workplace surveillance on reducing incident infection rates of SARS-CoV-2. Hypothesis 3A: Frequent point-of-care molecular testing over six months in the intervention mine will result in lower incident seropositivity rates compared to the control mine. Hypothesis 3B: Frequent point-of-care molecular surveillance in the intervention mine is cost-effective compared to the control mine. Specific Aim 4: To determine novel predictive host factors associated with incident SARS-CoV-2 infection in miners. Hypothesis 4: Miners with incident infection demonstrate less frequent use of cloth face coverings outside the workplace, greater mine dust exposure intensity, presence of dust-related lung disease, and racial/ethnic minority status than those not infected. Successful completion of the study established the acceptability and effectiveness of the proposed surveillance in work settings where common occupational mitigation strategies were not possible. Findings from this study provided broad-reaching implications for novel pandemic strategies to keep rural essential workplaces open. By working with the NIH RADx-UP Coordinating and Data Collection Center, this study provided crucial data for subsequent studies of vaccine interventions in rural minority essential workers." .
<https://okn.wobd.org/grant/1R56HL149881-01A1> <http://schema.org/url> "https://reporter.nih.gov/project-details/10266229" .
<https://okn.wobd.org/grant/1K12NS098482-01> <http://schema.org/identifier> "1K12NS098482-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_96> <http://schema.org/description> "Transgender (TG) people are a NIH-designated health disparities population with high morbidity and mortality across multiple health conditions, including HIV infection, mental health, and substance use. These conditions are a product of, and are exacerbated by, historical and ongoing discrimination and inequities in access to healthcare. In early 2020, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) was recognized as a global pandemic. To date, no data exists on COVID-19 disease in TG people. There is an urgent need to understand the burden of COVID-19 disease, investigate its impact on other health conditions and vulnerabilities burdening TG populations, and identify future public health intervention targets. This project aimed to fill this gap. To accomplish these goals, disparities in access to testing among TG people were identified and mitigated. The parent LITE study enrolled a baseline sample of more than 1,500 TG women in the eastern and southern U.S. to assess HIV risk across 24 months of biobehavioral follow-up using technology-enhanced, digital methods of data capture. Leveraging the LITE infrastructure and in partnership with two community-based organizations, this research aided in the development of LITE-CONNECT, a rapid, community-engaged mixed-methods assessment that enrolled over 2,000 TG men and women across the U.S. The objective of this supplemental study was to characterize access and barriers to COVID-19 testing, provide access to and evaluate the use of home-based COVID-19 antibody testing to identify past infection and potential immunity, connect TG men and women to available community-based COVID-19 testing and support services, and identify community-based solutions to support access to COVID-19 testing, interventions, and care among TG people. Results from this study were rapidly used to inform community-based efforts and national COVID-19 response that were inclusive of TG people. The research provided critical and timely insights about COVID-19 disease in TG people in a space in which almost no information currently exists. Early identification of disparities in COVID-19 morbidity and in access to COVID-19 testing and care was critical to ensuring access to services as the pandemic continues. Existing infrastructure and community collaborations were leveraged to gather new data, including unprecedented data from TG men, to guide urgently needed interventions to improve and optimize the health and wellbeing of TG people in the context of the COVID-19 pandemic." .
<https://okn.wobd.org/grant/1P01CA214274-01A1> <http://schema.org/url> "https://reporter.nih.gov/project-details/9491131" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_76> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR003107-01> .
<https://okn.wobd.org/grant/1R01ES028615-01> <http://schema.org/funder> <https://ror.org/00j4k1h63> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_137> <http://schema.org/datePublished> "2022-07-21"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://ror.org/00372qc85> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Organization> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_219> <http://schema.org/identifier> "phs003507" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/grant/1U01DA053941-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/10264591" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_58> <http://schema.org/funding> <https://okn.wobd.org/grant/1P30ES030283-01A1> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_152> <http://schema.org/name> "Ethno-epidemiology of Hepatitis C (HCV), HIV and Overdose associated with Drug Markets and Drug Tourism" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_36> <http://schema.org/dateModified> "2024-04-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_108> <http://schema.org/dateModified> "2024-01-18"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1S10OD018499-01> <http://schema.org/identifier> "1S10OD018499-01" .
<https://okn.wobd.org/grant/1P30ES030283-01A1> <http://schema.org/url> "https://reporter.nih.gov/project-details/9917940" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_87> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/ydsc-2z38> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01AI146165-01A1> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_57> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_49> <http://schema.org/funding> <https://okn.wobd.org/grant/1P30NS047101-01> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/200" .
<https://okn.wobd.org/grant/1K12HD047349-01> <http://schema.org/name> "Pediatric Critical Care Scientist Development Program" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/url> "https://radxdatahub.nih.gov/" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_221> <http://schema.org/description> "Many multilayered barriers increase risk for COVID-19 among AA including poverty, essential jobs with increased virus exposure, cultural norms (e.g., risk denial, medical/contact tracing mistrust), chronic health conditions, and limited access to healthcare and other services/resources. These barriers highlight the need for accessible, trusted COVID-19 testing and linkage to antiviral treatment and care services (LTC; e.g., health, prevention programs, community resources, contact tracing) and to community resources (e.g., food, rent assistance) to help slow COVID-19 spread in AA communities. The AA church is an institution with extensive influence in AA communities and may be an ideal setting for increasing reach of COVID-19 test-to-treat (TTT) interventions with LTC in hard hit AA communities. Yet, no controlled AA church-based studies exist on COVID-19 TTT interventions. The primary aim of this study was to fully test a culturally/religiously-tailored, church-based COVID-19 TTT with LTC intervention condition against a non-tailored education condition on COVID-19 rapid testing rates at 6 months with adult AA church members and the community members they serve. Churches were matched on membership size, denomination and past participation in church health intervention studies, then randomized to treatment condition. Twelve churches (6 churches per arm; 55 church and 20 community members/church; N=900 total) participated in the study. Antiviral and contact tracing intentions and use were examined at 6 months as secondary outcomes. Other types of COVID-19 testing and linkage to care use were also assessed. Guided by the Theory of Planned Behavior and Socioecological Model, the community-engaged approach included trained church leaders delivering a culturally, church-appropriate COVID-19 TTT Toolkit inclusive of digital tools: a) individual self-help materials and automated/tailored text messages; b) ministry group educational information; c) virtual/in-person church services with COVID-19 related materials/activities (e.g., sermons, pastors modeling rapid-self testing, testimonials, bulletins); and d) church-community level linkage to care (LTC) services (e.g., contact tracing, treatment, healthcare, community resources) provided by contact tracers serving as community health workers (CHW). Intervention churches hosted 2 COVID-19 TTT events and provided members with take-home COVID-19 rapid self-test kits. Potential mediators/moderators related to receipt of COVID-19 testing were evaluated, and a process evaluation was done to determine implementation facilitators, barriers, and fidelity related to increasing COVID-19 testing rates. This novel study was the first to fully test a COVID-19 TTT intervention in AA churches. It provided a theory-based, multilevel scalable model for equipping AA churches to deliver wide-reaching COVID-19 rapid testing and promote treatment with health agency partners." .
<https://okn.wobd.org/grant/1R01ES028615-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9403132" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_213> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/grant/75N93021C00016-0-9999-4> <http://schema.org/name> "CEIRR: SARS-CoV-2 Research Activities" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01AI107301-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_40> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_96> <http://schema.org/identifier> "phs002658" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_159> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/person/northwestern_university_and_john_hopkins_university> <http://schema.org/name> "Northwestern University and John Hopkins University" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_210> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_134> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1UL1TR000460-01A1> <http://schema.org/funder> <https://ror.org/0493hgw16> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_120> <http://schema.org/dateCreated> "2022-01-06"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_28> <http://schema.org/date> "2024-04-09"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1ZIAAI001175-01> <http://schema.org/funder> <https://ror.org/043z4tv69> .
<https://okn.wobd.org/person/charles_r_drew_university_of_medicine_and_science> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_163> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/grant/4UH3AI122309-03> <http://schema.org/startDate> "2015-09-25"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/centro_de_estudios_en_infectología_pediátrica> <http://schema.org/name> "Centro de Estudios en Infectología Pediátrica" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_157> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01HD106120-01> .
<https://okn.wobd.org/grant/2UL1TR000457-06> <http://schema.org/startDate> "2007-09-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_151> <http://schema.org/name> "A Dynamic COVID-19 Community-Engaged Testing Strategy in Alabama (COVID COMET AL)" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_201> <http://schema.org/dateModified> "2024-03-27"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_271> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_146> <http://schema.org/name> "SARS-CoV-2 Screening and Diagnostic Testing for Return to K-12 Schools" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_129> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005550> .
<https://okn.wobd.org/grant/1UM1HG008898-01> <http://schema.org/endDate> "2019-11-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01DK121072-01A1> <http://schema.org/identifier> "1R01DK121072-01A1" .
<https://okn.wobd.org/grant/1R35GM119850-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9142975" .
<https://okn.wobd.org/grant/1R01AI123538-01A1> <http://schema.org/name> "Role of Stx11 and STXBP2 in lytic granule exocytosis in health and disease" .
<https://ror.org/04byxyr05> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Organization> .
<http://schema.org/Organization> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2000/01/rdf-schema#Class> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_184> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2839062> .
<https://okn.wobd.org/grant/1R01HL140898-01> <http://schema.org/funder> <https://okn.wobd.org/organization/national_heart_lung_and_blood_institute> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_196> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_166> <http://schema.org/sameAs> "10.60773/td0b-xf65" .
<https://okn.wobd.org/grant/1P30AI073961-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/7252865" .
<http://purl.obolibrary.org/obo/MONDO_0000465> <http://schema.org/name> "atrioventricular block" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_48> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005550> .
<https://okn.wobd.org/grant/9P30AI050410-04> <http://schema.org/startDate> "2001-08-20"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/8G12MD007595-04> <http://schema.org/funder> <https://ror.org/0493hgw16> .
<https://okn.wobd.org/person/university_of_massachusetts_chan_medical_school> <http://schema.org/name> "University of Massachusetts Chan Medical School" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/196" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/38" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/159" .
<https://okn.wobd.org/grant/1P30AI064518-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/1R35GM138152-01> <http://schema.org/name> "Improving metagenomic analysis with novel algorithms and technologies" .
<http://schema.org/parentOrganization> <http://www.w3.org/2000/01/rdf-schema#range> <http://schema.org/Organization> .
<https://okn.wobd.org/grant/1UM1AI106716-01> <http://schema.org/endDate> "2020-11-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://schema.org/dateCreated> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_114> <http://schema.org/date> "2022-12-09"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_170> <http://schema.org/author> <https://okn.wobd.org/person/upenn> .
<https://okn.wobd.org/grant/1P30AI036214-01> <http://schema.org/funder> <https://ror.org/043z4tv69> .
<https://okn.wobd.org/grant/1T32CA203702-01A1> <http://schema.org/startDate> "2017-07-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_199> <http://schema.org/sameAs> <https://doi.org/10.60773/ad5b-vx98> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_138> <http://schema.org/dateCreated> "2022-01-29"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01HD091218-01> <http://schema.org/startDate> "2017-04-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/penn_state_university> <http://schema.org/name> "Penn State University" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_158> <http://schema.org/datePublished> "2023-08-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_207> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_71> <http://schema.org/author> <https://okn.wobd.org/person/university_of_connecticut> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR000460-01A1> .
<http://purl.obolibrary.org/obo/NCIT_C101788> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_80> <http://schema.org/identifier> "phs002575" .
<https://okn.wobd.org/person/cornell_university> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_87> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR002366-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_187> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_199> <http://schema.org/identifier> "phs002634" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_128> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_76> <http://schema.org/funding> <https://okn.wobd.org/grant/3OT2HL156812-01S2> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_192> <http://schema.org/datePublished> "2023-02-21"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_113> <http://schema.org/date> "2024-04-10"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1DP2DA040254-01> <http://schema.org/identifier> "1DP2DA040254-01" .
<https://okn.wobd.org/grant/1R01DK107585-01A1> <http://schema.org/name> "Innate responses following infection with enteric microbes" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_27> <http://schema.org/sameAs> <https://doi.org/10.60773/hz9w-yy91> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_221> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/9br0-er28> .
<https://okn.wobd.org/person/sognef_inc> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_208> <http://schema.org/author> <https://okn.wobd.org/person/association_for_utah_community_health> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_54> <http://schema.org/sameAs> "10.60773/7th6-st50" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_134> <http://schema.org/identifier> "phs002776" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_124> <http://schema.org/name> "Rolosense: An Innovative Platform for Automatic Mobile Phone Readout of Active SARS-CoV-2" .
<https://okn.wobd.org/person/university_of_washington> <http://schema.org/name> "University of Washington" .
<https://okn.wobd.org/grant/1R01AG066749-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9947647" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_68> <http://schema.org/description> "The data herein combined GC-MS and GC-DMS analysis of exhaled breath vapor compounds. The intent of this study was to develop a portable GC-DMS system to diagnose SARS-CoV-2 infections from a breath sample. The data were collected from hundreds of subjects in an IRB-sanctioned study. Breath vapor samples were collected from COVID-19(+) patients, including asymptomatic and symptomatic, and from healthy COVID-19(-) controls. Relevant human demographic information was also collected such as age, gender, height, weight, symptoms at time of sampling, etc." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_129> <http://schema.org/sameAs> <https://doi.org/10.60773/869q-b786> .
<https://okn.wobd.org/grant/1T32AI007291-01A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_82> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_190> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_46> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1P30AI027767-01> <http://schema.org/funder> <https://ror.org/043z4tv69> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_187> <http://schema.org/url> "https://radxdatahub.nih.gov/study/187" .
<https://okn.wobd.org/grant/2T32CA009140-11> <http://schema.org/name> "IMMUNOBIOLOGY OF NORMAL AND NEOPLASTIC LYMPHOCYTES" .
<http://purl.obolibrary.org/obo/MONDO_0005447> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/grant/6U48DP006395-01M001> <http://schema.org/identifier> "6U48DP006395-01M001" .
<https://okn.wobd.org/grant/1T32AI007291-01A1> <http://schema.org/endDate> "1991-08-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.obolibrary.org/obo/NCIT_C154635> <http://schema.org/name> "Death Domain" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/172" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_43> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/grant/1T32AI007384-01> <http://schema.org/endDate> "1995-07-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_135> <http://schema.org/identifier> "phs002777" .
<https://okn.wobd.org/grant/1R01AI141630-01A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_96> <http://schema.org/url> "https://radxdatahub.nih.gov/study/96" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_31> <http://schema.org/identifier> "phs002628" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_142> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_125> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_42> <http://schema.org/author> <https://okn.wobd.org/person/columbia_university> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_68> <http://schema.org/url> "https://radxdatahub.nih.gov/study/68" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_205> <http://schema.org/description> "This study worked with diverse correctional facilities across MN, RI, WA, and FL to characterize the incidence of COVID-19 disease progression and related outcomes. The goal was to identify barriers and facilitators to develop strategies to improve testing in these under-served populations by: Increasing the reach, access, uptake, and impact of COVID-19 testing among incarcerated people and staff in prison and jails. Individuals in congregate settings have been disproportionately affected by COVID-19, with correctional settings accounting for 39 of the 50 largest cluster outbreaks in the country to date. Schema of Correctional Facilities: Correctional facilities are amplifiers of infectious diseases for structural reasons: 1) Dormitory-style living and overcrowded conditions make social distancing nearly impossible 2) They have a focus primarily on security not health 3) Their medical departments are under-resourced and often disconnected from local public health agencies. Correctional facilities must be the focus of urgent intervention to understand the incidence of COVID-19, how it spreads in correctional facilities, and durable long-term strategies to reduce transmission, including testing and vaccines. However, the work from the COVID Prison Project showed that correctional systems have implemented a range of testing strategies, without coordination, such that synthesizing the information on COVID-19 incidence, outcomes and optimal testing strategies (including repeat testing and contact tracing) has been challenging. Incarcerated people decline testing due to concerns about confidentiality, implications for release, and fear of placement in solitary confinement. Through interviews, ethical concerns and potential solutions were identified for COVID-19 testing and vaccine strategies in correctional facilities using a community-engaged strategy. The project's work from the COVID Prison Project showed that correctional systems have implemented a range of testing strategies, without coordination, such that synthesizing the information on COVID-19 incidence, outcomes and optimal testing strategies (including repeat testing and contact tracing) was challenging. The goals of this study were to: (1) identify ethical concerns and potential solutions for COVID-19 testing and vaccine strategies in correctional facilities using a community-engaged strategy, and (2) characterize incidence of COVID-19, disease progression, and related-outcomes and effectiveness of testing and contact tracing in correctional facilities. Potential subjects had to be incarcerated at key facilities in Washington, Rhode Island, Minnesota, and Florida at the time of recruitment. These facilities were Everglades Correctional Institution and Homestead Correctional Institution in Florida, Shakopee and Stillwater correctional facilities in Minnesota, the Rhode Island Department of Corrections, and Yakima County Jail in Washington. Participating correctional facilities in Florida, Minnesota, Rhode Island, and Washington provided de-identified data on approximately 16,859 incarcerated adults and correctional staff. Data sources included de-identified data from medical records, administrative data, and policy documents pertaining to COVID-19. Three series of focus groups (6, 12, 18 months) across three distinct groups (incarcerated people, medical providers, and correctional leaders) and four sites amounted to 36 total focus groups over the study period. 74,812 COVID-19 tests were utilized to test and 16,859 incarcerated people and correctional staff were re-tested for active infection over a six-month period in the FL, MN, and RI state prison systems and the Yakima County Jail in WA." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_202> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/sfgj-td47> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_162> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005550> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_169> <http://schema.org/dateCreated> "2022-07-22"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_69> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/10239> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_57> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_205> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/kkcm-b102> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_119> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2901879> .
<https://ror.org/049v75w11> <http://schema.org/alternateName> "NIH NATIONAL INSTITUTE ON AGING" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_174> <http://schema.org/sameAs> <https://doi.org/10.60773/kha0-tt06> .
<https://okn.wobd.org/grant/1R01AI123105-01A1> <http://schema.org/name> "Early HIV Effects on Gut Immunity and Inflammation for Seeding Viral Reservoirs" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_53> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2901879> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_149> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_181> <http://schema.org/sameAs> "10.60773/prjv-tg60" .
<https://okn.wobd.org/person/umass_chan_medical_school_and_northwestern_university> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_144> <http://schema.org/description> "The SARS-CoV-2, also known as COVID-19, pandemic has caused disastrous and unprecedented public health and economic consequences in the U.S., seriously affecting Americans' physical and mental health. Death rates attributable to COVID-19 among minority populations are several folds higher than among predominantly White counties. South Florida and specifically Miami-Dade County is an epicenter of the COVID-19 pandemic, where non-Hispanic Blacks and Latinos are overrepresented in COVID-19 related hospitalizations and deaths. Pervasive structural inequities and social determinants of health are the main cause of health disparities due to a complex interaction of multiple factors including individual and societal risk factors. Understanding the impacts of these factors on health and social consequences of the pandemic has broad policy implications, especially for the acceptance of testing and future vaccines. This research helps address the impact of COVID-19 on vulnerable minority populations and examined: (1) the barriers to testing and uptake of future vaccines, (2) effectiveness of community engagement to increase the uptake of COVID-19 testing in the underserved communities, (3) acceptability, sensitivity and specificity of using less invasive testing methods compared to nasopharyngeal swabs, and (4) assessment of barriers and potential strategies to engage community members and community organizations in COVID-19 testing and vaccine deployment. Community-engaged research studies (in collaboration with community-based partners) were conducted to: (a) determine barriers to testing, and uptake of future vaccines, including health literacy, stigma, drug use and financial burden associated with testing, follow-up care, feasibility of effective self-isolation if positive, and perceived effectiveness of testing and vaccination, (b) assessment of the acceptability of extensive community outreach and deployment of a mobile COVID-19 testing unit to geographical areas occupied by underserved and vulnerable populations in close proximity to a community partner, Borinquen Health Care Center (BHCC), and (c) compare the acceptability, sensitivity, and specificity of alternative approaches to obtain samples, including medically administered nasopharyngeal swabs and saliva. The goal was to improve understanding of COVID-19-related health disparities; enhance access, effectiveness, and implementation of COVID-19 testing in vulnerable and/or underserved populations; and to mobilize the community to develop culturally-appropriate strategies to mitigate the COVID-19 epidemic and increase acceptance of future vaccines. The potential for evidence-based approaches to address COVID-19 disparities was facilitated by community-based partners that have the resources to provide community engagement, follow-up care, and public health mitigation for cases who test positive; the PI who managed a CLIA-certified laboratory at the university and a research team experienced in recruiting and retaining >1,000 study participants from the same vulnerable and underserved populations." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_142> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_182> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_168> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_108> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_55> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/NCIT_C16880> .
<https://okn.wobd.org/grant/1P30CA045508-01> <http://schema.org/funder> <https://ror.org/03q21mh05> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_77> <http://schema.org/description> "This study leveraged a current partnership with HIV Alliance, an Oregon-based nonprofit dedicated to supporting individuals living with HIV/AIDS and preventing new HIV infections, to embed a COVID-19 testing program with a brief motivational enhancement intervention in their Syringe Services Programs (SSPs). SSPs offer a natural venue for testing as well as vaccination, when available, for people who inject drugs. This project was undertaken to enhance COVID-19 testing access and reach for a significantly underserved population that is vulnerable to SARS-CoV-2 transmission and at increased risk for severe COVID-19 symptoms." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_63> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_189> <http://schema.org/sameAs> <https://doi.org/10.60773/veb6-px50> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_57> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_83> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_57> <http://schema.org/datePublished> "2023-10-18"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_150> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/person/temple_university> <http://schema.org/name> "Temple University" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_120> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_184> <http://schema.org/sameAs> "10.60773/5b7f-0206" .
<https://okn.wobd.org/person/johns_hopkins_bloomberg_school_of_public_health> <http://schema.org/name> "Johns Hopkins Bloomberg School of Public Health" .
<https://okn.wobd.org/grant/1R01DK113642-01A1> <http://schema.org/funder> <https://ror.org/00adh9b73> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_155> <http://schema.org/sameAs> <https://doi.org/10.60773/gkzn-9x83> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_158> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_108> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_130> <http://schema.org/funding> <https://okn.wobd.org/grant/1R35GM141535-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_219> <http://schema.org/datePublished> "2024-03-04"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1P30AI094189-01A1> <http://schema.org/name> "The Johns Hopkins Center for AIDS Research (JHU CFAR)" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_45> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_118> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_68> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR001860-01> .
<https://okn.wobd.org/grant/1R01HD091218-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_120> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_81> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_43> <http://schema.org/funding> <https://okn.wobd.org/grant/1K08AR073339-01> .
<https://okn.wobd.org/grant/1U54GM138062-01A1> <http://schema.org/endDate> "2026-07-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_160> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/grant/1R01MH115676-01A1> <http://schema.org/startDate> "2018-04-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_209> <http://schema.org/name> "ÓRALE COVID-19! Vaccination: An Initiative to Increase COVID-19 Vaccination in Yolo, Madera, Fresno, Stanislaus Counties in California" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_126> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_157> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005550> .
<http://purl.obolibrary.org/obo/NCIT_C136265> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/grant/1P30AI045008-01> <http://schema.org/name> "CENTER FOR AIDS RESEARCH" .
<https://okn.wobd.org/grant/1P30AI060354-01> <http://schema.org/startDate> "2004-07-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/111" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/127" .
<https://okn.wobd.org/person/yale_pediatric_genomics_discovery_program> <http://schema.org/name> "Yale Pediatric Genomics Discovery Program" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_36> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_53> <http://schema.org/identifier> "phs002543" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_143> <http://schema.org/description> "Project Goals: 1) Virological Testing: This study aimed to establish a nasal-swab FDA-approved testing regimen to monitor and identify disease outbreaks in a specialized school setting serving 450 children with moderate-to-severe IDD and the 500 staff supporting them, a setting at ultra-high risk for COVID-19 disease transmission. This study rapidly identified infections and developed approaches for isolating and contact-tracing to stem virus spread. 2) Serological Testing: Serology established background immunity levels in students and staff, from infection or vaccination, and followed those who are antibody-positive longitudinally to quantify temporal decay of IgG and neutralizing antibody levels. This study examined whether protective immunity in children with IDD, a population with prevalent immunological dysfunction, wanes at an accelerated rate compared to the population-at-large; by doing so this study addressed an important knowledge gap, and provided key data to inform public health policy. 3) Modeling to Optimize Testing: This study used network models and agent based simulation models (or hybrid approaches) to guide testing strategies and interventions at MCC. Simulations were conducted interactively and iteratively, to assist in planning and implementation of testing procedures, exploring the dynamic interplay between school operations and personnel interactions, potential infection risks and disease dynamics (including variant strains), and implementation of control measures (e.g. quarantine, isolation, contact-tracing and vaccination rates). 4) Mobile Unit Testing: This study built on a successful mobile approach to delivering mobile dental care to the IDD students of MCC (the SMILEmobile), by staffing, equipping and deploying a customized, disability-enabled, mobile testing unit, which was used to directly deliver rapid flexible testing to MCC. 5) Overcoming Testing & Vaccine Anxiety/Hesitancy: The study conducted focus group interviews at MCC to identify key community concerns, myths and misconceptions about vaccination, and then built on success in reducing vaccine hesitancy among URMC staff, to create a multimodal educational campaign that addressed these concerns. Strategies included a speakers' bureau, group discussions, and \"table talk\" conversations, combined with innovative visual approaches that communicated complex information in a readily accessible manner (via graphic medicine) and that promoted vaccine uptake (via narrative portraits of trusted peers and coworkers who have chosen to be vaccinated). Finally, this study assessed the impact of this program by deploying a validated, electronic patient reported outcome scale (PROMIS-29) already in widespread use across the UR health system and at Rochesters East High School, to collect longitudinal data from staff, parents/guardians and children (by proxy reporting) across multiple health domains (including anxiety, depression, sleep disturbance, and social functioning). This scalable approach revealed the full impact of the interventions and approaches undertaken, and is readily compatible with extension to other sites in the RADx network." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_85> <http://schema.org/url> "https://radxdatahub.nih.gov/study/85" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_81> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_116> <http://schema.org/datePublished> "2023-08-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_132> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/q2xk-0f98> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_166> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/4R33HD105590-03> <http://schema.org/url> "https://reporter.nih.gov/project-details/10732857" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_55> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_189> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_132> <http://schema.org/author> <https://okn.wobd.org/person/health_promed_san_juan> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/71" .
<https://okn.wobd.org/grant/1R01AI163029-01> <http://schema.org/startDate> "2021-07-12"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/montefiore> <http://schema.org/name> "Montefiore)" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_70> <http://schema.org/name> "Tracking the COVID-19 Epidemic in Sewage (TRACES)" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_133> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_147> <http://schema.org/url> "https://radxdatahub.nih.gov/study/147" .
<https://ror.org/049v75w11> <http://schema.org/name> "National Institute on Aging" .
<https://okn.wobd.org/grant/1P30ES030285-01> <http://schema.org/startDate> "2019-05-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_170> <http://schema.org/name> "Rapid Olfactory Tools for Telemedicine-Friendly COVID-19 Screening and Survey" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_170> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/NCIT_C37935> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_189> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/veb6-px50> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_196> <http://schema.org/name> "Self-Testing for Our Protection from COVID-19 (STOP COVID-19) Study" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_141> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_147> <http://schema.org/identifier> "phs002872" .
<https://okn.wobd.org/grant/1T32DA007292-01A1> <http://schema.org/funder> <https://ror.org/00fq5cm18> .
<https://okn.wobd.org/grant/1T32GM128596-01> <http://schema.org/funder> <https://ror.org/04q48ey07> .
<https://okn.wobd.org/grant/1R21AI133331-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_97> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR002538-01> .
<https://ror.org/0493hgw16> <http://schema.org/alternateName> "National Institute on Minority Health & Health Disparities" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_207> <http://schema.org/author> <https://okn.wobd.org/person/johns_hopkins_bloomberg_school_of_public_health> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_77> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_155> <http://schema.org/datePublished> "2023-12-07"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_88> <http://schema.org/identifier> "phs002633" .
<https://okn.wobd.org/grant/1R01ES021006-01A1> <http://schema.org/url> "https://reporter.nih.gov/project-details/8373025" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_136> <http://schema.org/name> "Microfluidic Isolation and Characterization of SARS-CoV-2 and Virus Related Exosomes" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_100> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/201" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_123> <http://schema.org/identifier> "phs002743" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_199> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_194> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_68> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_152> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/w25v-9n49> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_140> <http://schema.org/funding> <https://okn.wobd.org/grant/1U54GM115677-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_69> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/grant/9P30AI050410-04> <http://schema.org/funder> <https://ror.org/040gcmg81> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_65> <http://schema.org/name> "A Rapid Breathalyzer Diagnostics Platform for COVID-19" .
<https://okn.wobd.org/grant/1P01HL114471-01A1> <http://schema.org/startDate> "2013-07-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_157> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01HD091218-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_85> <http://schema.org/sameAs> "10.60773/c7y1-s751" .
<https://okn.wobd.org/person/maria_fareri_children_s_hospital_westchester_medical_center> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_69> <http://schema.org/identifier> "phs002602" .
<https://okn.wobd.org/grant/8P20GM103429-11> <http://schema.org/endDate> "2015-04-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_34> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/grant/1R03DK117252-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/133" .
<http://purl.obolibrary.org/obo/MONDO_0005109> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_204> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/grant/1R01AI141630-01A1> <http://schema.org/startDate> "2019-05-21"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R35GM141535-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_61> <http://schema.org/url> "https://radxdatahub.nih.gov/study/61" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_172> <http://schema.org/author> <https://okn.wobd.org/person/university_of_iowa> .
<http://purl.obolibrary.org/obo/NCIT_C50873> <http://schema.org/name> "Overdose" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_199> <http://schema.org/author> <https://okn.wobd.org/person/university_of_michigan> .
<https://okn.wobd.org/grant/1P30CA240139-01> <http://schema.org/identifier> "1P30CA240139-01" .
<https://ror.org/03q21mh05> <http://schema.org/identifier> "https://ror.org/03q21mh05" .
<http://schema.org/Person> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2000/01/rdf-schema#Class> .
<https://okn.wobd.org/person/upenn> <http://schema.org/name> "UPenn" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_44> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/NCIT_C16880> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_130> <http://schema.org/funding> <https://okn.wobd.org/grant/1R56HL149881-01A1> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_221> <http://schema.org/sameAs> "10.60773/9br0-er28" .
<https://okn.wobd.org/grant/2R37AI051652-06> <http://schema.org/endDate> "2014-06-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_211> <http://schema.org/dateCreated> "2023-08-02"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/2R37AI051652-06> <http://schema.org/url> "https://reporter.nih.gov/project-details/7730704" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_118> <http://schema.org/datePublished> "2022-08-12"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/sipa> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/grant/1UL1TR002541-01> <http://schema.org/startDate> "2018-05-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_156> <http://schema.org/funding> <https://okn.wobd.org/grant/3P50HD103525-01S1> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_158> <http://schema.org/description> "New York City (NYC) is a global epicenter of the SARS-CoV-2/COVID-19 pandemic, with 222,000 cases and more than 25,000 deaths at the time of study. Neighborhood-level disparities in cases and deaths in NYC can be explained by socioeconomic and racial/ethnic characteristics, where Latinx and Black New Yorkers and those living in high poverty neighborhoods are 1.5 times more likely to test positive and more than twice as likely to die as a result of COVID-19. The community of Mott Haven is located in the South Bronx - the poorest congressional district within the continental United States. Mott Haven is highly diverse (73% are Latinx and 24% are Black), and COVID-19 mortality was once among the highest NYC and higher than in NYC as a whole - an epicenter within an epicenter. Yet, although Mott Haven is clearly a priority community for COVID-related prevention, detection, vaccination, and treatment initiatives, fewer than 2% of residents had been tested at the time of study. COVID-19 secondary attack rates are highest in households, varying between 12-38%. This project involved a COVID-19 testing and mitigation intervention in public housing households in Mott Haven, which are characterized by crowding, intergenerational co-residence, and a high proportion of low wage \"essential workers\" who leave the home for work even during lockdown periods. This project evaluated the effectiveness of an innovative Nurse-Community Health Worker (CHW)-Family Partnership intervention designed to promote COVID-19 testing uptake, adoption of COVID-19 control measures, and mutual aid capacity at the household level. The intervention was adapted from the Nurse-Family Partnership model, which has been shown to be effective and cost-effective in improving maternal and child health outcomes in high-poverty, racially- and ethnically-diverse communities. CHWs provided culturally-appropriate support to families, addressing stigma, medical mistrust, and other common barriers to engagement in healthcare. A 2-arm randomized controlled trial was conducted, in which 270 households (810 individuals) were randomly assigned (2:1) to either the experimental group of families who received the Nurse-CHW-Family Partnership intervention and the offer of in-home testing, or the treatment-as-usual control group referred to free testing located within walking distance. Participants in both arms were assessed at baseline and monthly for 9 months. The findings from this study provided an evidence-base to inform current and future public health initiatives related to COVID-19 mitigation in other high-risk settings. Sustainability was addressed by building local capacity and expertise among participants, CHWs and CAB members, and partnering with them to develop the community's best practices for COVID-19. This intervention can be tailored to increase testing and other COVID-19 control measures in other settings of vulnerability and disadvantage." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_27> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/694009> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_115> <http://schema.org/sameAs> <https://doi.org/10.60773/1scn-wv48> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_99> <http://schema.org/author> <https://okn.wobd.org/person/ascension_wisconsin> .
<https://ror.org/04xeg9z08> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Organization> .
<https://okn.wobd.org/grant/1P30DK098722-01A1> <http://schema.org/name> "UCSF Nutrition Obesity Research Center" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_199> <http://schema.org/author> <https://okn.wobd.org/person/university_of_illinois_urbana_champaign> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_126> <http://schema.org/sameAs> <https://doi.org/10.60773/wp37-4648> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_55> <http://schema.org/sameAs> <https://doi.org/10.60773/fp1q-f015> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_38> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_90> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_180> <http://schema.org/identifier> "phs003050" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_271> <http://schema.org/author> <https://okn.wobd.org/person/san_ysidro_health_centers> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_123> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_204> <http://schema.org/dateModified> "2024-03-04"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_97> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_189> <http://schema.org/dateCreated> "2022-11-28"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01DA037628-01A1> <http://schema.org/startDate> "2015-03-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_114> <http://schema.org/name> "Multiparametric Integrated Molecular Detection of SARS-CoV-2 from Biofluids by Adapting Single Extracellular Vesicle Characterization Technologies" .
<https://okn.wobd.org/grant/1R01AI151059-01> <http://schema.org/funder> <https://ror.org/043z4tv69> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_135> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<http://purl.obolibrary.org/obo/MONDO_0005240> <http://schema.org/name> "kidney disorder" .
<https://okn.wobd.org/grant/1TL1TR001871-01> <http://schema.org/endDate> "2021-05-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_116> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/82" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_147> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005354> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_74> <http://schema.org/url> "https://radxdatahub.nih.gov/study/74" .
<https://ror.org/00adh9b73> <http://schema.org/alternateName> "NIH/National Institute of Diabetes, Digestive & Kidney Diseases" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_162> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_143> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0044339> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_97> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/person/maria_fareri_children_s_hospital_at_westchester_medical_center> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_109> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/grant/5R01DK035385-02> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/person/frederiksted_health_care_st_croix> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/grant/2UL1TR000457-06> <http://schema.org/identifier> "2UL1TR000457-06" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_170> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/694009> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_63> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_148> <http://schema.org/datePublished> "2023-08-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1P30ES023513-01A1> <http://schema.org/url> "https://reporter.nih.gov/project-details/8841257" .
<https://okn.wobd.org/person/the_ann_robert_h_lurie_children_s_hospital_of_chicago> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/grant/1U54GM104942-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/person/ocapica> <http://schema.org/name> "OCAPICA" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_78> <http://schema.org/funding> <https://okn.wobd.org/grant/4UH3AI122309-03> .
<https://okn.wobd.org/grant/1P30CA045508-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/person/upmc_children_s_hospital_of_pittsburgh_university_of_pittsburgh> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_172> <http://schema.org/dateCreated> "2022-08-19"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_146> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/qhrd-7c61> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_46> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/grant/1DP1AI158186-01> <http://schema.org/funder> <https://ror.org/00fj8a872> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_84> <http://schema.org/identifier> "phs002608" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_157> <http://schema.org/author> <https://okn.wobd.org/person/barnes_jewish_hospital> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_113> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/NCIT_C16880> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_77> <http://schema.org/identifier> "phs002521" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_49> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_271> <http://schema.org/dateCreated> "2024-06-27"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://purl.obolibrary.org/obo/MONDO_0012727> <http://schema.org/name> "mucocutaneous lymph node syndrome" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_146> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_147> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_67> <http://schema.org/description> "COVID-19 presented a public health emergency: There was a critical need for rapid, not reagent-intensive, non-invasive testing technologies. This program led to the production of a prototype system to diagnose COVID-19 infection using the body odor signature of the disease. The goal of this program was to maximize societal impact by creating a validated prototype that can be used in a community or workplace setting by minimally trained personnel for low-cost, on-the-spot diagnosis within minutes. The system was developed in a manner that puts it on a pathway for rapid FDA approval. The Research Aims were: Aim 1. Optimization, assembly, and integration of a prototype system with the ability to examine odor signature of COVID-19 in samples of body odor. The system was simple to use, posed essentially zero risk to the operator and the test subject, and reported a result within minutes. The production cost at scale was approximately $9,000 for the complete measurement system, with a per test cost of approximately $0.50. The design and construction of the prototype was conducted by Novo Engineering, a leading firm with extensive experience in medical device development. Aim 2. Software development. Software for the system from VOC sampling to final diagnostic result was developed to ensure error-free operation of the device. Preliminary results suggested that simple linear discriminant analysis (LDA) does an excellent job of classifying VOCs from human body odor as COVID-19 positive or negative (92% sensitivity and 87% specificity). Optimization of the sensor array (Aim 1) and use of richer feature sets in the classifier models led to further performance improvements in the prototype system. Aim 3. System Benchmarking and Validation. The full prototype system was benchmarked against a number of VOC mixtures, with and without in vitro skin models. The system went through extensive testing against body odor samples from individuals with pathological conditions other than COVID-19 and other sources of potentially confounding VOCs. The prototype was validated against 400 samples drawn from the COVID-SAFE program at Penn. The screening included all members of the Penn community, and represented incredible racial and ethnic diversity as well as a wide variance in age, sex, and gender. Aim 4. Regulatory Approval Plan. The plan was developed under the direction of Sr/Key personnel John Fuson, JD, an attorney at Crowell & Moring LLP and a former Associate Chief Counsel at FDA. Novo Engineering had extensive experience in guiding prototype design in alignment with the requirements for FDA approval. The proposed COVID-19 VOC-based testing device was regulated by the FDA, likely as a Class I or II medical device. Because there is no clear predicate device to reference in this case, a direct de novo petition was submitted to FDA asking the agency to categorize and clear the proposed COVID-19 testing device as Class I or Class II without reference to any predicate." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_55> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/fp1q-f015> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_181> <http://schema.org/sameAs> <https://doi.org/10.60773/prjv-tg60> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/43" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_32> <http://schema.org/identifier> "phs002516" .
<https://okn.wobd.org/grant/1R01HG011274-01> <http://schema.org/name> "Telomere-to-telomere assemblies of human genomes" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_120> <http://schema.org/description> "The 5534 prospective clinical study sought to examine the performance of the 5534 device, for the detection of SARS-CoV-2 nucleocapsid protein antigen compared to the Roche 6800 Cobas PCR for SARS-CoV-2 assay. The goal of the 5534 study was for EUA approval for the device to use among symptomatic persons by trained healthcare personnel collected nasal, saliva, and dried bloodspot specimens. Note: no device performance data were included in the dataset." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_129> <http://schema.org/sameAs> "10.60773/869q-b786" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_184> <http://schema.org/dateCreated> "2022-10-14"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_133> <http://schema.org/description> "Recent studies, including this one, have suggested that breath may allow us to diagnose COVID-19 infection and even monitor its progress. As compared to immunological and genetic-based methods using sample media like blood, nasopharyngeal swab, and saliva, breath analysis is non-invasive, simple, safe, and inexpensive; it allows a nearly infinite amount of sample volume and can be used at the point-of-care for rapid detection. Fundamentally, breath also provides critical metabolomics information regarding how human body responds to virus infection and medical intervention (such as drug treatment and mechanical ventilation). The objectives of the SCENT project are: (1) to refine automated, portable, high-performance micro-gas chromatography (GC) device and related data analysis / biomarker identification algorithms for rapid (5-6 minutes), in-situ, and sensitive (down to ppt) breath analysis and (2) to conduct breath analysis on up to 760 patients, and identify and validate the COVID-19 biomarkers in breath. Thus, in coordination with the RADx-rad Data Coordination Center (DCC), this study completed the following specific aims.\n(1) Refine 5 automated micro-GC devices to achieve higher speed and better separation capability. This study constructed 5 new automated and portable one-dimensional micro-GC devices that required only ~6 minutes of assay time (improved from current 20 minutes) at the ppt level sensitivity (Sub-Aim 1a). Then the devices were upgraded to 2-dimensional micro-GC to significantly increase the separation capability (Sub-Aim 1b). In the meantime, the study optimized and automated existing data processing and biomarker identification algorithms and codes to streamline the workflow so that the GC device could automatically process and analyze the data without human intervention (Sub-Aim 1c).\n(2) Identify breath biomarkers that distinguish COVID-19 positive (symptomatic and asymptomatic) and negative patients. This study recruited a training cohort of 380 participants, including 190 COVID-19 positive patients (95 symptomatic and 95 asymptomatic) and 190 COVID-19 negative patients from two hospitals (Michigan Medicine – Ann Arbor and the Henry Ford Hospital – Detroit). This study conducted breath analysis using machine learning to identify VOC patterns that match each COVID-19 diagnostic status.\n(3) Validated the COVID-19 biomarkers using refined micro-GC devices. Using the refined 2-D micro-GC devices from Sub-Aim 1b, this study recruited a new validation cohort of 380 participants (190 COVID-19 positive patients and 190 COVID-19 negative patients) to validate the biomarkers identified in Aim 2. This study leveraged existing engineering, data science, clinical, regulatory, and commercialization resources throughout the project to hit milestones, ensuring a high likelihood of rapid patient impact. Upon completion of this work, this study had a portable micro-GC device and accompanying automated algorithms that detect and monitor COVID-19 status for people in a variety of clinical and community settings." .
<https://okn.wobd.org/grant/1S10OD018499-01> <http://schema.org/endDate> "2015-07-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_88> <http://schema.org/description> "In the US, COVID-19 has unveiled a disproportionate health burden in low income and underserved segments of society. In Louisiana, some of the greatest health and economic consequences are evident in Black communities. There was an urgent need to establish effective testing strategies in these communities as the Fall/Winter virus surges unfolded. The Louisiana Clinical and Translational Science (LA CaTS) Center provided the essential infrastructure and key foundational support for biomedical research in this region; it was uniquely positioned to lead a community-engaged testing research project to determine differences in COVID-19 testing rates between community-based (churches, community centers, and schools) and medical clinic-based testing sites, and determine approaches that would increase uptake of testing in underserved Black communities in the South. These issues were addressed using a two-pronged approach. First, a community based participatory research approach was applied to determine differences in SARS-CoV-2 testing rates across distinct types of test sites within five urban underserved Black communities in the American South. A multimedia campaign was used to promote and conduct real-time reverse transcription polymerase chain reaction (RT-PCR) testing on salivary samples obtained from 2,000-3,000 adults at 1) medical clinics, 2) schools, 3) community centers, and 4) churches (in random order) within five ZIP codes with known low socioeconomic status (SES) and a high representation of Black residents. The primary outcome was the number of tests performed at each type of test site. Information on age, sex, race, height, weight, employment, and household income, etc. was collected to identify important correlates of testing rates. Second, the strong and well-integrated partnership with the Baton Rouge Mayor's Healthy City Initiative (HealthyBR) was further leveraged together with the LA CaTS Community Advisory Boards (CABs) to conduct community-based focus groups, to obtain qualitative data about the perceptions and attitudes related to testing access and potential barriers affecting such. This information was used to determine community-driven approaches that are effective in reducing barriers and to create strategies to increase SARS-CoV-2 testing uptake in urban underserved Black communities. Results of this project greatly increased understanding of the factors that have led to a disproportionate COVID-19 health burden in these underserved populations and lay the groundwork for developing strategies to reduce these disparities in all underserved Black communities. Resulting data informed the equitable deployment of future virus/flu testing and a SARS-CoV-2 vaccine." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_74> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/073r-9g87> .
<https://okn.wobd.org/grant/1UL1TR001873-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9261094" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_183> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_176> <http://schema.org/author> <https://okn.wobd.org/person/north_miami_beach_high_school> .
<http://purl.obolibrary.org/obo/NCIT_C35016> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_192> <http://schema.org/dateModified> "2023-02-21"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_39> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/person/fresenius_medical_care_north_america> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_166> <http://schema.org/author> <https://okn.wobd.org/person/johns_hopkins_bloomberg_school_of_public_health> .
<https://okn.wobd.org/grant/1U01HG010961-01> <http://schema.org/startDate> "2020-03-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/the_university_of_texas_health_science_center_houston_the_university_of_texas_health_science_center_at_tyler> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/62" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_74> <http://schema.org/identifier> "phs002657" .
<https://okn.wobd.org/grant/1R35GM141535-01> <http://schema.org/name> "Combined Computational and Experimental Analyses of Gene Regulation by MicroRNAs" .
<https://okn.wobd.org/grant/1UL1TR001873-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/2U54MD007595-11> <http://schema.org/name> "Xavier RCMI Renewal Application-Overall" .
<https://okn.wobd.org/grant/8P20GM103429-11> <http://schema.org/funder> <https://ror.org/04q48ey07> .
<https://okn.wobd.org/grant/1R01DA013806-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/person/thai_cdc> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_211> <http://schema.org/funding> <https://okn.wobd.org/grant/1P30AI027763-01> .
<https://okn.wobd.org/grant/1U54CA132379-01A1> <http://schema.org/identifier> "1U54CA132379-01A1" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_206> <http://schema.org/identifier> "phs003360" .
<https://okn.wobd.org/grant/1T32DA007292-01A1> <http://schema.org/startDate> "1993-08-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_129> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01DK121072-01A1> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_149> <http://schema.org/author> <https://okn.wobd.org/person/granite_school_district> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_40> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/grant/1UL1TR003167-01> <http://schema.org/identifier> "1UL1TR003167-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/funding> <https://okn.wobd.org/grant/1F30DK123915-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_184> <http://schema.org/identifier> "phs003081" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_126> <http://schema.org/sameAs> "10.60773/wp37-4648" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_178> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_218> <http://schema.org/date> "2024-03-04"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1P30AI027763-01> <http://schema.org/endDate> "1993-08-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1P30NS047101-01> <http://schema.org/name> "U of Calif, San Diego Neuroscience Microscopy Imaging" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_101> <http://schema.org/funding> <https://okn.wobd.org/grant/1T32AI007291-01A1> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_62> <http://schema.org/name> "A SARS-CoV-2 Breathalyzer for Direct Virus Detection" .
<https://okn.wobd.org/grant/1P20GM121342-01A1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_202> <http://schema.org/datePublished> "2023-12-06"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_86> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/NCIT_C16880> .
<https://okn.wobd.org/grant/1U54CA260492-01> <http://schema.org/identifier> "1U54CA260492-01" .
<https://okn.wobd.org/grant/1P30AI036214-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<http://purl.obolibrary.org/obo/MONDO_0013600> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_186> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_82> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_123> <http://schema.org/datePublished> "2022-12-02"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_29> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/dateModified> "2023-10-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/5R01DK035385-02> <http://schema.org/startDate> "1985-07-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/109" .
<https://okn.wobd.org/grant/1R01HL124209-01A1> <http://schema.org/startDate> "2014-12-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_148> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_88> <http://schema.org/funding> <https://okn.wobd.org/grant/1U54GM104940-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_101> <http://schema.org/sameAs> <https://doi.org/10.60773/n328-4344> .
<https://okn.wobd.org/grant/1R01AI140442-01> <http://schema.org/startDate> "2018-05-24"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://ror.org/040gcmg81> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Organization> .
<https://okn.wobd.org/grant/1R01HG009518-01A1> <http://schema.org/funder> <https://ror.org/00baak391> .
<https://okn.wobd.org/person/puerto_rico> <http://schema.org/name> "Puerto Rico)" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_75> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_156> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_163> <http://schema.org/sameAs> <https://doi.org/10.60773/v1h1-pp81> .
<https://okn.wobd.org/person/clemson_university> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_45> <http://schema.org/sameAs> "10.60773/c65t-e596" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_31> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_199> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/ad5b-vx98> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_109> <http://schema.org/date> "2023-05-16"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_191> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_135> <http://schema.org/dateCreated> "2022-01-29"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_175> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/9d1x-h432> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_47> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_217> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/grant/1P30AI073961-01> <http://schema.org/name> "University of Miami Developmental Center for AIDS Research (D-CFAR)" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_70> <http://schema.org/sameAs> "10.60773/tpfh-0630" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_82> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0013600> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/funding> <https://okn.wobd.org/grant/1R35GM138152-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_176> <http://schema.org/sameAs> "10.60773/dk7k-jh11" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_172> <http://schema.org/name> "Test Us Bank Study" .
<https://okn.wobd.org/grant/5T32HL007227-10> <http://schema.org/funder> <https://okn.wobd.org/organization/national_heart_lung_and_blood_institute> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_162> <http://schema.org/sameAs> <https://doi.org/10.60773/277p-e595> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_168> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/347537> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_53> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_130> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01GM089784-01A1> .
<https://okn.wobd.org/grant/1DP2GM137418-01> <http://schema.org/startDate> "2019-09-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_93> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/grant/1UM1AI106716-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/1S10OD023527-01> <http://schema.org/endDate> "2018-04-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_217> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<http://schema.org/healthCondition> <http://www.w3.org/2000/01/rdf-schema#range> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_153> <http://schema.org/dateCreated> "2022-04-20"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_120> <http://schema.org/sameAs> <https://doi.org/10.60773/5ff3-nc70> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_109> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/161" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_161> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/grant/1R01AI146165-01A1> <http://schema.org/endDate> "2024-12-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01NS076465-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/8181076" .
<https://okn.wobd.org/grant/1UL1TR002538-01> <http://schema.org/startDate> "2018-03-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1UL1TR001085-01> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_205> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005550> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_211> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_175> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1ZIAAI001222-01> <http://schema.org/name> "Characterization of the cellular and molecular bases of combined immunodeficiencies" .
<https://okn.wobd.org/person/fiu_research_clinic> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_92> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_204> <http://schema.org/url> "https://radxdatahub.nih.gov/study/204" .
<https://okn.wobd.org/person/upmc_children_s_hospital_of_pittsburgh> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/grant/5P30CA008748-20> <http://schema.org/startDate> "1977-01-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1P42ES010337-01> <http://schema.org/endDate> "2005-03-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_197> <http://schema.org/identifier> "phs003239" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_197> <http://schema.org/datePublished> "2023-04-13"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_71> <http://schema.org/description> "The purpose of this study was to develop a tool that can diagnose multisystem inflammatory syndrome in children (MIS-C.) Some children and young adults who have had COVID-19 develop this rare disease about a month after they recover. It can be serious, as it causes inflammation in various organs, including the heart, lungs, kidneys, brain, skin, eyes, and intestines. MIS-C has symptoms similar to several diseases, including COVID-19 and Kawasaki disease, making diagnosis difficult. Currently, patients must undergo a battery of tests in order to diagnose MIS-C, including bloodwork, x-rays, and echocardiograms, which can take several days, delay treatment, and subject parents and children to the anxiety that's associated with an undiagnosed, concerning illness. The new diagnostic test used an existing invention, a Grating-Coupled Fluorescence Plasmonic (GCFP) chip. It's a small gold chip that can analyze up to 400 biomarkers at once, whereas common methods are only able to analyze one biomarker at a time. The hope was to identify biomarkers that are only present, or are present in higher or lower numbers, when someone has MIS-C. The ability to include multiple biomarkers on one chip was very powerful, as several biomarkers were likely involved with this disease. The ability to identify these biomarkers would enable doctors to place a drop of a patient's saliva or blood on the chip, and the chip will quickly tell them if they have MIS-C or something else that looks like MIS-C. Participants were recruited at four hospitals in the U.S. and Colombia, collecting their blood, saliva, and health information, and followed them for up to four years. Scientists at five laboratories studied the blood and saliva to identify biomarkers, and also studied the microbiome to better understand why some children develop MIS-C or become seriously ill, and others do not." .
<http://purl.obolibrary.org/obo/MONDO_0003265> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_143> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/grant/1TL1TR001871-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9261157" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_33> <http://schema.org/description> "The Covidseeker and COVID-19 Citizen Science Study integrated Covidseeker (a tool for real-time geospatial temporal mobile data for digital contact tracing and SARS-CoV-2 Hotspotting) into a customized version of the COVID-19 Citizen Science Study. The Covidseeker and COVID-19 Citizen Science Study included a user-test of Covidseeker with the goal of refinement of the platform and related messaging to optimize recruitment, retention, and overall use of the technology. This study also included a randomized trial of Covidseeker, utilizing the Eureka digital research platform and related COVID-19 Citizen Science Study infrastructure, to determine optimal methods of deployment." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_175> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005015> .
<https://okn.wobd.org/person/university_of_florida> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_138> <http://schema.org/sameAs> <https://doi.org/10.60773/e4v6-7k61> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_161> <http://schema.org/description> "This project developed a biomimetic olfaction-and gustation-based sensors for detecting volatile organic compound (VOC) biomarkers against SARS-CoV-2. The project used computational design to deduce sets of odorant binding peptide (OBP) sequences that selectively bind to exhaled VOCs associated with SARS-CoV-2 from libraries of olfactory proteins. Chimeric peptides including these OBP sequence and a aromatic carbon-binding group were then synthesized, validated for vapor phase VOC binding, and then bound on to separate low-cost graphene and carbon nanotube sensor field effect transistors in multiplexed arrays developed in this project. The exhalant or simulated exhalant response data from these multiplexed OBP-functionalized sensor arrays were used to train an AI-driven diagnosis system to create a rapid, easily scalable test for SARS-CoV-2 based on direct exhaled breath." .
<http://schema.org/funder> <http://www.w3.org/2000/01/rdf-schema#range> <http://schema.org/Organization> .
<https://okn.wobd.org/person/children_s_hospital_of_orange_county> <http://schema.org/name> "Children's Hospital of Orange County" .
<https://okn.wobd.org/grant/3P50HD103525-01S1> <http://schema.org/identifier> "3P50HD103525-01S1" .
<https://www.uniprot.org/taxonomy/694009> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/person/be_health_empowered_bhe_group> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/person/ucsf_benioff_children_s_hospital_oakland_san_francisco> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_67> <http://schema.org/date> "2024-01-18"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_88> <http://schema.org/datePublished> "2023-08-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_93> <http://schema.org/sameAs> <https://doi.org/10.60773/85ty-n986> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_161> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/w35s-2a90> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/199" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_48> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR001085-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_174> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/kha0-tt06> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_51> <http://schema.org/name> "Bioinformatics Framework for Wastewater-based Surveillance of Infectious Diseases" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_124> <http://schema.org/description> "The data shared includes the response of sensor to different concentrations of pseudovirus and inactivated SARS-CoV-2 virus samples. The study measured sensitivity and specificity of the response. The study measured role of matrix and buffer conditions on assay response." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_118> <http://schema.org/author> <https://okn.wobd.org/person/university_of_kansas> .
<https://okn.wobd.org/grant/1TL1TR001871-01> <http://schema.org/identifier> "1TL1TR001871-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_108> <http://schema.org/identifier> "phs002699" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_120> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/5ff3-nc70> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_189> <http://schema.org/sameAs> "10.60773/veb6-px50" .
<https://okn.wobd.org/grant/1UL1TR001878-01> <http://schema.org/startDate> "2016-07-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/2P2CHD050924-11> <http://schema.org/url> "https://reporter.nih.gov/project-details/9041303" .
<https://okn.wobd.org/grant/1U54CA156732-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/8060716" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_92> <http://schema.org/sameAs> <https://doi.org/10.60773/a7c6-ff66> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_128> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_180> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0004981> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_83> <http://schema.org/author> <https://okn.wobd.org/person/the_community_action_place> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/funding> <https://okn.wobd.org/grant/1R01DK107585-01A1> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_157> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/132" .
<https://okn.wobd.org/grant/75N93021C00015-0-9999-2> <http://schema.org/startDate> "2021-04-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_88> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/157" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/author> <https://okn.wobd.org/person/ucsf_benioff_children_s_hospital_oakland_san_francisco> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/209" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_73> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005550> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_122> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_85> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_101> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005550> .
<https://okn.wobd.org/grant/1R01AI141630-01A1> <http://schema.org/funder> <https://ror.org/043z4tv69> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_190> <http://schema.org/sameAs> <https://doi.org/10.60773/a4fj-3408> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_77> <http://schema.org/dateModified> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_137> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_157> <http://schema.org/url> "https://radxdatahub.nih.gov/study/157" .
<https://okn.wobd.org/grant/1U19NS112953-01> <http://schema.org/startDate> "2019-09-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01HD106120-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/10280145" .
<https://okn.wobd.org/grant/1P30AI042853-01> <http://schema.org/endDate> "2002-08-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_125> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_202> <http://schema.org/sameAs> "10.60773/sfgj-td47" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_66> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005550> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_28> <http://schema.org/name> "2183 SARS-CoV-2 Rapid Antigen Test" .
<https://okn.wobd.org/grant/2R37AI051652-06> <http://schema.org/identifier> "2R37AI051652-06" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_51> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/grant/75N93021C00016-0-9999-4> <http://schema.org/funder> <https://ror.org/043z4tv69> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_44> <http://schema.org/funding> <https://okn.wobd.org/grant/2U54MD007601-31> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_137> <http://schema.org/date> "2024-01-18"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_142> <http://schema.org/sameAs> "10.60773/ywfr-4e53" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_73> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/47" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_186> <http://schema.org/name> "SARS-CoV-2 Screening in Dialysis Facilities: Building an Optimal Strategy to Protect a High Risk Population" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_54> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/7th6-st50> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_156> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/61bs-2j03> .
<https://okn.wobd.org/person/johns_hopkins_bloomberg_school_of_public_health> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_124> <http://schema.org/url> "https://radxdatahub.nih.gov/study/124" .
<http://purl.obolibrary.org/obo/MONDO_0004975> <http://schema.org/name> "Alzheimer disease" .
<https://okn.wobd.org/grant/8UL1TR000042-07> <http://schema.org/identifier> "8UL1TR000042-07" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_55> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_202> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/person/morehouse_school_of_medicine> <http://schema.org/name> "Morehouse School of Medicine" .
<https://okn.wobd.org/grant/7R01HG010040-02> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/grant/1P30DK063720-01> <http://schema.org/funder> <https://ror.org/00adh9b73> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_70> <http://schema.org/funding> <https://okn.wobd.org/grant/1UL1TR001863-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_216> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/person/physiq> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_208> <http://schema.org/url> "https://radxdatahub.nih.gov/study/208" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_67> <http://schema.org/name> "Effective, Reagent-Free Detection of the Odor Signature of COVID-19 Infection Using a Nano-Enabled Sensor Array" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/178" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/funding> <https://okn.wobd.org/grant/1S10OD018499-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_132> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_59> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/person/and_johns_hopkins_university_school_of_medicine> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/grant/1U54CA156732-01> <http://schema.org/identifier> "1U54CA156732-01" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_172> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_150> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/grant/1U01HG010961-01> <http://schema.org/name> "The construction and utility of reference pan-genome graphs" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_177> <http://schema.org/description> "Unlike other ethnic minority groups, data on the impacts of COVID-19 on Southeast Asian Americans (SEAAs) are limited, oftentimes aggregated with other Asian American groups, thus limiting targeted assistance efforts. Without adequate data to inform best practices around testing and vaccination, many SEAAs become invisible Americans who have difficulties navigating a health care system that inadvertently excludes them. SEAAs have large disparities gap due to a combination of historical trauma, discrimination, harsh immigrant policies, and language barriers. Many are undocumented, hold low wage jobs, and less likely to attend college. Social isolation, anxiety, and financial hardships resulting from COVID-19 have intensified existing health and mental health issues. Lack of disaggregated data and under-reporting of race/ethnicity data, potentially masks the true impacts of COVID-19 on SEAAs and thus exemplifies systemic barriers and structural racism that keep them invisible and hinder targeted assistance. The goal of this project, \"Southeast Asians in the U.S.: Health Equity And Research to Understand COVID-19 Stories (SEA US, HEAR US)\" was to understand and address multi-level social, ethical, and behavioral implications of COVID-19 testing, vaccination, and its sequelae among Cambodians, Filipinos, Thais, and Vietnamese Americans in Greater Los Angeles through a community-based approach. The central hypothesis was that provision of data-informed and community-informed best practices/guidelines will improve evidence-based COVID-19 testing, vaccination, and its sequelae among their communities. Aim 1: Conduct multi-level formative research using a mixed-methods approach to validate, refine, and tailor existing SEBI measures and potentially develop new, more culturally-relevant, measures for SEAAs. Focus groups with community members (N=30) and key informant interviews with community leaders (N=6) were conducted to confirm cultural relevancy, comprehension, and potential refinement of the existing RADx-UP Common Data Elements (CDEs) and the Social Determinants of Health (SDOH), COVID-19 research findings, and other relevant measures present in the PhenX Toolkit. Aim 2: Collect individual-level data about social, ethical, and behavioral implications (SEBI) of COVID-19 testing, vaccination, and its sequelae among Southeast Asian Americans in the Greater Los Angeles area through a prospective longitudinal study. Spanning 12 months (BL, 3, 6, and 12 months), the survey allowed a better understanding of critical areas in COVID-19 testing and vaccination such as structural, cultural, and intrapersonal barriers and assets in SEAA communities (N=1000). The study isolated barriers that hinder or facilitate testing and vaccination over time, such as lack of accessibility, health literacy, language barriers, self-efficacy, stigma, or lack of social capital. Findings identified areas for potential programs and interventions and/or better access points to underserved groups. Aim 3: Conduct in-depth interviews with community leaders and stakeholders (community-based and faith-based organizations) within SEAA communities to understand their capacity, perceptions, attitudes, beliefs, and intentions towards COVID-19 testing and vaccination. This approach provided insight into organizational infrastructure, community-level, and societal-level factors for COVID-19 testing and vaccinations from the perspectives of community leaders (N=60). The study was able to identify common potential gaps or assets in service delivery and navigation, and areas of resiliency between groups. SEA US, HEAR US studied Cambodians, Filipinos, Thais, and Vietnamese Americans at a time when health equity is a challenge and issues of structural discrimination and anti-Asian hate is at its peak. SEAAs are invisible Americans who will continue to experience health disparities and be structurally discriminated against in the absence of culturally targeted, relevant assistance. SEBISEAA gathered community-driven, culturally-sensitive data to inform existing and future COVID-19 programs and policies that improve necessary resources and support for these sub-ethnic AA communities." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_99> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_56> <http://schema.org/date> "2024-01-18"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/1R01EB025022-01> <http://schema.org/name> "QuBBD: Viral Evolution and Spread of Infectious Disease in Complex Network: Big Data Analysis and Modeling" .
<https://okn.wobd.org/grant/1P30ES030283-01A1> <http://schema.org/funder> <https://ror.org/00j4k1h63> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_130> <http://schema.org/sameAs> <https://doi.org/10.60773/77xd-fh20> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_101> <http://schema.org/funding> <https://okn.wobd.org/grant/1K12HD000850-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_132> <http://schema.org/url> "https://radxdatahub.nih.gov/study/132" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_159> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/funding> <https://okn.wobd.org/grant/3T32GM083937-01A1S1> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_136> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<http://purl.obolibrary.org/obo/MONDO_0005711> <http://schema.org/name> "congenital diaphragmatic hernia" .
<https://okn.wobd.org/grant/1R01AG066749-01> <http://schema.org/startDate> "2020-04-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_114> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/person/cornell_university> <http://schema.org/name> "Cornell University" .
<https://okn.wobd.org/grant/1P01AI118688-01A1> <http://schema.org/url> "https://reporter.nih.gov/project-details/9151384" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_195> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_175> <http://schema.org/name> "RADx-UP Supplement-Vaccine Hesitancy and Uptake" .
<https://okn.wobd.org/person/columbia_university> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_44> <http://schema.org/url> "https://radxdatahub.nih.gov/study/44" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_97> <http://schema.org/name> "Back to ECE Safely with SAGE: Reducing COVID-19 Transmission in Hispanic and Low-Income Preschoolers" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_142> <http://schema.org/datePublished> "2023-08-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_144> <http://schema.org/sameAs> "10.60773/gvj9-b203" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_58> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/grant/1UL1TR002345-01> <http://schema.org/startDate> "2017-06-19"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_205> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://ror.org/012pb6c26> <http://schema.org/alternateName> "National Heart Lung & Blood Institute" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_175> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/grant/1U19AI142733-01> <http://schema.org/url> "https://reporter.nih.gov/project-details/9674856" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_167> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_41> <http://schema.org/dateModified> "2023-09-27"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/4UH3OD023365-03> <http://schema.org/identifier> "4UH3OD023365-03" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_114> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2697049> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_60> <http://schema.org/author> <https://okn.wobd.org/person/pediatric_research_in_inpatient_settings_pris_network> .
<https://okn.wobd.org/person/puerto_rico> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_186> <http://schema.org/infectiousAgent> <https://www.uniprot.org/taxonomy/2901879> .
<https://okn.wobd.org/grant/1R01DE026471-01A1> <http://schema.org/name> "MICRORNA BIOMARKERS FOR OROPHARYNGEAL CANCER" .
<https://okn.wobd.org/grant/1UL1TR002538-01> <http://schema.org/identifier> "1UL1TR002538-01" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/45" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_127> <http://schema.org/name> "Assessing Testing Strategies for Safe Return to K-12 Schools in an Underserved Population" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_167> <http://schema.org/description> "People who inject drugs (PWIDs) are highly vulnerable to contracting SARS-CoV-2 and to the effects of the disease caused by SARS-CoV-2, coronavirus disease 2019 (COVID-19). PWIDs experience underlying medical conditions and unstable housing that put them at increased risk for COVID-19 morbidity and mortality. PWIDs also experience barriers such as a history of stigmatization and discrimination by health care systems and exposure to misinformation that reduces access to health care services, such as SARS-CoV-2 testing and vaccination. This project built on the Phase I Rapid Acceleration of Diagnostics project (#67; PI: Stormshak) that successfully embedded SARS-CoV-2 testing into syringe exchange programs (SEPs) across the state of Oregon, in collaboration with HIV Alliance (HIVA). The testing program's success was linked to a contingency management (CM) intervention that increased the rates of testing utilization from 4% to 24% (d = 1.36), even as nationwide testing utilization was decreasing. The first aim of the project was to test the sustained effectiveness of CM on testing outcomes, given the current context of increasing COVID-19 vaccine accessibility. Testing remains critical to prevent the transmission of SARS-CoV-2 among PWIDs who continue to be at high exposure risk, and for whom vaccine hesitancy is high. The study also leveraged the partnership with HIVA to establish a COVID-19 vaccine program at HIVA's SEPs. The second aim was to conduct a randomized control trial (RCT) to examine whether a brief motivational enhancement (ME) intervention (i.e., Connect2Test) augments the effects of CM on SARS-CoV-2 testing and vaccination uptake. The Phase I study demonstrated that CM improves SARS-CoV-2 testing utilization. CM is also known to increase immunization rates against other infectious diseases, such as Hepatitis B. Additionally, consistent with research showing that ME enhances the effects of CM on health behavior outcomes, the study anticipated that Connect2Test will augment CM's effects on testing and vaccination among PWIDs. Moreover, because ME elicits and strengthens motivation for long-term behavior change, whereas CM prompts immediate and short-term behavior change, the study anticipated that CM + ME, versus CM alone, will have long-term effects on SARS-CoV-2 testing, evidenced by participation in repeated testing over time. The third aim of the proposed project was to assess CM and Connect2Test implementation, including a cost-effectiveness analysis of CM alone versus CM plus Connect2Test, to improve long-term sustainability of testing, vaccination, and intervention approaches to mitigate the spread of SARS-CoV-2." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_209> <http://schema.org/sameAs> <https://doi.org/10.60773/96jm-wg84> .
<https://ror.org/01s5ya894> <http://schema.org/alternateName> "NIH National Institute of Neurological Disorders and Stroke" .
<https://okn.wobd.org/grant/1R01ES021006-01A1> <http://schema.org/name> "Study of Neural Tube Defects Etiology: Genome and Exposome" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_49> <http://schema.org/name> "Validation of Smart Masks for Surveillance of COVID-19" .
<https://ror.org/04byxyr05> <http://schema.org/alternateName> "National Institute of Child Health and Human Development" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/202" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_72> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_137> <http://schema.org/funding> <https://okn.wobd.org/grant/1R21AI129851-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_136> <http://schema.org/url> "https://radxdatahub.nih.gov/study/136" .
<https://okn.wobd.org/grant/1T32AI007384-01> <http://schema.org/funder> <https://ror.org/043z4tv69> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_122> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/bxqp-9045> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_119> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_53> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://ror.org/049v75w11> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Organization> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_138> <http://schema.org/sameAs> "10.60773/e4v6-7k61" .
<https://okn.wobd.org/grant/1P01CA214274-01A1> <http://schema.org/startDate> "2018-09-18"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_27> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/grant/5P30CA008748-20> <http://schema.org/endDate> "1987-12-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_138> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_206> <http://schema.org/url> "https://radxdatahub.nih.gov/study/206" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_162> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0012727> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_178> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Dataset> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_144> <http://schema.org/dateCreated> "2022-04-07"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_134> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/NCIT_C16880> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_84> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<http://schema.org/healthCondition> <http://www.w3.org/2000/01/rdf-schema#domain> <http://schema.org/MedicalEntity> .
<https://ror.org/00j4k1h63> <http://schema.org/alternateName> "NIH National Institute of Environmental Health Sciences" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/217" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_43> <http://schema.org/datePublished> "2022-07-21"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_127> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_156> <http://schema.org/description> "The study objective was to increase safe return to school for CMC (children with medical complexity) and school personnel through 3 complementary approaches/aims. Aim 1 proposed to determine the feasibility of in-home and school-based testing strategies for CMC, as well as to gain understanding of parent perceptions about in-person school attendance. Activities in this aim involved 3 cohorts: Cohort 1 were caregivers and CMC enrolled in a complex care program. Subjects were offered in-home testing kits and asked to complete quarterly surveys on parent perceptions of safe school attendance during the pandemic. Cohort 2 involved students and staff of a preschool providing care to typically developing and special needs students. Subjects were offered in-school and in-home testing, and were asked to complete the quarterly surveys. Cohort 3 involved students enrolled at a K-12 school exclusively serving children with special needs. Parents were asked to complete the quarterly surveys and may have also opted to share their child's COVID testing results performed at the school. Aim 2 attempted to broaden understanding of parent perceptions predicting school attendance by soliciting parents of CMC receiving care at a large academic medical center to complete the quarterly survey on perceptions of safe school attendance during the pandemic. Aim 3 was to establish a consensus set of stakeholder priorities to facilitate safe school attendance for CMC." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_155> <http://schema.org/funding> <https://okn.wobd.org/grant/8G12MD007595-04> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_169> <http://schema.org/description> "The Marshallese/Native Hawaiian/Pacific Islanders: Alternate Surveillance for COVID-19 in a Unique Population (MASC UP) study relied on innovative, culturally tailored participatory surveillance methods to identify and evaluate strategies to reduce the spread of COVID-19 in this high-risk, clustered population. First, a cohort was recruited to deploy a multi-modal, multi-level surveillance system in two of the largest Marshallese/Native Hawaiian/Pacific Islanders communities in the US: Northwest Arkansas (n = 300), Spokane County, and Seattle area Washington (n = 300). Each cohort member was followed longitudinally for at least 12 months. Modalities included providing kits to detect changes in body temperature, public service outreach to reduce stigma associated with reporting symptoms, and deploying social media and text message-based screening technology to augment conventional test-based surveillance. Second, a social contact network was constructed among participants from the surveillance cohort to identify community structures and networks that increased the risk of COVID-19 infection. The findings were used to integrate effective components into a surveillance ecosystem that can be disseminated to other clustered groups. The specific aims were to: 1) Create a longitudinal, multi-modal and multi-level surveillance cohort (n = 600) that targeted early detection of symptomatic and asymptomatic COVID-19 cases among Marshallese/Native Hawaiian/Pacific Islanders adults in the continental U.S.; 2) Characterize the social contact network among surveillance cohort members to identify community structures and networks that put individuals at increased risk of acquiring COVID-19; and 3) Identify effective modalities for participatory disease surveillance and sustainably integrate them into ongoing COVID-19 and other public health surveillance efforts for the Marshallese/Native Hawaiian/Pacific Islanders population. MASC UP demonstrated the value of culturally tailored, participatory disease surveillance developed and tested in real-world settings to mitigate COVID-19 disparities in a high-risk, clustered population that has been profoundly underserved by public health efforts to date. The findings can be disseminated and implemented for improved surveillance and disease prevention in other high-risk, non-institutionalized U.S. minority groups." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_137> <http://schema.org/dateCreated> "2022-01-29"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/funding> <https://okn.wobd.org/grant/1UM1HG008898-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_143> <http://schema.org/url> "https://radxdatahub.nih.gov/study/143" .
<https://okn.wobd.org/person/charles_r_drew_university_of_medicine_and_science> <http://schema.org/name> "Charles R. Drew University of Medicine and Science" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_74> <http://schema.org/author> <https://okn.wobd.org/person/university_of_california_santa_barbara> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_207> <http://schema.org/author> <https://okn.wobd.org/person/university_of_missouri_kansas_city> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_210> <http://schema.org/sameAs> "10.60773/ybnk-xd66" .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/162" .
<https://okn.wobd.org/grant/3P50HD103525-01S1> <http://schema.org/name> "WUIDDRC Supplement-Supporting the health and well-being of children with intellectual and developmental disability during COVID-19 pandemic" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_112> <http://schema.org/url> "https://radxdatahub.nih.gov/study/112" .
<https://okn.wobd.org/person/maria_fareri_children_s_hospital_westchester_medical_center> <http://schema.org/name> "Maria Fareri Children’s Hospital @ Westchester Medical Center" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_152> <http://schema.org/sameAs> "10.60773/w25v-9n49" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_49> <http://schema.org/identifier> "phs002524" .
<https://okn.wobd.org/grant/1DP2GM137418-01> <http://schema.org/endDate> "2024-05-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/110" .
<https://okn.wobd.org/person/sipa> <http://schema.org/name> "SIPA" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_34> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_115> <http://schema.org/funding> <https://okn.wobd.org/grant/1P30DK092950-01> .
<https://okn.wobd.org/grant/1R25EB020393-01A1> <http://schema.org/funder> <https://ror.org/00fj8a872> .
<https://okn.wobd.org/person/project_vida> <http://schema.org/name> "Project Vida" .
<https://okn.wobd.org/grant/2U54MD007601-31> <http://schema.org/startDate> "1997-09-01"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_204> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/80" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_97> <http://schema.org/identifier> "phs002661" .
<https://okn.wobd.org/person/association_for_utah_community_health> <http://schema.org/name> "Association for Utah Community Health" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_151> <http://schema.org/species> <https://www.uniprot.org/taxonomy/9606> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_80> <http://schema.org/name> "SCALE UP Utah: A Community-Academic Partnership to Address COVID-19 Among Utah Community Health Centers" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_123> <http://schema.org/date> "2022-12-02"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/person/children_s_hospital_of_michigan> <http://schema.org/name> "Children's Hospital of Michigan" .
<https://okn.wobd.org/grant/1R01HL140898-01> <http://schema.org/name> "Innate Immune Activation and Endothelial Cell Dysfunction in Acute Kawasaki Disease" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_152> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0005109> .
<https://okn.wobd.org/catalog/radx_data_hub> <http://schema.org/archivedAt> "https://radxdatahub.nih.gov/study/145" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_122> <http://schema.org/funding> <https://okn.wobd.org/grant/1P30GM114737-01> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_73> <http://schema.org/url> "https://radxdatahub.nih.gov/study/73" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_50> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0004981> .
<http://purl.obolibrary.org/obo/NCIT_C3137> <http://schema.org/name> "Inflammation" .
<https://okn.wobd.org/grant/1UL1TR002366-01> <http://schema.org/funder> <https://ror.org/04pw6fb54> .
<https://okn.wobd.org/grant/5T32GM007618-08> <http://schema.org/identifier> "5T32GM007618-08" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_150> <http://schema.org/sameAs> <https://doi.org/10.60773/qyrm-p781> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_75> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://ror.org/01y3zfr79> <http://schema.org/parentOrganization> "National Institutes of Health" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_33> <http://schema.org/name> "Covidseeker and COVID-19 Citizen Science: Leveraging Citizen Science and Real-Time Geospatial Temporal Mobile Data for Digital Contact Tracing and SARS-CoV-2 Hotspotting" .
<https://okn.wobd.org/grant/5R01DK035385-02> <http://schema.org/endDate> "1988-06-30"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_78> <http://schema.org/url> "https://radxdatahub.nih.gov/study/78" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_122> <http://schema.org/author> <https://okn.wobd.org/person/university_of_hawaii_at_manoa_and_university_of_guam> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_137> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/8yrw-qt94> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_111> <http://schema.org/sameAs> <https://doi.org/10.60773/mq9p-yx64> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_192> <http://schema.org/author> <https://okn.wobd.org/person/tufts_medicine> .
<https://okn.wobd.org/grant/1R01MH115676-01A1> <http://schema.org/name> "Joint genomic and statistical analyses of schizophrenia and bipolar to decipher genetic susceptibility" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_194> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/z740-hc64> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_159> <http://schema.org/author> <https://okn.wobd.org/person/charles_r_drew_university_of_medicine_and_science> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_80> <http://schema.org/description> "Racial/ethnic minority, low socioeconomic status (SES), and rural populations suffer profound health inequities across a wide variety of diseases and conditions, as well as a disproportionate burden of the negative health consequences of the COVID-19 pandemic. Latinos make up ~14% of the Utah population vs. ~40% of Utah's COVID-19 cases, and the case rate is over 3-fold higher in neighborhoods characterized by high vs. low deprivation. The case rate in Utah per 100,000 is 665 among Whites vs. 3,503 among Latinos, 3,470 among Pacific Islanders, 1,727 among African Americans, and 1,569 among Native Americans. Community Health Centers (CHCs) are optimal settings for addressing the screening and uptake of COVID-19 testing among underserved populations. Twelve Utah CHC systems participated in SCALE-UP Utah. Their 39 primary care clinics served over 115,000 unique patients annually (37% Latino, 11% Native American, 61% <100% poverty level, 51% uninsured, and 49% of clinics are in rural/frontier areas). SCALE-UP Utah was a state-wide, pragmatic, multilevel intervention study. The long-term objective was to increase the reach, uptake, and sustainability of COVID-19 screening and testing among underserved populations. The team had existing infrastructure and shovel ready clinic and population health management (PHM) interventions ready for implementation. SCALE-UP Utah built on long standing, funded partnerships, and implemented and evaluated three practical, feasible, scalable multi-level interventions to increase COVID-19 screening and uptake in Utah CHCs. Interventions leveraged widely adopted Health Information Technology (HIT) at the point of care, text messaging, and patient navigation. SCALE-UP Utah coordinated and synergized existing infrastructure and resources across the state, as well as strengthened infrastructure and data networks for rapid deployment of new screening and testing protocols, vaccination programs, etc. The project employed a rapid cycle research approach in which interventions were tested on a small scale, using short time frames (e.g., <1 month) and cyclical evaluation cycles. A critical aspect of these rapid-research cycles was that change can be quickly tested on a small scale, and then disseminated to other clinics/patients. The interventions were readily available for adoption by other low-resource healthcare settings; and, the data advanced population health and implementation science. The specific aims were: 1. Implement and evaluate clinic and PHM interventions for increasing the uptake of COVID-19 testing among CHC patients across Utah. 2. Examine implementation effectiveness outcomes, as well as characteristics of both clinics and patients that may influence intervention effects and implementation outcomes." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_149> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_210> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://ror.org/00372qc85> <http://schema.org/alternateName> "National Institute of Biomedical Imaging & Bioengineering" .
<https://okn.wobd.org/grant/1U19AI142733-01> <http://schema.org/identifier> "1U19AI142733-01" .
<https://okn.wobd.org/grant/1R21AI133331-01> <http://schema.org/endDate> "2019-05-31"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_45> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/c65t-e596> .
<https://okn.wobd.org/person/children_s_hospital_colorado> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Person> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_155> <http://schema.org/dateCreated> "2022-04-20"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_217> <http://schema.org/date> "2024-03-04"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_111> <http://schema.org/identifier> "phs002704" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_42> <http://schema.org/description> "Nucleic acid tests have become the gold-standard for diagnostic testing for COVID-19, usually performed in specialized laboratories. Most are based on reverse-transcription quantitative polymerase chain reaction (qRT-PCR). The time required for specimen transport and processing results in a turnaround time that is typically several days. The few rapid (< 1 hour) point-of-care (POC) tests are more expensive, still require sample preparation and specialized reagents, and do not have the throughput needed for population surveillance. Direct testing for the virus, which also reduces requirements for multiple reagents, is a necessary step to improving diagnostic testing. While four such antigen tests have been approved for detection of SARS-CoV-2 based on immunoassays to the N protein, sensitivity is limited and no quantitation of viral load is possible. This gap was addressed by DiagnostikosTM, an in-development rapid POC platform for direct, real-time, multiplexed, quantitative bioelectronic detection of biomolecules that employed an all-electronic detection device that functions at the single-molecule level. These single-molecule field-effect transistors (smFETs) are arrayed on a complementary metal-oxide-semiconductor (CMOS) integrated circuit chip. Chips were interfaced with an envisioned USS-stick-form-factor reader device. Robust single-domain antibodies, known as nanobodies and immobilized on these devices, were used for sensitive detection of viral particles and viral debris. The use of multiple nanobodies for a single protein and nanobodies for different proteins in a single assay allowed for significant improvements in specificity. Nanobodies were specific for one or more of the four major structural proteins in SARS-CoV-2; the nucleocapsid (N) protein engulfing the viral RNA, the spike (S) protein, the membrane (M) protein and the envelope (E) protein. No sample preparation or specialized reagents were required for detection, and the device were designed to operate with saliva, which has very recently been shown to be a reliable medium for detecting SARS-CoV-2. Individual sensor chips could manufactured at a cost of $35. With the addition of other nanobodies, these large dense arrays also allow detection of many pathogens in a single test. In this Direct-To-Phase-2 SBIR program, several key innovations that are required to make such a platform possible were pursued, including isolation of nanobodies for key structure proteins of SARS-CoV-2 (Specific Aim 1), development of the smFET platform for antigen detection (Specific Aim 2), development of large CMOS arrays of these smFET devices (Specific Aim 3), and verification of detection in increasingly complex samples up to and including clinical samples (Specific Aim 4). This project was a partnership between university researchers who developed the smFET technology and a venture-based start-up, Quicksilver Biosciences, spun out to commercialize smFET technology and develop smFET/CMOS arrays for molecular diagnostic applications." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_27> <http://schema.org/identifier> "phs002679" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_36> <http://schema.org/description> "The goal of this project was to develop an artificial intelligence-based data analytics and cloud computing platform, paired with U.S. Food and Drug Administration (FDA)-cleared wearable devices, to create a personalized baseline index that could indicate a change in health status for patients who have tested COVID-19 positive. The project involved the development and validation of a COVID-19 Decompensation Index (CDI) that was built off physIQ's existing wearable biosensor-derived analytics platform. Data were collected from 1,000 (400 Phase I and 600 Phase II) human subjects that were both pre-hospitalization subjects (found to be positive for COVID-19) and subjects that had been hospitalized and treated for COVID and then discharged. This combined population consisted of COVID-19 decompensation cases (defined as ≥ 3 on the WHO COVID-19 Ordinal Scale) and cases for which COVID-19 did not result in any kind of decompensation. The Phase I data were utilized for training of a CDI algorithm while Phase II data was utilized as a validation dataset. Performance was assessed using receiver operator characteristics (ROC) area under the curve (AUC) as the metric of performance." .
<https://okn.wobd.org/dataset/radx_data_hub/radx_130> <http://schema.org/sameAs> "10.60773/77xd-fh20" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_136> <http://schema.org/dateCreated> "2022-01-29"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_72> <http://schema.org/name> "A Confectionary-Based Screening Tool for Assessing Chemosensory Loss in COVID-19 Patients" .
<https://okn.wobd.org/grant/1R01AI088364-01> <http://schema.org/name> "Mendelian genetic predisposition to herpes simplex encephalitis in childhood" .
<https://okn.wobd.org/grant/3T32GM083937-01A1S1> <http://schema.org/name> "Tri-Institutional Training Program in Computational Biology & Medicine" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_60> <http://schema.org/funding> <https://okn.wobd.org/grant/4UH3AI122309-03> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_156> <http://schema.org/date> "2024-04-17"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/grant/4R33HD105590-03> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/MonetaryGrant> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_126> <http://schema.org/funding> <https://okn.wobd.org/grant/3P50HD103525-01S1> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_147> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0004992> .
<https://okn.wobd.org/person/university_of_illinois_urbana_champaign> <http://schema.org/name> "University of Illinois Urbana Champaign" .
<https://ror.org/00baak391> <http://schema.org/alternateName> "NIH/National Human Genome Research Institute" .
<https://okn.wobd.org/dataset/radx_data_hub/radx_274> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_49> <http://schema.org/healthCondition> <http://purl.obolibrary.org/obo/MONDO_0100096> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_69> <http://www.w3.org/2002/07/owl#sameAs> <https://doi.org/10.60773/dnv2-mx89> .
<https://okn.wobd.org/grant/1R01DA013806-01> <http://schema.org/funder> <https://ror.org/00fq5cm18> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_211> <http://schema.org/funding> <https://okn.wobd.org/grant/1P30MH062246-01> .
<http://purl.obolibrary.org/obo/NCIT_C50873> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/DefinedTerm> .
<https://okn.wobd.org/grant/5T32GM007618-08> <http://schema.org/funder> <https://ror.org/04q48ey07> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_58> <http://schema.org/funding> <https://okn.wobd.org/grant/5T32HL007227-10> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_68> <http://schema.org/dateCreated> "2021-11-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_132> <http://schema.org/dateCreated> "2022-01-15"^^<http://www.w3.org/2001/XMLSchema#date> .
<https://okn.wobd.org/dataset/radx_data_hub/radx_31> <http://schema.org/includedInDataCatalog> <https://okn.wobd.org/catalog/radx_data_hub> .
<https://okn.wobd.org/grant/3OT2HL156812-01S2> <http://schema.org/name> "ACTIV Integration of Host-targeting Therapies for COVID-19 Administrative Coordinating Center" .
